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Preface	  
Four	   years	   have	   passed	   since	   I	   started	   my	   PhD.	   During	  these	   years	   numerous	   people	   have	   helped	   and	   inspired	  me	  to	  successfully	  reach	   the	  end.	   	  Therefore	   I	  would	   like	  to	  thank	  some	  of	  the	  closest	  involved.	  	  	  First	  of	  all,	  my	  gratitude	  goes	  out	  to	  my	  promotor	  Jeroen	  for	  giving	  me	  the	  chance	  to	  deploy	  my	  scientific	  creativity.	  As	  I	  started	  my	  PhD,	  the	  both	  of	  us	  did	  not	  now	  where	  this	  PhD	  would	  start	   let	  alone	  where	  it	  would	  end.	  I	  think	  we	  both	  would	  have	  signed	  immediately	  for	  this	  result.	  Collaborations	   allowed	   me	   to	   apply	   the	   biosensing	  concepts	   to	   many	   biological	   relevant	   topics.	   Therefore	   I	  have	   to	   thank	  Nick,	  Wim	  and	  Prof.	  Deckmyn	   for	  bringing	  me	   in	   contact	   with	   their	   bacteriophages.	   Priscilla	   and	  Louise	   supported	   me	   with	   the	   bacterial	   work	   on	   L.	  
Pneumophila.	   Thank	   you	   very	   much	   for	   all	   the	   support	  and	  ideas.	  	  Another	   indispensable	   factor	   were	   my	   colleagues.	   All	  those	  great	  moments	  when	  we	  shared	  luck,	  joy,	  ideas	  that	  possibly	   could	   lead	   to	   a	   Nobel	   Prize,	   anger,	   and	  disappointment.	   Especially	   the	   desk	   buddies	   being	   Bert,	  Daan,	  Nicolas,	  Kris	  and	  Filip.	  But	  also	  all	  other	  colleagues	  among	  which	  Jeroen,	  Dinh,	  Federica,	  Elena,	  Karen,	  Steven,	  Phalghuni,	   Iulia,	   Evgeny,	   Jiadi	   …	   Some	   of	   you	   guys	   even	  have	  written	  articles	  with	  me,	  which	  was	  not	   always	   the	  easiest	  process,	  therefore	  Kris	  and	  Dragana,	  thank	  you	  for	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engaging	   yourself	   fully	   in	   the	   brainstorming	   and	  writing	  of	  all	  my	  articles.	  	  During	   these	   four	  years	  3	   thesis	   students	  helped	  me	  out,	  Deborah,	  Jeroen	  and	  Bjorn,	  you	  were	  great!	  Daarnaast	   wil	   ik	   hier	   ook	   mijn	   vrienden	   bedanken,	   die	  altijd	  klaar	  stonden	  voor	  de	  meer	  serieuze	  zaken	  van	  deze	  wereld.	   Willem,	   Ruben,	   Dries2,	   Jakke,	   Wouter,	   Evert,	  Anneleen,	  	  merci	  voor	  het	  feestgedruis!	  	  Maar	   de	   meeste	   steun	   heb	   ik	   gedurende	   mijn	   gehele	  studie	   periode	   gekregen	   van	   mijn	   ouders.	   Beste	   ouders,	  dit	   doctoraat	   is	   in	   grote	   mate	   jullie	   verdienste,	   bedankt	  om	   altijd	   in	  mij	   te	   geloven.	   Daarnaast	   kan	   ik	  mijn	   broer	  Filip	  en	  zijn	  vriendin	  Astrid,	  natuurlijk	  niet	  vergeten.	  Filip,	  ik	  ben	  eindelijk	  klaar	  voor	  de	  vele	  vragen	  die	  je	  mij	  altijd	  al	  wou	  stellen	  over	  de	  ‘neogenetic	  recombinator’.	  Dan	  rest	  er	  mij	  nog	  1	  iemand	  om	  te	  bedanken.	  Evelien,	  je	  was	  er	  bij	  mijn	  eerste	  succesjes	  bij,	  je	  was	  er	  in	  Mexico	  bij,	  maar	   je	   was	   er	   vooral	   toen	   we	   midden	   in	   de	   nacht	   de	  laatste	   verbeteringen	   aan	   dit	   doctoraat	   waren	   aan	   het	  aanbrengen.	   Je	   bent	   de	   beste,	   dat	  we	  nog	   vele	   successen	  samen	  mogen	  bereiken.	  	  	  	   Karel	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Abstract	  
In	   food	  quality,	   healthcare	   and	  biotechnology	   the	   presence	   of	   bacteria	  and	   viruses	   can	   have	   considerable	   consequences	   both	   willing	   and	  unwilling.	  Accurate	  identification	  and	  quantification	  of	  the	  bacteria	  and	  virusses	   is	   key	   in	   this	   context.	   Currently,	   there	   are	   only	   a	   limited	  number	  of	  truly	  fast	  and	  reliable	  methods	  available.	  Sensitive	  diagnostic	  tests	  could	  have	  a	   large	   impact	  on	  several	   crucial	  healthcare	  problems	  such	   as	   antibiotic	   resistance	   or	   could	   further	   improve	   food	   quality	  control.	  Therefore	  the	  aim	  of	  this	  disseration	  was	  to	  develop	  innovative,	  fast	   and	   highly	   sensitive	   bioassays	   on	   a	   compact	   fiber	   optic	   SPR	  biosensor	  platform	  (FO-­‐SPR),	   that	  can	  be	  used	  to	   identify	  and	  quantify	  bacteria	  and	  viruses	  in	  a	  multiplexed	  way.	  	  First,	   the	  FO-­‐SPR	  sensor	  was	  used	  to	  study	  the	  affinity	  and	  binding	  kinetics	   of	   small	   viral	   particles.	   These	   so-­‐called	   bacteriophages,	   can	  display	   peptide	   libraries	   with	   affinity	   for	   almost	   any	   target	   molecule.	  The	  target	  molecule,	  in	  this	  case	  eGFP,	  was	  immobilized	  on	  the	  FO-­‐SPR	  biosensor	  surface	  and	  afterwards	  exposed	  to	  the	  bacteriophage	  library,	  allowing	   real-­‐time	   monitoring	   of	   their	   interactions.	   Although	   the	  bioassay	   based	   on	   the	   detection	   of	   the	   entire	   viruses	   showed	   limited	  sensitivity,	  it	  proved	  to	  be	  a	  valuable	  tool	  for	  comparing	  binding	  kinetics	  of	  different	  viral	  particles,	  which	  expressed	  affinity	  peptides	  in	  different	  densities	  on	  the	  surface.	  	  Following,	   keeping	   in	   mind	   the	   need	   for	   both	   detecting	   and	  identifying	   pathogens	  within	   the	   same	   test,	   a	  more	   universal	   bioassay	  was	  created	  using	  the	  genetic	  material	  of	  micro-­‐organisms.	  The	  thermal	  denaturation	   of	   DNA	   complexes	   was	   measured	   using	   the	   FO-­‐SPR	  technology.	  Here,	  the	  target	  DNA	  was	  used	  to	  form	  complexes	  between	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two	  hybridization	  probes,	  each	  complementary	  to	  one	  half	  of	  the	  target	  molecule	  and	  immobilized	  both	  on	  the	  gold	  nanoparticles	  (Au	  NPs)	  and	  the	  sensor	  surface.	  Amplification	  with	  gold	  nanoparticle	  labels	  resulted	  in	   a	   clear	   signal,	   which	   superimposed	   the	   SPR	   signal	   caused	   by	  temperature	  changes	  during	  DNA	  melting	  analysis.	  	  This	   assay	   was	   then	   validated	   by	   measuring	   genetic	   variability	   in	  two	   genes	   of	   L.	   pneumophila,	   which	   is	   a	   common	   human	   pathogen	  responsible	   for	   atypical	   pneumonia.	   Although	   the	   two	   selected	   genes	  are	  frequently	  used	  for	  the	  quantification	  of	  these	  bacteria,	  one	  of	  them	  is	   well	   documented	   as	   highly	   variable	   and	   therefore	   prone	   to	  introducing	  amplification	  bias	   in	  PCR	  based	  molecular	  diagnostic	   tests.	  The	  FO-­‐SPR	  biosensor	  proved	   to	  be	  reliable	   for	  detecting	  mutations	   in	  those	  samples	  that	  previously	  displayed	  ambiguous	  qPCR	  quantification	  results.	  Moreover,	   it	   showed	   advantages	   as	   a	   high	   resolution	   and	   fast	  genetic	   screening	   tool	   that	   can	   compete	   with	   the	   current	   standard	  techniques	  for	  single	  point	  mutation	  (SNP)	  detection.	  Next,	   the	  possibilities	  of	   the	  FO-­‐SPR	  DNA	  biosensor	  were	  explored	  for	   target	  quantification.	  The	  FO-­‐SPR	  biosensor	  was	  able	   to	  monitor	   in	  real-­‐time	   quantitative	   ligation.	   The	   gradual	   increase	   in	   signal	   over	  multiple	  DNA	  ligation	  cycles	  was	  used	  to	  determine	  DNA	  concentrations	  in	  a	  broad	  dynamic	   range	  with	  a	  detection	   limit	  of	  100	   fM.	  Even	  more	  importantly,	  the	  obtained	  melting	  signal	  during	  each	  cycle	  of	  the	  ligation	  was	  sufficiently	  accurate	  to	  discriminate	  an	  SNP	  in	  the	  amplified	  target	  molecule.	  	  Finally,	  the	  FO-­‐SPR	  melting	  assay	  was	  applied	  to	  directly	  detect	  two	  bacterial	  species	  in	  one	  sample.	  To	  allow	  multiplex	  detection	  on	  FO-­‐SPR,	  hybridization	   probes	   complementary	   to	   two	   regions	   of	   interest	   in	  different	  bacteria	  were	   immobilized	  on	  a	  single	  FO-­‐SPR	  sensor	  and	  Au	  NPs.	  By	  choosing	  target	  regions	  with	  non-­‐overlapping	  melting	  curves	  in	  each	   bacteria,	   the	   presence	   of	   one	   or	   both	   bacteria	   could	   easily	   be	  identified.	  Even	  DNA	  targets	  with	  SNPs	  could	  be	  differentiated	  from	  the	  wild	  type	  targets.	   	  This	  achievement	  is	  a	  significant	  step	  towards	  a	  FO-­‐SPR	   biosensor	   for	   pathogenic	   bacteria.	   Further	   development	   of	   this	  platform	   concerning	   both	   the	   FO-­‐SPR	   biosensor	   hardware	   and	   the	  implemented	  bioassays	   could	  make	   this	   technology	   an	   ideal	   candidate	  for	  the	  next	  generation	  point	  of	  care	  biosensors.	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Bacteriën	  en	  virussen	  spelen	  een	  cruciale	  rol	  in	  de	  voedselveiligheid,	  de	  gezondheidszorg	  en	  de	  biotechnologische	  industrie.	  Deze	  rol	  kan	  zowel	  gewenst	  als	  ongewenst	  zijn.	  In	  beide	  gevallen	  is	  het	  belangrijk	  om	  over	  snelle	   meettechnieken	   te	   beschikken	   om	   de	   virale	   en	   bacteriële	  aanwezigheid	  nauwkeurig	   te	  bepalen.	  Tot	  op	  heden	  bestaan	  er	   slechts	  	  een	   beperkt	   aantal	   snelle	   en	   betrouwbare	   methodes	   om	   dit	   te	   doen.	  Nochtans	   kunnen	   dergelijke	   testen	   een	   grote	   impact	   hebben	   op	  problemen	   in	   de	   gezondheidszorg	   zoals	   antibioticaresistentie,	   of	   een	  verdere	  vooruitgang	  betekenen	  in	  de	  context	  van	  voedselveiligheid.	  	  Het	  doel	   van	   deze	   doctoraatsthesis	   was	   om	   een	   innovatieve	   biosensor	   te	  onwikkelen	  die	  toelaat	  om	  snel	  en	  betrouwbaar	  virussen	  en	  bacteriën	  te	  identificeren	  en	  te	  detecteren.	  Hierbij	  wordt	  gebruikt	  gemaakt	  van	  een	  detectieplatform	  gebaseerd	  op	  optische	  vezeltechnologie	  en	  het	  concept	  van	  oppervlakte	  plasmon	  resonantie	  (FO-­‐SPR).	  	  In	   een	   eerste	   deel	   werd	   een	   FO-­‐SPR	   biosensor	   ontwikkeld	   om	   de	  affiniteit	  en	  bindingskinetiek	  van	  kleine	  virale	  partikels	  te	  bepalen.	  Deze	  virale	  partikels,	  bacteriofagen	  genoemd,	  kunnen	  peptidebibliotheken	  tot	  expressie	   brengen	  met	   een	   affiniteit	   voor	   bijna	   eender	  welk	  molecule.	  Het	   doelmolecule,	   in	   dit	   geval	   eGFP	   werd	   op	   het	   FO-­‐SPR	   biosensor	  oppervlak	   geïmmobiliseerd	   en	   vervolgens	   blootgesteld	   aan	   de	  bacteriofaagbibliotheek,	  wat	  toeliet	  om	  de	  interacties	  rechtstreeks	  op	  te	  volgen.	   Hoewel	   deze	   biologische	   test,	   gebasseerd	   op	   detectie	   van	  volledige	  virale	  partikels,	  een	  beperkte	  gevoeligheid	  vertoonde,	  was	  het	  toch	   een	   waardevol	   hulpmiddel	   voor	   het	   vergelijken	   van	  bindingskinetieken	   van	   verschillende	   virale	   partikels	   die	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affiniteitspeptiden	   tot	   expressie	   brengen	   met	   een	   verschillende	  densiteit.	  Daaropvolgend,	   in	   een	   tweede	   deel,	   werd	   een	   meer	   universele	  biologische	   test	   ontwikkeld	   voor	   de	   gelijktijdige	   identificatie	   en	  kwantificering	   van	   bacteriën	   gebaseerd	   op	   de	   detectie	   van	   het	  genetische	   materiaal	   van	   de	   micro-­‐organismen.	   De	   thermische	  denaturatie	  van	  DNA	  complexen	  werd	  gemeten	  met	  behulp	  van	  de	  FO-­‐SPR	  technologie.	  Hierbij	  werd	  het	  doelwit	  DNA	  gebruikt	  om	  complexen	  te	   vormen	   tussen	   twee	   hybridizatieprobes,	   die	   elk	   complementair	   zijn	  aan	   een	   helft	   van	   het	   doelwitmolecule	   en	   geïmmobiliseerd	  werden	   op	  de	  gouden	  nanopartikels	  en	  op	  het	  sensoroppervlak.	  Singaalversterking	  met	   gouden	   nanopartikels	   resulteerde	   in	   een	   duidelijk	   signaal,	   dat	  sterker	   was	   dan	   het	   signaal	   veroorzaakt	   door	   de	  temperatuursverandering	   die	   gepaard	   gaat	   met	   het	   smelten	   van	   het	  DNA.	  	  	  In	   een	   derde	   hoofdstuk	   werd	   deze	   test	   gevalideerd	   via	   het	  meten	  van	  de	   genetische	   variabiliteit	   in	   twee	   genen	   van	  L.	  pneumophilia,	   een	  vaak	   voorkomende	   humane	   pathogeen	   die	   verantwoordelijk	   is	   voor	  atypische	   longontstekingen.	   	   Hoewel	   de	   geselecteerde	   genen	   vaak	  gebruikt	  worden	  voor	  kwantificering	  van	  deze	  bacterie,	  is	  één	  van	  beide	  toch	   zeer	   variabel	   en	   dus	   voorbestemd	   om	   amplificatiefouten	   te	  veroorzaken	   in	   PCR	   gebaseerde	   moleculaire	   diagnostische	   testen.	   Er	  werd	  hier	   aangetoond	  dat	   de	   FO-­‐SPR	   sensor	   een	   snel	   en	   betrouwbaar	  alternatief	   biedt	   voor	   de	   huidige	   standaardtechnieken	  met	   betrekking	  tot	  de	  detectie	  van	  puntmutaties	  in	  DNA.	  	  Vervolgens	  werden	  de	  mogelijkheden	  van	  de	  FO-­‐SPR	  DNA	  biosensor	  onderzocht	  voor	  wat	  betreft	  kwantificering	  van	  een	  doelwit.	  De	  FO-­‐SPR	  biosensor	  was	   in	  staat	  om	  kwantitatieve	   ligatie	   rechstreeks	   in	  kaart	   te	  brengen.	  	  De	  graduele	  toename	  van	  het	  signaal	  na	  verschillende	  ligatie-­‐cycli	  werd	  gebruikt	  om	  de	  DNA	  concentratie	  te	  bepalen	  met	  een	  breed	  dynamisch	  bereik	  en	  een	  detectielimiet	  van	  100	  fM.	  Bovendien	  was	  het	  smeltsignaal	   tijdens	   elke	   cyclus	   voldoende	   nauwkeurig	   om	   een	  puntmutatie	  in	  het	  doelmolecule	  te	  onderscheiden.	  	  	  Tot	   slot	   werd	   de	   FO-­‐SPR	   smelttest	   toegepast	   op	   2	   verschillende	  bacteriën	   in	   1	   staal.	   Om	   meervoudige	   detectie	   te	   realiseren,	   werden	  hybridizatieprobes,	   die	   complementair	   zijn	   aan	   twee	   geschikte	   regio’s	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van	   het	   DNA	   van	   de	   verschillende	   bacteriën,	   geïmmobiliseerd	   op	   één	  sensor	  en	  op	  Au	  NP’s.	  Door	  doelregio’s	  te	  kiezen	  met	  niet-­‐overlappende	  smeltcurves	   	  voor	  elke	  bacterie,	  kon	  de	  aanwezigheid	  van	  één	  of	  beide	  bacteriën	   gemakkelijk	   bepaald	   worden.	   Zelfs	   DNA	   doelwitten	   met	  puntmutaties	   kunnen	   gemakkelijk	   onderscheiden	   worden	   van	   het	  oorspronkelijke	  doelwit.	  	  Deze	  verwezenlijking	  is	  een	  belangrijke	  stap	  in	  de	  richting	  van	  een	  FO-­‐SPR	  biosensor	  voor	  pathogene	  bacteriën.	  	  In	  dit	  werk	  werd	  het	  potentieel	  van	  de	  FO-­‐SPR	  technologie	  voor	  de	  identificatie	   en	   kwantificering	   van	   bacteriën	   en	   virussen	   succesvol	  aangetoond.	   Een	   verdere	   ontwikkeling	   van	   dit	   diagnostisch	  meetplatform,	  zowel	  wat	  betreft	  de	  hardware	  als	  de	  geïmplementeerde	  biologische	   tests,	   is	   nodig	   om	   de	   stap	   naar	   de	   diagnostische	  markt	   te	  kunnen	  zetten.	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Chapter	  1 	  	  
General	  introduction	  The	  discovery	  of	  bacteria	  and	  viruses	   in	   the	  17th	  and	   late	  19th	  century,	  respectively,	  has	  been	  ever	  since	  a	  catalyst	  for	  the	  evolution	  of	  modern-­‐day	   medicine,	   food	   production,	   biotechnology	   and	   many	   other	   fields.	  However,	   the	  detection	  of	   these	  organisms	  has	  never	  been	   easy.	   Since	  the	   introduction	  of	  bacterial	  colony	   identification,	  only	   limited	  number	  of	   truly	   fast	   and	   reliable	   methods	   for	   bacterial	   detection	   have	   been	  developed.	  Nonetheless,	   there	   is	   a	   great	  need	   for	   such	   tools,	  mainly	   in	  medicine,	   to	   prevent	   overuse	   of	   antibiotics,	   but	   also	   for	   further	  improvement	  of	  food	  quality	  control	  or	  for	  environmental	  monitoring.	  	  The	  aim	  of	   this	  chapter	   is	   to	  give	  the	  reader	  an	   introduction	  to	  the	  different	  aspects,	  used	  in	  the	  framework	  of	  this	  thesis,	  for	  developing	  in	  
vitro	  diagnostic	  tools	  for	  detecting	  bacteria	  and	  viruses.	  First,	  a	  concise	  	  overview	  of	  diagnostic	  applications	  and	  their	  specific	  needs	  is	  provided,	  then	  the	  field	  of	  biosensors	  and	  their	  current	  strengths	  and	  limitations	  are	  discussed,	   followed	  by	  a	  more	  detailed	   introduction	   into	  a	   specific	  biosensing	   technique	   for	  DNA,	  DNA	  melting	   analysis.	   Next	   the	   Surface	  Plasmon	  Resonance	   (SPR)	   technology	   is	   introduced	   and	   its	   fiber-­‐optic	  implementation	  which	  will	  be	  used	  to	  create	  a	  new	  biosensing	  platform	  in	   combination	  with	  DNA	  melting	   analysis.	   Finally	   a	   brief	   overview	   of	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gold	   nanoparticle	   labels	   and	   surface	   functionalization	   strategies	   is	  given.	  To	  conclude,	  in	  the	  last	  section	  of	  this	  chapter,	  a	  clear	  scheme	  of	  the	  objectives	  and	  the	  outline	  of	  the	  complete	  manuscript	  is	  given.	  
1.1 Diagnostics	  ‘Medical	   diagnosis’	   is	   defined	   according	   to	   the	   Longman	   English	  dictionary	   as:	   ‘the	   process	   of	   discovering	   exactly	   what	   is	   wrong	   with	  
someone	   or	   something,	   by	   examining	   them	   closely’.	   However,	   merely	  examining	   is	   in	  most	   cases	   not	   enough	   to	   identify	   a	  medical	   problem.	  Therefore,	   various	   diagnostic	   tests	   have	   been	   and	   are	   still	   being	  developed	  as	   a	   crucial	   tool	   for	   caretakers	   to	  make	  a	   correct	  diagnosis.	  Diagnostic	  tests	  exist	  in	  all	  sorts	  and	  range	  -­‐	  from	  a	  simple	  predictor	  test	  for	   pregnancy	   to	   complex	   histopathology	   analysis	   of	   tissue	   to	   confirm	  presence	  of	  cancer	  during	  an	  actual	  operation.	  Unfortunately,	  quick	  and	  easy	   diagnostic	   tests	   are	   not	   available	   for	   every	   disease,	   especially	  lacking	   for	   confirming	   presence	   or	   absence	   of	   viral	   and	   bacterial	  pathogens.	  At	  the	  moment,	  their	  occurrence	  can	  only	  be	  measured	  in	  a	  specialized	  clinical	  laboratory	  environment	  as	  a	  result	  of	  rather	  complex	  assays,	   requiring	   days	   to	   weeks	   for	   positive	   identification.	   Therefore,	  practitioners	   often	   start	   with	   a	   non-­‐specific	   treatment	   using	   broad-­‐spectrum	   antibiotic	   agents,	  which	   are	   active	   against	  multiple	   bacteria.	  Although	  in	  the	  beginning	  this	  strategy	  was	  proven	  to	  be	  successful	  for	  patients	   treatment,	   it	   has	   boosted	   the	   antibiotic	   resistance	   in	   bacteria	  leading	  to	  the	  appearance	  of	  so	  called	  ‘super’	  bacteria,	  which	  can	  hardly	  be	   treated	   with	   any	   of	   the	   existing	   antibiotics1.	   Fast	   diagnostic	   tests,	  applicable	   at	   the	   POC	   could	   thereby	   become	   a	   valuable	   tool	   in	   the	  prevention	  of	  a	  further	  aggravation	  of	  antibiotic	  resistance.2	  	  In	   recent	   years,	   so	   called	   POC	   diagnostics	   have	   seen	   a	   rapid	  evolution,	   mainly	   spurred	   by	   a	   new	   approach	   in	   treating	   patients,	  known	  as	  personalized	  medicine.	  The	  idea	  originated	  from	  findings	  that	  substantially	   different	   genetic	   makeup	   exists	   in	   a	   patient	   population,	  requiring	   thus	   different	   treatments	   for	   patients	   with	   similar	   disease	  patterns3.	   This	   discovery	   made	   both	   medical	   research	   and	  pharmaceutical	   industry	   change	   their	   approach	   in	  medical	   treatments	  towards	   a	   tailor-­‐made	   therapy	   for	   each	   patient.	   Famous	   examples	   of	  personalized	   medicine	   are	   mostly	   found	   in	   oncology.	   For	   instance,	  
Biosensors	  
3	  
although	   only	   20	   percent	   of	   breast	   cancer	   cases	   occur	   due	   to	   the	  mutations	   in	   BRCA	   gene,	   these	   mutations	   raise	   a	   hereditary	   risk	   for	  breast	  cancer	   to	  almost	  80	  percent,	   justifying	  a	  mastectomy	   in	  women	  carrying	   these	   mutations	   as	   a	   preventive	   step4.	   Another	   example	   is	  overexpression	  of	  the	  HER-­‐2	  receptor	  occurring	  in	  30	  percent	  of	  breast	  cancer	   patients,	   which	   are	   recognized	   as	   susceptible	   to	   the	   treatment	  with	  drug	  Herceptin5,6.	  As	   a	   result,	   personalized	  medicine	  has	  boosted	  developments	  in	  molecular	  diagnostics	  towards	  POC	  sensors,	  which	  are	  not	  exclusively	  applicable	   for	  cancer	  screening	  but	  can	  also	  be	  applied	  in	  other	  medical	   fields	   such	  as	  antibiotic	   susceptibility	   in	   the	  case	  of	  a	  bacterial	   infection7.	   When	   bacterial	   resistance	   genes	   are	   found	   in	   a	  patient	   sample,	   the	   antibiotic	   treatment	   can	  be	   adopted	   to	   circumvent	  resistance,	  leading	  to	  the	  improvement	  of	  patient	  outcome8.	  	  Although	   personalized	   medicine	   has	   a	   great	   potential	   to	   improve	  present	   day	   patients	   treatments,	   only	   a	   handful	   of	   personalized	  medicine	  tests	  have	  been	  adopted	  in	  the	  clinic	  so	  far.	  Several	  factors	  are	  limiting	  the	  introduction	  of	  this	  new	  approach	  to	  medicine:	  -­‐ Scientific	  challenges	  –	  unknown	  markers,	  poor	  understanding	  of	  molecular	  mechanisms	  -­‐ Economic	  challenges	  –	  poor	  incentives	  -­‐ Operational	  issues	  –	  privacy	  concerns,	  data	  management.	  From	   these	   three	   challenges,	   the	  economic	   challenge	   is	   considered	  to	  be	  the	  most	  troublesome	  for	  POC	  tests,	  as	  personalized	  medicine	  can	  be	   a	   great	   creator	   of	   cost8,9.	   However,	   recently	   pharmaceutical	  companies	  started	  to	  use	  diagnostics	  as	  a	  screening/monitoring	  tool	  in	  the	  development	  process	  of	  new	  drugs.	  This	  new	  type	  of	  diagnostics	   is	  called	  companion	  diagnostics,	   as	   the	  diagnostic	   test	   and	  biomarker	   are	  used	  as	  an	  aid,	  not	  only	  during	  drug	  development	  but	  also	  in	  the	  follow	  up	   phase	   to	   prove	   drug	   efficacy	   and	   to	   optimize	   drug	   dosage	   for	  individual	   patients10.	   Furthermore,	   these	   companion	   diagnostics	   could	  cut	   costs	   in	   drug	   development	   by	   reducing	   clinical	   trial	   sizes	   and	  decrease	   the	   time	   to	   market.	   Not	   every	   companion	   diagnostics	   is	  economically	   or	   technologically	   achievable9.	   This	   is	   dependent	   on	   the	  disease	  area,	  as	  can	  be	  seen	   in	  Figure	  1.1:	  oncology	  and	  anti-­‐infectives	  are	   fields,	  which	  are	   interesting	   targets	   for	  development	  of	  companion	  diagnostics,	   as	   they	   are	  both	   scientifically	   and	   economically	   attractive.	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Therefore,	   taking	   into	   account	   the	   impact	   fast	   diagnostic	   tests	   could	  have	   in	   solving	   the	   problem	   of	   multiresistant	   ‘super’	   bacteria	   by	   (1)	  steering	   the	  administration	  of	  existing	  antibiotics	  and	  (2)	  reducing	   the	  cost	  of	  clinical	  trials	  for	  the	  development	  of	  new	  antibiotics,	  the	  focus	  of	  this	   manuscript	   is	   on	   developing	   fast	   molecular	   detection	   assays	   for	  bacteria	   and	  viruses	   that	   could	  be	   integrated	   in	   those	  diagnostic	   tests.	  The	   resulting	   diagnostic	   test	   will	   not	   only	   be	   of	   value	   for	   medical	  diagnostics	  but	  could	  also	  be	  used	  as	  a	  monitoring	  tool	  for	  food	  quality	  both	   at	   production	   facility	   and	   along	   the	   distribution	   chain.	   Here	   the	  convenience	   and	   speed	   of	   a	   POC	   test	   could	   drastically	   improve	   the	  response	   time	   in	   case	   of	   contamination	   both	   reducing	   the	   losses	   in	  production	   and	   preventing	   possible	   safety	   hazards11.	   Finally	   in	  environmental	   monitoring,	   similar	   tools	   could	   improve	   follow	   up	   of	  changes	   in	  environmental	  bacterial	  and	  viral	  populations.	  Especially	   in	  the	  light	  of	  monitoring	  the	  effect	  of	  climate	  changes	  but	  also	  to	  asses	  the	  impact	  of	  increasing	  amounts	  of	  antibiotic	  residues	  in	  the	  environment,	  new	  sensitive	  molecular	  tools	  are	  in	  urgent	  need12-­‐15.	  
	  
Figure	   1.1:	   Scientific	   potential	   and	   economic	   attractiveness	   of	   companion	  
diagnostics	   across	   different	   fields	   in	   medicine.	   The	   scaling	   on	   the	   x	   and	   y	   axis	  
represent	  respectively	  the	  scientific	  potential	  and	  economic	  attractiveness	  of	  the	  
development	   of	   companion	   diagnostics	   in	   various	   therapeutic	   areas	   and	   are	  
based	   on	   both	   qualitative	   factors	   (such	   as	   expert	   interviews)	   and	   quantitative	  
factors	   (such	   as	   data	   on	   price	   premiums	   for	   drugs	   launched	   in	   the	   same	  
therapeutic	  class).	  (According	  to	  Davis	  et	  al.9)	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1.2 Biosensors	  Biosensors	   are	   a	   particular	   class	   of	   analytical	   instruments	   used	   in	  diagnostics,	  which	  are	  distinguished	  by	  the	  incorporation	  of	  a	  biological	  sensing	   element16.	   As	   a	   result,	   every	   biosensor	   is	   composed	   of	   	   two	  major	   elements,	   a	   biorecognition	   and	   a	   transducing	   element17.	  Biorecognition	  elements	  are	   responsible	   for	   the	   specific	   recognition	  of	  the	  target	  analyte	  and	  mainly	  consist	  of	  antibodies	  and	  DNA,	  although	  in	  recent	  years	  new	  types	  have	  been	  developed,	  such	  as	  aptamers,	  affinity	  peptides,	  molecular	   imprinted	  polymers,	  antibody	  mimetics,	  etc.16	  This	  specific	  sensing	  of	  the	  biorecognition	  element	  is	  further	  translated	  into	  a	  measurable	  signal	  by	  transducers,	  which	  can	  be	  divided	  in	  four	  main	  categories	   according	   to	   the	   generated	   signal:	   electrochemical,	   optical,	  calorimetric	   and	   acoustic	   transducers18.	   Electrochemical	   and	   optical	  transducers	   are	   by	   far	   the	   most	   popular	   biosensor	   transducers,	   with	  electrochemical	  biosensors	  being	  mostly	  applied	  in	  commercial	  devices	  due	   to	   their	   ease	   of	   use,	   miniaturization	   possibilities	   and	   cost	   of	  production19.	  Development	   of	   biosensors	   achieved	   a	   breakthrough	   in	   the	   60’s	  with	   the	   creation	   of	   the	   glucose	   sensor.	   This	   sensor	   was	   a	   big	   step	  forward	   in	  the	  treatment	  of	  diabetes,	  resulting	   in	  an	   increased	   lifetime	  and	   improved	   quality	   of	   life	   for	   diabetes	   patients20.	   Even	   today,	   the	  glucose	   sensor	   remains	   the	   most	   sold	   biosensor16.	   However,	   despite	  this,	  the	  classic	  biosensor	  blueprint	  seen	  in	  the	  glucose	  sensor21	  (shown	  in	   Figure	   1.2A)	   is	   no	   longer	   applicable	   for	   the	   next	   generation	  biosensors,	   such	  as	   the	  bacterial	  and	  viral	  POC	   tests.	  These	  biosensors	  require	   the	   integration	   of	   complex	   molecular	   assays	   and	   sample	  preparation	  steps	  (Figure	  1.2B),	  with	  the	   latter	  emerging	  as	  one	  of	   the	  most	  crucial	  aspects	  of	   the	  assay.	  The	   ideal	   sample	  preparation	  allows	  using	  the	  assay	  on	  multiple	  sample	  matrices	  (e.g.,	  sputum,	  tissue,	  faeces,	  blood)	   and	   prevents	   the	   dissemination	   of	   sample	  matrix	   inhibitors	   to	  downstream	  DNA	  analysis22.	  Another	  added	  complexity	  lies	  in	  the	  actual	  transducer,	   as	   molecular	   diagnostics	   support	   detection	   of	   multiple	  targets	  in	  one	  sample.	  Finally,	  management	  of	  the	  obtained	  test	  results	  and	  their	  distribution	  introduces	  new	  concepts,	  such	  as	  remote	  patient	  monitoring,	  which	  can	  further	  increase	  patient	  quality	  of	  life23.	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Figure	  1.2:	  A)	  Overview	  of	  the	  working	  principal	  of	  a	  classic	  glucose	  sensor,	  from	  
sample	  to	  result.	  (Bayer	  glucose	  biosensor)	  B)	  Overview	  of	  the	  working	  principal	  
of	  a	  next	  generation	  POC	  biosensor,	  from	  sample	  to	  result.	  (Picture:	  Biocartis	  POC	  
biosensor)	  Sample	   preparation	   methods	   have	   been	   succesfully	   developed,	  which	   allow	   automated	   extraction	   of	   DNA	   from	   complex	   sample	  matrices	  ranging	  from	  sputum,	  to	  blood,	  to	  even	  stool.	  These	  techniques	  have	   been	   integrated	   in	   POC	   biosensors	   which	   are	   currently	   being	  commercialized24.	   The	   technologies	   are	   often	   based	   on	   lab-­‐on-­‐a-­‐chip	  (LOC)	   systems	   that	   either	   used	   micro-­‐fabricated	   structures,	   silica	  membranes,	   magenetic	   nano-­‐	   or	   microparticles	   or	   a	   combination	  thereof.	  These	   techniques	  have	  enabled	  extraction	  of	  high	  quality	  DNA	  and	   other	   biomarkers	   that	   can	   be	   used	   for	   downstream	   analysis22.	  Nonetheless	   further	   improvements	   in	   sample	  prep	   for	  POC	  biosensors	  are	   necessary,	   especially	   regarding	   the	   cost	   and	   complexity	   of	   these	  systems,	   another	   essential	   problem	   preventing	   next	   generation	   POC	  biosensors	   from	   making	   molecular	   diagnostics	   available	   outside	  specialized	   labs,	   lies	   in	   the	   classic	  principals	  used	   for	   target	  detection,	  such	   as	   fluorescence7,8,25.	   However,	   new	   technologies	   are	   being	  exploited	   to	   enable	   development	   of	   biosensors	   with	   potentially	   lower	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costs,	   short	   time	   to	   result	   and	   minimal	   interpretation	   whilst	   still	  reaching	   the	  required	  detection	   limits8.	  One	  of	   these	   technologies	  with	  great	  potential	  to	  fulfill	  the	  mentioned	  criteria	  is	  DNA	  melting	  analysis.
1.3 DNA	  melting	  DNA	   is	   considered	   to	   be	   the	   blueprint	   of	   life	   and	   is	   therefore	   a	   very	  interesting	  target	  molecule	  in	  diagnostics,	  particularly	  for	  the	  detection	  of	   bacteria	   and	   viruses	   where	   a	   short	   sequence	   of	   DNA	   carries	   much	  more	   information	   on	   the	   type	   of	   these	   organisms	   than	   any	   protein26.	  Moreover,	  numerous	  genes	  and	  mutations	  have	  been	  related	  to	  various	  human	   diseases.	   Mutations	   can	   either	   cause	   a	   predisposition	   for	   the	  particular	   disease	   or	   be	   the	   direct	   cause	   of	   the	   disease.	   In	   this	   regard	  mutations	  in	  both	  coding	  and	  regulating	  genes	  have	  been	  connected	  to	  most	   known	   diseases	   ranging	   from	   different	   types	   of	   cancer27	   to	  neurodegenerative	   diseases28,29,	   autoimmune	   diseases30	   and	   many	  more31.	   In	   viruses	   mutations	   are	   even	   more	   omnipresent	   as	   these	  unicellular	  organisms	  lack	  some	  of	  the	  specialized	  mutation	  prevention	  systems	   unique	   to	   eukaryote	   and	   prokaryote	   organisms32.	   These	  organisms	  use	  mutations	  to	  acquire	  new	  traits,	  leading	  in	  some	  cases	  to	  new	   viral	   strains.	   Mechanisms	   linked	   to	   virulence33	   such	   as	   drug	  resistance	  and	  zoogenesis	  are	  acquired	  by	  genetic	  alterations34	  such	  as	  mutations.	  Although	  in	  bacteria	  antibiotic	  resistance	  might	  be	  acquired	  by	  genetic	  mutations,	  	  a	  major	  part	  of	  antibiotic	  resistance	  is	  spread	  by	  horizontal	  gene	  transfer	  between	  bacteria35.	  	  Excellent	   tools	   for	   researchers	   such	   as	   sequencing	   have	   allowed	  scientists	   to	   gain	   valuable	   insights	   in	   the	   mechanisms	   underlying	  bacterial	   and	   viral	   evolution.	   Especially	   a	   recent	   evolution	   towards	  ‘deep	  sequencing’	  where	  the	  number	  of	  sequencing	  reads	  is	  increased	  to	  reduce	   the	   number	   of	   sequencing	   errors	   has	   enabled	   the	   discovery	   of	  rare	   mutations,	   which	   allow	   a	   better	   understanding	   of	   bacterial	   and	  viral	   evolutionary	   processes36.	   However	   currently	   these	   technologies	  are	  to	  complex	  and	  costley	  to	  be	  applied	  to	  routine	  clinical	  care	  or	  food	  safety.	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Figure	  1.3:	  Hybridization	  yield	  (x-­‐axis)	  plotted	  against	  the	  free	  energy	  at	  standard	  
environmental	  conditions	  being	  a	  temperature	  of	  20	  °C	  and	  an	  absolute	  pressure	  
of	  101.325	  kPa	  (y-­‐axis)	  where	  c	   is	  the	  concentration	  of	  the	  limiting	  species	  for	  a	  
standard	  bimolecular	  hybridization	  reaction.	  At	  room	  temperature,	  the	  binding	  of	  
both	  the	  correct	  target	  (black	  dot	  X)	  and	  the	  mutation-­‐bearing	  target	  (red	  dot	  M)	  
are	  thermodynamically	  favorable	  and	  practically	  indistinguishable.	  In	  contrast,	  at	  
the	  melting	  temperature,	  the	  hybridization	  yield	  of	  the	  correct	  target	  is	  50%,	  and	  
much	  lower	  for	  the	  mutated	  target	  (according	  to	  Zhang	  et	  al.42)	  This	   method	   is	   called	   DNA	   melting	   analysis.	   The	   melting	  temperature	  (Tm)	  of	  the	  DNA	  double	  helix	  is	  defined	  as,	  the	  temperature	  at	   which	   50%	   of	   the	   probe–target	   hybrids	   have	   dissociated.	   Practical	  implementations	   of	   DNA	   melting	   analysis	   use	   often	   fluorescence	   to	  monitor	  hybridization	  yield	  as	  a	  function	  of	  temperature	  (T).	  The	  Tm	  can	  in	   this	   case	   be	   determined	   from	   the	   inflection	   point	   in	   a	   plot	   of	   the	  fluorescence	  intensity	  (F)	  and	  T,	  or	  from	  the	  peak	  value	  of	  a	  curve	  with	  the	   derivative	   of	   fluorescence	   and	   temperature	   (-­‐dF/dT)	   plotted	   as	   a	  function	  of	  T43.	  Although	  DNA	  melting	  can	  be	  achieved	  with	  extreme	  values	  of	  pH,	  increasing	   dielectric	   constant,	   exposure	   to	   amides,	   urea	   and	   other	  solvents,	  or	  by	  applying	  external	  force,	  the	  focus	  in	  this	  thesis	  will	  be	  on	  thermal	  denaturation.	  During	   thermal	  denaturation	   the	   temperature	   is	  gradually	   increased	   leading	   to	   the	   break	   up	   of	   hydrogen	   bonded	   base	  pairs	  between	  complementary	   strands,	   resulting	   in	  an	  opening	  up	  and	  unwinding	   of	   the	   DNA	   double	   strand.	   The	   opening	   of	   the	   base	   pairs	  occurs	   in	   a	   cooperative	   manner	   causing	   the	   strands	   to	   completely	  separate.	  When	  DNA	   strands	   longer	   than	  130bp	   are	   analyzed,	  melting	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can	   occur	   in	   different	   steps,	   resulting	   in	   multiple	   melting	   transitions	  along	  one	  melting	  curve.	  During	  melting	  analysis,	  the	  fraction	  of	  DNA	  in	  the	  double	  stranded	  state	  (dsDNA)	  is	  determined,	  which	  is	  a	  function	  of	  4	  variables:	  enthalpy	  (ΔH°),	   entropy	   (ΔS°),	   temperature,	   and	   concentration	   of	   the	   ssDNA	  species,	  where	  enthalpy	  is	  the	  total	  energy	  in	  a	  thermodynamic	  system	  in	   	   a	   particular	   volume	   and	   under	   a	   particular	   pressure,	   whereas	  entropy	   is	   the	   progression	   of	   the	   thermodynamic	   system	   towards	  thermodynamic	   equilibrium.	   Theoretically,	   the	  melting	   behavior	   of	   an	  oligonucleotide	   can	   be	   expressed	   with	   the	   equilibrium	   state,	   which	   is	  dependent	  on	  the	  total	  free	  energy	  in	  the	  system.	  The	  total	  free	  energy	  is	  a	  measure	   for	   the	   relative	  stability	  of	   the	  DNA	  duplex.	  Research	  has	  been	   conducted	   to	   characterize	   thermodynamically	   all	   10	   possible	  nearest	   neighbor	   interactions	   (being	   AA,	   AT,	   AC,…)	   in	   a	   Watson	   and	  Crick	  DNA	  double	  helix44,45.	  When	  the	  enthalpy	  and	  entropy	  obtained	  in	  these	   experiments	   is	   used	   to	   calculate	   the	   free	   energy	   using	   the	  standard	   thermodynamic	   relationship	   (Equation	  1),	   it	   is	  observed	   that	  the	   base	   sequence	   rather	   than	   base	   composition	   determines	   the	   free	  energy	  and	  thus	  relative	  stabilities.	  In	  short,	  this	  means	  that	  even	  if	  two	  sequences	   consist	   of	   identical	   nucleotides,	   but	   the	   order	   of	   the	  nucleotides	   is	   different	   between	   them,	   their	   melting	   temperatures	   is	  different	  as	  well.	  This	  finding	  forms	  the	  basis	  of	  all	  melting	  analyses.	  ∆𝐺° = ∆𝐻° − 𝑇∆𝑆°  (1)	  The	   introduction	   of	   the	   intercalating	   dye,	   a	   molecule	   with	   high	  affinity	   for	   double	   stranded	   DNA,	   increased	   the	   application	   of	   DNA	  melting	  in	  DNA	  analysis46.	  Initially,	  the	  technology	  was	  used	  to	  evaluate	  the	   presence	   of	   the	   correct	   amplification	   product	   after	   DNA	  amplification	   with	   Polymerase	   Chain	   Reaction	   (PCR).	   The	   PCR	   is	   an	  enzyme-­‐based	   reaction	   where	   DNA	   is	   amplified	   with	   the	   help	   of	   a	  thermophilic	   enzyme,	  which	  elongates	   short	   strands	  of	  DNA	   (primers)	  complementary	   to	   a	   target	   region	   in	   the	  DNA	   (Figure	   1.4A).	  However,	  the	  first	  generation	  of	  intercalating	  dyes	  was	  inhibiting	  the	  Taq	  enzyme	  and	   thus	   the	   PCR	   reaction,	   unless	   used	   at	   relative	   low	   concentrations.	  On	   the	   other	   hand,	   lower	   concentrations	   of	   intercalating	   dyes	   were	  reducing	   the	   sensitivity,	   because	   the	   dye	   was	   rebinding	   during	   the	  dissociation	   process,	   resulting	   in	   a	   very	   broad	   melting	   signal	   (Figure	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1.4B).	   A	   new	   generation	   of	   intercalating	   dyes,	   named	   saturating	   dyes,	  resolved	  this	  problem	  and	  introduced	  high	  resolution	  melting	  (HRM)47.	  This	   post	   PCR	   technique	   enables	   fast	   and	   accurate	   DNA	   Tm	  determination	   allowing	   single	   nucleotide	   polymorphisms	   (SNP)	  detection	  even	  in	  DNA	  targets	  of	  more	  than	  100bp.	  	  	  
	  
Figure	  1.4:	  A)	  The	  basic	  principles	  of	  PCR,	  where	  a	  target	  region	  is	  amplified	  using	  
a	   thermophilic	   polymerase	   enzyme	   (Taq)	   that	   is	   used	   to	   elongate	   primers	  
complementary	  to	  the	  target	  (forward	  primer)	  and	  its	  amplicon	  (reverse	  primer).	  
The	  different	   temperatures,	  necessary	   to	  denature	   the	  amplicon	   from	  the	   target	  
and	   to	   allow	   the	   primers	   to	   bind	   (annealing	   temperature)	   are	   cycled	   in	   a	  
repetitive	   manner,	   allowing	   exponential	   amplification	   of	   the	   target	   DNA.	   B)	  
Working	  mechanism	  of	  an	  intercalating	  dye	  (green	  square),	  where	  the	  dye	  emits	  a	  
fluorescent	  signal	  upon	  binding	  with	  double	  stranded	  DNA.	  Standard	  intercalating	  
dyes,	   which	   cannot	   be	   used	   under	   saturating	   conditions,	   result	   in	   ‘dye	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displacement’	   upon	   melting,	   reducing	   the	   resolution	   of	   the	   melting	   analysis	   in	  
comparison	  with	  saturating	  dyes.	  Nonetheless,	   the	   method	   still	   possesses	   some	   downsides,	   as	   it	  requires	   optimization	   to	   detect	   particular	  mutations	   such	   as	   base	  pair	  neutral	  mutations48,	  and	  can	  only	  detect	  a	   limited	  number	  of	  targets	  at	  the	   same	   time.	   Therefore,	   we	   aim	   to	   improve	   the	   sensitivity	   of	   DNA	  melting	  by	  combining	   it	  with	  a	  real-­‐time	  biosensor	  (fiber	  optic	  surface	  plasmon	  resonance,	  FO-­‐SPR)	  and	  gold	  nanoparticle	  labels	  (Au	  NP).	  
1.4 Surface	  plasmon	  resonance	  
 General	  concept	  1.4.1While	   a	   detailed	   description	   of	   the	   physical	   principles	   behind	   the	  Surface	   Plasmon	   Resonance	   phenomenon	   is	   outside	   the	   scope	   of	   this	  PhD	  thesis	  and	  can	  be	  found	  in	  excellent	  review	  papers	  and	  textbooks49-­‐51,	   a	   brief	   overview	   of	   the	   general	   concepts	   is	   given	   to	   allow	   a	   better	  insight	  in	  the	  following	  chapters.	  	  Surface	  plasmon	  resonance	  (SPR)	  is	  a	  type	  of	  biosensor	  transducer	  that	   provides	   label-­‐free	   and	   real-­‐time	   monitoring	   of	   biomolecular	  interactions.	  Therefore	  biomolecules,	   such	  as	   for	  example	  an	  antibody,	  are	  immobilized	  on	  the	  SPR	  sensor	  surface,	  which	  is	  than	  exposed	  to	  the	  analyte	  containing	  sample.	  The	  biomolecular	   interactions	  will	   lead	  to	  a	  local	   upconcentration	   of	   the	   analyte	   on	   the	   sensor	   surface	   and	   thus	   a	  change	  of	  refractive	  index	  which	  can	  be	  measured	  by	  the	  SPR	  biosensor.	  	  The	  SPR	  biosensor	  working	  mechanism	  is	  based	  on	  the	  excitation	  of	  an	   electromagnetic	   wave	   at	   the	   sensor	   surface,	   which	   is	   sensitive	   to	  refractive	   index	   changes	   in	   the	   bulk	   medium52	   (such	   as	   a	   sample	  matrix).	   These	   electromagnetic	  waves	   can	   be	   excited	   in	   a	  metal	  when	  exposed	  to	  a	  light	  beam.	  At	  the	  atomic	  level	  metals	  are	  built	  of	  positively	  charged	  nuclei	  surrounded	  by	  a	  cloud	  of	  electrons.	  When	  exposed	  to	  the	  the	   light	   beam,	   the	   electrons	   	   start	   to	   move	   along	   this	   external	  electromagnetic	   field	   of	   the	   light,	   increasing	   their	   distance	   from	   the	  positive	   nuclei	   until	   counteracted	   by	   an	   external	   electromagnetic	   field	  generated	   by	   the	   charge	   difference	   between	   nucleus	   and	   electrons.	   At	  this	   point	   the	   electrons	   start	   moving	   back	   to	   the	   nuclei,	   creating	  oscilllations	   of	   the	   electron	   density	   at	   the	   metal	   surface,	   also	   called	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plasmons.	   The	   light	   beam	   used	   to	   excite	   plasmons	   needs	   to	   have	   the	  correct	   frequency	   (wavelength)	   in	   order	   to	   generate	   plasmons	   at	   the	  metal	  surface.	  This	  optimal	  plasmon	  frequency	  differs	  from	  one	  metal	  to	  another,	   below	   this	   frequency,	   light	   is	   reflected,	   whereas	   above	   this	  frequency	   it	   is	   transmitted.	   Gold	   and	   silver	   are	   two	   of	   the	   few	  metals	  with	  a	  plasma	  frequency	  in	  the	  visible	  range,	  with	  silver	  having	  slightly	  better	  optical	  properties	  for	  the	  excitation	  of	  SPR.	  However	  since	  	  gold	  is	  inert,	  it	  is	  more	  suited	  for	  biosensing	  and	  therefore	  more	  often	  found	  in	  SPR	  biosensors.	  	  The	   plasmons,	   occuring	   in	   the	   metal,	   will	   also	   be	   present	   at	   the	  interface	   of	   the	  metal	   with	   a	   dielectric,	   such	   as	   for	   example	   a	   sample	  matrix.	   These	   surface	   plasmon	   waves	   are	   evanescent	   waves	   (EW),	  meaning	   that	   the	   waves	   decay	   exponentially	   as	   a	   function	   of	   the	  distance	   from	  the	   interface	  at	  which	  they	  were	   formed.	  The	  size	  of	   the	  decaying	   SPR	   wave	   is	   related	   to	   its	   energy,	   wich	   depends	   on	   the	  wavelength	   at	  which	   it	  was	   excited.	   Therefore	   the	  most	   sensitive	   SPR	  region	   is	   determined	   as	   one	   third	   of	   the	   excitation	   wavelength	   (in	  general	   the	   penetration	   depth	   	   	   is	   200-­‐300	   nm	   ).	   To	   generate	   an	   SPR	  signal,	   light	   not	   only	  needs	   to	   have	   the	   right	   energy	   (wavelength),	   the	  photons	  of	  the	  light	  also	  need	  to	  be	  coupled	  to	  	  the	  surface	  plasmons.	  To	  achieve	  this	  energy	  coupling,	  the	  light	  needs	  the	  right	  momentum.	  The	  most	   frequently	  applied	  method	   to	   increase	   the	  momentum	  of	  the	   photons	   is	   by	   passing	   the	   light	   through	   a	   prism	   (Figure	   1.5).	   The	  light	  will	  undergo	  a	  change	  of	  speed	  and	  dispersion	  while	  entering	  the	  prism	   (because	   the	   permittivity	   of	   the	   prism,	   εP,	   is	   higher	   than	   the	  permittivity	   of	   the	   air,	   εa).	   This	   allows	   the	   photons	   to	   fulfill	   the	  requirements	   for	   total	   internal	   reflection	   (Snells	   law)	   resulting	   in	   an	  evanescent	  wave	   at	   the	   interface.	  Depending	  on	   the	   SPR	   configuration	  chosen,	   the	   evanescent	   wave	   can	   make	   its	   way	   through	   the	   sample	  dielectricum	   and	   couple	   with	   the	   plasmon	   wave	   on	   the	   metal-­‐dielectricum	  interface	  to	  generate	  a	  surface	  plasmon	  wave	  (SPW)	  (Otto	  configuration53,	   Figure	   1.5A).	   The	   Otto	   configuration	   has	   some	  drawbacks,	   mainly	   due	   to	   the	   fact	   that	   the	   prism	   and	   gold	   layer	   are	  being	   separated	   by	   the	   sample.	   The	   evanescent	   wave	   has	   to	   pass	  through	  the	  sample	  before	  reaching	  the	  metal	  surface,	   leading	  to	  a	   low	  coupling	  efficiency	  of	   the	  evanescent	  wave	  with	   the	  gold	  and	   thus	   to	  a	  lower	   efficiency	   in	   general.	   Alternatively,	   the	   metal	   can	   be	   coated	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directly	  on	  the	  prism	  (Kretschmann	  configuration54,	  Figure	  1.5B).	  Here,	  the	   evanescent	   wave	   penetrates	   through	   the	   metal	   film,	   creating	   a	  plasmonic	  propagating	  electron	  wave	  on	  the	  outside	  of	  the	  metal	  layer.	  This	   configuration	   is	   predominantly	   used	   for	   SPR	   signal	   excitation	   in	  many	  commercial	  SPR	  devices.	  
	  
Figure	   1.5:	   A)	   Scheme	   showing	   the	   Otto	   and	   B)	   the	   Kretschmann	   SPR	  
configuration.	   In	   the	  Otto	  configuration,	  prism	  and	  gold	   layer	  are	  divided	  by	  the	  
sample.	   In	   the	   Kretschmann	   configuration	   the	   prism	   is	   directly	   coupled	   to	   the	  
gold	   layer,	   allowing	   plasmon	   resonance	   wave	   (SPW)	   excitation	   at	   the	   opposite	  
side	   of	   the	   gold	   layer.	   (EW:	   evanescent	   wave,	   εP:	   permittivity	   prism,	   εs:	  
permittivity	  sample,	  εm	  permittivity	  gold)	  The	  resonance	  frequency	  of	  the	  evanescent	  surface	  plasmon	  wave	  is	  influenced	  by	  the	  composition	  of	  the	  medium	  close	  to	  the	  metal	  surface.	  SPR	   biosensors	   can	   interrogate	   changes	   in	   the	   resonance	   frequency	  using	   two	   different	   approaches.	   The	   first	   approach	   is	   based	   on	   Snells	  law,	  stating	  that	  light	  of	  a	  particular	  frequency	  will	  excite	  an	  evanescent	  wave	  when	  it	  strikes	  the	  refractive	  boundary	  with	  an	  angle	  of	  incidence	  above	  the	  critical	  angle.	  This	  approach	  is	  called	  angle	  resolved	  SPR	  and	  utilizes	  a	  laser	  at	  a	  fixed	  wavelength	  or	  another	  type	  of	  monochromatic	  light	  source	  (having	  a	  single	  frequency)	  to	  irradiate	  the	  sensor	  surface.	  Light	  with	   an	   angle	   of	   incidence	  below	  or	   above	   the	   critical	   angle	  will	  not	  be	  adsorbed	  by	  the	  metal,	  but	  instead,	  is	  reflected	  and	  captured	  with	  a	  diode	  array	  detector	  fixed	  on	  a	  motorized	  goniometer.	  The	  SPR	  wave	  is	   visible	   as	   a	   dip	   in	   light	   intensity	   at	   a	   particular	   reflection	   angle.	  Changes	   in	   the	   local	   refractive	   index	  at	   the	   sensor	   surface	  will	   slightly	  change	   the	   critical	   angle,	   necesseray	   to	   excite	   the	   SPW,	   therefore	   the	  detector	   on	   the	   goniometer	   continually	   measures	   the	   intensity	   of	   the	  reflected	   light	   at	   different	   angles	   and	   thus	   can	   detect	   any	   change	   in	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refractive	   index.	   This	   angle	   interrogation	   is	   very	   accurate	   and	   can	  register	  changes	  up	  to	  0.001°.	  	  The	  second	  approach	  allows	  the	  frequency	  (wavelength)	  of	  the	  light	  to	   vary	  while	   the	   angle	   of	   incidence	   is	   kept	   constant,	   only	   lightwaves	  with	  the	  right	  frequency	  for	  the	  set	  critical	  angle	  will	  excite	  SPWs55.	  For	  this	   SPR	   configuration	   a	   polychromatic	   light	   source	   is	   used	   in	  combination	   with	   a	   spectrophotometer,	   the	   wavelength	   at	   which	  resonance	  occurs	  will	  have	  a	  lower	  intensity.	  In	  the	  same	  way	  as	  angle	  interrogation,	  the	  wavelength	  at	  which	  the	  SPR	  is	  excited	  changes	  when	  molecules	   are	   bound	   to	   the	   metal	   surface,	   which	   enables	   real-­‐time	  monitoring	   of	   biomolecular	   interactions	   (Figure	   1.6).	   This	   approach	  does	   not	   	   reach	   the	   same	   sensitivity	   as	   angle	   interrogation,	   because	   a	  spectrophotometer	   does	   not	   allow	   the	   same	   level	   of	   accuracy	   as	   a	  goniometer56.	  In	  Figure	  1.6A	  a	  typical	  maesurement	  of	  a	  wavelength	  interrogation	  SPR	   device	   is	   shown.	   As	   described	   in	   the	   previous	   paragraph,	   the	  spectrophotometer	  registers	  the	  SPR	  phenomena	  as	  a	  decrease	  in	  signal	  intensity	  at	  a	  particular	  wavelength,	  when	  the	  local	  refrative	  index	  (ns)	  at	   the	   sensor	   surface	   changes	   (ns+Δns),	   the	   wavelength	   at	   which	   the	  intensity	   dip	   is	   found	   will	   shift.	   By	   monitoring	   continuously	   the	   local	  refractive	  index	  at	  the	  sensor	  surface,	  biomolecular	  interactions	  can	  be	  monitored	  over	   time.	  This	  principal	   is	  displayed	   in	  Figure	  1.6B,	  where	  different	   phases	   in	   a	   bioreceptor	   analyte	   interaction	   tracked	  with	   SPR	  are	  plotted.	  Such	  a	  plot	  is	  called	  a	  sensorgram.	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Figure	   1.6:	   A)	   Typical	   SPR	   wave	   as	   detected	   by	   a	   spectrophotometer.	   The	   SPR	  
wave	   generates	   an	   intensity	   dip	   at	   a	   particular	   wavelength,	   this	   wavelength	  
depends	   on	   the	   local	   refractive	   index	   at	   the	   sensor	   surface	   (ns)	   and	   shifts	  with	  
changes	  in	  this	  refractive	  index	  (ns+Δns)	  B)	  Sensorgram	  of	  an	  SPR	  measurement,	  
where	   shifts	   in	   signal	   are	   plotted	   versus	   time	   allowing	   to	   track	   biomolecular	  
itneractions	  at	  the	  sensor	  surface.	  Although,	   most	   commercial	   SPR	   devices	   are	   based	   on	   angle	  interrogation,	   they	   are	   very	   expensive	   and	   non-­‐flexible	   due	   to	   some	  characteristics	  of	  this	  method:	  -­‐ requirement	   for	   complex	   optical	   instruments,	  which	   are	   bulky,	  sensitive	  and	  need	  complex	  maintenance.	  -­‐ requirement	   for	   microfluidic	   channels	   in	   order	   to	   bring	   the	  sample	   to	   the	   sensor	   surface	   in	   a	   controlled	   way.	   The	   most	  general	   layout	   is	   shown	   in	   figure	   1.9B,	   where	   the	   prism-­‐gold	  sensors	   surface	   assembly	   is	   pressed	   on	   a	  microfluidic	   channel	  layout	  to	  create	  different	  sensing	  zones.	  	  Nonetheless,	  this	  SPR	  configuration	  has	  been	  recognized	  as	  reliable	  and	   sensitive	   becoming	   thus	   very	   popular	   for	   various	   laboratory	  applications,	   such	   as	   selection	   of	   high	   affinity	   monoclonal	   antibodies	  during	  their	  production57,	  monoclonal	  antibody	  therapy	  optimization	  58	  and,	   drug-­‐target	   interaction	   analysis59.	   All	   these	   applications	   are	  commonly	   being	   performed	   in	   large	   research	   laboratories	   or	   in	  pharmaceutical	   companies,	   which	   have	   the	   means	   to	   invest	   in	   these	  highly	   functional	   but	   pricey	   devices.	   On	   the	   other	   hand,	   many	  advantages	   of	   the	   SPR	   technique,	   being	   accuracy	   in	   measurements,	  
Surface	  Plasmon	  Resonance	  
17	  
automation	  and	  the	  wealth	  of	  information	  generated	  from	  even	  a	  single	  SPR	  measurement,	   are	   almost	   a	   guarantee	   for	   success	   in	  point	   of	   care	  testing.	   Therefore,	   new	   implementations	   of	   SPR	   technology	   should	  strive	   to	   make	   these	   devices	   more	   simple	   and	   affordable.	   One	   such	  implementation	  is	  the	  combination	  of	  SPR	  with	  optical	  fibers,	  which	  has	  several	   advantages	   as	   will	   be	   discussed	   in	   the	   next	   section	   of	   this	  chapter.	  
 SPR	  and	  optical	  fibers	  1.4.2Optical	   fibers	   (also	   known	  as	   fiber	   optics:	   FO)	   function	   as	  waveguides	  for	   light60	   and	   are	   therefore	   very	   popular	   in	   high-­‐speed	   data	  connections,	  as	  data	  can	  be	  transmitted	  by	  means	  of	  light	  with	  minimal	  loss	   in	   quality.	   In	   general,	   FOs	   consist	   of	   a	   glass	   or	   plastic	   core	  surrounded	  by	  a	  transparent	  cladding	  material	  (polymer)	  with	  a	  lower	  index	  of	   refraction.	  The	  cladding	   is	  necessary	   to	  keep	   light	   in	   the	   fiber	  core	  by	  means	  of	  the	  same	  total	  internal	  reflection	  used	  to	  excite	  SPWs.	  When	   light	   travels	   trough	   the	   FO,	   it	   bounces	   back	   and	   forth	   off	   the	  boundary	  between	  the	  core	  and	  the	  cladding.	  Only	  light	  with	  an	  angle	  of	  incidence	   below	   the	   critical	   angle,	   is	   reflected	   and,	   thus	   able	   to	   travel	  along	  the	  FO.	  Light	  capable	  of	  traveling	  through	  a	  particular	  FO	  is	  said	  to	  have	  an	  angle	  of	  incidence,	  within	  the	  acceptance	  angle	  θa	  of	  the	  FO.	  The	  range	  of	  incident	  angels	  a	  particular	  FO	  can	  transport	  is	  expressed	  with	  the	  Numerical	  Aperture	  (NA).	  In	   general,	   FOs	   can	  be	  divided	   in	   two	   types,	  multimode	   and	   single	  mode	  FOs.	  Multimode	  FOs	  typically	  have	  a	  diameter	  larger	  than	  10	  µM	  and	  thus	  a	  larger	  NA,	  which	  results	  in	  a	  higher	  light	  gathering	  capacity.	  Because	  of	  the	  larger	  NA	  (and	  thus	  θa),	  multimode	  FOs	  can	  suffer	  from	  modal	   dispersion,	   which	   is	   a	   spread	   of	   a	   light	   signal	   in	   time	   due	   to	  propagation	   with	   different	   modes61.	   Therefore	   multimode	   FOs	   have	   a	  limited	  transport	  distance	  in	  comparison	  with	  single	  mode	  fibers,	  which	  can	  	  only	  support	  a	  single	  light	  mode	  (Figure	  1.7).	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Figure	  1.7:	  Illustration	  of	  the	  numeric	  aperture	  in	  a	  multimode	  fiber	  and	  a	  single	  
mode	  fiber.	  Because	  a	  multimode	  fiber	  supports	  different	  modes,	  it	  can	  propagate	  
light	  with	  different	  incident	  angles	  (θa).	  Therefore,	  it	  is	  often	  used	  in	  combination	  
with	  a	  white	  light	  source.	  A	  single	  mode	  fiber,	  only	  accepts	  a	  very	  limited	  number	  
of	  incident	  angels	  and	  is	  therefore	  used	  in	  combination	  with	  laser	  light	  sources.	  As	   described	   in	   paragraph	   1.4.1	   for	   a	   two	   dimensional	   surface,	   a	  prism	   is	   necessary	   to	   generate	   total	   internal	   reflection	   of	   the	   incident	  light	   and	   excite	   the	   surface	  plasmons	   in	   the	  metal	   layer	   of	   the	   sensor.	  Because	   a	  multimode	   fiber-­‐optic	   cable	   uses	   total	   internal	   reflection	   to	  propagate	  light,	  the	  FOs	  can	  be	  modified	  to	  allow	  SPR	  sensing	  without	  a	  prism62.	  Like	  prism	  based	  SPR	  sensing,	   fiber-­‐optic	  SPR	  can	  be	   found	  in	  various	   configurations63	   with	   different	   FO	   core	   materials,	   geometries	  and	   diameters.	   Here,	   only	   the	   two	   most	   popular	   fiber-­‐optic	   SPR	  configurations	  are	  discussed	  (Figure	  1.8).	  The	  first	  configuration,	  known	  as	  transmission	  FO-­‐SPR	  configuration,	  is	  mostly	  used,	  mainly	  because	  in	  usage,	  it	  resembles	  many	  of	  the	  prism	  based	  SPR	  configurations64.	  Here,	  both	  the	  protective	  jacket	  and	  the	  cladding	  are	  removed	  in	  the	  middle	  of	  a	  piece	  of	  FO.	  The	  bare	  fiber,	  i.e.	  fiber	  core,	  is	  directly	  coated	  with	  an	  SPR	  suitable	  metal	   such	   as	   gold.	  When	   light	   is	   transmitted	   in	   the	   FOs,	   the	  light	   will	   excite	   an	   SPR	   wave	   at	   the	   gold-­‐coated	   sensing	   region.	  However,	   only	   the	   light	   with	   the	   exact	   wavelength	   and	   mode	   is	  converted	   in	   SPR	   waves	   while	   the	   remaining	   light	   is	   reflected	   and	  captured	   on	   the	   other	   end	   of	   the	   FO	   using	   a	   spectrophotometer.	   This	  light	  will	   have	   a	   decreased	   intensity	   at	   the	   exact	  wavelength	   at	  which	  the	  SPR	  is	  excited	  (Figure	  1.6A).	  Alternatively,	  the	  fiber-­‐optic	  cable	  can	  also	   be	   stripped	   from	   its	   cladding	   at	   one	   end	   (reflection	   optical	   fiber	  SPR	  configuration,	  Figure	  1.8)65.	  When	  this	  fiber-­‐optic	  ‘pig	  tail’	  is	  coated	  with	  gold,	   it	   can	  also	  be	  used	   for	  SPR	  sensing,	   requiring	  however	  very	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accurate	   cutting	   and	   creating	   a	   perfect	   perpendicular	   angle	   that	   will	  reflect	  the	  incident	  light	  at	  the	  distal	  fiber	  end.	  
	  
Figure	   1.8:	   Schematic	   drawing	   of	   the	   two	   most	   popular	   fiber-­‐optic	   SPR	  
configurations.	   In	   the	   transmission	   FO-­‐SPR	   configuration	   (top)	   light	   is	   directed	  
into	  one	  end	  of	  the	  fiber	  and	  captured	  at	  the	  other	  end.	  In	  the	  reflection	  optic	  fiber	  
SPR	  configuration	  (bottom)	   light	   is	  emitted	  and	  captured	  at	   the	  same	  end	  of	   the	  
optical	   fiber.	   Both	   configurations	   do	   not	   require	   a	   prism,	   as	   evanescent	   waves	  
arise	  due	  to	  the	  total	  internal	  reflection	  in	  the	  optical	  fiber	  .	  There	  are	   several	   advantages	  of	   the	   reflection	   fiber-­‐optic	  SPR	   (FO-­‐SPR)	  sensor	  configuration	  (Figure	  1.9A).	  Firstly,	   it	  can	  be	  used	  as	  a	  dip	  probe,	   which	   is	   transferred	   from	   one	   sample	   to	   another,	   rendering	  	  microfluidic	   flow	  cells,	   commonly	  used	   in	  commercial	  SPR	  devices	   like	  e.g.,	  BIACORE,	  obsolete	  (Figure	  1.9B).	  Secondly,	  because	  complex	  optical	  equipment	   including	   prisms	   and	   expensive	   angle	   interrogation	  detectors	  are	  not	  necessary,	   the	  FO-­‐SPR	  sensor	   is	  much	  more	  compact	  than	   a	   Kretschmann	   configured	   sensor	   (Figure	   1.9).	   This	   opens	   new	  possible	  applications	   for	  SPR,	   for	  example	  as	  a	   tool	   to	  perform	  remote	  sensing	  at	  difficult	  accesible	  locations.	  Finally,	  the	  reduced	  cost	  of	  an	  FO-­‐SPR	  sensor	   (compared	   to	  current	  commercial	  SPR	  devices)	  could	  even	  promote	  the	  technology	  towards	  disposable	  sensors.	  	  All	   these	   advantages	   of	   FO-­‐SPR	   come	   however	   at	   a	   price	   of	   lower	  sensitivity	   compared	   to	   their	   commercial	   counterparts.	   Nevertheless,	  although	  FO-­‐SPR	  sensors	  are	   in	  general	  10	   times	   less	   sensitive66,	   their	  sensitivity	   can	   be	   improved	   to	  match	   or	   even	   outperform	   classic	   SPR	  devices	  by	  using	  smart	  labeling	  techniques,	  such	  as	  gold	  nanoparticles.	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Figure	   1.9:	   A)	   Layout	   of	   a	   fiber-­‐optic	   SPR	   dip	   probe	   sensor.	   B)	   Layout	   of	   a	  
kretschmann	  SPR	  sensor	  as	  can	  be	  found	  in	  most	  commercial	  SPR	  devices	  such	  as	  
the	  popular	  Biacore	  devices.	  
1.5 Gold	  nanoparticles	  Gold	  nanoparticles	  (Au	  NPs)	  are	  versatile	  nanometer	  scale	  particles	  that	  are	  used	   in	  many	  applications.	  Because	  of	   their	  special	  properties	   (e.g.	  plasmonic,	   catalytic,	   scattering,	   quenching),	   they	  have	   a	   great	   potental	  as	   transducers	   and	   signal	   amplification	   labels	   in	   biosensor	   design67.	  Furthermore,	   they	   are	   also	  widely	   used	   outside	   the	   biosensor	   field	   as	  drug	  carriers68	  or	  therapeutic	  agents	  in	  medicine69,70.	  Depending	  on	  the	  apllication,	   Au	   NPs	   can	   have	   various	   shapes	   and	   have	   to	   be	  functionalized	  with	  diverse	  bioreceptors71.	  In	  this	  dissertation,	  spherical	  Au	  NPs	  coated	  with	  DNA	  molecules	  will	  be	  used.	  Spherical	  Au	  NPs	  have,	  as	  a	  consequence	  of	   their	  nanosize,	  distinct	  physical	  properties	  compared	   to	  gold.	  The	  optical	  effect	  of	  Au	  NPs	   is	  a	  result	  of	  interactions	  between	  light	  and	  free	  electrons	  of	  gold,	  causing	  a	  concerted	  oscillation	  of	  electron	  charge,	  which	  is	  in	  resonance	  with	  the	  frequency	   of	   visible	   light.	   Similar	   to	   the	   earlier	   described	   SPR	  phenomena	  in	  bulk	  gold,	  the	  localized	  SPR	  of	  Au	  NPs	  is	  also	  sensitive	  to	  its	   local	  environment,	  with	  however	  particle	  size	  also	  playing	  a	  crucial	  role.	  This	   is	  directly	  reflected	   into	   the	  change	  of	  Au	  NPs	  solution	  color	  from	   intense	   red	   to	   blue	   when	   particle	   size	   increases.	   Even	   more	  interesting	  is	  that	  Au	  NPs,	  when	  used	  as	  SPR	  signal	  amplification	  labels,	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improve	   sensitivity	   not	   only	   due	   to	   an	   increased	   binding	   mass	   and	  refractive	   index,	   but	   also	   due	   to	   the	   increased	   perturbation	   of	   the	  evanescent	  field72.	  
1.6 Surface	  functionalization	  In	   order	   to	   use	   the	   SPR	   biosensors	   and	   gold	   nanoparticle	   labels	   their	  respective	   surfaces	   have	   to	   be	   functionalized	   with	   the	   desired	  biomolecules.	  A	  wide	   range	  of	   chemical	   reactions	  are	  available	   to	   coat	  almost	   any	   surface	   with	   any	   kind	   of	   biomolecule73.	   The	   best	  functionalization	   method	   depends	   on	   the	   surface,	   biomolecule	   and	  application.	  In	  this	  dissertation	  only	  one	  surface	  material	  is	  used	  (gold)	  in	   combination	  with	   a	   small	   number	  of	  biomolecules,	   of	  which	  DNA	   is	  used	   the	  most.	   Three	   types	   of	   chemical	   bonds	   are	   often	   used	   for	  DNA	  immobilization,	   surface	   adsorption74,	   semi-­‐covalent75	   bond	   and	   the	  covalent	  bond76.	  	  	  The	  easiest	  way	  of	  DNA	  immobilization	  on	  a	  gold	  surface	  is	  by	  direct	  adsorption	   of	   the	   ssDNA	   (Figure	   1.10A).	   This	   approach	   allows	   high	  density	   immobilization	   through	   hydrophobic	   interactions	   between	   the	  ssDNA	  and	  the	  gold	  surface77.	  However,	  because	  the	  affinity	  of	  the	  DNA	  for	  the	  gold	  surface	  is	  lowered	  when	  ssDNA	  hybridizes	  into	  dsDNA,	  it	  is	  released	  from	  the	  surface78.	  Therefore	  this	  method	  is	  not	  applicable	  for	  our	  intended	  assay.	  	  Another	   often	   used	   strategy	   is	   direct	   DNA	   immobilization	   with	   a	  semi-­‐covalent	  bond	  (Figure	  1.10B),	  here	  DNA	  is	  functionalized	  at	  either	  the	   5’	   or	   3’	   end	  with	   a	   thiol	   group,	   which	   has	   a	   high	   affinity	   for	   gold	  (homolytic	   bond	   strength	   of	   44	   kcal/mol)75.	   This	   method	   also	   allows	  immobilizing	  high	  densities	  of	  DNA	  with	  excellent	  stability79.	  Lastly	   DNA	   can	   also	   be	   imobilized	   indirectly	   on	   a	   gold	   surface	   by	  means	   of	   a	   self	   assembling	   monolayer	   (SAM).	   SAM	   layers	   are	  spontaneously	   formed,	   highly	   structured	   monolayers	   of	   organic	  molecules.	  Molecules	   capable	   of	   forming	   SAM	   layers	   consist	   of	   a	   head	  group,	  a	  chain	  and	  a	  functional	  group.	  The	  molecules	  attach	  first	  on	  the	  gold	   surface	   with	   a	   thiol	   head	   group,	   which	   is	   followed	   by	   a	   slow	  organization	   process	   mediated	   by	   alkanechains.	   The	   alkanechains	  tigthly	   pack	   together	   through	   van	   der	   Waals	   interactions,	   until	   they	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reach	   the	   conformation	   with	   the	   lowest	   free	   energy80.	   The	   functional	  group	  is	  assembled	  far	  from	  the	  substrate	  and	  is	  used	  to	  attach	  DNA	  or	  another	   biomolecule	   on	   the	   surface.	   In	   the	   SAM	   layer,	   vizualized	   in	  Figure	   1.10C,	   this	   functional	   group	   is	   a	   carboxyl	   group	   which	   can	   be	  used	  to	  covalently	  bind	  5’	  or	  3’	  amine	  functional	  DNA	  or	  it	  can	  be	  used	  to	  bind	  the	  protein	  streptavidin	  which	  has	  high	  affinity	  for	  the	  molecule	  biotin	  which	   also	   can	   be	   attached	   to	   either	   end	   of	   a	   DNA	   strand.	   The	  alkanechains	   in	   the	   SAM	   can	   be	   equiped	   with	   polyethyleneoxide	  repeats,	   known	   for	   their	   protein	   repelling	   properties.	   As	   a	   result	   the	  sensor	   surface	   will	   have	   a	   less	   or	   non-­‐fouling	   functionalization	   layer.	  The	   indirect	   SAM	   approach	   of	   DNA	   immobilization	   results	   in	   a	   highly	  organized	   DNA	   layer,	   but	   at	   a	   lower	   density	   and	   at	   a	   larger	   	   distance	  from	  the	  sensor	  surface,	  and,	  hence,	  	  this	  approach	  will	  not	  result	  in	  the	  highest	  SPR	  sensitivity.	  	  	  
	  
Figure	  1.10:	  A)	  Direct	  adsorption	  of	  ssDNA	  on	  a	  gold	  surface.	  B)	  Immobilization	  of	  
thiol	  functionalized	  ssDNA	  on	  a	  gold	  surface.	  C)	  Indirect	  immobilization	  of	  amine	  
and	   biotin	   functionalized	   DNA	   on	   a	   Self	   Assembling	   Monolayer	   of	   alkanethiols	  
with	  a	  carboxyl	  functional	  end	  group.	  From	   the	   previous	   paragraphs,	   we	   conclude	   that	   direct	  immobilization	  of	  DNA	   is	   the	  best	   suited	  DNA	   immobilization	   strategy	  for	  a	  sensitive	  SPR	  DNA	  biosensor	  as	  it	  will	  allow	  the	  highest	  density	  of	  DNA,	  closest	  to	  the	  sensor	  surface.	  In	  this	  regard	  it	  has	  to	  be	  noted	  that	  hybridization	   reactions	   between	   a	   surface	   immobilized	   probe	   and	  solution	   target	   sequence	   are	   subject	   to	   greater	   complexity	   than	   bulk	  hybridization	  and	  are	  therefore	  less	  well	  understood.	  However	  the	  vast	  number	   of	   applications	   in	   modern	   microarray	   and	   biosensing	  technology	   have	   made	   the	   interest	   grow,	   leading	   to	   some	   excellent	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reviews	   on	   this	   topic81-­‐83.	   In	   comparison	   with	   bulk	   hybridization,	   a	  target	   sequence	   encounters	   locally	   higher	   charges	   and	   nucleic	   acid	  concentrations,	  which	  are	  not	  present	   in	   solution.	  Probe	  density84	   and	  ionic	   strength85,	   allow	   to	   control	   surface	   DNA	   hybridization	   reactions.	  After	   DNA	   immobilization,	   the	   densely	   packed	   DNA	   is	   not	   ideally	  oriented	  on	   the	   surface	   to	   allow	  easy	  hybridization.	  Depending	  on	   the	  sequence	  of	  the	  immobilized	  DNA	  it	  can	  fold	  back	  to	  the	  surface,	  due	  to	  affinity	  of	  particular	  nucleotides	  for	  the	  surface86.	  Exposure	  of	  the	  gold	  surface	   after	   DNA	   immobilization	   to	   SAM	   forming	   agents	   such	   as	   the	  alkanethiols	   discussed	   in	   the	   previous	   paragraph,	   allows	   to	   orient	   the	  ssDNA	  on	  the	  gold	  surfaces87	  (Figure	  1.11A).	  	  In	  addition,	  these	  reagents	  also	  render	  the	  surface	  protein	  repellant	  which	   is	  very	   important	   for	  bio-­‐sensing	  applications88.	   In	  Figure	  1.11B	  an	   SPR	   sensorgram	   in	   a	   complex	   matrix	   (PCR	   mixture)	   is	   shown,	  measured	  with	   a	   backfilled	   (light	   blue)	   and	  non-­‐backfilled	   (dark	  blue)	  DNA	  coated	  SPR	  sensor.	  The	  backfilled	  sensor	  does	  not	  bind	  any	  of	  the	  components	  in	  the	  PCR	  mixture,	  keeping	  a	  steady	  baseline	  signal,	  while	  the	   non-­‐backfilled	   sensor	   has	   an	   increasing	   signal	   in	   the	  PCR	  mixture,	  which	  not	  returns	  to	  baseline	  level	  when	  the	  sensor	  is	  exposed	  to	  buffer.	  These	   results	   prove	   that	   when	   the	   biosensor	   is	   applied	   outside	   the	  optimized	  buffer	   conditions,	  on	   real	   seal	   samples,	   complex	  matrices	  of	  proteins	   and	   other	   compounds	   can	   be	   encountered	  which	   disturb	   the	  biosensor	  performance89	  (Figure	  1.11B).	  Furthermore,	  this	  non-­‐specific	  interaction	   is	   not	   only	   of	   danger	   for	   the	   sensor	   performance,	   but	   can	  also	   lead	   to	   inactivation	   of	   enzymes	   used	   in	   some	   DNA	   detection	  assays90.	  
	  
Figure	   1.11:	   A)	   Conceptual	   drawing	   of	   backfilling	   a	   ssDNA	   functionalized	   gold	  
surface.	   B)	   Actual	   SPR	   measurement	   in	   a	   PCR	   mixture	   (complex	   matrix)	   with	  
(dark	  blue)	  and	  without	  PEO	  alkane	  thiol	  backfiller	  (from	  Janssen	  et	  al.89)	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For	  Au	  NPs	   the	  same	   functionalization	  strategies	  can	  be	  applied	  as	  for	  planar	  gold	  surfaces.	  However,	  these	  functionalized	  nanostructures,	  also	   called	   Spherical	   Nucleic	   Acid	   (SNA)91,	   acquire	   through	   the	   high	  density	   of	   the	   DNA	   monolayer	   very	   unique	   characteristics.	   The	   most	  peculiar	   characteristics	   of	   SNAs	   are:	   (1)	   resistance	   to	   nuclease	  degradation92,	   (2)	   capability	   to	   transfect	   cell	   lines	   without	   ancillary	  physical	   or	   chemical	   transfection93	   and	   finally	   (3)	   higher	   binding	  constants	   for	   their	  complementary	  DNA	  than	  single	  stranded	  probes94.	  Especially	   this	   last	   trait	   is	   used	   in	   the	   assays	   described	   in	   this	  dissertation	   to	   improve	   DNA	   detection.	   For	   instance,	   Au	   NPs	   can	   be	  linked	   together	   through	   hybridization	   of	   complementary	   DNA	  molecules	  on	  their	  surface.	  In	  this	  process,	  the	  highly	  specific	  DNA-­‐DNA	  interactions	   hold	   the	   Au	   NPs	   together	  without	   their	   cores	   interacting.	  	  As	   a	   result,	   either	   lowering	   the	   salt	   concentration	   of	   the	   solution	   or	  increasing	   the	   temperature	  can	  easily	  reverse	   the	  particle	  aggregation.	  When	   these	   DNA	   interlinked	   Au	   NP	   microstructures	   are	   melted,	   the	  melting	   occurs	   over	   a	   much	   smaller	   temperature	   range	   compared	   to	  particle-­‐free	   oligonucleotides95.	   Furthermore,	   the	   actual	   melting	  temperature	   for	   the	   AuNP	   DNA	   microstructures	   will	   be	   considerably	  higher	  than	  for	  the	  same	  particle-­‐free	  oligonucleotides.	  Both	  effects	  can	  be	   attributed	   to	   multiple	   inter-­‐particle	   connections,	   creating	   a	   much	  stronger	   bond	   between	   interlinked	   nanoparticles	   than	   between	  particle-­‐free	  oligonucleotides.	  Additionally,	  Au	  NPs	  have	  high	   local	   salt	  concentrations	   in	   their	   immediate	   surroundings,	   which	   further	  stabilizes	   the	   DNA	   duplexes	   and	   increase	   the	   melting	   temperature.	  These	   features	  make	  Au	  NPs	   ideal	  candidates	   for	   labeling	  molecules	   in	  DNA	  mutation	  assays.	  Multiple	  Au	  NP	  aggregation	  assays	  have	  already	  proven	  that	  this	  method	  is	  highly	  sensitive,	  even	  in	  the	  case	  of	  a	  single	  nucleotide	  polymorphism96-­‐98.	  In	   this	   research	  project	  we	  will	   apply	  SNAs	  as	   signal	   enhancement	  nanostructures	  in	  FO-­‐SPR	  based	  bioassays,	  as	  these	  nanolabels	  can	  both	  improve	  the	  sensor	  as	  well	  as	  the	  assay	  performance,	  leading	  to	  unmet	  mutation	  detection	  capabilities.	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1.7 Objectives	  and	  outline	  of	  this	  thesis	  Bacteria	   and	   viruses	   influence	   everyday	   human	   life,	   both	   in	   a	   positive	  and	  negative	  way.	  Recently,	  they	  have	  even	  been	  transformed	  into	  living	  ‘factories’,	  capable	  of	  producing	  consumer	  products,	  such	  as	  plastics	  and	  gasoline.	  Nonetheless,	  some	  micro-­‐organisms	  remain	  a	  threat	  to	  human	  health,	   e.g.	   pathogenic	   viruses	   and	   bacteria,	   especially	  with	   increasing	  resistance	   of	   bacteria	   towards	   existing	   antibiotic	   agents.	   As	   a	   result	  there	   is	   a	   strong	   need	   to	   accurately	   identify	   and	   quantify	   micro-­‐organisms	   in	   a	   short	   period	   of	   time,	   allowing	   a	   physician	   to	  make	   the	  right	   treatment	  decisions	  and	   follow	  up	  on	   treatment	   success.	  Current	  detection	   techniques	   still	   consist	   mainly	   of	   culturing	   the	   bacteria	   or	  virus	  before	  identifying	  them,	  a	  process	  that	  lasts	  for	  most	  bacteria	  days	  to	   even	   weeks.	   This	   method	   has	   certain	   advantages	   such	   as	   a	   clear	  discrimination	  of	  life	  versus	  death	  bacteria,	  and	  a	  clear	  overview	  of	  the	  full	   spectrum	   of	   bacteria	   present,	   thoughthe	   detection	   speed	   in	  culturing	   assays	   is	   low.	   As	   discussed	   earlier	   the	   ‘time’	   issue	   has	   been	  resolved	   by	   the	   introduction	   of	   	   the	   PCR	   technology	   	   However,	   this	  detection	  method	  is,	  due	  to	  its	  complexity,	  not	  always	  easily	  applicable	  outside	   a	   specialized	   lab	   environment.	   Therefore,	   new	   means	   of	  detection,	  quantification	  and	  identification	  of	  bacteria	  and	  viruses	  are	  a	  necessity	   to	   improve	   not	   only	   healthcare	   but	   also	   food	   safety,	   limit	  antibiotic	  overuse	  and	  enable	  a	  better	  tracking	  of	  bacterial	  evolution.	  A	  very	  interesting	  technology	  in	  this	  aspect	  is	  SPR,	  which	  allows	  real	  time	  monitoring	  of	  biological	  interaction	  processes,	  such	  as	  binding	  and	  denaturing	   of	   DNA.	   Until	   recently,	   SPR	   has	   never	   been	   applied	  widely	  for	  DNA	  analysis	  because	  the	  assay	  resulted	  often	  in	  false	  results,	  if	  not	  extensively	   optimized	   for	   each	   new	   DNA	   target99.	   Furthermore,	  commercial	   SPR	   devices	   enable	   the	   monitoring	   of	   biomolecular	  reactions	   under	   equilibrium	   conditions,	   i.e.	   a	   constant	   temperature,	  allowing	   only	   hybridization	   to	   be	  monitored.	   Because	   single	  mutation	  has	  very	  limited	  effect	  on	  the	  hybridization	  of	  DNA	  duplex	  that	  consists	  of	   multiple	   basepairs,	   detecting	   mutations	   is	   challenging	   with	   the	  commercial	  SPR	  devices.	  Contrary	  to	  this,	  the	  impact	  a	  single	  base	  pair	  change	   can	   have	   on	   thermal	   denaturation	   of	   hybridized	   DNA	   is	  substantially	   higher,	   which	   allows	   easy	   discrimination	   of	   sequences	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containing	  a	  mutation.	  Despite	  the	  original	  sensitivity	  of	  SPR	  technology	  being	  limited	  the	  potential	  of	  FO-­‐SPR	  to	  be	  combined	  with	  Au	  NPs72	  and	  thermal	   denaturation	   has	   a	   large	   potential	   to	   improve	   sensitivity	  considerably	  for	  DNA	  analysis.	  
The	   aim	  of	   this	  work	   is	   to	   develop	   innovative,	   fast	   and	  highly	  
sensitive	   bioassays	   on	   a	   compact	   fiber	   optic	   SPR	   biosensor	  
platform,	   that	   can	   be	   used	   to	   identify	   and	   quantify	   bacteria	   and	  
viruses	  in	  a	  multiplexed	  way.	  	  Bacteria	  and	  viruses	  are	  detected	  either	  directly	   or	   by	   means	   of	   their	   DNA	   using	   DNA	   melting	   analysis.	   This	  unique	  combination	  of	  techniques	  will	  open	  up	  new	  opportunities	  in	  the	  development	   of	   POC	   biosensors	   for	   bacteria	   and	   viral	   detection.	   A	  schematic	   overview	   of	   the	   thesis	   and	   the	   correlation	   between	   the	  different	  chapters	  can	  be	  found	  in	  Figure	  1.12.	  
	  
Figure	   1.12:	   Visualization	   of	   PhD	   structure	   showing	   the	   connections	   between	  
different	  chapters.	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In	   Chapter	   2	   a	   literature	   review	   is	   made	   of	   new	   molecular	  diagnostic	  methods	  capable	  of	  detecting	  the	  smallest	  possible	  alteration	  in	   DNA,	   a	   single	   nucleotide	   polymorphism	   (SNP).	   The	   focus	   of	   this	  chapter	   is	   on	   fast	   and	   robust	   technologies	   for	   sensitive	   and	   specific	  target	  detection	  that	  could	  potentially	  be	  used	  in	  POC	  tests.	  The	  chapter	  is	   limited	   to	   assay	   design	   and	   largely	   excludes	   detection	   methods	   as	  most	   of	   these	   assays	   can	   be	   applied	   on	   multiple	   detection	   platforms	  with	   optical,	   electrochemical	   and	  mass	   sensitive	   transducers	   amongst	  which	  the	  FO-­‐SPR	  biosensor.	  	  The	  first	  experimental	  chapter,	  Chapter	  3,	  deals	  with	  development	  of	   a	   biosensor	   for	   direct	   detection	   of	   micro-­‐organisms.	   Because	   viral	  particles	  are	  substantially	  smaller	   than	  bacteria	   (low	  nanometer	  range	  versus	   low	  micrometer	  range),	   they	  are	  a	  good	  benchmark	   for	   the	  FO-­‐SPR	  biosensor	  sensitivity	  towards	  small	  particulate	  organisms.	  For	  this	  proof	  of	  concept,	  bacteria	  specific	  viral	  particles,	  named	  bacteriophages,	  are	  used.	  These	  bacteriophages	  can	  express	  short	  peptides	  on	  their	  coat	  proteins,	   transforming	   them	   in	   affinity	   labels.	   Although,	   affinities	   of	  individual	  peptides	  are	  normally	   characterized,	  a	  new	   trend	   is	   shifting	  towards	  usage	  of	  the	  entire	  phage	  as	  affinity	  label	  because	  of	  increased	  receptor	   density,	   stability	   and	   functionality.	   Therefore,	   bioassays	   are	  needed	   that	   can	   characterize	   binding	   kinetics	   of	   the	   entire	   phage	  particle.	  FO-­‐SPR	  is	  used	  to	  this	  extent,	  since	  one	  SPR	  measurement	  can	  capture	   all	   kinetic	   binding	   parameters	   of	   the	   phage	   affinity	   label.	   The	  FO-­‐SPR	  phage	  assay	  is	  applied	  on	  the	  selection	  of	  a	  phage	  affinity	  label	  for	  the	  fluorescent	  protein	  eGFP.	  Although,	  FO-­‐SPR	  is	  a	  true	  asset	  in	  the	  determination	  of	  binding	  constants	  for	  non-­‐conventional	  affinity	  labels,	  the	   limitations	   of	   the	   FO-­‐SPR	   measuring	   principal	   is	   revealed	   when	  using	  label-­‐free	  assays.	  In	  Chapter	  4	  a	  new	  assay	  is	  developed,	  not	  based	  on	  detection	  of	  the	  complete	  micro-­‐organism,	   but	   on	   the	   presence	   of	   its	   genetic	  material.	  DNA	  can	  be	  used	  both	  to	  quantify	  and	  identify	  micro-­‐organisms,	  as	  each	  micro-­‐organism	   contains	   genetic	   codes,	   which	   are	   unique	   to	   the	  particular	   micro-­‐organisms.	   In	   this	   proof-­‐of-­‐concept	   research,	   a	   new	  biosensor	   is	   developed	   combining	   FO-­‐SPR	  with	   DNA	  melting	   analysis.	  The	  detection	  of	   single	  nucleotide	  alterations	   in	   target	  DNA	  strands	  of	  variable	  length	  is	  addressed.	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In	  Chapter	  5,	  the	  FO-­‐SPR	  DNA	  melting	  assay	  is	  further	  advanced,	  in	  order	   to	   allow	   high	   resolution	   DNA	   melting	   directly	   in	   a	   PCR	  amplification	  mix.	  	  Subsequently,	  the	  assay	  is	  applied	  on	  a	  real	  test	  case	  using	   a	   common	   human	   pathogen,	   Legionella	   pneumophila	   bacteria.	  Usually,	   the	   PCR	   assay	   is	   applied	   on	   sputum	   samples	   to	   detect	   this	  bacteria.	   However,	   the	   assay	   was	   found	   to	   be	   unable	   to	   detect	   some	  subspecies	  when	  they	  contain	  a	  particular	  mutation.	  In	  this	  chapter,	  the	  performance	   of	   the	   FO-­‐SPR	   melting	   DNA	   assay	   is	   validated	   against	  current	  state-­‐of-­‐the-­‐art	  DNA	  screening	  assays.	  	  In	  Chapter	   6,	   the	  FO-­‐SPR	  DNA	  melting	  assay	   is	   improved	   towards	  simultaneous	   DNA	   quantification	   and	   multiplex	   target	   identification.	  This	  will	   require	   several	   changes	   to	   the	   original	   FO-­‐SPR	   DNA	  melting	  assay,	   with	   special	   attention	   for	   the	   speed	   of	   the	   original	   FO-­‐SPR	  melting	   assay,	   which	   will	   be	   increased,	   while	   safeguarding	   the	  resolution	  in	  order	  to	  detect	  SNP	  containing	  samples.	  This	  chapter	  will	  capture	   the	   full	   potential	   of	   the	   FO-­‐SPR	  melting	   assay	   as	   it	   will	   allow	  detection	   and	   quantification	   of	   bacteria	   in	   a	   single	   assay,	   resulting	   in	  considerable	  reduction	  of	  the	  total	  assay	  time	  compared	  to	  other,	  more	  conventional	  techniques.	  	  In	  Chapter	  7,	  	  the	  througput	  of	  the	  biosensor	  is	  further	  increased	  by	  simultaneously	  detecting	  two	  bacteria	  using	  the	  FO-­‐SPR	  biosensor.	  The	  FO-­‐SPR	   sensor	   tip	   and	   the	   Au	   NP	   labeles	   are	   therefore	   functionalized	  with	  two	  different	  sets	  of	  hybridization	  probes,	  each	  targeting	  a	  region	  of	  interest	  in	  a	  different	  bacterial	  species.	  To	  improve	  the	  sensitivity	  of	  this	  assay,	  a	  multiplex	  PCR	  will	  be	  used	  	  to	  amplify	  the	  target	  DNA.	  This	  also	  allows	  the	  FO-­‐SPR	  to	  monitor	  in	  real-­‐time	  the	  PCR	  reaction,	  which	  makes	  this	  multiplex	  FO-­‐SPR	  also	  a	  quantitative	  assay.	  The	  assay	  will	  be	  	  able	   to	   resolve	   the	   presence	   of	   one	   or	   both	   bacteria	   and	   could	   even	  detect	  mutations	  in	  the	  target	  sequences.	  Finally,	   in	   Chapter	   8	   the	   most	   important	   achievements	   in	   the	  development	   of	   the	   FO-­‐SPR	   DNA	   biosensor	   are	   summarized.	   These	  milestones	   are	   put	   in	   perspective	   of	   the	   entire	   development	   process,	  necessary	  to	  integrate	  the	  FO-­‐SPR	  platform	  in	  a	  POC	  biosensor	  capable	  of	   micro-­‐organism	   detection.	   In	   this	   regard	   suggestions	   are	   made	   for	  future	   improvements	   to	   both	   the	   biosensor	   and	   the	   presented	  bioassays.	   This	   overview	   will	   not	   only	   focus	   on	   detection	   of	   micro-­‐
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organisms	  but	  also	  on	  opportunities	   for	   the	  FO-­‐SPR	  biosensor	   in	  other	  fields.	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2.1 Introduction	  Recent	   advances	   in	   the	   field	   of	   molecular	   biology	   have	   created	  opportunities	   for	   the	  development	  of	  novel	  diagnostic	  methods,	  which	  are	   becoming	   irreplaceable	   not	   only	   in	   the	   detection	   and	   typing	   of	  diseases,	   but	   as	   well	   in	   steering	   the	   drug	   therapy,	   being	   either	   with	  antibiotics	   or	   novel	   cancer	   drugs.	   For	   instance,	   numerous	   genes	   have	  been	   related	   to	   various	   human	   diseases1	   promoting	   thus	   genetic	  screening	   to	   become	   applicable	   in	   prenatal	   diagnostics,2	   detection	   of	  cancer,3	   cardiovascular	   disease4	   and	   many	   other	   pathologies5,6.	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Moreover,	   molecular	   diagnostics	   can	   even	   be	   used	   to	   enhance	   cancer	  therapy	   through	   assessing	   a	   patient’s	   susceptibility	   for	   certain	  treatments7-­‐9.	  These	   so	   called	   'companion	  diagnostics'	   are	   increasingly	  becoming	  an	  essential	  guide	  for	  the	  successful	  application	  of	  a	  number	  of	  treatments10.	  Furthermore,	  molecular	  diagnostic	  methods	  are	  used	  in	  microbiology11	  for	  identifying	  pathogens	  and	  their	  antibiotic	  resistance	  genes,	   hence	   guiding	   treatments	   towards	   correct	   antibiotic	   type/dose	  and	   preventing	   further	   growth	   in	   global	   antibiotic	   resistance	   of	  bacterial	  pathogens12.	  Currently,	  however,	  the	  molecular	  diagnostics	  field	  is	  still	  limited	  to	  laborious	  and	  costly	  methods	  that	  require	  significant	  infrastructure	  and	  skills,	   only	   available	   at	   specialized	   laboratory	   facilities.	   For	   human	  genetic	   screening	   the	   preferable	  method	   is	   sequencing	   because	   it	   can	  capture	   the	   complete	   spectrum	   of	   genetic	   variation	   in	   an	   individual13.	  Although	   in	   recent	   years	   sequencing	   technologies	   have	   experienced	   a	  dramatic	  drop	  in	  price	  and	  time	  to	  result,14,15	  some	  hurdles	  still	  severely	  limit	   its	   direct	   application	   in	   routine	   diagnostics13:	   (1)	   reliable	  sequencing	   results	   depend	   in	   first	   place	   on	   careful	   construction	   of	   a	  sequence	   library	  and	  sample	  preparation16	  and	  (2)	   the	  amount	  of	  data	  generated	  by	   sequencing	  and	   the	   complexity	  of	   their	  processing	   is	  not	  compatible	  with	  routine	  applications17,18.	  In	  microbiological	  applications,	   the	  preferred	  method	   for	  pathogen	  detection	   and	   evaluation	   of	   antibiotic	   resistance	   still	   relies	   on	   actual	  selective	   bacterial	   growth,	   limiting	   the	   speed	   of	   these	   assays	   to	   48h.19	  Molecular	   diagnostics	   such	   as	   PCR	   are	   able	   to	   improve	   the	   sample	  throughput,	  time	  to	  detection	  and	  sensitivity	  for	  non-­‐cultivable	  bacteria	  but	   are	   introducing	   new	   problems	   such	   as	   sample	   preparation,	  expertise	  and	  facility	  requirements20.	  Recently,	   the	   trend	   in	  developing	   rapid	  and	   cost-­‐effective	  point-­‐of-­‐care	  (POC)	  diagnostics	  has	   increased	   tremendously.	  Devices	   that	  allow	  detection	  of	  genetic	  changes,	  such	  as	  point	  mutations,	  with	  minimal	  user	  intervention	   and	   laboratory	   requirements	   and	   which	   could	   even	   be	  deployed	  in	  resource	  limited	  regions	  are	  being	  developed21,22.	  Although	  this	   next	   generation	   of	   molecular	   diagnostic	   devices	   presents	   a	   large	  improvement	  compared	  to	  classical	  methods,	  they	  remain	  linked	  to	  the	  intrinsic	   limitations	  of	   the	  PCR	  method	  such	  as	   total	  analysis	   time	  and	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high	   sensitivity	   towards	   sample	   contamination.	   Furthermore	   the	   cost	  per	   test	  remains	   too	  high	   for	   the	   intended	  markets	  such	  as	  developing	  countries23.	  In	   recent	   years,	   several	   new	   methods	   for	   detection	   of	   genetic	  mutations	   have	   become	   available	   that	   are,	   currently,	   at	   least	  comparable	  to	  PCR	  in	  their	  performance.	  These	  new	  developments	  have	  been	   promoted	   to	   drastically	   improve	   and	   simplify	   present-­‐day	   POC	  tools,	  enabling	  sensitive	  detection	   in	  minutes’	   time	  and	  at	  a	   fraction	  of	  the	   cost	   of	   current	  methods.	  However	  not	   a	   lot	   of	   these	  new	  concepts	  have	   found	   their	   way	   to	   commercial	   applications	   due	   to	   numerous	  obstacles	  such	  as	  performance,	  price	  and	  applicability24,	  allowing	  classic	  PCR	  to	  remain	  the	  method	  of	  choice	  for	  molecular	  diagnostics.	  	  
2.2 Aim	  of	  this	  chapter	  In	  this	  chapter	  a	  selection	  is	  made	  of	  new	  molecular	  diagnostic	  methods	  that	   could	   break	   this	   spell	   and	   live	   up	   to	   the	   promises	   of	   improving	  molecular	   diagnostics.	   There	   will	   be	   a	   particular	   focus	   on	   single	  nucleotide	   polymorphism	   (SNP)	   detection	   for	   two	   reasons:	   one,	   SNP	  mutation	  detection	  can	  be	  taken	  as	  a	  benchmark	  and	  two,	  the	  impact	  of	  a	  SNP	  on	   the	  overall	  double	  strand	   is	   limited	  and	  strongly	  depends	  on	  multiple	   factors,	  making	   this	  one	  of	   the	  most	   challenging	  mutations	   to	  detect.	   The	   chapter	   is	   limited	   to	   assay	   design	   and	   largely	   excludes	  detection	  methods	   as	  most	   of	   these	   assays	   can	  be	   applied	  on	  multiple	  detection	  platforms	  (i.e.	  optical,	  electrochemical,	  mass	  based,	  etc.).	  New	   assays	   are	   categorized	   in	   the	   following	   three	   fields	   based	   on	  the	  applied	  methodology:	  	  1 Hybridization	  mediated	  SNP	  detection	  2 Protein	  mediated	  SNP	  detection	  3 SNP	  detection	  through	  thermal	  denaturation	  of	  hybrids.	  Each	   of	   these	   topics	   will	   be	   discussed	   elaborately	   in	   the	   following	  paragraphs,	  with	  a	  particular	  focus	  on	  sensitivity	  and	  applicability	  of	  the	  methods.
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2.3 	  Hybridization	  mediated	  SNP	  detection	  
2.3.1 Single	  hybridization	  probes	  Detection	  of	  SNPs	  through	  direct	  hybridization	  remains	  one	  of	  the	  most	  popular	   methods	   for	   genotyping.	   However,	   the	   greatest	   challenge	   in	  these	  assays	  is	  the	  specificity	  of	  the	  hybridization,25	  because	  the	  impact	  of	   a	   single	  variable	  nucleotide	  on	   the	  overall	  double	   strand	   stability	   is	  rather	   limited	   (Figure	   2.1).	   For	   example,	   the	   influence	   of	   a	   SNP	   on	   a	  20bp	  DNA	  double	  helix	  target	  comprises	  only	  5%	  of	  the	  total	  number	  of	  basepairs.	   Several	   factors	   can	   improve	   the	   selectivity	   of	   hybridization,	  all	   being	   related	   to	   the	   mass	   transport	   and	   kinetics	   involved	   in	   the	  hybridization	   process26.	   Therefore,	   parameters	   such	   as	   temperature,	  ionic	   strength,	   sequence	   and	   oligonucleotide	   concentration,	   which	   all	  have	   a	   direct	   influence	   on	   mass	   transport	   and	   kinetics,	   need	   to	   be	  precisely	   controlled	   ensuring	   optimal	   hybridization	   efficiency27.	  However,	   for	   every	   new	   target,	   new	   optimal	   parameters	   need	   to	   be	  defined,	   requiring	   a	   substantial	   investment	   in	   assay	   optimization	   and	  making	  the	  detection	  of	  multiple	  DNA	  targets	  very	  complex.	  
 
Figure	  2.1:	  Basic	   concept	   of	   hybridization	  based	   strategies	   for	   SNP	  detection.	   In	  
this	  direct	  hybridization	  of	  two	  complementary	  strands	  detection	  of	  a	  mutation	  is	  
difficult,	   as	   the	   mutation	   only	   gives	   lower	   hybridization	   yields	   in	   short	   target	  
sequences.	  Detection	  platforms	  can	  be	  of	  any	  kind:	   fluorescent,	   electrochemical,	  
SPR.	  These	   limitations	   have	   pushed	   SNP	   detection	   towards	   a	   new	  generation	  of	   assays	  where,	   the	   influence	  of	   specific	   conditions	  on	   the	  hybridization	   process	   are	   being	   eliminated	   as	   much	   as	   possible.	   By	  introducing	   a	   better	   control	   over	   hybridization,	   new	   assays	   have	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become	  more	  sensitive	  and	  robust.	  One	  example	  of	  improved	  specificity	  of	  the	  hybridization	  process	  is	  the	  introduction	  of	  secondary	  structures	  (e.g.	  stem-­‐loop)	   in	  reporter	  oligonucleotides.	  These	  reporter	  molecules	  can	   hybridize	   to	   a	   target	   sequence,	   only	   after	   the	   target	   strand	   has	  displaced	   the	   secondary	   structure	   through	   a	   process	   called	   branch	  migration28,29.	   Branch	   migration	   can	   happen	   between	   any	   single	  stranded	   DNA	   and	   a	   double	   stranded	   molecule	   when	   they	   share	   a	  homologous	   region	   for	   binding	   the	   single	   strand	   to	   the	   duplex.	   As	   a	  result	   of	   the	   homologous	   regions,	   the	   single	   strand	   can	   attack	   the	  existing	  duplex	  resulting	   in	   three-­‐stranded	  structure	  where	  all	   strands	  compete	  for	  binding	  their	  complementary	  strands.	  In	  the	  presence	  of	  a	  SNP,	   the	   thermodynamic	   driving	   force	   towards	   breaking	   up	   the	  secondary	   structure	   in	   the	   reporter	   sequence	  and	  hybridization	   to	   the	  target	  molecule	  will	  be	  lowered	  explaining	  why	  these	  structured	  probes	  possess	  increased	  specificity	  and	  robustness	  in	  comparison	  with	  simple	  complementary	   strands30.	   One	   of	   the	   first	   implementations	   of	   the	  branch	   migration	   process	   in	   molecular	   diagnostics	   was	   Molecular	  Beacons	  (MB).	  
2.3.2 Molecular	  beacons	  MBs	  are	  a	  particular	  class	  of	  branch	  migrating	  molecules,	  as	  they	  use	  a	  self-­‐complementary	  region	  as	  the	  competing	  DNA	  duplex	  in	  the	  process	  of	  SNP	  identification	  (Figure	  2.2)31.	  The	  MBs	  internal	  structure	  forms	  an	  oligonucleotide	   hairpin	   probe	   with	   a	   fluorophore	   and	   a	   quencher	  conjugated	  to	  the	  opposite	  ends	  of	  the	  oligomer.	  When	  the	  complement	  of	  the	  MB	  is	  not	  present,	  they	  form	  a	  stem-­‐loop	  structure	  that	  brings	  the	  quencher	   in	   close	   proximity	   to	   the	   fluorophore,	   resulting	   in	   a	   low	  fluorescent	  signal.	  From	  the	  moment	  the	  target	  sequence	  is	  present,	  the	  hairpin	   unfolds	   in	   favour	   of	   target	   hybridization,	   resulting	   in	   an	  increased	  fluorescence	  signal.	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Figure	  2.2:	  Molecular	  beacon	  strategy	  for	  SNP	  detection.	  Mutation	  discrimination	  
is	   improved	  by	   introducing	  a	  secondary	  structure	   (hairpin)	   in	   the	  DNA	  reporter	  
strand	   which	   drastically	   lowers	   the	   hybridization	   yield	   in	   case	   of	   a	   mutation,	  
resulting	   in	   lower	   fluorescence.	   The	   hairpin	   also	   brings	   together	   quencher	   and	  
fluorophore	  when	  the	  MB	  is	  not	  bound	  to	  the	  DNA	  target.	  Although	   the	   new	   generation	   of	   point	   of	   care	   (POC)	   biosensors	   is	  making	   molecular	   diagnostics	   available	   outside	   specialized	   labs,	   the	  technology	   makes	   use	   of	   classic	   principals	   such	   as	   fluorescence	   and	  quantitative	   PCR	   to	   detect	   a	   sample32-­‐34.	   This	   technology	   limits	   the	  abilities	   of	   the	   molecular	   diagnostic	   POC	   test,	   as	   it	   cannot	   reach	   the	  strongpoints	   such	   as	   ease	   of	   interpretation,	   time	   to	   results	   and	   assay	  cost35	   that	   made	   the	   initial	   generation	   of	   biosensors	   so	   successful.	  However	   new	   technologies	   can	   be	   developed,	   which	   could	   enable	  development	  of	   biosensors	  with	  potentially	   lower	   costs,	   time	   to	   result	  and	   require	   minimal	   interpretation	   whilst	   still	   reaching	   the	   required	  detection	   limits32.	   One	   of	   these	   high	   potential	   technologies	   is	   DNA	  melting	  analysis.	  
2.3.3 Binary	  DNA	  probes	  An	  alternative	   for	  molecular	  beacons,	  known	  as	  binary	  probe,	   is	  based	  on	  a	  simple	  division	  of	  the	  probe	  into	  two	  individual	  parts	  (Figure	  2.3),	  where	  the	  individual,	  shorter	  probes,	  also	  known	  as	  the	  analyte	  binding	  arms,	  are	  used	  to	  bind	  to	  the	  target.	  The	  individual	  binding	  arms	  can	  be	  labelled	   with	   any	   kind	   of	   reporter	   molecule	   that	   only	   gives	   a	   signal	  when	  both	  are	  bound	  to	  the	  target,	  resulting	  in	  a	  remarkable	  increase	  in	  both	   specificity	   and	   sensitivity	   towards	   SNP	   detection.	   The	  improvements	   in	  performance	  can	  be	  explained	  by	  the	  relatively	  short	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length	   of	   the	   individual	   fragments	   of	   the	   binary	   probe,	   which	   consist	  each	   of	   7-­‐10	   bases,	   emphasizing	   considerably	   the	   effect	   of	   a	   single	  variable	  base	  on	  the	  DNA	  hybrid.	  	  	  
 
Figure	  2.3:	  General	  concept	  of	  binary	  probes	  where	  a	  probe	  is	  split	  into	  two	  halves	  
to	  increase	  the	  impact	  of	  a	  mutation	  on	  the	  hybridization	  yield.	  Binary	  probes	  use	  
always	  reporters,	  which	  require	  the	  presence	  of	  the	  two	  probes	  hybridized	  to	  the	  
target	  in	  order	  to	  activate	  a	  reporter	  molecule	  or	  reaction.	  Initially,	   binary	   probes	   were	   mainly	   used	   in	   combination	   with	  fluorescence	   resonance	   energy	   transfer	   detection	   (FRET).	  Kolpashchikov	   et	   al.	   have	   recently	  made	   improvements	   on	   the	   binary	  probe	   concept,	   through	   integration	   of	   an	   RNA	   aptamer.	   Aptamers	   are	  RNA	   or	   DNA	   oligonucleotides	   selected	   for	   their	   binding	   capacity	  towards	   a	   particular	   molecule,	   being	   in	   this	   case	   the	   fluorescent	   dye	  malachite	   green	   (Figure	   2.4).	   The	   aptamer	   was	   integrated	   into	   the	  binary	  probe	  concept	  by	  splitting	  its	  sequence	  in	  two	  parts,	  each	  linked	  to	   a	   target-­‐binding	  probe.	  The	  aptamer	  only	  becomes	   functional	  when	  its	  two	  target-­‐binding	  probes	  are	  bound	  to	  the	  target	  DNA	  strand,	  which	  brings	   the	   individual	   aptamer	   parts	   in	   each	   other’s	   vicinity.	   Once	  functional,	  the	  aptamer	  can	  bind	  the	  malachite	  green	  dye	  stabilizing	  it	  in	  a	  more	  fluorescent	  conformation,	  which	  results	  in	  a	  2000	  fold	  increase	  in	   the	   fluorescence	   signal36.	   The	   assay	   is	   able	   to	   detect	   41	   out	   of	   the	  possible	  42	  mutations	  in	  a	  14bp	  nucleotide	  target	  strand37.	  However	  the	  assay	  is	  limited	  in	  sensitivity	  by	  the	  affinity	  of	  the	  aptamer	  for	  the	  target	  dye.	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Figure	  2.4:	  Design	  of	   the	  binary	  malachite	   aptamer.	  On	   the	   left,	   the	   structure	  of	  
the	  parent	  malachite	  aptamer	   is	   shown,	  which	   stabilizes	   the	  dye	   resulting	   in	  an	  
increased	  fluorescence.	  This	  aptamer	  is	  split	  in	  two	  halves,	  each	  extended	  with	  a	  
target	   binding	   arm,	   resulting	   in	   the	   binary	  malachite	   aptamer.	  When	   the	   target	  
DNA	   strand	   is	  present,	   the	   functional	  malachite	   aptamer	   is	   formed.	  Reproduced	  
after	  Kolpashchikov	  et	  al.37	  Binary	  probe	  assays	  can	  be	  further	  improved	  with	  the	  integration	  of	  a	   ribozyme	   (Figure	   2.5)38	   which	   are	   DNA/RNA	   sequences	   with	   an	  enzymatic	  activity.	  In	  the	  first	  application	  of	  this	  concept,	  the	  assay	  was	  designed	   to	   integrate	   a	   deoxyribozyme	   in	   DNA	   probes	   that	   bind	  specifically	   to	   a	   20bp	   target.	   When	   bound	   to	   this	   target,	   the	   two	  fragments	   form	   the	   functional	   ribozyme,	   which	   then	   cleaves	   a	  phosphodiester	   bond	   in	   a	   DNA	   reporter	   molecule,	   resulting	   in	  separation	  of	  a	  fluorescent	  FAM	  at	  the	  5’	  end	  from	  a	  black	  hole	  quencher	  at	   the	   3’	   end.	   Mutations	   can	   in	   this	   way	   be	   discriminated	   but	   not	  identified,	  by	  calculating	  the	  ratios	  between	  probe	  fluorescence.	  This	  is	  done	  by	  registration	  of	  fluorescence	  intensities,	  after	  subtraction	  of	  the	  background	   fluorescence,	   at	  517	  nm	   in	   the	  presence	  of	   the	   true	   target	  and	   in	   the	  presence	  of	  each	  mismatched	  oligonucleotide.	  The	  resulting	  fluorescent	   signal	   can	   easily	   discriminate	   11	   of	   20	   tested	   SNPs	   in	   the	  target	   strand	   with	   a	   high	   signal	   to	   noise	   ratio	   compared	   to	   MBs.	  Furthermore,	   integration	   of	   a	   ribozyme	   in	   a	   binary	   probe	   has	   the	  advantage	  that	  the	  formation	  of	  one	  functional	  ribozyme	  can	  be	  used	  to	  activate	   multiple	   reporter	   molecules,	   which	   results	   in	   a	   strong	   signal	  amplification.	   As	   a	   result,	   the	   detection	   limit	   of	   this	   ribozyme-­‐based	  assay	   is	   1	   nM,	   which	   is	   two	   orders	   of	   magnitude	   lower	   than	   the	  previously	   described	   malachite	   based	   assay.	   Use	   of	   more	   efficient	  DNAzymes	  in	  similar	  assays	  has	  shown	  to	  further	  improve	  the	  detection	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limit,	   with	   the	   theoretical	   detection	   limit	   being	   10-­‐15	   M	   due	   to	   the	  general	  limitations	  of	  enzyme	  catalysed	  reactions39.	  	  
 
Figure	  2.5:	  Design	  of	  the	  binary	  deoxyribozyme	  probe.	  A)	  Structure	  of	  the	  parent	  
deoxyribozyme	  E6,	  which	  is	  transformed	  into	  the	  binary	  deoxyribozyme	  biE6	  with	  
hairpin	  forming	  target	  binding	  arms	  to	  reduce	  non-­‐specific	  binding.	  B)	  Scheme	  for	  
fluorescent	   detection	   of	   the	   analyte-­‐dependent	   catalytic	   activity	   of	   biE6.	   FAM	  
indicates	   fluorescein,	   BHQ	   is	   black	   hole	   quencher.	   Reproduced	   after	  
Kolpashchikov	  et	  al.38	  Further	  improvements	  in	  detection	  limit	  are	  possible	  with	  catalytic	  cascades,	  where	  a	  specific	  recognition	  event	  results	  in	  the	  activation	  of	  multiple	   DNAzymes	   and	   thus	   even	   stronger	   signal	   amplification.	   The	  group	  of	  Willner	  proved	  this	  concept	  for	  the	  detection	  of	  a	  SNP	  involved	  in	  the	  Tay-­‐Sachse	  genetic	  disorder40.	  They	  made	  a	  combination	  of	  a	  Zn2+	  dependent	   ligation	   DNAzyme	   and	   an	   Mg2+	   dependent	   DNAzyme	   that	  cuts	   a	   fluorophore/quencher	  DNA	   substrate,	   resulting	   in	   fluorescence.	  Both	  DNAzymes	   are	   integrated	   in	   the	   binary	   probes,	   and	   thus	   depend	  on	   highly	   specific	   hybridization	   events	   before	   activation.	   In	   short,	  presence	  of	   the	   target	  strand	  opens	  a	   loop	   in	   the	   inactive	  Zn2+	   ligation	  enzyme,	   which	   catalyses	   the	   ligation	   of	   a	   5’	   imidazole	   modified	   DNA	  strand	   with	   a	   3’	   hydroxylated	   DNA	   strand.	   This	   ligation	   product	  assembles	   the	   functional	   Mg2+	   dependent	   DNAzyme,	   which	   cleaves	  another	   sequence,	   releasing	   a	   fluorescent	   reporter	   strand	   from	   its	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quencher.	  Main	  advantage	  of	  this	  enzyme	  cascade	  is	  that	  the	  presence	  of	  one	   target	   molecule	   results	   in	   activation	   of	   multiple	   DNAzymes,	  allowing	   activation	   of	   multiple	   reporter	   molecules	   and	   thus	   enabling	  lower	  detection	  limits.	  With	  the	  most	  optimal	  assay	  design	  it	  is	  possible	  to	  detect	  the	  mutant	  with	  an	  SNP	  from	  the	  wild	  type	  25bp	  DNA	  target	  at	  concentrations	  up	  to	  10	  pM.	  Similar	   assays	   have	   also	   been	   performed	   with	   peroxidase	   like	  DNAzymes,	   which	   are	   more	   suited	   for	   POC	   diagnostics,	   as	   the	  colorimetric	   reaction	   does	   not	   require	   specialized	   readout	   equipment.	  Peroxidase	  DNAzymes	   are	   characterized	   by	   a	   high	   density	   of	   G	   triplet	  repeats,	   which	   bind	   with	   high	   affinity	   to	   hemine.	   The	   hemine	   is	  responsible	   for	   the	  catalytic	  activity	  of	   the	  DNAzyme	  as	   it	   can	  catalyze	  the	   oxidation	   of	   either	   3,3'-­‐Diaminobenzidine	   (DAB)	   or	   2,2-­‐azino-­‐bus(3ethylbenzyiothiozoline-­‐6-­‐sulfonic	   acid)	   (ABTS2-­‐)	   by	   means	   of	  H2O2	   into	   their	   respective	   blue	   and	   brown	   coloured	   radicals.	   The	   first	  attempt	  to	  use	  this	  DNAzyme	  in	  a	  binary	  probe	  resulted	  in	  a	  somewhat	  poor	   detection	   limit	   of	   1	   µM.41	   The	   assay	   was	   further	   improved	   by	  splitting	   the	  DNAzyme	   asymmetrically,	   leading	   to	   a	   lower	   background	  signal	   due	   to	   a	   decreased	   tendency	   of	   the	   DNAzyme	   to	   self-­‐assemble	  without	  the	  target	  strand.	  This	  method	  has	  also	  been	  applied	  for	  longer	  targets	   (up	   to	   44bp),	   by	   the	   introduction	   of	   competing	   probes	   for	   the	  target	  sequence	  with	  a	  detection	  limit	  of	  5	  nM42.	  	  Combining	   DNAzymes	   with	   bimolecular	   beacons	   leads	   to	   even	  further	   improvements	   in	   assay	   detection	   limit43.	   Bimolecular	   beacons	  are	  two	  molecular	  beacons,	  which	  have	  complementary	  regions.	  When	  a	  target	   strand	   is	   present,	   it	   will	   bind	   to	   one	   of	   the	   molecular	   beacons	  (MB1),	  opening	  the	  stem-­‐loop	  of	  MB1,	  which	  can	  then	  bind	  the	  second	  MB	   (MB2).	   Binding	   of	   MB2	   with	   MB1	   liberates	   the	   target,	   making	   it	  available	   for	  opening	  up	  another	  MB1.	  This	  process	   is	  called	   ‘catalysed	  hairpin	  assembly’	  and	  will	  result	  in	  a	  self-­‐propagating	  chain	  reaction	  of	  molecular	   beacon	   hybridization	   events.44	   The	   method	   as	   such	   can	   be	  also	   used	   in	   combination	   with	   DNAzymes	   to	   construct	   nanowires	  consisting	   of	   functional	   DNAzymes.	   The	   first	   configuration	   of	   this	  method	   had	   a	   detection	   limit	   of	   10-­‐9	   M	   of	   target	   molecules45	   when	  combined	   with	   a	   magnesium	   DNAzyme	   that	   could	   cut	   a	   reporter	  oligonucleotide,	   releasing	   a	   fluorophore	   from	   a	   quencher.	   When	   this	  concept	  was	  combined	  with	  repeating	  horseradish	   like	  DNAzymes	  that	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can	   catalyse	   the	   formation	   of	   a	   colorimetric	   substrate,	   an	   even	   more	  sensitive	  assay	  was	  created,	  capable	  of	  detecting	  SNPs	  in	  a	  19bp	  target	  derived	   from	   the	   BRCA1	   oncogene	   at	   concentrations	   of	   10-­‐13	   M46.	  Although	   this	   assay	   is	   extremely	   sensitive,	   the	   long	   assay	   time	   of	   4-­‐6	  hours	   necessary	   to	   reach	   this	   sensitivity	   is	   not	   suited	   for	   a	   POC	  diagnostic	   test.	   Therefore,	   it	   is	   currently	   combined	   with	   PCR	   for	  achieving	  better	  sensitivity	  in	  a	  shorter	  time	  period47.	  
2.3.4 DNA	  junction	  forming	  probes	  As	   an	   extension	   to	   the	   principles	   of	   binary	   probes,	   a	   combination	   is	  made	  between	  them	  and	  MBs,	  resulting	  in	  several	  advantages	  over	  both	  traditional	   strategies,	   foremost	   in	   an	   increased	   sensitivity	   and	  specificity.	   In	  general,	   the	  assay	  consists	  of	  4	  oligonucleotides	   that	  can	  only	  assemble	  in	  a	  DNA	  four-­‐way	  junction	  in	  the	  presence	  of	  the	  analyte	  and	   a	   molecular	   beacon.	   Both	   binary	   probes	   have	   complementary	  regions	  to	  the	  analyte	  and	  at	  the	  same	  time	  have	  binding	  arms	  that	  are	  complementary	   to	   the	   MB	   separating	   the	   quencher	   from	   the	  fluorophore	   at	   the	   MB	   ends	   upon	   hybridization.	   However,	   the	   binary	  probes	  need	  sufficient	   conformational	   freedom	  to	  bind	  both	   the	   target	  oligonucleotide	  and	  the	  MB	  at	  the	  same	  time,	  which	  is	  ensured	  through	  connection	  of	  these	  binding	  domains	  by	  triethylene	  glycol	  linkers.	  In	  the	  absence	  of	  analyte,	  both	  the	  molecular	  beacon	  and	  the	  binary	  probes	  are	  in	  a	  stable	  hairpin	   form,	   limiting	  chances	  of	  non-­‐specific	  hybridization.	  These	  junction	  probes	  are	  able	  to	  discriminate	  a	  SNP	  at	  any	  position	  in	  a	  20bp	  target	  with	  a	  more	  clear	  discrimination	  than	  a	  conventional	  MB.48	  Moreover,	   the	   junction	   probes	   can	   be	   applied	   on	   analytes	  with	   strong	  secondary	  structures	  directly	  at	  room	  temperature	  without	  any	   loss	  of	  sensitivity	   towards	   the	  SNP,49	   showing	  a	   clear	   advantage	  over	  MBs	  on	  that	  aspect.	  The	  highly	  specific	  analytical	  power	  of	  junction	  probes50	  can	  also	   be	   used	   to	   analyse	   the	   presence	   of	   multiple	   interesting	   genetic	  markers	  in	  one	  target.	  In	  recent	  research,	  junction	  probes	  are	  applied	  to	  detect	   the	  presence	  of	  both	  a	  Mycobacterium	   specific	   sequence	  and	  an	  antibiotic	  resistance	  mutation	  (towards	  Rifampin)	  (Figure	  2.6).	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Figure	   2.6:	   Design	   of	   the	   logic	   gate	   binary	   probe,	   designed	   to	   detect	   multiple	  
regions	  in	  one	  target.	  The	  Yes	  gate	  is	  made	  of	  a	  first	  molecular	  beacon	  (MB1),	  that	  
is	  combined	  with	  3	  different	  probes	  that	  only	  activate	  MB1	  in	  the	  presence	  of	  the	  
target	  DNA	  by	  hybridizing	  both	  with	  the	  target	  and	  the	  molecular	  beacon	  resulting	  
in	   a	   highly	   specific	   detection.	   A	   next	   logic	   gate,	   is	   used	   to	   locate	  mutations	   in	   a	  
particular	   locus,	  and	   is	   therefore	  named	  OR	  as	   its	  activation	  can	  be	  the	  result	  of	  
multiple	   mutations.	   This	   logic	   gate	   uses	   a	   different	   molecular	   beacon	   (MB2)	  
labelled	   with	   another	   fluorescent	   label.	   Activations	   is	   done	   by	   only	   two	   binary	  
probes,	   one	   present	   in	   different	   versions,	   for	   all	   possible	   target	   mutations.	  
Adapted	  from	  Cornett	  et	  al.	  51	  This	   application	   used	   two	   junction	   probe	   designs	   to	   detect	   both	   a	  general	  locus	  present	  in	  all	  Mycobacteria	  tuberculosis	  and	  a	  SNP	  present	  only	   in	   Rifampin	   resistant	   strains	   of	   the	   M.	   tuberculosis.	   The	  combination	   of	   these	   junction	  probes	   results	   in	   a	  DNA	   ‘Logic	  Gate’52,53	  meaning	   that	   the	   presence	   of	   none,	   one	   or	   two	   junction	   probe	   signals	  results	  in	  an	  NO,	  YES,	  OR,	  AND	  answer	  to	  two	  questions:	  ‘Is	  there	  any	  M.	  
tuberculosis	  present	  in	  the	  sample?’	  and	  ‘Is	  this	  M.	  tuberculosis	  Rifampin	  resistant?’51.	  A	   variant	   of	   the	   initial	   junction	   probe,	   known	   as	   the	   three-­‐way	  junction	   (Figure	  2.7),	   is	   designed	   in	   such	  a	  way	   that	   the	   analyte	  binds	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together	  with	  an	  assistant	  probe,	  probe	  B	  to	  a	  reporter	  sequence,	  probe	  A,	   containing	  both	  a	  quencher	  and	   fluorophores,	   forming	   thus	  a	   three-­‐way	  motif.	  In	  the	  initial	  assay	  design	  the	  junction	  allowed	  the	  formation	  of	  a	  double	  stranded	  restriction	  enzyme	  recognition	  site	  in	  the	  reporter	  probe	  (probe	  A),	  resulting	  in	  the	  separation	  of	  the	  fluorescent	  label	  from	  the	  quencher	  and	  a	  detectable	  fluorescent	  signal54.	  The	  same	  process	  is	  repeated	  with	  a	  MB	  resulting	  in	  a	  sensitive	  self-­‐recycling	  assay	  that	  can	  detect	   SNPs	   in	   short	   oligonucleotides	   at	   low	   concentrations55.	   This	  concept	   is	  applied	  successfully	  using	  different	  detection	  concepts,	  such	  as	  colorimetric,	  electrochemical	  and	  fluorescence	  detection56-­‐60.	  
 
Figure	   2.7:	   Three-­‐way	   junction	   concept	  where	   the	   target	   strand	   and	   a	   reporter	  
strand	  (probe	  A)	  can	  hybridize	  with	  the	  help	  of	  an	  assistant	  probe	  (probe	  B)	  into	  a	  
3-­‐way	  structure.	  Only	  when	  this	  structure	  is	  formed,	  a	  restriction	  site	  is	  generated	  
that	   liberates	   the	   quencher	   from	   the	   reporter.	   Afterwards	   the	   analyte	   can	   be	  
recycled	   by	   denaturing	   the	   3-­‐way	   structure	   to	   activate	   a	   next	   reporter	   strand,	  
resulting	  in	  signal	  amplification.	  Adapted	  from	  Nakayama	  et	  al.54	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Werner	  and	  coworkers	  combined	  the	  three-­‐way	  junction	  with	  silver	  nanoclusters,	   creating	   an	   assay	   that	   can	   identify	   the	   exact	   basepair	  substitution	   in	   the	   SNP.	   The	   assay	   is	   based	   on	   earlier	   research	   of	   the	  group,	   which	   states	   that	   a	   silver	   nanocluster	   can	   emit	   a	   fluorescent	  signal	   in	   the	   presence	   of	   particular	   basepairs	   and	   that	   the	   emission	  wavelength	  changes	  when	  these	  basepairs	  are	  altered.	  To	  apply	  this	  in	  a	  real	   assay,	   they	   labelled	   a	   reporter	   strand	   with	   silver	   nanoclusters	  (consisting	   of	   ±	   30	   silver	   atoms)	   and	   combined	   this	   with	   a	  complementary	  ‘enhancer’	  strand,	  which	  formed	  a	  three-­‐way	  junction	  in	  the	   presence	   of	   the	   target	   sequence61.	   Hybridization	   of	   both	   reporter	  and	  enhancer	  strand	  to	  the	  target	  moves	  the	  enhancer	  sequence	  in	  close	  proximity	  of	  the	  nanocluster,	  which	  results	  in	  a	  fluorescent	  signal.	  When	  a	  mutation	  is	  present	  in	  the	  target	  sequence,	  the	  enhancer	  sequence	  will	  be	  shifted,	  resulting	   in	  a	  change	  of	   the	  sequence	   in	   the	   local	  vicinity	  of	  the	   silver	   nanocluster	   leading	   to	   a	   corresponding	   shift	   of	   the	  fluorescence	  emission	  band	  of	  the	  silver	  nanocluster	  of	  up	  to	  60	  nm.	  The	  assay	   proved	   to	   be	   highly	   sensitive	   and	   can	   even	   discriminate	   easily	  between	   3	   out	   of	   4	   possible	   base	   variations	   for	   one	   SNP	   position.	  Furthermore	   the	   assay	   is	   applicable	   on	   both	   short	   (20bp)	   and	   long	  oligonucleotides	   (120bp).	   Although	   no	   LOD	   has	   been	   determined,	   the	  lowest	   concentration	   estimated	   from	   the	   calibration	   curve	   at	   which	  SNPs	  can	  be	  clearly	  discriminated	  is	  2	  µM.	  
2.3.5 Toehold	  mediated	  hybridization	  Even	   though	   the	   above	   mentioned	   ‘next	   generation’	   hybridization	  probes	   can	   be	   applied	   on	   complex	   targets	   harnessing	   secondary	  structures	  and	  are	  able	  to	  discriminate	  all	  types	  of	  SNPs	  in	  a	  target,	  they	  still	   rely	   in	   general	   on	   complex	   designs	   and	   require	   optimization	   for	  performance	   under	   particular	   conditions,	   such	   as	   ionic	   strength	   and	  temperature.	   Another	   type	   of	   structured	   probe,	   namely	   the	   toehold	  probe	   tackles	   these	   limitations62.	   Toehold	   probes	   are	   DNA	   duplexes	  where	   the	   reporter	   strand	   has	   a	   short	   extension,	   which	   is	   used	   as	   a	  nucleation	   site	   for	   hybridization	   with	   a	   complementary	   target	   strand	  (Figure	  2.8).	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Figure	   2.8:	   Toehold	   concept,	   where	   the	   reporter,	   is	   extended	   with	   a	   non-­‐
overlapping	   region,	   complementary	   to	   a	   region	   on	   the	   DNA	   target,	   which	  
drastically	   increases	   hybridization	   speed	   and	   specificity	   when	   the	   reporter	   is	  
hybridized	   to	   a	   protector	   containing	   strand	   (the	   protector	   is	   a	   fluorophore	  
quenching	  molecule).	  Toeholds	  were	   first	   applied	   for	   SNP	   detection	   by	   Z.	   Zhang	   et	  al.	   63	  and	  improved	  by	  Subramanian	  et	  al.64	  where	  they	  were	  used	  to	  initiate	  the	  formation	  of	  a	  DNA	  origami	  structure.	  The	  presence	  of	  a	  SNP	  in	  the	  target	   sequence	   inhibits	   the	   strand	   displacement	   of	   the	   toehold,	  resulting	   in	   the	  absence	  of	   the	  DNA	  origami	   complex.	  Each	  of	   the	   four	  possible	  A,	  C,	  G	  or	  T	  base	  pair	  substitutions	  results	  in	  the	  formation	  of	  a	  different	   DNA	   origami	   that	   corresponds	   to	   the	   letter	   of	   the	   displaced	  nucleotide.	   The	   origami	   structure	   itself	   is	   read	   out	   using	   an	   Atomic	  Force	  microscope.	  Zhang	   et	   al.	   redesigned	   the	   original	   toehold	   probe	   into	   a	   SNP	  detection	   method,	   which	   is	   almost	   completely	   insensitive	   towards	  changes	   in	   temperature,	   salinity	   and	   target	   concentration65.	   This	   SNP	  detection	   consists	   of	   a	   fluorescently	   labelled	   reporter	   strand	   and	   its	  reverse	  compliment	  labelled	  with	  a	  quencher	  (Figure	  2.9).	  The	  toehold	  reporter	  probe	  is	  designed	  in	  such	  a	  way	  that	  hybridization	  to	  both	  the	  quencher	   sequence	   and	   the	   complementary	   DNA	   target	   sequence	   are	  not	   fully	   overlapping,	   resulting	   in	   ssDNA	   toehold	   domain.	   In	   contrast	  with	   an	   original	   toehold,	   in	   this	   assay	   both	   hybridization	   events	   are	  catalysed	  with	   a	   toehold	   reporter	   probe.	  Without	   the	   reverse	   toehold,	  probes	   would	   discriminate	   nucleic	   acids	   on	   a	   single-­‐base	   level	   using	  initial	   association	   kinetics,	   rather	   than	   thermodynamics,	   which	   would	  drastically	  limit	  the	  SNP	  discrimination	  power.	  	  




Figure	  2.9:	  Toehold	  exchange	  assay	  according	  to	  D.	  Zang	  et	  al.65.	  In	  this	  assay,	  the	  
reporter	  oligonucleotide	  contains	  a	  toehold	  domain	  that	  speeds	  up	  hybridization	  
both	   to	   the	   target	   strand	   and	   the	   protector	   strand,	   resulting	   in	   a	   hybridization	  
assay	  that	  is	  subject	  to	  equilibrium	  hybridization	  even	  under	  stringent	  conditions,	  
such	  as	  high	  salinity,	  temperature	  variability	  and	  high	  DNA	  concentrations.	  The	   presence	   of	   the	   toehold	   increases	   the	   kinetics	   of	   the	  displacement	   reaction,	   normally	   having	   a	   half-­‐life	   of	   months	   under	  typical	   conditions	   to	   a	   half-­‐life	   of	   10s.	   This	   equilibrium-­‐based	   toehold	  design	   is	  able	   to	  discriminate	  SNPs	  at	  any	  position	   in	  target	  sequences	  with	  a	  concentration	  of	  up	  to	  1	  nM	  even	  when	  secondary	  structures	  are	  present	   in	   the	   target.	   The	   hybridization	   yield	   does	   not	   change	   when	  excessive	   target	   is	   added	   (200x),	  when	   the	   temperature	   is	  varied	  over	  more	   than	   20°C	   or	   if	   Mg2+	   concentration	   is	   increased	   with	   several	  µmoles.	   However,	   a	   downside	   to	   this	   highly	   robust	   assay	   with	   the	  increased	   specificity	   is	   much	   slower	   reaction	   kinetics	   similar	   to	   all	  assays	  that	  rely	  on	  conformational	  constrained	  probes66.	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2.4 Protein	  mediated	  SNP	  detection	  Hybridization	  based	  assays	  have	  clearly	  evolved	  in	  the	  last	  5	  years	  both	  in	   specificity	   and	   sensitivity	   reaching	   a	   level	   where	   these	   assays	   can	  compete	  with	  other	  means	  of	  detection.	  However,	   they	  are	  still	  mainly	  applied	  to	  detection	  of	  SNPs	  in	  short	  oligonucleotides.	  Contrary	  to	  this,	  protein	   enzymes	   and	  mismatch	   binding	   ligands	   are	   not	   limited	   to	   the	  target	  oligonucleotide	  length.	  This	  can	  be	  explained	  by	  the	  fact	  that	  both	  protein	   enzymes	   and	   protein	   ligands	   recognize	   specifically	   the	  uncomplimentary	   base	   pairs,	   thereby	   not	   being	   constrained	   to	  hybridization	  processes	  for	  recognition	  of	  the	  SNP	  and	  as	  such	  have	  no	  limitation	  in	  target	  length.	  
2.4.1	  	  	  	  	  Mismatch	  binding	  ligands	  Mismatch	   binding	   ligands	   are	   a	   class	   of	   reporters	   that	   specifically	  recognize	  mismatched	   base	   pairs	   and	   bind	   to	   them	  with	   high	   affinity.	  One	   of	   the	   best-­‐known	  mismatch	   binding	   ligands	   is	   the	   protein	  MutS,	  which	  is	  a	  part	  of	  the	  post	  replicative	  mismatch	  repair	  system	  of	  the	  E.	  
coli	   bacterium.	   Recognition	   of	   a	   mismatch	   triggers	   structural	  conformational	   change	   of	   this	   protein,	   which	   results	   in	  MutS	   strongly	  binding	  mismatched	   base	   pairs.	   MutS	   can	   be	   applied	   for	   identifying	   a	  mismatch	  in	  a	  target	  directly	  on	  microarrays68.	  Another	  application	  for	  MutS	  can	  be	  to	  enhance	  the	  discriminative	  power	  of	  polymerase	  based	  assays.	  For	  example,	  Tan	  and	  co-­‐workers	  showed	  that	  binding	  of	  MutS	  to	   a	  mismatch	   in	   a	   target-­‐primer	   complex	   assisted	   in	   inhibition	   of	   the	  polymerase	   reaction	   upon	   the	   presence	   of	   a	  mutation69.	   Furthermore,	  MutS,	   in	   combination	  with	   a	   hairpin	   probe,	   is	   used	   in	   electrochemical	  assays	   for	   detection	   of	   SNPs.	   Here,	   the	   hairpin	   is	   used	   to	   detect	   the	  target	  DNA,	  by	  opening	  up	   in	   the	  presence	  of	   the	   target	  DNA,	  while	   in	  case	   of	   a	   mutation	   the	   electrical	   resistance	   is	   further	   increased	   upon	  binding	  of	  MutS	  to	  a	  SNP	  allowing	  sensitive	  and	  discriminative	  detection	  up	  to	  100	  pM	  of	  the	  target	  DNA70.	  The	  main	  limitation	  in	  use	  of	  MutS	  is	  the	  disability	  to	  discriminate	  among	  different	  mutations	  and	  to	  identify	  multiple	  mutations	  in	  one	  strand.	  These	  limitations	  can	  be	  prevailed	  by	  combining	   MutS	   with	   gold	   nanoparticles	   (Au	   NPs)	   labelled	  oligonucleotides	   complementary	   to	   the	   target	   sequence.	   When	   a	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mismatch	  is	  present	  in	  the	  target	  strand,	  MutS	  binds	  to	  this	  Au	  NP-­‐DNA	  complex.	  This	  influences	  the	  melting	  temperature	  resulting	  in	  a	  shift	  to	  higher	   values	   in	   the	   presence	   of	   MutS.	   The	   various	   nucleotide	  mismatches	   influence	   the	   melting	   temperature	   differently	   allowing	   to	  discriminate	  among	  base	  pair	  substitutions71.	  Another	   group	   of	   non-­‐protein	   molecules,	   known	   as	   intercalators,	  with	  affinity	  for	  particular	  mismatches,72	  can	  also	  be	  used	  as	  mismatch	  binding	   ligands.	   Although	   some	   of	   these	   intercalating	   molecules	   have	  been	  applied	  for	  SNP	  detection,73-­‐75	  they	  are	  not	  widely	  used	  because	  in	  general	   they	   can	   detect	   only	   a	   particular	   subset	   of	   base	   pair	  substitutions.	  
2.4.2	  	  	  	  	  Ligation	  based	  SNP	  detection	  Ligation	   enzymes	   catalyse	   covalent	   joining	   of	   two	   adjacent	  oligonucleotides	  in	  one	  strand.	  Strands	  can	  only	  be	  joined	  when	  the	  nick	  is	   located	   between	   fully	   adjacent	   nucleotides	   and	   if	   there	   is	   a	   perfect	  match	   between	   the	   template	   and	   the	   oligonucleotides	   at	   the	   nick.	  Landegren	  and	   coworkers	  were	   the	   first	   to	   exploit	   these	  properties	  of	  the	   enzyme	   in	   an	   assay	   where	   oligonucleotides	   were	   joined	   in	   the	  presence	  of	  a	  SNP76.	  Since	  then,	  the	   ligase	  enzyme	  is	  a	  popular	  tool	   for	  SNP	  detection	  as	  the	  combination	  of	  short	  oligonucleotide	  hybridization	  and	   the	   selective	   enzymatic	   activity	   ensures	   high	   assay	   specificity77.	  Ligase	   enzymes	   can	   be	   used	   in	   simple	   assays	   for	   SNP	   detection	  when	  combined	  with	  Au	  NPs78,79.	  One	  of	  these	  assays	  is	  based	  on	  the	  feature	  of	  DNA	  having	  a	  strong	  tendency	  to	  bind	  to	  the	  Au	  NP	  surface	  when	  in	  the	  single	   stranded	   form,	   a	   feature	   that	   is	   strongly	   diminished	   after	  hybridization	  into	  double	  stranded	  DNA.	  In	  the	  presence	  of	  a	  24bp	  wild	  type	   strand,	   two	   ssDNA	   strands,	   of	   which	   one	   has	   a	   fluorophore,	   are	  ligated,	   allowing	   the	   target	   and	   the	   ligated	   product	   to	   form	   a	   stable	  double	  stranded	  helix.	  On	  the	  other	  hand,	   the	  presence	  of	  a	  SNP	  in	  the	  target	   molecule	   prevents	   ligation	   of	   the	   two	   ssDNA	   oligonucleotides.	  Because	  these	  two	  oligonucleotides	  are	  individually	  too	  short	  to	  form	  a	  stable	  double	  helix	  with	  the	  target	  molecule,	  they	  remain	  in	  ssDNA	  form	  and	   thus	   bind	   to	   the	   Au	   NP,	   which	   results	   in	   fluorescence	   quenching.	  Not	  only	  is	  this	  assay	  highly	  sensitive	  towards	  SNPs,	   it	  also	  has	  a	  fairly	  low	  LOD	  of	  0.3	  nM	  of	  target	  DNA.	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In	   another	   ligation	   assay	   combined	   with	   Au	   NPs,	   different	   SNP	  mutations	   are	   discriminated	   in	   a	   24bp	   target	   sequence	   using	   a	  colorimetric	  approach79.	  The	  assay	  relies	  on	  the	  hybridization	  of	  Au	  NPs	  to	  a	  glass	   slide	   surface,	  which	  are	  both	  modified	  with	  oligonucleotides	  complementary	   to	   the	   target	   strand.	   In	   the	   absence	   of	   a	   SNP	   in	   the	  target	   molecule,	   the	   Au	   NPs	   are	   ligated	   to	   the	   surface,	   followed	   by	   a	  signal	   enhancement	   through	   a	   silver	   deposition	   on	   the	   Au	   NPs.	   This	  assay	  allows	  even	  discrimination	  of	  SNP	  position	  in	  the	  target	  molecule	  because	  presence	  of	  mutations	  at	   increasing	  distance	   from	  the	   ligation	  site	   decreases	   the	   inhibitory	   influence	   on	   the	   ligation	   reaction.	   As	   a	  result,	   a	   gradual	   increase	   in	   ligation	   yield	   is	   visible	  with	   each	   shift	   in	  mutation	  position.	  In	  a	  similar	  approach,	  ligation	  of	  Au	  NPs	  to	  a	  surface	  is	  measured	  in	  real-­‐time	   with	   Surface	   Plasmon	   Resonance	   Imaging	   (SPRi).	   Surface	  plasmon	  resonance	  uses	  a	  partial	  coupling	  of	  the	  energy	  of	  a	  light	  wave	  with	  a	  noble	  metal,	  in	  order	  to	  measure	  refractive	  index	  changes	  at	  the	  noble	  metal	  surface80,	  thereby	  enabling	  detection	  of	  surface	  events	  such	  as	  the	  binding	  of	  biomolecules.	  In	  SPRi,	  a	  Charge	  Coupled	  Device	  (CCD)	  camera	  is	  used	  to	  image	  the	  noble	  metal	  surface,	  which	  is	  prepared	  in	  an	  array	  format	  where	  each	  active	  spot	  is	  used	  as	  an	  SPR	  active	  measuring	  point.	   This	   layout	   greatly	   increases	   the	  measurement	   throughput.	   For	  SNP	   detection,	   each	   spot	   of	   the	   array	   is	   functionalized	   with	   different	  short	  oligonucleotides	  complementary	   to	  half	  of	   the	   target	   strand.	  The	  other	  half	  of	  the	  target	  strand	  is	  complementary	  to	  the	  oligonucleotide	  immobilized	  on	  the	  Au	  NPs	  surface.	  These	  capture	  oligonucleotides	  bare	  a	  different	  base	  at	  a	  known	  mutation	  site	  (A-­‐T-­‐C-­‐G)	  of	  the	  target	  strand.	  Hybridization	   of	   target	   strands	   to	   the	   capture	   oligonucleotides	   on	   the	  SPRi	   spot	   triggers	   further	   hybridization	   with	   an	   oligonucleotide	  attached	   to	   Au	   NPs.	   Next,	   the	   Au	   NP-­‐oligonucleotide	   and	   the	   capture	  oligonucleotide	  are	  ligated,	  but	  ligation	  will	  only	  occur	  on	  spots	  where	  a	  perfect	  sequence	  match	  is	  present	  at	  the	  ligation	  site,	  resulting	  thus	  in	  a	  covalent	   coupling	   of	   Au	   NPs	   to	   the	   corresponding	   array	   spot.	  Subsequent	   chemical	   denaturation,	   removes	   all	   non-­‐ligated	   Au	   NPs,	  which	   results	   in	   a	   very	   specific	   signal	   present	   only	   at	   the	  patch	  of	   the	  array	   where	   a	   100%	   complementary	   capture	   oligonucleotide	   is	  hybridized81.	   Although	   this	   method	   is	   innovative	   as	   mutations	   can	   be	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detected	  at	   the	  nucleotide	   level,	   its	   applicability	   is	   limited	  as	   it	   is	   only	  applicable	  for	  known	  mutation	  sites.	  Even	   more	   interesting	   is	   a	   POC	   concept	   that	   results	   in	   a	   highly	  sensitive	  assay,	  requiring	  only	  a	  couple	  of	  minutes	  without	  the	  need	  for	  any	  specialized	  instruments.	  Here,	  the	  highly	  specific	  ligation	  reaction	  is	  integrated	   in	   a	   lateral	   flow	   test	   and	   combined	   with	   the	   colorimetric	  properties	  of	  Au	  NPs82,83.	  As	  in	  the	  previous	  assay,	  presence	  of	  the	  target	  DNA	  results	  in	  the	  ligation	  of	  two	  oligonucleotides.	  However	  this	  assay	  uses	   oligonucleotides	   labeled	   with	   digoxin	   and	   the	   other	   one	   labeled	  with	   biotin.	   Antibodies	   specific	   for	   digoxin	   are	   immobilized	   on	   a	  detector	  zone	  of	  a	  nitrocellulose	  membrane	  (test	  zone),	  while	  molecules	  with	   high	   affinity	   towards	   biotin	   (being	   either	   an	   antibody	   or	  streptavidin)	  are	   immobilized	  on	  Au	  NPs.	   In	   the	  presence	  of	   the	   target	  strand,	   the	   nanoparticles	   are	   captured	   on	   the	   test	   zone,	   resulting	   in	   a	  colored	  band	  that	  can	  be	  seen	  with	  the	  bare	  eye.	  	  The	   detection	   limit	   of	   ligation	   assays	   for	   SNP	   detection	   can	   be	  further	   improved	   when	   used	   to	   create	   padlock	   probes,	   which	   are	  circular	   templates	   for	   an	   isothermal	   amplification	   reaction	   known	   as	  rolling	  circle	  amplification	  (RCA)	  (Figure	  2.10).	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Figure	   2.10:	   Rolling	   circle	   SNP	   detection	   concept:	   A)	   The	   rolling	   circle	   concept	  
where	  a	   circular	  primer	   is	  used	   to	   repetitively	   extend	  a	   target	   sequence;	  B)	   the	  
integration	  of	   SNP	  detection	   in	   rolling	   circle	   reaction:	   a	  padlock	  probe	  becomes	  
circular	  only	  in	  the	  presence	  of	  a	  particular	  mutation	  (as	  indicated	  on	  the	  figure),	  
or	  alternatively	  in	  the	  absence	  of	  SNP,	  depending	  on	  the	  assay	  design	  (not	  shown).	  
The	   circular	   padlock	   is	   further	   extended	   and	   detected	   with	   a	   reporter	  
oligonucleotide.	  This	   reaction	   requires	   a	   special	   polymerase	   enzyme,	   phi29,	   which	  creates	  a	  ssDNA	  ribbon	  of	  repeating	  padlock	  sequences.	  RCA	  combines	  the	   specificity	   introduced	   by	   the	   ligation	   step	   with	   a	   strong	   signal	  amplification	   resulting	   from	   the	   high	   template	   copy	   numbers.84	  When	  further	   combined	  with	  Au	  NPs,	   a	  very	   sensitive	   colorimetric	  assay	  can	  be	  developed	  for	  SNP	  detection.	  The	  ligation	  of	  a	  circular	  primer	  into	  a	  padlock	  probe	  is	  initiated	  in	  the	  presence	  of	  the	  target	  strand.	  After	  the	  target	  has	  been	  amplified	  with	  RCA,	  its	  multiple	  copies	  can	  be	  cut	  out	  of	  the	   ssDNA	   ribbon	   using	   a	   restriction	   enzyme.	   These	   cut	   fragments	  interlink	   specifically	  Au	  NPs,	   resulting	   in	   a	   characteristic	   color	   shift	   of	  the	  gold	  solution,	  which	  is	  visible	  with	  the	  bare	  eye.	  Because	  of	  the	  high	  amplification	   efficiency	   of	   the	   RCA	   polymerase,	   the	   assay	   can	   reach	   a	  detection	   limit	  of	  70	   fM	  even	   in	   the	  presence	  of	  high	  copy	  numbers	  of	  wild	  type	  DNA.85	  A	  similar	  combination	  of	  RCA	  and	  Au	  NPs,	  but	  without	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the	   restriction	   step,	   also	   allows	   sensitive	   surface	   enhanced	   raman	  spectroscopy	   (SERS)	   detection	   of	   SNPs	   in	   a	   target	   strand.	   This	   SERS	  based	  assay	  even	  outperformed	  PCR	  for	  SNP	  detection86.	  Zang	   and	   co-­‐workers87	   further	   exploited	   the	   circular	   ligation	  concept,	   for	   developing	   an	   ultrasensitive	   SNP	   detection	   assay88.	   Here,	  the	   presence	   of	   a	   SNP	   in	   the	   target	   strand	   triggers	   formation	   of	   a	  circular	  ligation	  product	  on	  which	  multiple	  other	  circular	  templates	  can	  interlock	   by	   means	   of	   a	   complementary	   sequence.	   The	   interlocking	  circular	   primers	   contain	  DNAzymes,	  which	   are	   amplified	  with	   an	   RCA	  amplification,	   resulting	   in	   thousands	   of	   copies	   of	   the	   DNAzyme.	   This	  strategy	   allows	   creation	   of	   1000	   active	   enzymes,	   even	   if	   only	   a	   single	  SNP	   containing	   target	   strand	   is	   present,	   resulting	   in	   an	   ultrasensitive	  assay	  also	  when	  SNP	  expression	  is	  low.	  The	  assay	  was	  applied	  to	  detect	  the	  K-­‐ras	  SNP	  and	  reached	  a	  detection	  limit	  of	  71	  aM	  even	  when	  applied	  directly	  on	  blood	  serum.	  Although	   RCA	   offers	   an	   elegant	   target	   amplification	   strategy	   for	  ligation	   products,	   the	   ligase	   reaction	   on	   its	   own	   can	   also	   be	   used	   to	  amplify	   the	   target	  sequence.	   In	  a	  process	  called	   ligation	  chain	  reaction	  (LCR),	   a	   thermophilic	   ligase	   from	   Thermus	   thermophilus	   is	   used	   (tth	  ligase89)	   that	   enables	   multiple	   sequential	   ligation	   cycles.	   After	   each	  ligation	  reaction,	   the	   temperature	   is	   increased	   to	  denature	   the	   ligation	  product	   from	   the	   target	   sequence,	   making	   place	   for	   two	   new	  oligonucleotides	  to	  be	  ligated.	  The	  main	  advantage	  of	  this	  strategy	  is	  the	  high	  specificity	  of	  the	  reaction	  due	  to	  the	  ligation	  enzyme	  catalyzing	  the	  reaction	  only	   if	   the	  sequences	  at	   the	  nick	  are	  perfectly	  complementary	  and	   because	   hybridization	   at	   elevated	   temperatures	   is	   more	   specific.	  Nonetheless,	   this	   technology	  has	  never	  been	  very	  popular	  because	   the	  LCR	   products	   cannot	   be	   easily	   detected,	   except	   for	   laborious	  methods	  such	   as	   gel-­‐electrophoresis90,91.	   However,	   recent	   developments	   have	  implemented	   the	   LCR	   reaction	   on	   new	   platforms	   allowing	   more	  straightforward	   detection	   of	   LCR	   products.	   For	   instance,	   Cheng	   et	   al.	  designed	   an	   assay	   to	   fluorescently	   detect	   LCR	   products	   by	   using	   a	  cationic	  conjugated	  polymer	  (CCP)92.	  The	  assay	  uses	  two	  sets	  of	  probes,	  one	   complementary	   to	   the	   target	  DNA	  and	  another	  one	   to	   the	   reverse	  complement.	   In	   the	   presence	   of	   the	   target,	   the	   first	   set	   of	   probes,	  complementary	  to	  the	  WT	  target,	  is	  ligated	  creating	  a	  new	  template	  for	  the	   ligation	   reaction	   of	   the	   second	   set	   of	   probes.	   This	   enables	   an	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exponential	  amplification	  of	  the	  target	  sequence.	  Subsequently,	  the	  CCP	  is	   added	   and	   binds	   electrostatically	   to	   the	   negatively	   charged	   DNA.	  Because	   CCP	   has	   unique	   light	   absorbing	   properties93,	   it	   is	   used	   to	  transfer	   excitation	   energy	   to	   a	   5’	   FAM	   label	   on	   the	   ligation	   probes,	  resulting	  in	  a	  strong	  fluorescence	  of	  LCR	  products.	  Non-­‐ligated	  products	  are	   degraded	   with	   exonuclease	   I	   and	   exonuclease	   III.	   Resulting	   FAM	  labelled	  monomer	   by-­‐products	   have	   only	   a	   very	  weak	   affinity	   for	   CCP	  leading	   to	   a	   low	   background	   signal.	   The	   assay	   allowed	   detection	   of	  targets	  up	  to	  1	  fM	  and	  could	  be	  applied	  on	  mixtures	  of	  WT	  and	  mutated	  DNA.	  	  Trau	   and	   co-­‐workers	   used	   a	   somewhat	   similar	   approach	   to	   allow	  electrochemical	  detection	  of	  LCR	  products94.	  In	  short,	  they	  showed	  that	  a	   successful	  LCR	  could	  both	  be	  detected	  by	   the	   intercalator	  methylene	  blue	  that	  changes	  the	  redox	  current	  or	  by	  a	  HRP	  labelled	  probe	  through	  electrocatalytic	   reduction	   of	   hydrogen	   peroxide.	   The	   second	   approach	  proved	  to	  be	  more	  useful	  as	  it	  was	  able	  to	  detect	  the	  target	  strand	  at	  100	  times	   lower	   concentrations	   and	   with	   higher	   specificity	   than	   the	  methylene	  blue	  approach.	  Albeit,	  HRP	  remains	  a	  bit	  unpractical	  for	  POC	  integration	  as	  the	  reaction	  requires	  a	  continuous	  stream	  of	  H2O2,	  which	  is	  not	  a	  stable	  component.	  Finally,	   a	   method	   was	   developed	   to	   monitor	   LCR	   in	   real-­‐time95,96	  ligating,	  in	  the	  presence	  of	  a	  target	  sequence,	  probes	  immobilized	  on	  Au	  NPs.	  Therefore,	  in	  every	  cycle	  of	  the	  LCR	  reaction,	  an	  increasing	  fraction	  of	   the	   Au	   NPs	   is	   ligated,	   leading	   to	   an	   increasing	   amount	   of	   closely	  linked	  Au	  NPs.	  Their	   interlinking	  results	   in	  a	  characteristic	   shift	   in	   the	  absorption	  band	  of	  the	  Au	  NPs	  solution,	  which	  is	  monitored	  in	  real	  time	  using	   a	   standard	   spectrophotometer.	   The	   resulting	   assay	   has	   a	   very	  wide	   dynamic	   range	   spanning	   6	   orders	   of	  magnitude	  with	   a	   detection	  limit	  of	  20	  aM	  and	  strong	  discriminative	  power,	  even	  in	  the	  presence	  of	  1500x	  excess	  of	  mutant	  target	  DNA.	  Next	  to	  ligases,	  another	  class	  of	  enzymes,	  so	  called	  nicking	  enzymes,	  can	  be	  used	  for	  recognition	  of	  specific	  sequences,	  which	   is	   followed	  by	  cutting	   one	   of	   the	   strands	   in	   the	   double	   stranded	  DNA.	   Although	   they	  can	   only	   recognize	   a	   particular	   subset	   of	   sequence	   motives,	   which	   is	  limiting	   their	   universal	   use,	   they	   can	   be	   used	   in	   combination	   with	   a	  three-­‐way	   junction	   for	   specific	   target	   recycling97,98.	   This	   strategy	   was	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applied	   for	   developing	   an	   ultrasensitive	   and	   specific	   assay	   in	  combination	  with	  MBs99.	  In	  this	  assay,	  a	  MB	  is	  nicked	  when	  forming	  an	  Y	  junction,	  which	  can	  only	  be	  created	  in	  the	  presence	  of	  a	  target	  molecule.	  The	   opened	   MB	   serves	   afterwards	   as	   a	   primer	   for	   an	   RCA	   reaction,	  while	   the	   target	  molecule	   is	   recycled.	  The	  RCA	  product	   allows	   specific	  hybridization	   of	   multiple	   quantum	   dots,	   which	   are	   measured	   with	  voltammetry	   after	   being	   dissolved	   in	   acid.	   The	   assay	   has	   a	   dynamic	  range	  of	  6	  orders	  and	  a	  detection	   limit	  of	  11	  aM.	  Similar	  strategies	   for	  target	  recycling	  using	  nicking	  enzymes	  but	  without	  RCA	  are	  applied	  and	  can	   also	   reach	   sub-­‐femtomolar	   detection	   limits	   without	   losing	  specificity,	  thus	  proving	  the	  versatility	  of	  the	  method100-­‐102.	  Target	   recycling	   can	   also	   be	   achieved	   with	   exonucleases,	   which	  independently	   catalyse	   the	   degradation	   of	   the	   target	   reporter	   duplex	  starting	  at	   the	  single	  stranded	  part	  of	  a	  blunt	  or	  recessed	  3’	  end.	  They	  were	  first	  used	  in	  combination	  with	  MBs	  in	  order	  to	  digest	  the	  MBs	  that	  get	   opened	   upon	   target	   binding,	   freeing	   thus	   the	   target-­‐sequence	  (Figure	  2.11)103.	  This	  strategy	  has	  two	  advantages,	  the	  target	  is	  released	  from	   the	   MB	   and	   can	   bind	   another	   one,	   while	   the	   fluorophore	   is	  separated	   permanently	   from	   the	   quencher	   of	   the	   degraded	   MB.	   This	  approach	   allows	   reaching	   a	  much	   lower	   detection	   limit	   than	   a	   classic	  MB	   assay	   with	   the	   same	   amount	   of	   target	   DNA	   without	   any	   loss	   in	  specificity.	   A	   similar	   target	   recycling	   strategy	   is	   applied	   for	   SNP	  detection	  by	  Xuan	  et	  al.	  on	  an	  electrochemical	  detection	  platform104.	   In	  their	   assay,	   target	   binding	   opens	   the	   stem	   of	   a	   MB	   resulting	   in	   its	  enzymatic	  digestion	  and	  release	  of	  a	  methylene	  blue	  labelled	  nucleotide.	  This	  nucleotide	   can	  bind	  with	  a	  much	  higher	  efficiency	   to	  a	  negatively	  charged	   indium	   thin	   oxide	   (ITO)	   electrode	   than	   the	   MB,	   because	   the	  repulsive	   negative	   charges	   between	   ITO	   and	   the	   single	   nucleotide	   are	  lower	   than	   the	   ones	   between	   ITO	   and	  MB.	   The	   assay	   can	   detect	   label	  free,	   pM	   concentrations	   of	   the	   target	   sequence	   while	   differentiating	  SNPs	  with	   a	   high	   specificity.	   The	   sensitivity	   of	   this	   strategy	   is	   further	  improved	   by	   Tang	   and	   co-­‐workers,	   who	   used	   the	   liberation	   of	   a	  DNAzyme	   upon	   exonuclease	   III	   digestion105	   instead	   of	   a	   labelled	  nucleotide.	   This	   led	   to	   an	   improvement	   of	   one	   order	   of	   magnitude	   in	  detection	   limit	   to	   10	   fM,	   while	   specificity	   towards	   SNP	   detection	   was	  unaffected.	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Figure	   2.11:	   Target	   recycling	   concept	   combining	   a	   MB	   with	   exonuclease	   III	   to	  
liberate	  the	  target	  after	  bound	  with	  the	  MB.	  Because	  a	  blunt	  end	  is	  created	  at	  the	  
3’	  end	  of	  the	  MB,	  only	  the	  MB	  will	  be	  degraded,	  separating	  the	  quencher	  from	  the	  
fluorophore,	  while	  the	  target	  can	  open	  a	  new	  MB	  in	  a	  next	  round	  of	  exonuclease	  III	  
degradation.	  According	  to	  Zuo	  et	  al.103	  A	  new	  type	  of	  nuclease,	  known	  as	  CEL1	  endonuclease,	  combines	  the	  mismatch	   specificity	   of	   mismatch	   binding	   enzymes	   with	   exonuclease	  activity.	  The	  enzyme	  is	  therefore	  used	  to	  increase	  the	  sensitivity	  of	  SNP	  analysis	  on	  a	  microarray,	  as	  the	  enzyme	  can	  detect	  mismatches,	  inserts	  and	   deletions	   of	   up	   to	   12bp	   initiating	   degradation	   of	   mismatched	  oligonucleotides.	   Performing	   SNP	   analysis	   on	   a	   microarray	   requires	  highly	  specific	  hybridization,	  which	  can	  be	  achieved	  by	  lowering	  the	  salt	  concentrations	  and	  adjusting	  the	  hybridization	  temperature	  close	  to	  the	  target	   melting	   temperature.	   Because	   this	   approach	   lowers	   the	  sensitivity	  of	  the	  assay	  severely,	  CEL1	  endonuclease	  is	  used	  to	  digest	  all	  mismatched	  DNA	   on	   the	  microarray	   before	   readout	   of	   the	   fluorescent	  signal.	  One	  of	  the	  first	  applications	  of	  CEL1	  endonuclease	  was	  improving	  microarray	   screening	   for	   antibiotic	   resistance	   in	   Klebsiella	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2.5 SNP	  detection	  through	  thermal	  denaturation	  of	  hybrids	  Enzymes	  are	  effective	  tools	  for	  detection	  of	  SNPs	  even	  in	  the	  presence	  of	  complex	   media	   such	   as	   blood.	   However,	   most	   of	   the	   enzymatic	   SNP	  assays	  are	  only	  applicable	  on	  known	  mutations,	  which	  is	  just	  a	  fraction	  of	   those	   causing	   diseases109.	   Moreover,	   the	   capability	   of	   detecting	  unknown	   mutations	   allows	   following	   up	   on	   acquisition	   of	   new	  mutations110,111.	   Therefore,	   methods,	   such	   as	   DNA	   melting	   that	   allow	  screening	   of	   mutations	   in	   a	   much	   more	   generic	   way,	   are	   appreciated	  alternatives.	  	  When	   a	   DNA	   duplex	   is	   thermally	   denatured,	   the	   temperature	   at	  which	   half	   of	   the	   strands	   are	   in	   the	   fully	   hybridized	   state,	   while	   the	  other	  half	   is	   in	  the	  single	  stranded	  state,	   is	  known	  as	  the	  melting	  point	  (Tm)	   and	   is	   highly	   sequence	   dependent.	   Changes	   in	   the	  DNA	   sequence	  have	  a	  direct	  effect	  on	   the	   thermodynamic	   stability	  of	   the	  DNA	  duplex	  resulting	  in	  a	  predictable	  change	  in	  Tm112-­‐114.	  However,	  DNA	  melting	  was	  initially	   not	   easily	   applicable	   for	   identifying	   SNPs	   routinely	   as	   the	  minimal	   thermodynamic	  effect	  of	  a	  SNP	  on	  a	  DNA	  double	  strand	  could	  not	  be	  detected	  with	  then	  standard	  fluorescent	  intercalating	  dyes.	  These	  intercalating	   dyes	   are	   fluorescent	   molecules	   that	   increase	   their	  fluorescence	   upon	   binding	   double	   stranded	   DNA.	   However,	   because	  intercalating	   dyes	   inhibit	   PCR,	   they	   are	   used	   at	   non-­‐saturating	  concentrations,	   at	   which	   the	   dye	   can	   redistribute	   during	   the	   DNA	  melting	   process	   to	   the	   remaining	   double	   stranded	   part	   of	   the	   DNA	  complex,	   resulting	   in	   a	   hampered	   resolution	   of	   the	   melting	   curve.	  Initially,	   this	   problem	  was	   solved	  using	   specially	   designed	   fluoresence	  resonance	   energy	   transfer	   (FRET)	   hybridization	   probes,	   which	   even	  allowed	   multiplex	   melting	   analysis	   of	   different	   targets	   using	   multiple	  fluorescent	   dye	   molecules115.	   Later	   on,	   the	   technology	   was	   made	  generally	  applicable	  by	   introducing	  saturating	  dyes.	  These	  dyes	  can	  be	  used	  at	  a	  much	  higher	  concentration	  without	  PCR	  inhibition.	  As	  a	  result,	  monitoring	   of	   DNA	   melting	   is	   made	   available	   at	   unmet	   resolution	  without	  the	  use	  of	  labelled	  detection	  probes,	  providing	  a	  universal	  SNP	  detection	   platform.116	   The	   technology	   has	   been	   commercialized	   and	   is	  gaining	   popularity	   as	   a	   worthy	   alternative	   for	   differential	   gel	  electrophoresis,117	   the	   golden	   standard	   technique	   for	   mutation	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detection,	   which	   is	   based	   on	   gel	   separation	   of	   PCR	   products	   with	  mutations.	  	  DNA	   melting,	   is	   also	   being	   applied	   as	   a	   first	   line	   fast	   mutation	  screening	   tool	   to	   identify	   possible	   mutational	   hotspots118,119.	  Nonetheless,	  the	  technology	  is	  not	  perfect	  and	  requires	  optimization	  for	  detection	   of	   some	   types	   of	   mutations	   such	   as	   base	   pair	   neutral	  mutations,	  where	  for	  example	  a	  G:C	  from	  C:G	  is	  mutated	  or	  A:T	  from	  T:A	  base-­‐pair120.	  Recently,	  new	  developments	  have	  been	  made	  in	  the	  field	  of	  DNA	  melting	  technology	  increasing	  both	  sensitivity	  and	  applicability	  of	  the	   method.	   In	   general,	   one	   can	   distinguish	   two	   approaches	   in	   DNA	  melting	  analysis,	  liquid	  and	  solid	  phase	  DNA	  melting	  methods.	  
2.5.1 Liquid	  phase	  DNA	  melting	  Liquid	   phase	   DNA	   melting	   monitors	   the	   denaturation	   of	   DNA	   free	   in	  solution	   and,	   in	   comparison	  with	   solid	   surface	  melting,	   the	   DNA	   does	  not	   need	   to	   be	   chemically	   modified	   for	   surface	   immobilization.	  Furthermore,	   the	  method	  can	  be	  applied	   immediately	  after	  PCR	  as	   the	  saturating	   intercalating	  dye	  does	  not	   inhibit	   amplification,	  which	   even	  allows	  monitoring	   the	   amplification	   process,	   thereby	   resulting	   in	   both	  quantification	  and	  direct	   identification	  of	  amplicons.	  As	  the	  technology	  has	   mostly	   been	   used	   in	   combination	   with	   a	   traditional	   PCR	   sample	  preparation	  and	  on	  bulky	  high	  resolution	  melting	  (HRM)	  enabled	  qPCR	  devices,	   the	   technology	  was	   for	  a	   long	  time	  considered	  as	  not	  being	   fit	  for	   POC	   concepts.	   In	   an	   attempt	   to	   solve	   this	   problem,	   Crews	   et	   al.	  integrated	   DNA	   melting	   analysis	   in	   a	   microfluidic	   chip121.	   Here,	   the	  liquid	  flows	  through	  a	  microfluidic	  channel	  over	  a	  temperature	  gradient.	  While	   the	  sample	   is	  slowly	  heated	  along	  this	  gradient,	   the	  DNA	  double	  strand	   is	   melted,	   which	   is	   visible	   by	   a	   decrease	   in	   the	   fluorescence	  intensity	  of	  the	  intercalating	  dye.	  As	  the	  position	  along	  the	  microfluidic	  channel,	   where	   the	   fluorescence	   signal	   is	   switched	   off,	   represents	   the	  melting	   point,	   this	   method	   is	   called	   spatial	   DNA	  melting.	   Spatial	   DNA	  melting	   allows	   monitoring	   both	   DNA	   denaturation	   and	   renaturation	  along	   the	   temperature	   gradient	   since	   the	   fluorescence	   intensity	  increases	   when	   leaving	   the	   temperature	   gradient	   in	   the	   opposite	  direction	   as	   a	   result	   of	   gradual	   re-­‐annealing	   of	   the	   DNA	   duplex.	   The	  method	   proved	   to	   be	   highly	   sensitive	   towards	   SNPs	   and	   allowed	   to	  discriminate	   heterozygous	   mixtures	   of	   WT	   and	   mutant	   DNA	   in	   real	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clinical	   samples	   even	  when	   targets	   exceeded	   150bp.	   The	   concept	  was	  further	  developed	  and	  integrated	  in	  a	  chip	  for	  direct	  genotyping	  from	  a	  human	  saliva	  sample122	  proving	  the	  applicability	  of	  the	  concept.	  Another	  label	  free	  DNA	  melting	  approach	  is	  to	  monitor	  the	  change	  in	  movement	  of	  the	  molecule	  rather	  than	  the	  change	  in	  fluorescence.	  This	  method	   is	   called	   thermophoresis	   and	   has	   some	   particular	   advantages	  over	   traditional	   DNA	   melting.	   The	   movement	   of	   molecules	   in	   a	  temperature	  gradient	  depends	  on	  their	  size,	  charge,	  ionic	  shielding	  and	  hydration,	   implying	   that	   change	   in	   any	   of	   these	   parameters	   can	   be	  monitored	   by	   the	   changes	   in	   thermophoresis.	   Using	   this	   method,	  Wienken	  et	  al.	  were	  able	  to	  detect	  SNPs	  of	  target	  sequences	  in	  very	  low	  sample	   volumes	   (250	   nl).	   Although	   thermophoresis	   has	   only	   been	  applied	  on	  short	  oligonucleotides	  (22bp)	  at	  high	  concentrations	  (1	  µM),	  the	   method	   is	   very	   sensitive	   towards	   secondary	   structures	   and	  nucleotide	  modifications	  such	  as	  methylation123.	  Currently,	   one	   of	   the	  major	   limitations	   of	   DNA	  melting	   is	   that	   the	  small	   free	   energy	   difference	   caused	   by	   the	   polymorphisms	   results	   in	  only	  a	  minimal	  variation	  of	  the	  melting	  profile	  measured	  as	  a	  function	  of	  change	   in	   fluorescence	   intensity,	  requiring	  careful	  experimental	  design	  and	  data	  analysis.	  Lee	  et	  al.	  designed	  a	  strategy	  to	  amplify	   the	  thermal	  dynamic	   difference	   allowing	   easy	   discrimination	   of	   mutations.	   By	  monitoring	  DNA	  melting	  inside	  an	  optofluidic	  cavity	  that	  is	  excited	  with	  a	   laser,	   a	   gain	   in	   laser	   signal	   intensity	   is	   realized	   that	   is	  dependent	  on	  the	   hybridization	   state	   of	   the	  DNA	   in	   the	   cavity124.	   As	   can	   be	   noted	   in	  this	  assay,	  the	  generated	  laser	  output	  of	  the	  optical	  cavity	  is	  monitored	  instead	   of	   fluorescence,	   which	   results	   in	   a	   strong	   amplification	   of	   the	  signal.	  The	  method	  is	  highly	  sensitive	  and	  can	  detect	  a	  SNP	  in	  a	  100bp	  target	   with	   25x	   signal	   intensity	   difference	   between	   the	   WT	   and	   the	  mutant	  DNA,	  allowing	  more	  easy	  discrimination	  of	  SNPs	  in	  comparison	  with	  standard	  HRM.	  However	  the	  method	  is	  only	  proven	  to	  work	  at	  very	  high	  DNA	   concentration	   (250	  µM),	   limiting	   this	   technique	   to	  post	  PCR	  DNA	  melting	  analysis.	  DNA	  melting	   technologies	  are	  also	   limited	   in	   their	   ability	   to	  detect	  multiple	   targets	   in	   parallel	   in	   one	   sample.	   This	   is	   due	   to	   the	   fact	   that	  only	   one	   intercalating	   dye	   can	   be	   used	   at	   a	   time,	   resulting	   in	   the	  detection	   of	   only	   a	   single	   target.	   In	   recent	   work,	   Li	   and	   co-­‐workers,	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increased	   the	   potential	   for	  multiplexing	   both	   DNA	  melting	   assays	   and	  PCR	  by	  combining	  different	  fluorescent	  labels	  with	  Tm	  labels,	  creating	  a	  two-­‐dimensional	   label	   (Figure	   2.12)125.	   The	   assay	   uses	   two	   different	  oligonucleotides	  that	  are	  ligated	  together	  in	  the	  presence	  of	  the	  specific	  target	  sequence.	  The	   two	  oligonucleotides	  consist	  of	  different	  domains	  necessary	  for	  multiplexing.	  	  Both	   right	   and	   left	   ligating	   probe	   have	   a	   genomic	   DNA-­‐specific	  binding	  site	  and	  primers,	  whereas	   the	   left	   ligating	  oligonucleotide	  also	  contains	   a	  Tm	   tag.	  The	  Tm	   tag	   is	   a	   sequence	  not	   complementary	   to	   the	  target.	  For	  each	  target	  a	  unique	  set	  of	  Tm	  tags	  is	  made	  which	  are	  ligated	  in	   the	   presence	   of	   particular	   local	   SNPs.	   The	   specificity	   of	   the	   ligation	  reaction	   allows	   introduction	   of	   a	   different	   tag	   if	   the	   target	   contains	   a	  particular	   SNP.	   Because	   each	   Tm	   tag	   comes	   with	   a	   different	   sequence	  variation,	   their	   melting	   temperatures	   are	   diverse.	   After	   the	   tag	   is	  ligated,	  the	  ligation	  product	  containing	  the	  temperature	  tag	  is	  amplified	  with	   an	   asymmetric	   PCR	   and	   probes	   are	   used	   to	   hybridize	   to	   the	  amplified	   tags.	   Finally	   a	   melting	   analysis	   is	   performed	   to	   identify	   the	  amplified	  tags.	  Performing	  simultaneous	  genotyping	  of	  48	  forensic	  SNPs	  occurring	  on	  23	  different	  human	  chromosomes	  proved	  the	  usefulness	  of	  the	  assay.	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Figure	   2.12:	   Combination	   of	   fluorescent	   labels	   and	   ligation	   labels	   that	   affect	  
melting	   temperature	   in	   order	   to	   increase	   multiplexibility	   of	   SNP	   assays.	   Each	  
target	  has	  its	  own	  fluorescent	  label,	  while	  internal	  target	  variation	  (SNPs)	  results	  
in	   ligation	  of	  an	  extra	  tag	  (Tm	  tag),	  which	  is	   incorporated	  in	  the	  asymmetric	  PCR	  
product.	   The	   amplified	   tags	   are	   used	   to	   identify	   the	   target	   and	   the	   resulting	  
change	  of	  melting	  temperature	  is	  used	  to	  generate	  a	  2D	  label.	  Figure	  reproduced	  
according	  to	  Liao	  et	  al.125	  Therefore	   three	   different	   reactions	   using	   each	   a	   unique	   Tm	   tag,	  allowed	   identifying	  32	  possible	  alleles	  per	  reaction,	   resulting	   in	  a	   total	  of	  96	  identified	  alleles.	  The	  robustness	  of	  the	  method	  was	  proven	  by	  its	  direct	  application	  on	  clinical	  samples.	  
2.5.2	  	  	  	  	  Surface-­‐immobilized	  DNA	  melting	  DNA	  melting	  performed	  on	  a	   surface	  has	   some	  advantages	  over	   liquid	  phase	   melting,	   such	   as	   extra	   options	   to	   increase	   sensitivity	   and	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parallelization	   of	   DNA	   analysis126,127	   that	   compensate	   for	   the	   possible	  downsides,	   mostly	   being	   slow	   hybridization	   kinetics	   due	   to	   steric	  hindrance	   and	   electrostatic	   repulsion,128,129	   as	   well	   as	   the	   need	   for	  labeled	  oligonucleotides	  for	  surface	  immobilization130.	  To	  overcome	  the	  first	   limitation,	   extensive	   research	   has	   been	   done	   on	   surface	  immobilization	   methods.	   It	   has	   become	   clear	   that	   the	   density	   and	  conformation	   of	   the	   DNA	   on	   the	   sensor	   surface	   are	   critical	   for	  hybridization	   efficiency131-­‐133.	   These	   two	   parameters	   can	   be	   carefully	  controlled	   using	   small	   alkane	   thiol	   molecules	   or	   extending	   the	  oligonucleotides	  with	   adenine	   repeats,	   known	   to	  have	  high	  affinity	   for	  gold	  surfaces.	  Both	  approaches	  help	  organizing	  the	  DNA	  strands	  on	  the	  sensor	   surface	   while	   also	   diluting	   the	   strands	   on	   the	   surface,	   which	  results	   in	   better	   accessibility	   of	   the	   target	   strands	   and	   improved	  hybridization	   kinetics134-­‐138.	   Other	   options	   include	   the	   use	   of	   small	  internal	   complementary	   DNA	   strands	   that	   can	   boost	   hybridization	  kinetics	  on	  surfaces	  by	  assisting	  in	  DNA	  organization	  and	  presentation,	  a	   strategy	   that	   can	   result	   in	   a	   5-­‐fold	   increase	   in	   hybridization	   rate139.	  Moreover,	   new	   strategies	   allow	   DNA	   surface	   immobilization	   within	  minutes140,	  making	  it	  an	  easy	  procedure.	  Lastly,	  it	  has	  been	  even	  shown	  that	  labeling	  is	  not	  a	  necessity	  for	  surface	  immobilization141.	  Mirkin	  and	  co-­‐workers	  were	  the	  first	  to	  show	  the	  great	  potential	  for	  DNA	   melting	   assays	   on	   surfaces142.	   They	   discovered	   enhanced	  resolution	  in	  melting	  analysis	  when	  DNA	  is	  immobilized	  on	  Au	  NPs,	  the	  so-­‐called	   spherical	   nucleic	   acids.	   In	   comparison	   with	   DNA	   melting	   in	  solution,	  where	  the	  melting	  phase	  occurs	  over	  a	  range	  of	  approximately	  20	   °C,	   gold	   labeled	   DNA	   has	   a	   melting	   transition	   over	   a	   very	   narrow	  temperature	  range	  (ca.	  2-­‐8°C)	  which	  is	  shifted	  to	  a	  higher	  temperature	  range.	  One	  explanation	  for	  this	  melting	  behavior	  is	  the	  number	  of	  inter-­‐particle	   connections	   at	   the	   nanoparticle	   surface,	   which	   results	   in	   a	  collectively	  stronger	  bond	   that	  melts	  at	  higher	   temperatures.	  Together	  with	  a	  higher	  local	  salt	  concentration	  at	  the	  NP	  surface,	  this	  cooperative	  binding	  results	  in	  a	  more	  narrow	  melting	  transition.	  This	  was	  proven	  by	  a	   broader	   melting	   transition	   when	   the	   number	   of	   strands,	   and	  consequently	   the	   number	   of	   inter-­‐particle	   connections	   on	   the	  nanoparticle	   surface,	   were	   diluted142,143.	   Using	   this	   enhanced	   melting	  resolution,	  Stehr	  et	  al.,	  designed	  a	  SNP	  detection	  assay,	  in	  which	  Au	  NPs	  acted	  both	  as	  carriers	  of	  reporters	  for	  the	  target	  DNA	  and	  local	  heating	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elements144,145.	  As	  stated	  earlier,	  Au	  NPs	  have	  a	  strong	  light	  adsorption	  wavelength,	   which	   varies	   with	   the	   size	   of	   the	   nanoparticle.	   When	   a	  pulsed	   laser	   source	   is	   used	   at	   this	   specific	   adsorption	   band	   of	   the	   Au	  NPs,	  an	  optothermal	  conversion	  can	  be	  realized.	  Au	  NPs	  transform	  light	  into	  thermal	  energy,	  resulting	  in	  a	  fast	  temperature	  increase	  in	  the	  local	  nanoparticle	   surrounding.	   This	   highly	   sensitive	   and	   fast	   SNP	   assay	   is	  capable	  of	  performing	  DNA	  melting	  analysis	   for	   SNPs	   in	   a	  30bp	   target	  strand	  in	  less	  than	  a	  millisecond.	  Although	   DNA	   melting	   on	   nanoparticle	   surfaces	   allows	   better	  melting	   transitions,	   their	   monitoring	   is	   limited	   to	   either	   use	   of	   laser	  absorption	   or	   scattering	   techniques	   such	   as	   dynamic	   light	   scattering	  (DLS)	   or	   classic	   spectrometry	   based	  methods146.	   These	   techniques	   are	  all	  somewhat	  limited	  in	  sensitivity	  as	  they	  measure	  a	  bulk	  effect	  and	  do	  not	   support	   easy	   real-­‐time	   monitoring	   of	   the	   melting	   process.	   Other	  options	   include	   electrochemical	   sensors	   such	   as	   the	   one	   recently	  described	   to	   monitor	   the	   transition	   from	   single	   stranded	   to	   double	  stranded	  DNA147.	  By	   immobilizing	   the	  complementary	  DNA	  strand	  of	  a	  29bp	   target	   on	   a	   diamond	   surface,	   which	   allows	   excellent	   thermal	  conduction,	   the	   biosensor	   is	   used	   to	   monitor	   DNA	   binding	   during	  temperature	   cycling.	   Because	   the	   solution	  was	   heated	   from	   below	   the	  diamond	   sensor	   surface,	   the	   authors	   observed	   a	   strong	   heat	   transfer	  resistance	  when	  DNA	  was	  single	  stranded,	  while	  the	  resistance	  was	  not	  present	   when	   the	   DNA	   was	   in	   a	   double	   stranded	   state.	   Using	   this	  principal	  of	  heat	  resistance,	  the	  authors	  can	  derive	  the	  melting	  point	  of	  the	   DNA	   duplex	   from	   the	   temperature	   measurement	   at	   the	   sensor	  surface	   corrected	   for	   the	  heating	  power	   input.	  This	  method	  made	  SNP	  detection	   readily	   available	  on	  a	   cheap	  platform,	  with	  a	   sub	  nanomolar	  (600	  pM)	  sensitivity,	  although	  the	  concept	  was	  only	  able	  to	  detect	  SNPs	  in	  short	  oligonucleotides.	  	  As	  discussed	  earlier,	  SPRi	  allows	  direct	  measuring	  of	  DNA	  behaviour	  at	  a	  surface	  in	  real-­‐time	  and	  with	  high	  precision,	  making	  this	  technology	  ideally	   suited	   for	   DNA	   melting.	   Fiche	   et	   al.,	   were	   one	   of	   the	   first	   to	  implement	   continuous	   real-­‐time	   DNA	   melting	   monitoring	   on	   an	   SPRi	  chip148.	   This	   strategy	   allowed	   detection	   of	   SNPs	   in	   short	  oligonucleotides,	   albeit	   at	   high	   DNA	   concentrations	   (1	   µM).	   The	   assay	  was	   further	   optimized	   towards	   a	   universal	   HRM	   protocol	   on	  microarrays	   for	   detection	   of	   low	   abundant	  DNA	  with	  mutations149.	   By	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using	  temperature	  cycling,	  they	  were	  able	  to	  concentrate	  the	  target	  DNA	  on	   the	   array	   surface.	   Hybridization	   at	   the	   optimal	   temperature	   of	   the	  target	  sequence	  allowed	  a	  10-­‐fold	  increase	  in	  hybridization	  of	  mutated	  DNA	   on	   the	   surface	   in	   comparison	   with	   the	   sample	   content.	   This	  approach	   lead	   to	   ultrasensitive	   detection	   of	   mutated	   DNA	   in	  heterozygous	  mixtures	  even	  when	  the	  DNA	  of	  interest	  was	  present	  at	  a	  fraction	  (1%)	  of	  total	  DNA	  concentration.	  Nonetheless,	  in	  general,	  these	  melting	  transitions	  did	  not	  show	  the	  same	  narrow	  melting	  transitions	  as	  observed	   on	   the	   nanoparticles	   surfaces	   (<10°C)	   because	   the	   assay	  monitors	  melting	  behavior	  of	  unlabeled	  DNA	  strands.	  These	   limitations	   will	   be	   addressed	   in	   the	   next	   chapters	   of	   this	  dissertation,	   where	   the	   narrow	   melting	   transitions	   of	   Au	   NPs	   will	   be	  combined	   with	   SPR	   real-­‐time	   monitoring	   of	   the	   melting	   process,	  enabling	   great	  possibilities	   for	   SNP	  detection.	  The	   combination	  of	   SPR	  and	   gold	   nanoparticle	   melting	   analysis	   is	   only	   possible	   due	   to	   an	   in-­‐house	   developed	   FO-­‐SPR	   platform	   integrated	   in	   a	   fiber-­‐optic	   dipstick	  (FO-­‐SPR),	   which	   can	   be	   handled	   more	   easily	   and	   allows	   precise	  temperature	  control,	  even	  at	  elevated	  temperatures.	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2.6 Conclusion	  The	   last	   3	   years	   have	   seen	   a	   remarkable	   evolution	   in	   SNP	   detection	  techniques,	  leading	  to	  unmet	  resolution	  by	  employing	  albeit	  simple	  but	  clever	   techniques.	   This	   evolution	   has	   made	   classic	   labor	   intensive	  assays	   such	   as	   DGGE,	   PCR,	   FISH	   and	   others	   obsolete	   and	   allowed	   the	  design	  of	  simple	  and	  fast	  SNP	  assays	  that	  can	  be	  integrated	  in	  POC	  tests.	  In	  general,	  the	  improvements	  in	  SNP	  detection	  have	  been	  achieved	  with	  technological	  advances	  in	  one	  of	  the	  following	  three	  domains:	  1. Hybridization	  sensitivity	  2. Enzymatic	  cascades	  3. Thermal	  DNA	  denaturation	  Better	   understanding	   of	   processes	   that	   determine	   the	   speed	   and	  specificity	   of	   hybridization	   have	   enabled	   the	   design	   of	   target	   specific	  DNA	   probes	   for	   detecting	   SNPs	   at	   room	   temperature.	   Employment	   of	  specific	  short	  hybridization	  oligonucleotides	  resulted	  in	  more	  sensitive	  and	   robust	   SNP	   detection.	   Furthermore,	   integration	   of	   binary	   and	  ternary	   probes,	   which	   rely	   on	   independent	   hybridization	   events,	  resulted	   in	  both	  high	   specificity	   and	   sensitivity	  within	   the	   same	  assay.	  This	   was	   achieved	   by	   activation	   of	   a	   label	   only	   when	   all	   probes	   are	  hybridized	  to	  the	  target	  strand.	  Although	  these	  advanced	  hybridization	  probes	   are	   ideally	   suited	   for	   SNP	   detection,	   they	   still	   rely	   on	   complex	  DNA	   binding	   probe	   designs.	   This	   problem	   has	   been	   addressed	   by	   the	  reversible	  toehold,	  a	  universally	  applicable	  concept	  that	  allows	  to	  make	  hybridization	   probes	   insensitive	   to	   external	   factors,	   such	   as	  temperature	   and	   ionic	   concentration,	   for	   their	   specificity	   and	  sensitivity.	  This	  enabled	  SNP	  identification	  under	  almost	  any	  condition.	  A	   lot	   of	   efforts	   have	   been	  made	   to	  make	   SNP	   assays	   work	   at	   low	  target	  concentrations.	  Therefore	  several	  strategies	  have	  been	  employed	  to	   strongly	   amplify	   SNP	   detection	   signals,	   such	   as	   use	   of	   multiple	  enzymes	  for	  SNP	  detection.	  Also,	  some	  enzymes	  only	  work	  in	  case	  of	  a	  perfect	   sequence	   match,	   so	   enzymes	   not	   only	   increase	   sensitivity	   but	  can	   also	   be	   used	   to	   enhance	   reaction	   specificity.	   One	   of	   the	   most	  important	   findings	   in	  the	   last	  decade	  are	  so-­‐called	  enzymatic	  cascades,	  which	  rely	  on	  the	  activation	  of	  multiple	  enzymes	  in	  the	  presence	  of	  the	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target	   sequence	   resulting	   in	  detection	   limits	   that	   can	   compete	  or	   even	  outperform	   PCR	   DNA	   amplification.	   This	   is	   very	   important,	   as	   PCR	   is	  known	   to	   introduce	   errors	   while	   amplifying	   target	   sequences,	   which	  decreases	   the	   sensitivity	   of	   the	  method150.	   Another	   important	   concept	  introduced	  through	  this	  approach	   is	  enzymatic	   target	  recycling.	   In	   this	  concept	   specific	   enzymes	   degrade	   the	   reporter	   probe	   while	   bound	   to	  the	   target	   sequence	   allowing	   the	   next	   reporter	   to	   bind	   to	   the	   target.	  These	  self-­‐amplifying	  strategies	  result	  in	  highly	  sensitive	  assays,	  whilst	  maintaining	  specificity.	  	  Lastly,	  a	  lot	  of	  research	  has	  been	  done	  on	  the	  improvement	  of	  DNA	  analysis	   by	   monitoring	   thermal	   denaturation,	   as	   this	   assay	   allows	  screening	   for	   unknown	  mutations.	   Of	   all	   new	   techniques,	   HRM	   is	   the	  only	  one	  that	  is	  becoming	  a	  standard	  procedure	  both	  in	  research	  and	  in	  clinical	   laboratories151.	   New	   developments	   have	   made	   the	   technology	  even	  more	  versatile,	  especially	  the	  application	  of	   the	  technology	  on	  Au	  NP	   supports,	   resulting	   in	   improved	   SNP	   sensitivity.	   Furthermore	   the	  first	  microfluidic	   integrated	  POC	  test	  based	  on	  the	  DNA	  melting	  assays	  has	  seen	  the	  light,	  proving	  that	  bulky	  thermocyclers	  are	  not	  a	  necessity	  for	  HRM.	  In	   light	   of	   these	   conclusions,	   the	   following	   chapters	   of	   this	  dissertation	  will	  describe	  the	  implementation	  of	  novel	  bioassays	  for	  SNP	  detection	   on	   a	   FO-­‐SPR	   biosensor.	   This	   miniaturized	   and	   robust,	   real-­‐time	   biosensor	   will	   allow	   us	   to	   evaluate	   directly	   some	   of	   the	   above-­‐mentioned	  assays	  for	  the	  detection	  of	  micro-­‐organisms.	  Because	  the	  FO-­‐SPR	   biosensor	   will	   be	   particularly	   suited	   for	   solid	   phase	   melting	  analysis,	   the	   focus	   will	   be	   on	   this	   assay	   in	   combination	   with	   enzyme	  based	   target	   amplification,	   to	   allow	   both	   specific	   identification	   and	  sensitive	  detection	  within	  a	  reasonable	  time	  period.	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  3 	  	  
FO-­‐SPR	  monitoring	  of	  viral	  particle	  affinities	  	  	  Part	  of	  this	  chapter	  has	  been	  published	  in:	  
	  Knez	   K.,	   Noppe	   W.,	   Geukens	   N.,	   Janssen	   K.,	   Spasic	   D.,	   Heyligen	   J.,	  Vriens	  K.,	   Thevissen	  K.,	   Cammue	  B.,	   Petrenko	  V.,	   Ulens	   C,	   Deckmyn	  H.	  and	  Lammertyn	  J.,	  Affinity	  comparison	  of	  p3	  and	  p8	  peptide	  displaying	  bacteriophages	   using	   surface	   plasmon	   resonance. Analytical Chemistry, 
(in press).  	  
3.1 	  Introduction	  The	  interest	  in	  multivalent	  bioreceptors	  has	  been	  increasing	  in	  the	  last	  years	   with	   applications	   acknowledged	   in	   very	   diverse	   research	   fields,	  such	  as	  cell	  biology,	  where	  their	  role	  was	  studied	  in	  the	  process	  of	  cell	  attachment1,	   cell	   receptor	   clustering2,3	   and	   molecular	   motion4,	   but	   as	  well	   in	   the	   fields	   of	   drug	   development5,	   affinity	   chromatography6	   and	  biosensors7.	  The	  concept	  of	  using	  multivalent	  bioreceptors	  due	  to	  their	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higher	   selectivity	   towards	   a	   target	   of	   interest8	   became	   especially	  appealing	  in	  the	  biosensors	  field,	  as	  the	  ever-­‐increasing	  demands	  on	  the	  performance	  of	  biosensors	  continuously	  drives	  research	  towards	  more	  selective	   and	   sensitive	   receptors.	   Recently,	   it	   was	   even	   shown	   that	  immobilizing	   receptors,	   namely	   antibodies,	   at	   high	   densities	   of	   more	  than	   100.000	   receptor	   copies	   per	  magnetic	   particle,	   allows	   to	   control	  binding	  kinetics,	   resulting	   in	  extremely	   low	  dissociation	  constants	  (Kd)	  in	  the	  femtomolar	  range9.	  	  This	  trend	  has	  also	  been	  introduced	  in	  the	  field	  of	  filamentous	  phage	  particles,	  which	  can	  express	  multiple	  receptors	  on	  their	  surface	  through	  one	  of	   their	   five	  unique	   coat	  proteins,	   promoting	   thereby	  usage	  of	   the	  entire	   phage	   as	   a	   receptor	   rather	   than	   the	   individual	   proteins10.	   The	  most	  used	  coat	  proteins,	  as	  illustrated	  in	  Figure	  3.1,	  are	  the	  minor	  coat	  protein	   p3,	   present	   in	   5	   copies	   at	   the	   phage	   distal	   end	   and	   the	  major	  coat	   protein	   p8,	   present	   much	   more	   abundantly	   all	   over	   the	   virus	  surface	   with	   up	   to	   2700	   copies11.	   Normally	   these	   phages	   display	   a	  library	  of	  peptides12,13,	  used	  to	  select	  individual	  high	  affinity	  ligands	  in	  a	  procedure	   called	  panning.	  Here,	   the	  phage	  display	   library12,	   consisting	  of	  different	  peptides	  expressed	  on	  the	  bacteriophage	  surface	  as	  part	  of	  their	  coat	  proteins,	  is	  used	  to	  present	  the	  peptides	  to	  targets	  of	  interest	  with	   the	   aim	   of	   selecting	   those	   peptides	   with	   the	   strongest	   affinity.	  Thus,	  p8	  expressing	  phages	  were	  used	  in	  the	  past	  only	  to	  select	  peptides	  with	   lower	  affinities,	  as	   their	  dense	  packing	  on	   the	  surface	  results	   in	  a	  stronger	   binding	   due	   to	   avidity	   masking	   low	   individual	   peptide	  affinity14-­‐17.	  However,	  with	   the	   trend	  of	   implementing	  whole	  phages	  as	  receptors	   on	   biosensors18,19,	   p8	   expressing	   phages	   have	   become	  valuable	   due	   to	   the	   advantages	   of	   high	   receptor	   valence,	   rivaling	   high	  affinities	  and	  binding	  capacity	  of	  p3	  expressing	  phages	  or	  classic	  affinity	  labels	   such	   as	   antibodies.	   Furthermore,	   phages	   can	   have	   few	   clear	  advantages	   in	  such	  applications	  compared	   to	  nano-­‐	  and	  microparticles	  with	   high	   receptor	   density.	   Firstly,	   they	   can	   be	   directly	   used	   as	   a	  scaffold	   for	   the	   peptide	   affinity	   labels6,7,20,21.	   Secondly,	   phages	   can	   be	  easily	   produced	   while	   the	   peptides	   remain	   confined	   to	   their	   original	  conformation	   used	   during	   the	   peptide	   selection	   phase,	   which	   can	   be	  crucial	  for	  the	  peptide	  function22,23.	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3.2 Aim	  of	  this	  chapter	  Despite	   numerous	   advantages	   of	   using	   the	   entire	   phage	   as	   a	   receptor	  rather	  than	  the	  individual	  peptides,	  binding	  kinetics	  of	  complete	  phage	  particles	  have	  never	  been	  studied	  in	  detail.	   In	  this	  chapter,	  we	  will	  use	  an	  in	  house	  developed	  fiber-­‐optic	  surface	  plasmon	  resonance	  (FO-­‐SPR)	  biosensor24,25	   to	   study	   the	   affinity	   and	   binding	   kinetics	   of	   phages.	  Moreover,	  we	  will	   evaluate	   if	   dense	   packing	   of	   the	   peptides	   on	   phage	  surfaces	   truly	   results	   in	   increased	   affinity	   by	   means	   of	   avidity	   as	   has	  been	   theorized	  multiple	   times26-­‐28.	   As	   illustrated	   in	   Figure	  3.1,	  we	  will	  study	  whether	  the	  location	  of	  the	  expressed	  peptides	  on	  the	  phage	  p3	  or	  p8	  coat	  protein	   is	   influencing	   the	  affinity	   towards	  a	   target	  molecule	  or	  whether	  it	  is	  primarily	  influencing	  the	  orientation	  on	  the	  FO-­‐SPR	  sensor	  surface.	   This	   will	   be	   discerned	   by	   analyzing	   different	   phases	   of	   SPR	  measurements	  during	  phage	  binding.	  It	  can	  be	  expected	  that	  expression	  of	   affinity	   peptides	   on	   the	   p8	   coat	   proteins	   will	   result	   in	   a	   phage	  orientation	  closer	  to	  the	  biosensor	  surface	  and	  an	  increase	  of	  the	  sensor	  signal,	   which	   will	   mainly	   disturb	   the	   initial	   phase	   of	   the	   SPR	  measurement,	  used	  to	  determine	  the	  association	  rate	  (kon).	  On	  the	  other	  hand,	  monitoring	  of	  the	  dissociation	  rate	  (koff),	  will	  give	  a	  better	  insight	  in	   the	  actual	   influence	  of	  high	  valence	  on	   the	  affinity	  of	   the	  phages,	   as	  high	  valence	  results	  in	  very	  low	  dissociation29.	  	  As	   a	   model	   system,	   we	   used	   phages	   panned	   with	   affinity	   for	  enhanced	  Green	  Fluorescent	  Protein	  (eGFP).	  This	  256	  amino	  acid	  eGFP	  is	  a	  common	  protein	  label	  for	  both	  in	  vivo	  and	   in	  vitro	  experiments30-­‐32.	  Because	   of	   the	   widespread	   use	   of	   eGFP,	   phages	   with	   affinity	   for	   this	  protein	  can	  be	  used	   for	  different	  applications,	   such	  as	  purification	  and	  extraction	  of	  recombinant	  eGFP	  labeled	  proteins,	  much	  in	  the	  same	  way	  as	  protein	  A	  or	  G	  are	  used	  as	  a	  universal	  affinity	  label	  for	  antibodies33,34.	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Figure	  3.1:	  Concept	  of	  fiber	  optic	  SPR	  based	  screening	  for	  eGFP-­‐binding	  phages.	  A)	  
Visualization	   of	   the	   filamentous	   phages,	   displaying	   peptides	   selective	   for	   eGFP	  
either	   at	   the	   N-­‐terminus	   of	   the	   p3	   protein	   (blue)	   or	   p8	   protein	   (red).	   Each	  
individual	  coat	  protein	  expresses	  one	  peptide.	  The	  p9	  protein	  is	  marked	  solely	  for	  
clarification	   (yellow);	   B)	   Measurement	   concept	   with	   the	   FO-­‐SPR	   sensor	   coated	  
with	   the	  eGFP	  protein	   (green)	  and	   interaction	  with	   the	   two	   types	  of	  phages;	   the	  
expression	   of	   peptides	   on	  p3	   or	   p8	   proteins	   can	  have	   a	   strong	   influence	   on	   the	  
affinity	  of	  the	  filamentous	  phage	  and	  consequently	  their	  orientation	  when	  bound	  
to	   the	   FO-­‐SPR	   sensor	   surface.	   C)	   The	   two	   expected	   sensorgrams	   are	   visualized	  
with	   a	   red	   and	   blue	   curve,	   corresponding	   to	   the	   p8	   and	   the	   p3	   peptide,	  
respectively.	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3.3 	  Materials	  and	  methods	  
3.3.1	  Phage	  panning	  Depending	   on	   the	   phage	   library	   used	   (Table	   3.1),	   two	   different	  panning	  strategies	  were	  followed:	  1.	   For	   the	   linear	   6-­‐mer	   (p3L6),	   15-­‐mer	   (p3L15)	   and	   cyclic	   6-­‐mer	  (p3C6)	  phage	  display	  libraries,	  a	  tube	  panning	  procedure	  was	  applied	  as	  described	   earlier35.	   Briefly,	   after	   coating	   eGFP	   (5	   µg/mL)	   in	   immuno-­‐tubes	  followed	  by	  post	  coating	  with	  0.4%	  milk	  powder	  in	  PBS,	  the	  phage	  libraries	   were	   incubated	   overnight	   at	   4°C	   (or	   2.5	   hours	   at	   room	  temperature	   (RT)	   for	   the	   next	   rounds).	   Subsequently	   the	   tubes	   were	  washed	  to	  remove	  unbound	  phage	  and	  eluted	  with	  0.1	  M	  glycine	  pH	  2.0	  for	   10	   min.	   The	   eluted	   phages	   were	   neutralized	   and	   incubated	   with	  
E.coli-­‐TG1	  cells	  (Stratagene,	  Diegem,	  Belgium)	  cells	  at	  37°C	  for	  30	  min.	  Infected	   cells	   were	   plated	   on	   agar-­‐tetracycline	   plates	   for	   phage	  amplification.	  	  2.	   The	   linear	   9-­‐mer	   landscape	   (p8L9-­‐LS)	   library	   was	   panned	   as	  described	   earlier36.	   The	   method	   was	   identical	   to	   the	   above-­‐described	  method	  for	  p3	  phages	  except	  for	  the	  usage	  of	  a	  microtiter	  plate	  instead	  of	  immuno-­‐tubes.	  Furthermore	  the	  eluted	  phages	  were	  neutralized	  and	  incubated	   with	   “starved”	   E.coli	   K91	   BluKan	   cells	   at	   RT.	   Infected	   cells	  were	   further	   grown	   in	   NZY-­‐tetracycline-­‐medium	   (Sigma	   Aldrich,	  Bornem,	  Belgium)	  in	  an	  overnight	  incubation	  step	  at	  37°C.	  	  For	   both	   p3	   and	   p8	   phages,	   three	   rounds	   of	   selection	   were	  performed.	   From	   the	   third	   panning	   round,	   single	   clone	   phages	   were	  isolated,	  identified	  (through	  DNA	  sequencing)	  and	  tested	  for	  binding	  to	  eGFP	   using	   ELISA	   and	   FO-­‐SPR	   technology.	   All	   selected	   phages	   were	  finally	  stored	  in	  PBS-­‐5%	  glycerol	  (w/v%)	  at	  -­‐20°C	  until	  further	  use.	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Table	  3.1:	  Phage	  libraries	  and	  phage	  clones.	  
Phage	  
library	  




p3	  phages	   	   	   	  p3C6	   Cyclic	   6-­‐mer	   peptide	   type	   3	   library.	  Peptides	   are	   expressed	   at	   the	   N-­‐terminus	  of	  the	  p3	  coat	  protein	   1A6;	   1B2;	  1C3;	   1D2;	  1F7;	  1H3	   G.	  Vlasuk,	  Corvas,	  San	  Diego	  CA,	  USA	  p3L6	   Linear	   6-­‐mer	   peptide	   type	   3	   library.	  Peptides	   are	   expressed	   at	   the	   N-­‐terminus	  of	  the	  p3	  coat	  protein	   2F7;	  2H3	   G.P.	  Smith,	  University	  of	  Missouri,	  Columbia	  MO,	  USA	  p3L15	   Linear	   15-­‐mer	   peptide	   type	   3	   library.	  Peptides	   are	   expressed	   at	   the	   N-­‐terminus	  of	  the	  p3	  coat	  protein	   3D6;	   3E5;	  3F3;	   3G2;	  3G4;	  3G6	   G.P.	  Smith,	  University	  of	  Missouri,	  Columbia	  MO,	  USA	  
p8	  phages	   	   	   	  p8L9-­‐LS	   Linear	   9-­‐mer	   peptide	   library	   inserted	  in	   the	   p8	   coat	   protein	   by	   deleting	  replacing	  amino	  acids	  2-­‐5.	  A	  so	  called	  Landscape	  Phage	  Library	  
4R3.3;	  4R3.5;	  4R3.6;	  4R3.10;	  4R3.11;	  4R3.12;	  4R3.13;	  4R3.14;	  4R3.15	  
V.A.	  Petrenko,	  Auburn	  University,	  Auburn	  AL,	  USA	  
control	  
phages	  
	   	   	  
	   Non-­‐binding	  eGFP	  phages	   B1	   	  	  
3.3.2	  Expression	  and	  purification	  of	  eGFP	  The	   cDNA	   encoding	   eGFP	   was	   cloned	   into	   the	   pFastBac	   vector	  (Invitrogen)	   as	   a	   N-­‐terminal	   His-­‐tagged	   fusion.	   Baculovirus	   was	  produced	   using	   the	   Bac-­‐to-­‐Bac	   expression	   system	   according	   to	   the	  manufacturer’s	  guidelines	  (Invitrogen).	  His-­‐tagged	  eGFP	  was	  expressed	  in	   Sf9	   insect	   cells	   using	   P2	   recombinant	   baculovirus.	   eGFP-­‐His	   was	  purified	   from	   cleared	   cell	   lysate	   using	   Ni	   Sepharose	   beads	   (GE	  Healthcare).	  Impurities	  were	  washed	  out	  with	  40	  mM	  imidazole	  in	  PBS	  buffer	   and	   bound	   protein	   was	   eluted	   with	   250	  mM	   imidazole	   in	   PBS.	  eGFP-­‐His	   was	   further	   purified	   by	   gel	   filtration	   on	   a	   Superdex	   200	  10/300	   GL	   column	   (GE	   healthcare)	   with	   PBS	   as	   a	   running	   buffer.	  Purified	   protein	   was	   concentrated	   to	   2	   mg/ml	   and	   stored	   a	   4˚C	   until	  further	  use.	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3.3.3	  SPR	  device	  setup	  The	  FO	  sensors	  were	  made	  of	  a	  HL-­‐2000	  tungsten	  halogen	  lamp	  (Ocean	  optics,	   Dunedin,	   USA),	   a	   miniature	   UV-­‐VIS	   spectrophotometer	  (USB4000,	  Ocean	  Optics,	  Dunedin,	  USA)	  and	  an	  FO	  sensor,	  as	  previously	  described	   in	   Pollet	   et	   al.37	   The	   FO-­‐SPR	   setup	   was	   built	   in	   order	   that	  replaceable	  and	  interchangeable	  FO-­‐SPR	  sensors	  can	  be	  coupled	  with	  a	  bifurcated	  optical	   fiber	   to	  guide	  white	   light	   from	   the	   tungsten	  halogen	  lamp	   into	   the	   sensor.	   The	   light	   will	   first	   pass	   the	   SPR	   sensitive	   gold	  zone,	   afterwards	   it	   will	   reflect	   back	   at	   the	   tip	   and	   travel	   towards	   the	  spectrometer	   (Figure	  3.2).	  Binding	  phenomena	  at	   the	  gold	  surface	  will	  result	   in	   a	   shift	   of	   the	   typical	   spectral	   resonance	   SPR-­‐dip	   recorded	   by	  the	  spectrometer.	  	  
	  
Figure	  3.2:	  A)	  Picture	  of	  the	  measuring	  setup	  with	  all	  components.	  B)	  Schematic	  
close	  up	  of	  the	  sensing	  region	  with	  yellow	  arrows	  indicating	  incident	  light,	  which	  
excites	  surface	  plasmons	  and	  red	  arrows	  indicating	  reflected	  light	  in	  the	  SPR	  
sensor	  tip	  which	  is	  analyzed	  with	  a	  spectrometer.	  All	   components	   of	   the	   FO-­‐SPR	   device	   were	   mounted	   on	   a	   robotic	  arm	   (High-­‐Z	   S400,	   CNC-­‐Step,	   Geldern,	   Germany)	   enabling	   automated	  handling.	  The	  temperature	  of	  the	  samples	  is	  controlled	  using	  a	  modified	  T1	  thermocycler	  (Biometra,	  Gottingen,	  Germany).	  Because	  temperature	  can	   cause	   SPR	   signal	   drift,	   the	   temperature	   was	   also	   monitored	  externally	   using	   a	   NI-­‐DAQ	   (National	   instruments,	   Austin,	   USA)	   with	  three	   highly	   responsive	   T-­‐type	   WK-­‐200	   thermocouple	   threads	  (Labfacillity,	   Leeds,	   United	   Kingdom).	   The	   interchangeable	   SPR	  measurement	  probes,	  were	  easily	  coupled	  to	   the	  SPR	  device	   through	  a	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subminiature	   version	   A	   connector	   (SMA-­‐type	   connector,	   Thorlabs,	  Munchen,	  Germany).	  
3.3.4	  FO-­‐SPR	  sensor	  tip	  FO	   sensors	   were	   designed	   and	   manually	   manufactured	   as	   previously	  described	  in	  Pollet	  et	  al.38	  In	  short,	  a	  400	  µm	  0.39	  NA	  multimode	  TEQS	  optical	   fiber	   (Thorlabs,	  Germany)	  was	  cut	   consistent	   to	  a	   length	  of	  2.8	  cm,	  next	  the	  fiber	  was	  assembled	  into	  an	  SMA	  connector	  after	  removal	  of	   the	   protective	   cladding.	   Following,	   the	   fiber	   end	   was	   placed	   in	  acetone	  for	  5	  min	  to	  loosen	  the	  hard	  polymer	  cladding.	  Afterwards,	  the	  FO	  sensor	  was	  carefully	  cleaned	  with	  isopropyl	  ethanol	  and	  rinsed	  with	  water.	   Subsequently,	   the	   FO	   sensors	   were	   coated	   with	   a	   50	   nm	   gold	  layer	  using	  a	  sputter	  coater	  (Balzers,	  Pfäffikon,	  Switzerland).	  The	  freshly	  prepared	  fibers	  were	  immediately	  incubated	  with	  1	  µM	  of	  a	  biotin	  self-­‐assembling	  monolayer	  (SAM)	  formation	  reagent	  (Dojindo,	  Japan),	  which	  was	  used	  as	   a	   scaffold	   to	   immobilize	  biotinylated	  eGFP	  on	   the	  FO-­‐SPR	  sensor	  surface	  (Figure	  3.1)	  
3.3.5	  FO-­‐SPR	  sensor	  tip	  preparation	  The	  gold	  sensing	  layer	  of	  the	  FO-­‐SPR	  sensor	  tip,	  was	  functionalized	  with	  a	   self-­‐assembling	   monolayer	   (SAM),	   to	   couple	   biomolecules	   on	   the	  sensor	   tip.	   The	   SAM	   consisted	   of	   alkane	   thiol	   chains	   with	   a	   biotin	  functional	   head	   group	   (Dojindo	   Molecular	   Technologies,	   Munich,	  Germany).	  During	   an	   overnight	   incubation	   (1	   µM	  of	   thiols	   in	   ethanol),	  the	   thiol	   groups	   attached	   to	   the	   gold	   surface,	   while	   the	   alkane	   chains	  oriented	   themselves	   into	   a	   well-­‐organized	   monolayer.	   After	   12	   h	   of	  incubation,	   the	  probes	  were	  rinsed	   in	  ethanol	   to	   remove	  any	  unbound	  alkane	   thiols	   and	   were	   stored	   at	   4°C	   prior	   to	   use.	   For	   binding	  biotinylated	   eGFP	   on	   the	   sensor	   tip,	   10	   µg/mL	   of	   streptavidin	  (Invitrogen,	   Stockholm,	   Sweden)	   was	   immobilized	   on	   the	   SAM	   biotin	  groups	  in	  50	  mM	  MES	  buffer	  with	  pH	  6.0.	  The	  surface	  was	  washed	  with	  rinsing	  solution	  (50	  mM	  NaOH,	  1	  M	  NaCl)	  to	  remove	  all	  non-­‐specifically	  bound	  molecules,	  followed	  by	  binding	  of	  biotinylated eGFP (10µg/mL).	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3.3.6	  FO-­‐SPR	  measurements	  of	  phage	  binding	  For	   screening,	   phages	   were	   serially	   diluted	   twofold	   starting	   from	  2x1012	  phages/mL.	  Both	  phage	  binding	  and	  phage	  dissociation	   to	  and	  from	   the	   eGFP	   coated	   sensor	   tip,	   respectively,	   were	  monitored	   for	   15	  min	   in	   100	   µL	   volumes.	   Afterwards,	   the	   FO-­‐SPR	   sensor	   tip	   was	  regenerated	  for	  60	  s	  in	  phosphate	  washing	  buffer	  (PBS,	  0.1%	  Tween	  20,	  1	  M	  NaCl)	  under	  continuous	  stirring.	  In	  between	  two	  measurements	  the	  FO-­‐SPR	  sensor	  tip	  was	  equilibrated	  in	  measurement	  buffer	  (MES,	  0.1%	  Tween	  20,	  pH	  6.0)	  during	  5	  min.	  Dilution	  series	  of	  two	  different	  phages	  were	   simultaneously	   analyzed	   using	   two	   different	   measurement	  channels	  of	   the	  FO-­‐SPR	  device.	  Moreover,	   the	  repetition	  dilution	  series	  of	  the	  same	  phage	  were	  analyzed	  on	  different	  measurement	  channels	  to	  minimize	  FO-­‐SPR	  sensor	  tip	  artifacts.	  Binding	  of	  both	  biotinylated	  eGFP	  and	   filamentous	   phages	   (colored	  with	   the	   intercalating	   dye	   Sybr	   gold,	  Life	   Technologies,	   Oslo,	   Norway)	   on	   the	   probe	   surface	   was	  characterized	  using	  an	  inverted	  fluorescence	  microscope.	  
3.3.7	  ELISA	  The	   wells	   of	   a	   streptavidin	   coated	   ELISA	   plate	   (Thermo	   scientific,	  Rockford,	  USA)	  were	   incubated	  with	   100	  µl	   of	   5	   µg/ml	   biotin-­‐eGFP	   in	  TBS	   for	   1.5	   hours	   at	   room	   temperature	   and	   subsequently	   washed.	  Afterwards,	  the	  eGFP-­‐binding	  phages	  were	  added	  in	  a	  concentration	  of	  1x1011	   phages/ml	   in	  MES	  buffer	   (pH	  6.0,	   50	  mM,	  0.1%	  Tween	  20)	   for	  1.5	  hours	  at	  RT	  and	  extensively	  washed	  with	  MES.	  Next	  the	  wells	  were	  incubated	  with	   rabbit	   anti-­‐fd	   bacteriophage	   antibody	   (Sigma,	   Bornem,	  Belgium)	   at	   a	   concentration	   of	   0.66	   µg/ml	   and	   a	   secondary	   antibody,	  goat	   anti	   rabbit-­‐IgG	   conjugated	   with	   alkaline	   phosphatase	   (Jackson	  ImmunoResearch,	  West-­‐Grove,	   USA)	   at	   a	   concentration	   of	   0.24	   µg/ml	  for	   1	   hour	   each	   at	   RT	   in	   following	   buffer:	   50	  mM	  Tris,	   150	  mM	  NaCl,	  0.1%	  Tween	  20,	  1	  mg/ml	  BSA,	  pH7.5.	  After	  extensive	  washing	  with	  MES,	  the	   substrate,	  p-­‐nitrophenylphosphatein	   in	  1	  M	  diethanolamine,	  1	  mM	  MgCl2+	  pH	  9.8	  was	  added	  to	  each	  well.	  Finally	  the	  absorbance	  at	  405	  nm	  was	   monitored	   during	   15	   min	   using	   a	   plate	   reader	   (Fluostar	   Optima,	  Ortenberg,	  Germany).	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3.3.8	  Data	  analysis	  The	  FO-­‐SPR	  set-­‐up	  was	  controlled	  using	  an	  in	  house	  developed	  National	  Instruments	   Labview	   script	   (National	   Instruments).	   This	   script	   timed	  the	  measurements	  of	  the	  spectrometer	  by	  sending	  trigger	  signals	  to	  the	  Ocean	   optics	   spectrometer	   enabling	   exact	   time	   control	   over	  spectrometer	   measurements.	   Data	   was	   logged	   in	   TDMS	   compression	  allowing	  extended	  time	  measurements.	  The	  data	  was	  extracted	  from	  the	  TDMS	   files	   using	   a	   Matlab	   (The	   Mathworks,	   Natick,	   USA)	   script	   that	  recognizes	  motives	   in	   the	  SPR	  data,	  which	   increased	   the	  speed	  of	  data	  processing.	   Downstream	   data	   analysis	   of	   the	   SPR	   measurements	   was	  performed	   using	   Excel	   (Microsoft,	   Redmond,	   USA)	   and	   Origin	  (Originlabs,	  Northampton,	  USA).	  The	  kinetic	  data	  of	  phage	  binding	  was	  derived	   from	   the	  SPR	  measurements	  using	  Prism	  (Graphpad	  Software,	  San	  Diego,	  USA),	  by	  fitting	  the	  SPR	  binding	  curves	  with	  a	  1:1	  Langmuir	  model.
3.4 	  Results	  
3.4.1	  Optimization	  of	  the	  FO-­‐SPR	  assay	  for	  phage-­‐eGFP	  interaction	  Phage	   affinity	   towards	   the	   target	   protein,	   i.e.	   eGFP	   in	   this	   study,	   was	  evaluated	   in	   a	  direct	   interaction	  assay	  using	   the	  FO-­‐SPR	  biosensor.	  To	  establish	  the	  assay,	   immobilization	  of	  eGFP	  onto	  the	  FO-­‐SPR	  sensor	  tip	  surface	   was	   optimized	   first.	   Because	   the	   eGFP	   molecule	   has	   a	   tightly	  packed	   barrel	   structure,	   which	   makes	   functional	   groups	   less	  accessible39,	   immobilization	  was	  done	   through	  biotin	  and	   streptavidin.	  Thus,	  eGFP	  was	  labeled	  with	  a	  small	  biotin	  molecule	  in	  solution	  before	  being	  bound	  to	  a	  streptavidin	  molecule	  on	  the	  SPR	  sensor.	  This	  resulted	  in	   a	   higher	   immobilization	   efficiency	   due	   to	   use	   of	   a	   modification	  reaction	   in	   free	   solution	   rather	   than	   directly	   on	   the	   sensor	   surface,	  which	  is	  known	  to	  cause	  steric	  hindrance	  and	  electrostatic	  repulsion40.	  Moreover,	   the	   tetramer	   structure	   of	   streptavidin41	   holds	   an	   extra	  advantage,	   as	   multiple	   eGFP	   biotin	   molecules	   can	   be	   immobilized	   on	  one	  streptavidin	  molecule.	  The	   streptavidin	   immobilization	   was	   tested	   in	   buffered	   solutions:	  MES	   (pH	   6),	   PBS	   (pH	   7.4),	   Acetic	   Acid	   (pH	   5.2)	   in	   order	   to	   achieve	  optimal	   protein	   density	   on	   the	   probe	   surface	   (Figure	   3.3,	   part	  A,	   blue	  bars).	  According	  to	  the	  SPR	  signal,	  the	  highest	  streptavidin	  density	  was	  
Results	  
91	  
realized	  in	  MES	  buffer	  with	  pH	  6.0.	  This	  result	  is	  in	  accordance	  with	  the	  pI	   for	  both	   streptavidin	   (pI=	  6.3)42	  and	  biotin	   (pI=	  3.5)43,	  making	  both	  molecules	  oppositely	  charged	  at	  pH	  6.0,	  allowing	  them	  to	  diffuse	  closely	  to	   the	   surface	   which	   increases	   the	   chances	   for	   a	   binding	   event44.	  Although	   these	  molecules	   should	   be	   even	  more	   oppositely	   charged	   at	  pH	   5.2,	   a	   lower	   binding	  was	   observed.	   This	   can	   be	   explained	   through	  charges	   generated	   on	   the	   FO-­‐SPR	   sensor	   surface	   as	   a	   result	   of	  deprotonated	   SAM	   functional	   groups	   at	   this	   pH,	   repelling	   the	   highly	  charged	  streptavidin	  molecules.	   In	  a	   similar	  experiment,	  differences	   in	  the	  immobilization	  efficiency	  of	  biotinylated	  eGFP	  appeared	  to	  be	  much	  more	  pronounced	   (Figure	  3.3,	   part	  A,	   green	  bars).	   For	   instance,	   at	   pH	  7.4	  a	  shift	  of	  less	  than	  1	  nm	  was	  observed,	  whereas	  lowering	  the	  pH	  to	  6.0	   doubled	   the	   amount	   of	   eGFP	   on	   the	   probe	   surface.	   By	   introducing	  extra	  ions	  in	  this	  buffer,	  the	  density	  on	  the	  FO-­‐SPR	  surface	  was	  further	  improved	  and	  a	  better	  reproducibility	  was	  achieved	  (Figure	  3.3,	  part	  A,	  pH	  6.0*).	  Subsequently,	   one	   of	   the	   phage	   clones	   panned	   for	   eGFP	   (1B2	   -­‐	   p3	  phage)	  was	  randomly	  selected	  for	  optimizing	  phage	  binding	  to	  eGFP	  on	  the	   FO-­‐SPR	   sensor	   tip	   surface	   (Figure	   3.3,	   part	  A).	   	   In	   a	   standard	  PBS	  buffer	   with	   pH	   7.4,	   a	   minor	   SPR	   signal	   shift	   was	   visible	   at	   a	  concentration	  of	  5x1013	  phages/mL,	  which	  was	  only	  marginally	  higher	  than	  the	  SPR	  signal	  of	  a	  non-­‐eGFP	  selected	  control	  phage.	  In	  fact,	  a	  large	  part	  of	  the	  FO-­‐SPR	  signal	  shift	  can	  be	  attributed	  to	  the	  glycerol	  matrix	  of	  the	  phage	  storage	  buffer,	  as	  glycerol	  has	  a	  higher	  refractive	  index45	  than	  the	   measuring	   buffer.	   The	   low	   binding	   signals	   of	   phages	   can	   be	  explained	  by	  negative	  charges	  of	  eGFP	  on	  the	  probe	  surface,	  as	  well	  as	  on	   the	   phage	   surface	   at	   pH	   7.4,	   which	   prevents	   binding	   interactions.	  Knowing	   that	   eGFP	   has	   a	   pI	   around	   pH	   6.046,	   while	   the	   filamentous	  phages	  have	   a	  pI	   around	  4.047,	   buffers	  with	   a	   similar	  pH	  were	   applied	  (pH	   5-­‐7.4)	   in	   order	   to	   decrease	   the	   charges	   on	   both	   surfaces.	   Results	  show	   that	   by	   lowering	   the	   pH,	   the	   SPR	   signal	   steadily	   increased,	  reaching	  saturation	  at	  pH	  5.0	  (Figure	  3.3,	  part	  B).	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Figure	  3.3:	   Influence	   of	   pH	   and	   ionic	   strength	   on	   the	  binding	   of	   phages	   to	   eGFP	  
using	   FO-­‐SPR:	   A)	  Optimization	   of	   streptavidin	   and	   eGFP	   binding	   at	   different	   pH	  
values	   and	   in	   the	   presence	   of	   300	   mM	   (*)	   NaCl	   (n=4);	   B)	   Binding	   of	   an	   eGFP-­‐
specific	  or	  control	  phage	  clone	  at	  different	  pH	  values	  and	  in	  the	  presence	  of	  137	  
(**)	  or	  300	  mM	  (*)	  NaCl	  (n=4).	  Error	  bars	  indicated	  are	  the	  standard	  deviations	  of	  




Figure	  3.4:	  A)	  SPR-­‐binding	  curves	  of	  an	  eGFP-­‐specific	  and	  control	  phage	  clone	  at	  
pH	  6.0	  and	  7.4;	  B)	  Microscopy	  images	  of	  the	  FO-­‐SPR	  sensor	  tip	  with	  biotin	  SAM	  FO-­‐
SPR	   probe	   (top),	   after	   eGFP	   immobilization	   (middle)	   and	   after	   phage	   binding	  
(bottom).	  Scale	  bar	  =	  100	  µm.	  
3.4.2	  FO-­‐SPR	  screening	  of	  selected	  phages	  with	  affinity	  for	  eGFP	  Using	  the	  above	  described	  optimized	  conditions	  for	  binding	  of	  phages	  to	  the	   FO-­‐SPR	   sensor	   tip	   surface,	   both	   p3	   and	   p8	   eGFP	   panned	   phages	  were	   screened	   for	   their	   affinity	   towards	   eGFP.	   Phage	   measurements	  were	   conducted	   at	   4	   different	   concentrations	   in	   a	   range	   of	   1011-­‐1012	  phages/mL.	   The	   intrinsic	   non-­‐specific	   binding	   of	   a	   native	   non-­‐panned	  filamentous	   phage	   to	   eGFP	   was	   first	   examined.	   This	   interaction	  appeared	   to	   be	   negligible,	   even	   at	   the	   highest	   tested	   concentration	  (2x1012	   phages/mL,	   Figure	   3.5,	   part	   A).	   Next,	   the	   binding	   of	   eGFP	  panned	   p3	   phage	   clones	   was	   measured.	   These	   p3	   phages	   can	   be	  distinguished	  according	  to	  the	  type	  of	  peptide	  they	  express,	  being	  either	  a	   linear	   peptide	   or	   a	   cyclic	   peptide	   (by	   the	   introduction	   of	   cysteine	  groups	  which	  can	  form	  disulfide	  bonds49).	  Although	  all	  linear	  p3	  phages	  showed	   a	   clear	   difference	   in	   interaction	   with	   eGFP	   compared	   to	   the	  native	  phage	  (Figure	  3.5,	  part	  A),	  substantially	  higher	  SPR	  signal	  shifts	  were	   noted	   for	   the	   p3	   cyclic	   phages	   (Figure	   3.5,	   part	   B).	   Phages	  expressing	   cyclic	   peptides	   are	   known	   to	   have	   considerably	   better	  affinities	   than	   phages	   expressing	   linear	   peptides,	   because	   of	   a	  structurally	  more	   stable	   binding	   conformation,	  with	   limited	   structural	  entropy	  in	  the	  unbound	  state,	  favoring	  higher	  binding	  affinities50.	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Figure	  3.5:	  Binding	  of	  phage	  clones	  to	  eGFP	  as	  determined	  with	  FO-­‐SPR:	  A)	  Non-­‐
eGFP	  panned	  native	  phage	  together	  with	  the	  linear	  p3	  expression	  phages;	  B)	  the	  




Figure	  3.6:	  Binding	  of	  p8	  expressing	  landscape	  phage	  clones.	  SPR	  measurements	  were	   further	  validated	  with	  an	  endpoint	  ELISA	  test	   (Figure	  3.7),	  which	   showed	   similar	   trends	   for	   individual	   clones	   in	  both	  assays.	  Thus,	   clones	  1H3	  and	  4R3.12	  appeared	  as	  one	  of	   the	  best	  binding	   p3	   and	   p8	   phages,	   respectively,	   according	   to	   both	   assays.	  However,	  a	  discrepancy	  was	  observed	  in	  the	  overall	  signal	  intensity	  for	  p3	   and	  p8	  phages	   in	   the	   two	  assays.	  Whereas	  p3	  phages	   gave	   a	  much	  higher	   signal	   in	   the	   ELISA	   assay	   than	   p8	   phages,	   SPR	   binding	   signals	  were	  a	  mirror	  image	  of	  these	  results.	  Here,	  an	  explanation	  can	  be	  found	  with	   the	   underlying	   mechanisms	   of	   the	   two	   bioassays:	   FO-­‐SPR	  measurements	  monitor	  phage	  clones	   interactions	  with	  eGFP	   label	   free,	  while	  the	  ELISA	  measurements	  are	  based	  on	  a	  sandwich	  type	  of	  assay.	  Therefore,	  in	  the	  ELISA,	  an	  antibody	  against	  the	  p8	  protein	  (R@fd-­‐IgG)	  is	   used	   to	   identify	   phages,	   after	   they	   have	   bound	   to	   eGFP	   on	   the	  microtiter	   plate	   surface.	   As	   a	   result,	   when	   the	   p8	   coat	   protein	   is	  expressing	  peptides	  selective	  for	  eGFP,	  the	  epitope	  for	  the	  antibody	  can	  be	  modified,	  resulting	  in	  a	  lower	  binding	  efficiency	  of	  the	  antibody.	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Figure	   3.7:	   Comparison	   of	   phage	   binding	   (1011	   phages/mL)	   with	   eGFP	   as	  
obtained	   with	   ELISA	   and	   FO-­‐SPR.	   (*)	   phage	   clone	   measured	   at	   lower	  
concentration	   with	   FO-­‐SPR	   (108	   phages/mL)	   (n=4,	   error	   bars	   represent	   the	  
standard	  deviation	  of	  the	  mean).	  Higher	   SPR	   binding	   signals	   obtained	   with	   p8	   phages	   are	   not	   only	  indicating	  higher	  affinity/avidity	   for	   the	  eGFP	   immobilized	  on	   the	  SPR	  sensor,	   but	   can	   also	   be	   attributed	   to	   the	   orientation	   of	   phages	   on	   the	  sensor	  surface	  (Figure	  3.1).	  Nonetheless,	  as	   the	  number	  and	  density	  of	  affinity	  peptides	  displayed	  on	  the	  p8	  coat	  protein	  is	  much	  higher	  than	  in	  p3	  phages,	  p8	  phages	  are	  capable	  of	  binding	  multiple	  times	  to	  different	  eGFP	   molecules	   on	   the	   sensor	   surface.	   Earlier	   reports	   on	   multivalent	  antibodies	   showed	   that	   avidity	   mainly	   results	   in	   a	   decrease	   in	  dissociation	  constant51,52.	  The	  same	  effect	  should	  be	  observed	  when	  SPR	  dissociation	   kinetics	   of	   p8	   phages	   are	   compared	   to	   p3	   phages.	   To	  evaluate	   this	  hypothesis,	  binding	  curves	  of	   the	  best	  binding	  p3	  and	  p8	  phages	  (being	  clones	  1H3,	  1F7,	  1A6,	  4R.11,	  4R.12)	  were	  studied	  in	  more	  detail.	  
3.4.3	  Binding	  kinetics	  For	  each	  of	  the	  5	  selected	  phage	  clones,	  the	  kinetic	  binding	  parameters	  such	   as	   association	   rate	   (kon)	   and	   dissociation	   rate	   (koff)	  were	   derived	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from	   the	   individual	   SPR	  measurements	   (Figure	   3.8).	   The	   ratio	   of	   both	  constants	   further	   determined	   the	   dissociation	   constant	   (Kd)	   for	   each	  phage	  (summarized	  in	  Table	  3.2).	  	  	  
Table	   3.2:	   Kinetic	   parameters	   (± std.	   dev.	   of	   4	  measurements)	   of	   eGFP-­‐binding	  
phages	  measured	  by	  FO-­‐SPR.	  
Phage	   1H3	   1F7	   1A6	   4R3.12	   4R3.11	  
kon	  	  (s-­‐1	  x	  M-­‐1)	   1.2±0.1x108	   3.8±0.3x108	   3.6±0.2x108	   1.9±x0.1x1011	   2.3±1.1x108	  koff	  	  (s-­‐1)	   2.7±0.1x10-­‐3	   4.0±0.6x10-­‐3	   6.0±0.2x10-­‐3	   2.2±0.1x10-­‐3	   1.0±0.1x10-­‐3	  Kd	  	  (M)	   2.3±0.3x10-­‐11	   1.1±0.2x10-­‐11	   1.6±0.4x10-­‐11	   1.2±0.1x10-­‐14	   4.5±0.9x10-­‐12	  	  Kd	  values	   for	  both	  p8	  phages	  were	  at	   least	  one	  order	  of	  magnitude	  lower	  than	  for	  the	  p3	  phages,	  confirming	  our	  previous	  conclusions	  that	  p8	  phages	  have	   a	   higher	   affinity	   for	   eGFP.	  Nonetheless,	   the	  p3	  phages	  also	   had	   a	  Kd	   in	   the	   pM	   range	   (Figure	   3.8),	  which	   is	   equivalent	   to	   the	  best	  performing	  antibodies53.	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Figure	   3.8:	   Binding	   curves	   of	   5	   eGFP-­‐binding	   phage	   clones	   with	   the	   highest	  
interaction	   signal	   in	   the	   screening	   experiment:	   A)	   p3	   phage	   clone	   1H3;	   B)	   p3	  
phage	   clone	   1F7;	   C)	   p3	   phage	   clone	   1A6;	   Measured	   signal	   is	   depicted	   in	   black	  
while	  fitted	  curve	  values	  for	  deriving	  binding	  parameters	  are	  shown	  in	  red.	  The	  actual	  SPR	  binding	  curves	  revealed	  that	  the	  SPR	  signal	  is	  almost	  a	   flat	   line	  during	  the	  dissociation	  phase	  of	  p8	  phages,	   indicating	  only	  a	  minimal	   amount	   of	   dissociation	   from	   the	   sensor	   surface	   (Figure	   3.9).	  This	   result	   verified	   the	   hypothesis	   that	   the	   increase	   in	   affinity	   of	   p8	  phages	   is	   influenced	   considerably	   by	   a	   change	   in	   koff.	   Surprisingly,	   p3	  phages	  also	  displayed	  a	  very	  slow	  dissociation	  phase	  (Figure	  3.8),	  which	  indicated	   that	   even	   the	   five-­‐plex	  multivalence	   of	   the	   p3	   protein	   has	   a	  considerable	   impact	   on	   the	   affinity,	   as	   was	   also	   found	   in	   earlier	  work54,55.	  In	  a	  recent	  publication,	  highly	  valent	  magnetic	  particles	  (1µm	  diameter),	  which	  are	  comparable	  to	  p8	  landscape	  phages,	  showed	  very	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similar	  binding	  kinetics	  and	  a	  similar	  increase	  in	  both	  kon	  and	  koff	  rates	  as	  p8	  phages.	  Moreover,	  the	  affinity	  of	  these	  magnetic	  particles	  towards	  a	  protein	   immobilized	  on	  a	   flat	   surface	   (prostate	   specific	   antigen)	  was	  comparable	   to	   the	   affinity	   of	   the	   p8	   phages	   for	   eGFP	   used	   in	   this	  research	  with	  Kd-­‐values	  in	  the	  fM	  range9.	  	  
	  
Figure	   3.9:	   Binding	   curves	   of	   5	   eGFP-­‐binding	   phage	   clones	   with	   the	   highest	  
interaction	  signal	   in	   the	  screening	  experiment:	  A)	  p8	  phage	  clone	  4R3.12;	  B)	  p8	  
phage	  clone	  4R3.11.	  The	  measured	  signal	   is	  depicted	   in	  black	  while	   fitted	  curve	  
values	  for	  deriving	  binding	  parameters	  are	  shown	  in	  red.	  
3.4.4	  Competitive	   assays	   for	   testing	   the	   specificity	   of	   the	   phage-­‐
eGFP	  interactions	  The	   specificity	   of	   the	   highest	   affinity	   phages	   (being	   clones	   1F7,	   1A6,	  4R3.11	   and	   4R3.12)	   towards	   eGFP	   was	   evaluated	   in	   two	   different	  assays.	  	  In	   the	   first	   assay,	   eGFP	   immobilized	   on	   the	   sensor	   surface	   was	  competing	   for	   phage	   binding	   with	   free	   eGFP	   in	   solution.	   Increasing	  concentrations	  of	  free	  eGFP	  are	  likely	  to	  decrease	  the	  number	  of	  phages	  capable	  of	  binding	  to	  the	  sensor,	  if	  binding	  is	  specific	  (Figure	  3.10,	  part	  A).	   As	   expected,	   the	   high	   peptide	   densities	   of	   the	   landscape	   phages	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Figure	   3.10:	   A)	   Free	   eGFP	   dose-­‐dependently	   competes	   with	   sensor-­‐bound	   eGFP	  
for	  binding	  to	  phages;	  B)	  The	  highly	  homologous	  Venus	  protein	  dose-­‐dependently	  
increases	   the	   binding	   signal	   of	   eGFP-­‐binding	   phages	   bound	   to	   the	   sensor,	  
indicating	   low	   affinity	   interaction	   of	   phages	   with	   Venus	   protein.	   Symbols	  
represent	   experimental	   data,	   while	   the	   lines	   are	   a	   logistic	   sigmoidal	   fit.	   (n=4,	  
error	  bars	  represent	  the	  standard	  deviation	  of	  the	  mean)	  In	  a	  second	  assay,	  the	  specificity	  towards	  eGFP	  was	  tested	  using	  an	  eGFP	  homologous	  protein,	  namely	  Venus	  protein,	  which	  differs	  in	  only	  6	  out	   of	   256	   amino	   acids	   of	   native	   GFP,	   resulting	   in	   a	   red	   shift	   in	   the	  emission	  spectrum	  of	  the	  fluorescent	  protein56.	  Surprisingly,	  the	  Venus	  protein	  did	  not	  inhibit	  binding	  with	  eGFP	  on	  the	  FO-­‐SPR	  surface	  for	  all	  4	  phages	   tested,	   even	   at	   Venus	   concentrations	   as	   high	   as	   200	   µg/mL,	  demonstrating	   that	   the	   phages	   are	   indeed	   highly	   specific	   for	   eGFP.	  Nevertheless,	  Venus	  protein	  did	  increase	  the	  binding	  signal	  indicating	  a	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certain	   degree	   of	   cross-­‐reactivity	   (Figure	   3.10,	   part	   B).	   For	   3	   phages,	  only	  a	  very	   small	   shift	   in	  SPR	  binding	  was	   recorded	  above	   the	  normal	  binding	   signal,	   suggesting	   that	   the	   phages	   indeed	   did	   bind	   a	   small	  amount	  of	  the	  Venus	  protein,	  which	  increased	  the	  density	  on	  the	  sensor	  surface.	   In	   contrast,	   the	   signal	   of	   clone	   4R3.12,	   increased	   to	   200-­‐300	  percent	   in	   the	   presence	   of	   200	   µg/mL	   Venus	   protein.	   This	   signal	  increase	  can	  only	  result	  from	  high	  amounts	  of	  Venus	  protein	  binding	  to	  the	  phage	  that	  is	  already	  bound	  to	  the	  FO-­‐SPR	  sensor.	  However,	  affinity	  of	   this	   phage	   for	   eGFP	   must	   be	   higher	   than	   for	   the	   Venus	   protein	  because	  the	  phage	  is	  not	  displaced	  from	  the	  FO-­‐SPR	  sensor,	  as	  was	  the	  case	   for	   free	   eGFP	   in	   the	   competitive	   assay.	   This	   corresponds	   with	  previous	   reports	   showing	   that	   affinity	   molecules	   developed	   for	  ‘Aequorea	   victoria’-­‐derived	   fluorescent	   proteins,	   such	   as	   eGFP	   and	  Venus	   protein,	   have	   affinity	   for	   all	   of	   these	   highly	   homologous	  proteins57.	  
3.5 	  Conclusion	  This	   paper	   presents	   the	   first	   FO-­‐SPR	   based	   kinetic	   analysis	   of	  bacteriophage	  affinities,	  where	  phages	  are	  used	  as	  a	  whole	  with	  either	  the	   minor	   coat	   protein	   p3	   or	   the	   major	   coat	   protein	   p8	   expressing	  peptides	  selective	  for	  eGFP.	  As	  expected,	  the	  higher	  peptide	  densities	  on	  the	   p8	   coat	   protein	   resulted	   in	   a	   better	   affinity	   towards	   the	   target	  protein	  (eGFP)	  compared	  to	  phages	  expressing	  peptides	  through	  the	  p3	  coat	  protein,	  with	  Kd	  values	  being	  up	  to	  3	  orders	  of	  magnitude	  lower	  for	  some	   p8	   phage	   clones.	   This	   difference	   in	   affinities	   could	   be	   partially	  explained	   with	   the	   orientation	   of	   p8	   phages,	   as	   the	   p8	   coat	   protein	  expresses	   affinity	   peptides	   throughout	   the	   entire	   phage	   surface,	   the	  phages	  are	  positioned	  with	  the	  longer	  side	  closer	  to	  the	  sensor	  surface,	  which	   increased	   the	   SPR	   signal	   during	   the	   association	   phase.	   Another	  contributing	   aspect	   to	   such	   high	   affinities	   of	   p8	   phages	   was	   the	  observed	  decrease	  in	  dissociation	  rate,	  which	  is	  exclusively	  attributable	  to	   multivalent	   interactions.	   Nonetheless,	   p3	   phages	   also	   express	   the	  peptides	   multivalent,	   having	   an	   especially	   strong	   effect	   on	   the	   koff	   of	  these	  phages,	   resulting	   in	   little	  phage	  dissociation	  once	  bound	  to	  eGFP	  on	   the	   sensor	   surface.	   SPR	   measurements,	   together	   with	   the	   ELISA	  assays,	   also	   revealed	   considerable	   differences	   in	   eGFP-­‐binding	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parameters	   among	   different	   p3	   and	   p8	   clones,	   making	   some	   phage	  clones	  more	  suited	  for	  certain	  applications	  than	  for	  others.	  The	   application	   of	   FO-­‐SPR	   on	   viral	   particles	   is	   a	   useful	   tool	   for	  selection	   of	   viral	   clones	   with	   high	   affinities.	   For	   this	   application	   the	  technology	  can	  even	  have	  a	  larger	  added	  value,	  when	  FO-­‐SPR	  would	  be	  applied	   during	   the	   early	   panning	   stage	   of	   viral	   clone	   selection,	   as	   the	  kinetic	   parameters	   could	   guide	   the	   phage	   affinity	  maturation	   towards	  binding	   parameters	   optimally	   suited	   for	   the	   intended	   application.	  However	   the	   assay	   is	   maybe	   not	   the	   best	   choice	   for	   POC	   biosensor	  applications,	   as	   it	   	   lacks	   sensitivity,	   with	   a	   detection	   limit	   of	   108	   viral	  particles.	   The	   needs	   for	   clinical	   applications	   cannot	   be	   met	   without	  additional	   amplification	   strategies.	   Furthermore,	   the	   assay	   does	   not	  allow	  to	  discriminate	  between	  different	  viral	  particles,	  any	  particle	  with	  affinity	  for	  the	  receptor	  on	  the	  FO-­‐SPR	  sensor	  will	  result	  in	  a	  signal.	  	  Other	  options	  include	  detection	  by	  means	  of	  antibodies,	  however	  in	  combination	   with	   SPR	   similar	   problems	   as	   in	   the	   above	   mentioned	  assay	  might	  	  be	  encountered.	  The	  mass	  density	  of	  bacteria	  and	  viruses	  is	  low,	  which	  does	  not	  allow	  detecting	   these	  micro-­‐organisms	  sensitively	  using	  SPR	  (results	  not	  shown).	  Therefore	  in	  the	  following	  chapters,	  not	  the	   detection	   of	   the	   micro-­‐organism	   as	   a	   whole	   will	   be	   targeted	   but	  instead,	   the	   genetic	   material	   will	   be	   used.	   This	   allows	   more	   easily	   to	  improve	   the	   LOD	   as	   the	   genetic	   material	   is	   more	   abundant	   and	   can	  easily	   be	   identified.	   Furthermore	   unique	   regions	   in	   the	   genome	   of	  closely	  related	  micro-­‐organisms	  enable	  straightforward	  identification.	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Chapter	  4 	  	  
FO-­‐SPR	  high-­‐resolution	  genetic	  screening	  Part	  of	  this	  chapter	  has	  been	  published	  in:	  Knez	  K.,	  Janssen	  K.,	  Pollet	   J.,	  Spasic	  D.,	  Lammertyn	   J.	  (2012).	  Fiber	  optic	  high-­‐resolution	   genetic	   screening	   using	   gold-­‐labeled	   gene	  probes.	  Small,	  8(6),	  868-­‐872.	  
	  
4.1 	  Introduction	  The	   fast	  moving	   field	   of	   genetic	   screening	   is	   currently	   revolutionizing	  medical	   diagnostics	   and	   life	   sciences1,2.	   Nevertheless,	   the	   accurate	  detection	   of	   a	   single	   nucleotide	   polymorphism	   (SNP),	   the	   smallest	  possible	   type	   of	   genetic	   variability,	   still	   remains	   a	   challenging	   task.	  These	   single	   base	   pair	   alterations	   at	   the	   genetic	   level	   can	   have	  significant	  effects	  at	  the	  phenotype	  level.	  SNPs	  are	  linked	  with	  complex	  pathologies	   such	   as	   cancer3,	   cystic	   fibrosis4,	   infectious	   diseases5	   and	  many	  others6.	  Detection	   and	   identification	   of	   SNPs	  will	   allow	   for	  more	  accurate	   diagnostics,	  will	   improve	   drug	   development	   and	   can	   simplify	  treatment	   decisions.	   Consequently,	   there	   is	   an	   increasing	   demand	   for	  screening	   technologies,	   which	   has	   catalyzed	   the	   development	   of	   new	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methods	   for	   SNP	   analysis7-­‐9.	   Currently,	   sequencing	   is	   the	   method	   of	  choice	   for	   SNP	   screening	   and	   discovery.	   Despite	   the	   major	   advances	  offered	   by	   next-­‐gen-­‐sequencing,	   the	   technology	   is	   not	   yet	   ready	   to	   be	  used	  in	  routine	  point-­‐of-­‐care	  applications	  because	  of	  labor	  intensity	  and	  cost.	   To	  make	   genetic	   screening	  more	   accessible	   significant	   effort	   has	  been	  put	  in	  the	  development	  of	  faster	  and	  less	  expensive	  assays10,11,	  yet	  the	  design	  of	  robust	  microarrays	   for	  genotyping	  with	  single	  nucleotide	  resolution	  on	  a	  genome-­‐wide	  scale	  has	  proven	  to	  be	  a	  very	  difficult	  task.	  In	   this	   respect,	   High	   Resolution	   Melting	   (HRM),	   which	   is	   actually	   an	  improved	   embodiment	   of	   classical	   DNA	   melting	   analysis,	   is	   gaining	  popularity11-­‐13.	  HRM	  technology	  is	  a	  post	  PCR	  method	  that	  characterizes	  nucleic	   acid	   samples	   based	   on	   their	   dissociation	   behavior	   during	  melting.	   This	   approach	   has	   a	   number	   of	   distinct	   advantages	   such	   as	  reduced	  total	  assay	  time	  and	  cost.	  However,	  there	  are	  some	  issues	  with	  fluorescence	  based	  HRM.	  Results	  are	  not	  consistently	  unambiguous	  and	  variations	   in	   the	  wild	   type	  melting	   behavior	   can	   hamper	   reliable	   SNP	  detection14.	  
4.2 	  Aim	  of	  this	  chapter	  In	  the	  search	  for	  an	  improved,	  highly	  sensitive	  and	  cost	  effective	  genetic	  profiling	   technique,	   we	   present	   a	   new	   HRM	   method	   based	   on	   DNA	  probes	  and	  gold	  nanoparticles	  (Au	  NPs).	  Au	  NPs	  have	  proven	  to	  be	  very	  efficient	   labeling	   agents	   for	   Surface	   Plasmon	   Resonance	   (SPR)	   based	  study	  of	  oligonucleotide	   interactions15	  and	  offer	   significant	  advantages	  over	  fluorescent	  dyes16-­‐18.	  In	   this	   proof-­‐of-­‐concept	   work,	   we	   apply	   Fiber	   Optic	   –	   Surface	  Plasmon	  Resonance	  (FO-­‐SPR)	  sensors	  (Figure	  4.1)	  in	  combination	  with	  high-­‐resolution	   sample	   heating	   to	   monitor	   the	   melting	   behavior	   of	  synthetic	  DNA	  duplexes,	   enabling	  SNP	  screening.	   In	  order	   to	   show	   the	  power	   and	   applicability	   of	   this	   FO	   sensor	   we	   tested	   different	   genetic	  targets	  of	  varying	  length	  and	  makeup.	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Figure	  4.1:	  A)	  Schematic	  representation	  of	  an	  FO	  genetic	  screening	  assay	  with	  DNA	  
target	   (1),	   DNA	   probe	   functionalized	   FO-­‐SPR	   sensor	   (2)	   and	   DNA	   probe	  
functionalized	   Au	   NP	   (3).	   Gene	   probes	   hybridize	   at	   the	   FO	   surface,	   and	   are	  
subsequently	   melted	   off	   by	   a	   gradual	   increase	   of	   the	   temperature.	   B)	  
Representative	  sensorgram.	  DNA	  targets	  and	  DNA	  Au	  NP	  probes	  were	  allowed	  to	  
hybridize	   for	   10min	   at	   50°C,	   resulting	   in	   a	   shift	   of	   the	   SPR	   wavelength.	  
Subsequently,	  the	  temperature	  is	  increased	  stepwise	  to	  accurately	  determine	  the	  
melting	   temperature	   (Tm).	  At	  Tm	  DNA-­‐Au	  NP	   complex	  melts	   off,	   decreasing	   the	  
SPR	  signal.	  
4.3 	  Materials	  and	  methods	  
4.3.1	  Reagents	  All	   synthesized	  oligonucleotides	  were	  purchased	   from	   Integrated	  DNA	  Technologies	   (Belgium).	   All	   general	   chemicals	   were	   obtained	   from	  Sigma-­‐Aldrich	   (Belgium)	   unless	   stated	   otherwise.	   Optics	   and	   optical	  components	  were	  purchased	  from	  Ocean	  Optics	  (Dunedin,	  USA).	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4.3.2	  Device	  setup	  The	  FO-­‐SPR	  device	  used	  was	  identical	  to	  the	  setup	  described	  in	  Chapter	  3	  Section	  3.3.3.	  When	  the	  gold	  layer	  is	  coated	  with	  DNA	  as	  is	  in	  the	  case	  the	   FO-­‐SPR	   HRM	   assay,	   the	   FO-­‐SPR	   sensor	   can	   be	   used	   to	   monitor	  interactions	   of	   this	   immobilized	   DNA	   with	   free	   DNA	   in	   a	   solution.	   In	  order	  to	  augment	  assay	  sensitivity	  the	  complementary	  gene	  probes	  are	  labeled	   with	   Au	   NP.	   The	   thermocycler	   temperature	   was	   monitored	  externally	   using	   a	   NI-­‐DAQ	   (National	   instruments,	   Austin,	   USA)	   with	  three	   highly	   responsive	   T-­‐type	   WK-­‐200	   thermocouple	   threads	  (Labfacillity,	   Leads,	   United	   Kingdom).	   This	   allowed	   us	   to	   monitor	   the	  exact	   temperature	   at	   the	   FO	   surface	   and	   derive	   the	   exact	   melting	  temperature	  by	  combining	  temperature	  data	  with	  the	  SPR	  sensorgram.	  	  Spectrophotometer	   data	   was	   processed	   in	   real-­‐time	   using	  Omnidriver	   software	   (Ocean	   optics,	   Dunedin,	   USA)	   and	   an	   in	   house	  written	  Matlab	   script	   (The	  Mathworks	   Inc,	   Natick,	   USA).	   Temperature	  logging	  of	   the	  NI-­‐DAQ	  was	  managed	  using	   a	   custom	  Labview	  program	  (National	  Instruments,	  Austin).	  	  	  
4.3.3	  FO	  sensor	  tips	  FO-­‐SPR	   sensor	   tips	   were	   manufactured	   as	   described	   in	   Chapter	   3	  Section	   3.3.4.	   	   The	   freshly	   coated	   FO	   sensors	   were	   immediately	  incubated	  with	  1	  µM	  reduced	  DNA	  with	  a	  3’	  thiol	  endgroup	  (Table	  4.1)	  to	   create	  a	  dense	  DNA	  surface	   coating.	  The	   reduction	  of	   the	   thiol-­‐DNA	  was	   done	   by	   incubating	   50	   µM	   thiol-­‐DNA	   for	   3	   h	   in	   0.1	  M	   phosphate	  buffer	  (PB)	  containing	  0.18	  M	  Dithiotreithol	  (DTT,	  Acros	  Organics,	  Geel,	  Belgium).	   Afterwards,	   the	   DTT	   was	   removed	   from	   the	   activated	   DNA	  using	  NAP5	  Sephadex	  columns	  (GE	  Healthcare,	  Pittsburgh,	  USA).	  The	  FO	  sensors	  are	   incubated	  overnight	   in	  the	  DNA	  PB	  solution	  to	  get	  a	  dense	  DNA	  covering.	  Afterwards	   the	  FO	  sensor	  was	   rinsed	   three	   times	   in	  PB	  with	  0.01%	  SDS	  and	  stored	  in	  a	  fridge.	  The	  final	  DNA	  density	  on	  the	  FO	  sensor	  was	  estimated	  0.40	  ±	  0.02	  strands	  per	  nm2.	  	  
4.3.4	  Gold	  nanoparticles	  Au	   NPs	   with	   a	   diameter	   of	   approximately	   20	   nm	   were	   produced	  using	   the	   citrate	   reduction	   method	   as	   described	   by	   Frens	   et	   al.19.	   In	  order	   to	   functionalize	   the	   Au	  NPs	  with	  DNA,	   the	   citric	   acid	   stabilizing	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agent	   was	   gradually	   exchanged	   with	   DNA	   oligonucleotides,	  functionalized	  with	  a	  5’	  or	  3’	  thiol	  endgroup	  (Table	  4.1).	   	  Similar	  to	  the	  functionalization	  of	   the	  FO	  sensor	  surface,	   the	   thiol-­‐DNA	  was	  added	  to	  the	   gold	   nanoparticles	   in	   a	   final	   concentration	   of	   1	   µM.	   To	   maximize	  DNA	  loading	  on	  the	  Au	  NPs	  a	  fast	  salt	  maturation	  protocol	  as	  described	  in	  Hurst	  et	  al.20	  was	  used.	  After	  5	  h,	  the	  Au	  NPs	  were	  washed	  three	  times	  in	   PB	  with	   0.01%	   SDS,	   to	   remove	   the	   excess	   of	   salt	   and	   any	   unbound	  DNA.	   Finally	   the	  beads	  were	  dissolved	   in	  PBS	  300	  mM	  NaCl.	   The	   final	  DNA	  density	   on	   the	  AU	  NPs	  was	   determined	   using	  DTT	   stripping	   of	   a	  fluorescently	   labeled	  gene	  probe.	  On	  each	  Au	  NP	  approximately	  230	  ±	  10	  strands	  were	  counted.	  	  
4.3.5	  Oligonucleotides	  Synthetic	   DNA	   oligonucleotides	   were	   purchased	   from	   IDT	   (Haasrode,	  Belgium).	  The	  capture	  probes	  on	  the	  FO-­‐surface	  and	  on	  the	  Au	  NPs	  were	  attached	  with	  a	  C-­‐3	  or	  C-­‐6	  thiol	  group	  at	  concordant	  the	  3’	  and	  5’	  end	  of	  the	   oligonucleotide	   sequence.	   All	   the	   oligonucleotide	   probes	   were	  equipped	  with	  either	  a	  poly	  A	  or	  poly	  T	  spacer	  in	  order	  to	  improve	  the	  hybridization	   efficiency	   of	   the	   DNA20.	   Three	   target	   sequences	   were	  chosen	   to	   demonstrate	   the	   measuring	   principle	   and	   the	   superior	  sensitivity	  of	  the	  FO-­‐SPR	  biosensor	  platform.	  	  In	   a	   first	   proof	   of	   principle	   experiment	   a	   short	   30bp	   target	   was	  chosen,	  further	  referred	  to	  as	  target	  1.	  The	  sequence	  was	  adopted	  from	  the	   literature21,	   therefore	   the	   spacer	   differs	   of	   the	   oligonucleotide	  probes	  from	  the	  other	  targets.	  To	  the	  best	  of	  our	  knowledge	  target	  1	  has	  no	  real-­‐life	  functionality.	  	  Target	  2	  is	  a	  part	  of	  the	  coding	  sequence	  of	  the	  P53	  tumor	  suppressor	  gene	  ,	  which	  is	  found	  to	  be	  involved	  in	  more	  than	  50%	  of	  all	   cancers	   22.	  The	  55bp	  sequence	   is	  known	   to	  be	  a	  mutational	  hot	   spot23,	   however	   screening	   this	   target	   for	   SNPs	   is	   challenging	  because	   it	   has	   a	   GC	   ratio	   of	   59%	   and	   is	   therefore	   prone	   to	   secondary	  structures.	   The	   last	   target	   was	   an	   80bp	   bacterial	   target	   comprising	   a	  gene	   of	   the	   Legionella	   pneumophila	   bacteria	   genome,	   crucial	   for	   the	  pathogenicity	   of	   the	   Legionella	   pneumophila	   strain.	   The	   sequence	   is	  used	   in	   routine	   quantification	   of	   bacteria	   numbers	   and	   was	   first	  described	  in	  a	  paper	  by	  Yanez,	  et	  al.24	  For	   every	   sequence	   three	   random	   base	   pair	   substitutions	   were	  chosen,	   the	  mutations	   are	   located	   in	   the	  middle	   or	   either	   at	   the	   3’	   or	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5’end.	  We	  chose	  these	  positions	  to	  prove	  that	  the	  detection	  principle	  is	  not	  depending	  on	  the	  position	  of	  the	  mutation	  and	  furthermore	  that	  the	  FO	   sensor	   can	   consistently	   locate	   the	   position	   of	   the	   mutation.	  Sequences	  of	  the	  DNA	  targets	  and	  the	  DNA	  probes	  used	  in	  this	  paper	  are	  listed	  in	  	  Table	  4.1.	  	  
Table	  4.1:	  Summary	  of	  all	  synthetic	  DNA	  sequences	  used	  for	  FO-­‐SPR	  HRM	  	  
Targets	  
Target	  1	  (30	  bp)	   	   Target	  2:	  P53	  cancer	  gene	  locus	  (56	  bp)	  
Wild	  type	  5-­‐	  GAG	  GGA	  TTA	  TTG	  TTA	  AAT	  ATT	  GAT	  AAG	  GAT	  -­‐3	  
Middle	  MM	  5-­‐	  GAG	  GGA	  TTA	  TTG	  TTA	  AAC	  ATT	  GAT	  AAG	  GAT	  -­‐3	  
5’	  MM	  5-­‐	  GAG	  GGA	  TTA	  TTG	  TTA	  AAT	  ATT	  GAT	  AAA	  GAT	  -­‐3	  
3’	  MM	  5-­‐	  GAG	  AGA	  TTA	  TTG	  TTA	  AAT	  ATT	  GAT	  AAG	  GAT	  -­‐3	  	  
Wild	  type	  5-­‐	  TTC	  CTG	  CAT	  GGG	  CGG	  CAT	  GAA	  CCG	  GAG	  GCC	  CAT	  CCT	  CAC	  CAT	  CAT	  CAC	  ACT	  GGA	  AG	  -­‐3	  
Middle	  MM	  5-­‐	  TTC	  CTG	  CAT	  GGG	  CGG	  CAT	  GAA	  CCG	  GAG	  ACC	  CAT	  CCT	  CAC	  CAT	  CAT	  CAC	  ACT	  GGA	  AG	  -­‐3	  
5’	  MM	  5-­‐	  TTC	  CTG	  CAT	  GGG	  CGG	  CAT	  GAA	  CCG	  GAG	  GCC	  CAT	  CCT	  CAC	  CAT	  CAT	  CAC	  ACT	  AGA	  AG	  -­‐3	  
3’	  MM	  TTC	  CTG	  CAT	  GGA	  CGG	  CAT	  GAA	  CCG	  GAG	  GCC	  CAT	  CCT	  CAC	  CAT	  CAT	  CAC	  ACT	  GGA	  AG	  -­‐3	  
Target	  3:	  Legionella	  P.	  amplicon	  dotA	  gene	  (80	  bp)	  
Wild	  type	  5-­‐	  ATT	  GTC	  TCG	  CGC	  GAT	  TGC	  TAT	  ACA	  GCA	  AAT	  GTA	  TGT	  GAC	  TTT	  ATC	  TAC	  GGT	  GGC	  ACA	  GGT	  GAT	  GGT	  TAA	  TAA	  TGA	  TCC	  GG	  -­‐3	  
Middle	  MM	  5-­‐	  ATT	  GTC	  TCG	  CGC	  GAT	  TGC	  TAT	  ACA	  GCA	  AAT	  GTA	  TGT	  GAA	  TTT	  ATC	  TAC	  GGT	  GGC	  ACA	  GGT	  GAT	  GGT	  TAA	  TAA	  TGA	  TCC	  GG	  -­‐3	  
5’	  MM	  5-­‐	  ATT	  GTC	  TCG	  CGC	  GAT	  TGC	  TAT	  ACA	  GCA	  AAT	  GTA	  TGT	  GACTTT	  ATC	  TAC	  GGT	  GGC	  ACA	  GGT	  GAT	  GGT	  TAA	  TAA	  TAA	  TCC	  GG	  -­‐3	  
3’	  MM	  5-­‐	  ATT	  GTC	  TCG	  CGC	  GAT	  TGC	  TCT	  ACA	  GCA	  AAT	  GTA	  TGT	  GACTTT	  ATC	  TAC	  GGT	  GGC	  ACA	  GGT	  GAT	  GGT	  TAA	  TAA	  TGA	  TCC	  GG	  -­‐3	  
Non-­‐matching	  DNA	  template	  (37	  bp)	  5-­‐	  TTCCCCGGCCTGGGCTCG	  GGACCCACTCGTGCTGTCC-­‐3	  
Probes	  
FO	  sensor	  Oligonucleotide	   Au	  NP	  Oligonucleotide	  Target	  1	   	  5-­‐	  TAA	  CAATAATCC	  CTC	  A20/3ThioMC3-­‐D/	  -­‐3	   5-­‐/5ThioMC6/A20	  ATC	  CTT	  ATC	  AAT	  ATT	  -­‐3	  Target	  2-­‐	  P53	  target	   	  5-­‐	  CCT	  CCG	  GTT	  CAT	  GCC	  GCC	  CAT	  GCA	  GGA	  A	  T18	  /3ThioMC3-­‐D/	  -­‐3	   5-­‐	   /5ThioMC6/T18	   CTT	   CCA	   GTG	   TGA	   TGA	  TGG	  TGA	  GGA	  TGG	  G	  -­‐3	  Target	  3	  -­‐	  Bacterial	  target	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5-­‐	  AGT	  CAC	  ATA	  CAT	  TTG	  CTG	  TAT	  AGC	  AAT	  CGC	  GCG	  AGA	  C	  AAT	  T18/3ThioMC3-­‐D/	  -­‐3	   5-­‐	   /5ThioMC6/T18	   CCG	   GAT	   CAT	   TAT	   TAA	  CCATCA	  CCT	  GTG	  CCA	  CCG	  TAG	  ATA	  A	  
4.3.6	  Calculation	   of	   the	   probability	   of	   ssDNA	   secondary	   structure	  
formation	  in	  the	  target	  sequences	  (using	  mFold25	  	  and	  DINAfold25)	  Finally	   we	   evaluated	   the	   probability	   of	   the	   hybridization	   of	   our	   DNA	  targets	   into	  secondary	  structures	  (self-­‐hybridization)	   in	  comparison	   to	  the	  probability	  of	  hybridizing	  to	  its	  complementary	  sequence	  (forming	  a	  normal	   dsDNA	   sequence).	   This	   is	   important	   because	   these	   structures	  could	  influence	  or	  hamper	  the	  Tm	  measurements.	  The	   chance	  of	   secondary	   structures	  was	   calculated	  using	   the	  well-­‐known	  mFold	  algorithm	  to	  calculate	  the	  Gibbs	  free	  energy	  for	  secondary	  structures	  and	  the	  theoretical	  Tm	  (self-­‐hybridization	  of	  the	  ssDNA	  of	  the	  targets).	  For	   the	  dsDNA	  of	   the	   target	  and	   its	   complementary	   sequence	  the	  DINAmelt	  model	  was	  applied.	  The	   results	   clearly	   show	   that	   the	   Gibbs	   free	   energy	   for	   all	   the	  targets	   is	   in	   favor	   of	   hybridization	   with	   its	   complementary	   sequence	  into	  dsDNA	  (Table	  4.2).	  Furthermore	  the	  calculated	  Tm	  of	  the	  secondary	  structures	   was	   much	   lower	   than	   the	   Tm	   that	   was	   predicted	   for	   the	  targets	  and	  the	  Tm	  that	  was	  measured	  using	  both	  HRM	  and	  FO-­‐SPR.	  We	  therefore	   can	   conclude	   that	   the	   melting	   analysis	   was	   by	   no	   means	  influenced	  by	  the	  secondary	  structures.	  
Table	  4.2:	  Summary	  of	  the	  theoretical	  calculation	  of	  the	  Gibbs	  free	  energy	  and	  the	  
melting	   temperature	   for	   the	   secondary	   structures	   of	   the	   ssDNA	   of	   the	   3	   target	  
sequences	   as	   compared	   to	   the	   Gibbs	   free	   energy	   of	   the	   formation	   of	   the	   dsDNA	  
structure	   of	   target	   DNA	   with	   its	   complementary	   sequence.	   The	   values	   were	  
obtained	  using	  respectively	  the	  mFold	  model	  for	  ssDNA	  secondary	  structures	  and	  
the	  DINAmelt	  model	   for	   the	  dsDNA	  of	   the	   targets.	   The	  DINAMelt	  model	  was	  not	  
applicable	   for	  sequence	  3	  because	  of	   its	   length.	   (All	  models	  were	  made	  using	  an	  
NaCl	  concentration	  of	  300mM	  and	  a	  DNA	  concentration	  of	  10nM).	  
	   	   Target	  1:	   Target	  2:	   Target	  3:	  
DINAMelt	  
	  ΔG	  (Kcal/mol)	  	  
	   	  	   -­‐	  43.2	   	  	  -­‐	  115.8	   	  	  NA	  Tm	  (C°)	  	   	   59.9	   85.1	   NA	  
mFold	  
	  
	   	  	   	   	  ΔG	  (Kcal/mol)	   	   0.51	   -­‐2.91	   -­‐1.26	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  Tm	  (C°)	   	   32.0	   73.9	   61.3	  Finally	   we	   also	   evaluated	   the	   ssDNA	   secondary	   structures	   of	   the	  immobilized	  probes	  on	  both	  Au	  NP	  and	  FO-­‐SPR	  surface.	   (using	  mFold,	  data	   not	   shown)	   The	   Gibbs	   free	   energy	   of	   these	   probes	   was	   not	  favorable	   for	   the	   formation	   of	   these	   structures.	   Due	   to	   the	   length	   of	  these	   sequences	   as	   compared	   to	   the	   full	   length	   of	   the	   targets,	   their	  melting	   points	   were	   below	   the	   hybridization	   temperatures	   applied	   in	  the	   tests	   described	   in	   this	   article.	   Therefore	   we	   can	   conclude	   self-­‐hybridization	  and	  secondary	  structures	  did	  not	  influence	  our	  results.	  
4.3.7	  FO	  sensor	  high	  resolution	  melting	  assay	  The	  SPR	  melt	  analysis	  uses	  the	  binding	  and	  release	  of	  Au	  NPs	  on	  the	  SPR	  surface	  by	  means	  of	  DNA	  strands.	  As	  described	  in	  Figure	  4.1,	  the	  general	  measurement	  procedure	  uses	  a	  single	  stranded	  DNA	  target,	  which	  binds	  simultaneously	   a	   NP	   and	   the	   SPR	   sensors	   surface,	   both	   functionalized	  with	  an	  oligonucleotide	  complementary	  to	   the	  5’	  and	  the	  3’	  side	  of	   the	  target,	  respectively.	   In	  the	  case	  of	  a	  mismatch	  in	  the	  sequence,	  binding	  of	  the	  target	  to	  both	  the	  NP	  and	  the	  SPR	  fiber	  will	  be	  hindered.	  This	  will	  result	   in	   a	   lower	   binding	   signal.	   However,	   previous	   research	   showed	  that	   depending	   on	   the	   locus	   of	   the	   mutation	   and	   the	   type	   of	   single	  nucleotide	   polymorphism,	   detection	   of	   these	   single	   base	   variations	  could	  become	  difficult	  and	  demands	  an	  elaborate	  assay	  optimization26.	  Therefore	  a	  heating	  step	  was	  introduced.	  By	  slowly	  heating	  the	  analyte	  solution,	   the	   bound	   DNA	   will	   melt	   and	   the	   nanoparticles	   will	   detach	  from	   the	   sensor	   surface.	   Base	   pair	  mismatches	  will	   affect	   and	   cause	   a	  shift	  in	  the	  melting	  temperature	  (Tm).	  	  All	  buffer	  components	  for	  the	  melting	  experiments	  were	  purchased	  from	   Sigma	   Aldrich	   (Bornem,	   Belgium)	   unless	   stated	   otherwise.	   For	  every	  melting	   experiment	   15	   µL	   of	   the	   DNA	   target	   in	   a	   concentration	  ranging	  from	  picomolar	  to	  nanomolar	  concentrations	  was	  added	  to	  125	  µL	   PBS	   with	   300	   mM	   NaCl	   and	   functionalized	   gold	   nanoparticles	  (concentration	   depended	   on	   experiment).	   In	   order	   to	   prevent	  evaporation	   because	   of	   the	   heating	   cycles,	   all	   reaction	   vials	   were	  covered	  with	  a	  thin	  layer	  of	  silicon	  oil	  (Bio-­‐Rad,	  Hercules,	  USA).	  	  Before	  each	  measurement,	  the	  samples	  were	  very	  briefly	  exposed	  to	  94°C	  for	  5	  s.	  Subsequently,	  the	  temperature	  was	  dropped	  to	  the	  optimal	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hybridization	  temperature	  of	  the	  target	  to	  allow	  the	  DNA	  to	  bind	  to	  both	  the	   fiber	   surface	   and	   the	   Au	   NPs.	   After	   15	   min,	   the	   temperature	   was	  slowly	   augmented	   (0.1	   °C	   s-­‐1)	   to	   determine	   the	   precise	   Tm.	   Blank	  measurements	   were	   executed	   using	   a	   non-­‐matching	   DNA	   template	  consisting	  of	  a	  scrambled	  DNA	  sequence	  with	  a	  length	  of	  37bp.	  
4.3.8	  HRM	  reference	  measurements	  
Without	  pre-­‐amplification	  The	  melting	  points	  of	   the	  oligonucleotide	   targets	  were	  validated	  using	  standard	   HRM	   analysis	   on	   a	   Qiagen	   Rotorgene	   6000	   (Qiagen,	  Germantown,	  USA)	  device	  in	  combination	  with	  Evagreen	  saturating	  dye	  (Biotium,	   Hayward,	   USA).	   The	   synthetic	   reverse	   complement	   of	   every	  target	  sequence	  was	  ordered	  to	  get	  a	  double	  stranded	  sequence	  suited	  for	   HRM	   analysis.	   The	  melting	   reactions	  were	   performed	   in	   the	   same	  PBS	  300	  mM	  NaCl	  buffer	  as	  the	  FO	  melt	  reactions	   in	  order	  to	  compare	  the	  melting	  points	  and	  the	  results.	  The	  reaction	  mixture	  consisted	  of	  1.5	  µL	   Evagreen	   dye	   (20	   X),	   10	   µM	   of	   the	   DNA	   target,	   10	   µM	  DNA	   of	   the	  target	   complement	   in	   a	   final	   volume	   of	   15	   µL.	   The	   thermal	   cycle	   and	  heating	   steps	   were	   similar	   to	   the	   thermal	   sequence	   of	   the	   FO	   sensor	  melt	   reaction	   and	   consisted	   of	   a	   quick	   denaturation	   step	   of	   1	   min	   at	  94°C	   followed	   by	   a	   hybridization	   step	   of	   10	  min	   and	   finally	   a	   heating	  step,	  with	  a	  temperature	  gradient	  of	  0.1	  °C	  s-­‐1.	  	  Raw	   melting	   curves	   of	   both	   HRM	   and	   SPR	   measurements	   were	  analyzed	  in	  the	  same	  way.	  All	  melting	  points	  were	  determined	  using	  the	  first	  derivative	  of	  the	  measurement	  signal	  divided	  by	  the	  first	  derivative	  of	  the	  temperature.	  
With	  pre-­‐amplification	  Because	   the	  bacterial	   sequence	   is	   a	  PCR	   target,	   the	   sequence	  was	   also	  analyzed	   using	   HRM	   with	   a	   pre-­‐amplification	   step.	   HRM	   reaction	  mixtures	   were	   prepared	   using	   AccuMelt™	   HRM	   SuperMix	   (Quanta	  bioscience,	   Gaithersburg,	   USA)	   according	   to	   the	   manufacturers	  recommendations.	  	  Primers	  were	  ordered	  and	  used	  in	  the	  amounts	  asas	  described	   by	   Yanez24.	   The	   samples	   were	   amplified	   using	   shuttle	   PCR.	  The	  TAQ	  enzyme	  was	  activated	  at	  95°C	  for	  5	  min,	  afterwards	  40	  cycles	  of	   60°C	  annealing/extension	   for	  30	   s	   followed	  by	   a	  denaturing	   step	   at	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95°C	  for	  5	  s	  were	  performed.	  	  The	  actual	  melting	  analysis	  was	  initiated	  at	   60°C	   and	   ended	   at	   95°C	   with	   a	   temperature	   gradient	   of	   0.1°C	   s-­‐1.
4.4 Results	  The	   SPR	  melt	   analysis	   uses	   the	   binding	   and	   release	   of	   Au	   NP	   labeled	  gene	  probes	  on	  the	  SPR	  surface	  to	  detect	  variations	  in	  the	  synthetic	  DNA	  sequence.	  As	   illustrated	   in	  Figure	  4.1,	  a	  single	  stranded	  DNA	  target	  (1)	  will	  simultaneously	  bind	  to	  an	  Au	  NP	  (3)	  and	  the	  FO	  sensor	  surface	  (2).	  Both	   FO	   sensor	   and	   Au	  NP	   are	   functionalized	  with	   an	   oligonucleotide	  sequence	   complementary	   to	   the	   5’	   and	   the	   3’	   ends	   of	   the	   target,	  respectively.	  In	  the	  case	  of	  a	  mismatched	  sequence,	  binding	  of	  the	  target	  to	   the	  Au	  NP	  and	   the	  SPR	   fiber	  will	   be	   influenced,	   resulting	   in	   slightly	  altered	   hybridization	   kinetics.	   However,	   variations	   in	   the	   locus	   of	   the	  mutation	   and	   the	   type	   of	   SNP	   make	   detection	   of	   these	   small	   kinetic	  variations	   challenging,	   requiring	   elaborate	   assay	   optimization26.	  Nevertheless,	  by	  slowly	  heating	  the	  sample,	  the	  surface-­‐bound	  DNA	  will	  melt	  and	  the	  Au	  NPs	  will	  detach	  from	  the	  sensor	  surface,	  causing	  an	  SPR	  wavelength	   shift.	   FO-­‐SPR	   based	   Tm	   analysis	   involves	   hybridization	   of	  the	   target	  DNA	  at	   two	  distinct	   sites,	   the	  FO-­‐SPR	  sensor	  and	   the	  Au	  NP	  reporter.	   It	   is	   well	   known	   that	   local	   surface	   geometry	   and	   -­‐functionalization	   can	   significantly	   influence	   the	  hybridization	  behavior	  of	   DNA	   on	   a	   support27,28.	   It	   can	   therefore	   be	   envisioned	   that	   FO-­‐SPR	  analysis	  offers	   the	   intrinsic	   capability	   to	  not	  only	  detect	   SNPs	  but	  also	  offer	   information	  on	   the	   location	  of	   the	  SNP.	  Classic	  HRM	  cannot	  offer	  this	   advantage.	   Figure	   4.1	   shows	   the	   shift	   in	   SPR	   signal	   for	   a	   non-­‐matching	   DNA	   template	   (red)	   and	   two	   positive	   DNA	   samples	   (yellow,	  SNP	  and	  green,	  wild-­‐type).	  The	  data	  clearly	  show	  the	   influence	  of	  DNA	  binding,	   superimposed	   on	   the	   temperature-­‐induced	   change	   in	   SPR	  wavelength	   shift29,30.	  When	   the	   Tm	   is	   reached,	   Au	   NPs	   will	   dissociate	  from	   the	   fiber	   surface,	   causing	   a	   significant	   signal	   shift.	   Above	   the	  Tm,	  the	   FO	  will	   be	   free	   of	   Au	   NPs	   and	   only	   the	   temperature	   induced	   SPR	  shift	  is	  observed.	  Because	  the	  FO	  sensor	  uses	  the	  Tm	  as	  the	  only	  point	  of	  differentiation,	   it	   holds	   a	   clear	   advantage	   compared	   to	   previously	  reported	  SPR	  SNP	  sensors,	  which	  typically	  require	  specific	  conditions	  or	  additional	  sample	  manipulations27,28,31,32.	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To	  validate	   the	  use	  of	   FO-­‐SPR	  as	   an	   SNP	  detection	  platform,	   three	  targets,	  each	  with	  specific	  properties	  were	  chosen.	  Target	  1	  consists	  of	  a	  30bp-­‐long	   random	   synthetic	   DNA	   sequence.	   Target	   2	   is	   a	   challenging	  56bp	  sequence	  with	  a	  high	  GC	  content	  of	  59%.	  It	  is	  a	  part	  of	  the	  coding	  sequence	   of	   the	   P53	   tumor	   suppressor	   gene,	   which	   is	   found	   to	   be	  involved	  in	  over	  50%	  of	  all	  cancers22	  and	  known	  to	  be	  a	  mutational	  hot	  spot23.	  Finally,	  the	  FO	  genomic	  assay	  was	  used	  to	  detect	  SNPs	  in	  an	  80bp	  sequence	  (target	  3),	  which	  is	  part	  of	  a	  defect	  in	  the	  organelle	  trafficking	  gene	   (dotA)	   of	   L.	   pneumophila27,33.	   Target	   3	   is	   particularly	   interesting	  because	   it	   can	   be	   expected	   that	   practical	   assay	   embodiments	   will	  involve	  measurements	  on	  samples	  produced	  through	  PCR	  amplification.	  Amplicons	   are	   typically	   80	   to	   120bp-­‐	   long,	   whereas	   most	   reports	   on	  SNP	  detection	  platforms8,34-­‐36	   focus	  on	  short	  oligonucleotide	  sequences	  (<30bp)	   because	   the	   impact	   of	   an	   SNP	   is	   more	   apparent	   at	   these	  sequence	   lengths	  (more	  details	  on	  the	  sequences	  used	  can	  be	   found	   in	  the	  supporting	  information).	  Two	   important	   assay	   parameters	   were	   evaluated	   to	   optimize	   the	  biosensor	  sensitivity	  for	  SNP	  detection.	  First,	  the	  performance	  of	  the	  FO	  sensor	   was	   tested	   at	   different	   concentrations	   of	   target	   DNA	   while	  keeping	   the	   Au	   NP	   concentration	   constant	   at	   1	   nM.	   Hybridization	  increases	   at	   higher	   concentrations	   of	   the	   target	   DNA,	   and	   this	   will	  impact	   Tm	   up	   to	   the	   moment	   where	   the	   sensor	   surface	   is	   completely	  saturated,	   at	   which	   point	   the	   SPR	   wavelength	   shift	   upon	   binding	   can	  also	   be	   expected	   to	   level	   off.	   Part	   A	   in	   Figure	   4.2	   clearly	   shows	   the	  concentration-­‐dependent	   evolution	   of	   Tm	   for	   target	   concentrations	  between	  1	  pM	  and	  1	  µM.	  The	  accuracy	  with	  which	  Tm	  can	  be	  determined	  is	  excellent,	  even	  for	  sub-­‐nanomolar	  concentrations	  of	  target	  DNA.	  	  An	   analogous	   experiment	   was	   conducted	   with	   variable	   Au	   NP	  concentrations	  while	  keeping	  the	  concentration	  of	  target	  DNA	  constant	  at	  10	  nM	  (Figure	  4.2,	  part	  B).	  High	  Au	  NP	  concentrations	  induced	  larger	  SPR	   shifts,	   however,	   the	   Tm	   remained	   constant	   for	   all	   measured	   NP	  concentrations.	   Based	   on	   the	   data	   presented	   in	   Figure	   4.2,	   Au	   NP	  concentrations	   of	   1	   nM	   and	   DNA	   target	   concentrations	   of	   10nM	  were	  chosen	   for	   all	   further	   experiments	   as	   these	   conditions	   allowed	   for	  maximal	  SPR	  shifts	  with	  minimal	  Tm	  variability.	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For	   each	   of	   the	   DNA	   targets	   three	   types	   of	   mismatches	   were	  evaluated	   respectively	   at	   the	   3`	   end,	   the	   middle	   or	   at	   the	   5`	   end.	  Mismatches	   were	   chosen	   at	   these	   sites	   to	   test	   whether	   FO	   sensor	   is	  capable	  of	  detecting	  them,	  irrespective	  of	  their	  location.	  	  
Figure	  4.2:	  A)	  Effect	  of	  synthetic	  DNA	  target	  concentration	  on	  the	  SPR	  wavelength	  
shift	  and	  Tm.	  B)	  Effect	  of	  the	  Au	  NP	  concentration	  on	  the	  SPR	  wavelength	  shift	  and	  
the	  concentration	  dependent	  evolution	  of	  Tm.	  Results	  are	  based	  on	  experiments	  
with	   target	  1,	  other	   targets	   showed	  similar	   trends.	  Error	  bars	   indicate	   standard	  
deviations	  (n=3).	  Figure	  4.3	  shows	  the	  first	  derivative	  of	  the	  melting	  curves	  obtained	  for	  target	  2.	  As	  can	  be	  seen	  in	  the	  graph,	  the	  FO	  sensor	  allows	  for	  a	  clear	  differentiation	   of	   single	   nucleotide	  mutations.	   FO-­‐SPR	   derived	   Tm	   is	   a	  good	  indicator	  for	  SNP	  identification.	  	  The	   FO-­‐SPR	   measurements	   were	   validated	   using	   classical	  fluorescence-­‐based	   melting	   analysis	   on	   an	   HRM-­‐ready	   qPCR	   device	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(Rotorgene	  6000,	  Qiagen,	  USA).	  For	  the	  HRM	  assay,	  relatively	  high	  DNA	  concentrations	  (10µM)	  were	  necessary	  to	  get	  an	  acceptable	  readout.	  	  	  
	  
Figure	   4.3:	   First	   derivative	   of	   the	   melting	   curves	   for	   the	   p53	   target,	   and	   three	  
different	  mutants	  as	  obtained	  with	  the	  FO-­‐SPR	  sensor.	  All	   remaining	   conditions,	   such	   as	   hybridization	   temperature,	   time	  and	  melting	  steps	  were	  identical	  to	  those	  used	  for	  the	  FO	  melting	  assay.	  For	  target	  3,	  a	  full	  HRM	  assay	  with	  amplification	  of	  the	  target	  was	  also	  performed,	  while	  this	  was	  not	  possible	  for	  the	  first	  two	  targets	  because	  of	  their	  limited	  length	  (Figure	  4.4).	  The	   results	   of	   both	   the	   FO-­‐	   and	   the	  HRM	  assay	   for	   the	   first	   target	  show	  a	   significant	  difference	   in	  Tm	   for	   the	  SNP	   sequences	  versus	   their	  wild	  type	  counterparts.	  However,	  the	  FO-­‐SPR	  assay	  offers	  the	  additional	  benefit	  of	  also	  providing	  information	  on	  the	  location	  of	  the	  SNP.	  The	  3’	  mismatch	   had	   the	   most	   significant	   impact	   on	   the	   Tm,	   while	   the	   5’	  mismatch	  and	  middle	  mismatch	  were	  harder	  to	  differentiate.	  Note	  that	  classic	   HRM	   measurements	   did	   not	   allow	   for	   discrimination	   between	  the	   5’	   mutant	   and	   the	   wild	   type	   sequence.	   Finally,	   for	   target	   3,	   the	  detection	  of	  SNPs	  was	  improved	  with	  the	  new	  FO	  assay.	  Both	  HRM	  and	  pre-­‐amplification	  HRM	  hardly	   show	   any	   difference	   in	   Tm	   compared	   to	  the	  wild	  type	  sequence.	  




Figure	  4.4:	  General	  comparison	  between	  SNP	  data	  obtained	  by	  the	  FO-­‐SPR	  melting	  
assay	  and	  fluorescence	  based	  HRM.	  The	  bars	  indicate	  the	  difference	  between	  the	  
Tm	   of	   SNPs	   relative	   to	   the	   Tm	   of	   the	   wild	   type	   sequences.	   Error	   bars	   indicate	  
standard	   deviations	   (n=3).	   Note	   that	   pre-­‐amplification	   HRM	   can	   also	   produce	  
negative	  ΔTm	  values	  since	  the	  analysis	  relies	  on	  the	  difference	  in	  melting	  behavior	  
of	   different,	   yet	   fully	   complementary	   amplicons	   whereas	   the	   other	   techniques	  
monitor	  the	  melting	  of	  mis-­‐matched	  sequences,	  which	  will	  always	  have	  lower	  Tm	  
as	   opposed	   to	   the	   wild-­‐type	   sequences.	   See	   supporting	   information	   for	   the	   full	  
data.	  In	  contrast	   to	   the	  other	   targets,	   target	  3	  gave	   the	  smallest	  Tm	  shift	  for	  the	  5’	  mutation.	  One	  would	  expect	  that	  mutations	  close	  to	  either	  the	  gold	  surface	  of	  the	  optical	  fiber	  or	  the	  Au	  NP	  would	  result	  in	  a	  maximal	  Tm	  shift	  because	  of	  surface	  effects	  27,28.	  However,	  the	  results	  of	  the	  HRM	  reference	  measurements	   show	   that	   the	  mutation	  hardly	   influences	   the	  Tm,	   which	   is	   an	   indication	   of	   the	   very	   high	   duplex	   stability	   of	   this	  particular	   sequence	   and	   this	   in	   turn	   could	   explain	   the	   behavior	  observed	  during	  the	  FO-­‐SPR	  measurement.	  As	  expected,	  comparison	  of	  the	  relative	  magnitude	  of	  the	  Tm	  shift	  for	  different	   targets	   indicates	   that	   the	   sequence	   length	   has	   an	   important	  impact	  on	  the	  sensitivity.	  One	  can	  see	  that,	  independent	  of	  the	  detection	  technique,	  the	  signal	  decreases	  gradually	  with	  increasing	  target	   length.	  For	  longer	  sequences	  such	  as	  target	  3,	  the	  mismatch	  has	  only	  a	  limited	  impact	  on	  the	  duplex	  stability	  of	  the	  80bp	  sequence;	  hence	  the	  mutation	  only	  minimally	  disturbs	  the	  hybridization.	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4.5 	  Conclusion	  In	   conclusion,	   we	   have	   presented	   an	   FO-­‐SPR	   sensor	   for	   real-­‐time	  monitoring	  of	  melting	  curves	  using	  Au	  NP	  linked	  gene	  probes.	  We	  first	  validated	  the	  system	  using	  a	  range	  of	  target-­‐	  and	  Au	  NP	  concentrations	  for	  ultra-­‐sensitive	  SNP	  detection.	  Results	  showed	  that	   the	  combination	  of	   thermal	   cycling	   and	   the	   FO-­‐SPR	   sensor	   transforms	   traditional	   SPR	  and	   its	   FO	   counterpart	   into	   a	   fast	   and	   highly	   applicable	   genetic	  screening	   tool.	   Secondly,	   we	   have	   shown	   that	   SNP	   detection	   is	   not	  limited	   to	   short	   length	   targets	   but	   can	   be	   easily	   extended	   to	   longer	  target	   sequences,	   such	   as	   those	   typically	   produced	   during	   PCR.	  Moreover,	  sequences	  with	  a	  high	  G/C	  content	  did	  not	  negatively	  impact	  sensor	  resolution.	  	  Results	  were	  validated	  using	   commercially	   available,	   fluorescence-­‐based	  HRM.	  The	  FO	  sensor	  showed	  improved	  resolution	  and	  allowed	  to	  easily	   differentiate	   mutations.	   Furthermore,	   we	   have	   shown	   how	   FO-­‐sensor	   melting	   analysis	   could	   be	   used	   to	   locate	   the	   mismatch	   to	   a	  specific	   sequential	   site.	   This	   could	   be	   an	   extra	   advantage	   if	   the	   FO	  sensor	   would	   be	   used	   as	   a	   routine	   SNP	   detection	   tool	   prior	   to	  sequencing,	  as	  it	  would	  allow	  for	  shorter	  sequencing	  domains.	  The	  FO-­‐SPR	  is	  therefore	  ideally	  suited	  for	  genetic	  screening;	  we	  showed	  that	  in	  less	   than	   20	   minutes	   mutations	   in	   the	   p53	   gene	   or	   bacteria	   could	  accurately	  be	   identified.	  Even	  if	  additional	  sample	  preparation,	  such	  as	  post	   PCR	   cleanup	   would	   be	   necessary	   prior	   to	   FO-­‐SPR	   analysis,	   total	  assay	  time	  can	  easily	  be	  limited	  to	  less	  than	  2	  hours.	  These	  results	  prove	  that	   the	   FO-­‐SPR	   sensor	   can	   make	   a	   difference	   in	   the	   choice	   for	  treatment	  options	   for	   cancer	  or	   for	  bacterial	   infections	  where	   fast	   but	  accurate	   diagnostics	   are	   crucial	   for	   the	   patient	   survival37.	  The	   robust	  nature	  of	  the	  FO-­‐SPR	  sensor	  would	  also	  allow	  for	  the	  application	  in	  the	  food	  and	  water	  industry,	  where	  detection	  of	  pathogenic	  microorganisms	  is	  essential	  for	  the	  public	  safety.	  	  In	   order	   to	   proof	   that	   the	   FO-­‐SPR	  melt	   assay	   truly	   can	   live	   up	   to	  these	   great	   promises	   the	   assay	  will	   be	   applied	   in	   the	   next	   chapter	   on	  clinical	   samples	   and	   the	   performance	   of	   the	   assay	   will	   be	   directly	  compared	   to	   routine	   genetic	   screening	   techniques	   such	   as	   sequencing	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and	  fluorescence	  based	  HRM.	  This	  will	  allow	  us	  to	  evaluate	  whether	  the	  FO-­‐SPR	  melt	  assay	  is	  a	  potential	  POC	  candidate.	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Chapter	  5 	  	  
FO-­‐SPR	  DNA	  melting	  for	  detection	  of	  Legionella	  
pneumophila	  Part	  of	  this	  chapter	  has	  been	  published	  in:	  Knez	   K.,	  Janssen	   K.,	  Spasic	   D.,	  Declerck	   P.,	  Vanysacker	   L.,	  Denis	   C.,	  Tran	  T.,	  Lammertyn	   J.	  (2013).	  Spherical	   Nucleic	   Acid	   enhanced	   FO-­‐SPR	  DNA	  melting	  for	  detection	  of	  mutations	  in	  Legionella	  pneumophila.	  Analytical	  
Chemistry,	  85(3),	  1734-­‐1742.	  
5.1 Introduction	  The	   development	   of	   fast,	   sensitive	   and	   affordable	   technologies	   for	   the	  detection	  of	  DNA	  in	  clinical	  and	  environmental	  diagnostics	  has	  been	  the	  subject	   of	   intense	   research	   to	   date1,2.	   Of	   particular	   interest	   is	   the	  accurate	   detection	   of	   point	   mutations,	   so	   called	   single	   nucleotide	  polymorphisms	  (SNPs),	   in	  genetic	  material	  of	  various	  origins.	   It	   is	  well	  known	   that	   these	   SNPs	   for	   example	   can	   play	   a	   significant	   role	   in	   the	  onset	   and	   development	   of	   many,	   if	   not	   all,	   types	   of	   cancer3,4,	   cystic	  fibrosis5,	   and	   antibiotic	   resistance	   for	   bacteria6.	   As	   such	   their	  identification	  is	  vitally	  important	  for	  making	  accurate	  clinical	  treatment	  decisions7,8.	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Likewise,	   SNPs	   can	   also	   be	   highly	   important	   when	   dealing	   with	  pathogen	   detection	   not	   only	   in	   healthcare	   settings	   but	   also	   for	   food,	  environmental	  and	  public	  safety	  applications.	  An	  effective	  illustration	  of	  this	   is	   Legionella	   pneumophila,	   which	   is	   one	   of	   the	   most	   common	  pathogenic	   Legionella	   species,	   accounting	   for	   more	   than	   90%	   of	  Legionnaires'	   disease	   outbreaks9.	   Human	   infection	   occurs	   through	  inhalation	  of	  aerosols	  generated	  near	  man-­‐made	  water	  ducts	  where	  the	  bacterium	   can	   thrive,	   particularly	   in	   hot	  water	   systems	   such	   as	   public	  showers,	  or	  even	  cooling	  towers10.	  Bacterial	  numbers	  therefore	  need	  to	  be	   tightly	   monitored11.	   Moreover,	   virulence	   of	   L.	   pneumophila	   varies	  greatly	  among	  different	  serogroups,	  with	  serogroup	  1	  being	  responsible	  for	   a	   large	   fraction	   of	   all	   infections12.	   Hence,	   these	   bacteria	   not	   only	  need	   accurate	   quantification	   but	   also	   classification	   based	   on	   small	  genetic	   variations	   between	   different	   serogroups.	   In	   this	   respect,	  quantitative	   PCR	   (qPCR),	   standalone	   or	   in	   combination	   with	   a	   high	  resolution	  melting	   assay	   (HRM),	   is	   often	   used	   for	   fast	   identification	   of	  pathogenic	  bacteria	  in	  both	  environmental13	  and	  clinical	  samples14,	  and	  is	   accepted	   as	   an	   alternative	   for	   the	   more	   time	   consuming	   bacterial	  cultures.	   The	   method	   is	   generally	   known	   for	   its	   high	   sensitivity	   and	  specificity15,	  but	  a	  good	  assay	  is	  highly	  dependent	  on	  the	  region	  within	  the	   genome	   that	   is	   targeted	   for	   amplification.	   This	   region	   needs	   to	   be	  well	   conserved	   in	   order	   to	   allow	   for	   the	   design	   of	   efficient	   primers.	  However,	  one	  of	  the	  regions	  often	  used	  to	  quantify	  L.	  pneumophila	  -­‐	  ‘the	  defect	   in	   organelle	   trafficking’	   gene	   (dotA)	   -­‐	   was	   recently	   found	   to	   be	  highly	   variable16-­‐18.	   Mutations	   in	   the	   priming	   regions	   can	   thus	   cause	  significant	  bias	  in	  PCR	  based	  quantification	  or	  even	  complete	  inhibition	  of	  amplification19.	  Next-­‐generation	   sequencing	   could	   address	   some	   of	   these	   concerns	  by	  providing	   access	   to	   the	   full	   genetic	  make-­‐up	  of	   a	   sample.	  However,	  despite	   rapid	  advancement	  of	   these	   sequencing	   technologies,	   they	   still	  remain	  largely	  impractical	  for	  applications	  such	  as	  mutation	  analysis	  of	  
L.	  pneumophila	  due	  to	  the	  demanding	  technical	  requirements	  as	  well	  as	  the	   high	   costs.	  Moreover,	  within	   a	   particular	   species,	   only	   a	   relatively	  small	   number	   of	   sequence	   variations	   can	   be	   expected	   across	   the	  genome20	  and	  as	  such,	  full	  sequence	  availability	  is	  not	  necessary	  in	  most	  cases21.	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The	   complexities	   of	   next-­‐generation	   sequencing	   can	  be	   avoided	  by	  making	  use	  of	  the	  fact	  that	  hybridization	  of	  short	  oligonucleotides	  with	  the	  target	  genetic	  material	  is	  quantitatively	  sensitive	  to	  the	  number	  and	  position	  of	  mismatches22-­‐24.	  These	  mismatches	  between	  target	  sequence	  and	   probe	   sequence	   are	   changing	   the	   melting	   point,	   which	   can	   be	  detected.	  When	  these	  assays	  are	  performed	  with	  probes	  immobilized	  on	  solid	   surfaces,	   they	   become	   amenable	   to	  multiplexing25	   and	   are	  more	  sensitive26	   compared	   to	   the	   commonly	   used	   qPCR-­‐HRM	   assays27-­‐29.	  Moreover,	   if	   the	   solid	   support	   is	   a	   gold	   nanoparticle	   (Au	   NP),	   the	  sensitivity	  of	  DNA	  melting	  can	  significantly	   increase24,30,31	  compared	  to	  traditional	  probe	  based	  melting	  analyses.	  The	  properties	  of	   these	  DNA	  functionalized	   Au	   NPs	   are	   so	   unique	   that	   they	   warranted	   the	  introduction	   of	   a	   new	   terminology:	   spherical	   nucleic	   acids	   (SNA)32.	  When	   SNAs	   are	   applied	   as	   labeling	   probes	   in	   DNA	   dehybridization,	  cooperative	  effects	  of	   the	  DNA	  strands	  near	   the	  SNAs	  surface	   result	   in	  exceptionally	  sharp	  transitions	  between	  the	  double-­‐	  and	  single	  stranded	  state.	   Therefore,	   SNAs	   can	   increase	   the	   resolution	   in	   discriminating	  various	  types	  of	  mutations	  when	  implemented	  in	  a	  DNA	  melting	  assay.	  Surface	  Plasmon	  Resonance	   (SPR)	  was	   introduced	   to	  monitor	  DNA	  melting	   in	   real-­‐time	   by	   Fiche	   et	   al.33	   Using	   this	   approach,	   SNPs	   were	  directly	   detected	   in	   short	   oligonucleotides	   immobilized	   on	   a	   SPR	  imaging	  array.	  As	  described	  in	  the	  previous	  chapter,	  we	  combined	  SNAs	  with	   Fiber	   Optic	   (FO)-­‐SPR,	   which	   allowed	   monitoring	   of	   DNA	  hybridization	  and	  melting	  in	  real-­‐time	  with	  even	  higher	  resolution	  and	  in	   longer	  DNA	  strands.	  As	  SNAs	  are	  excellent	  signal	  enhancers	   for	  SPR	  which	  also	  narrow	  the	  width	  of	  the	  melting	  signal,	  this	  biosensor	  has	  an	  outstanding	   resolution	   for	   fast	   and	   accurate	   detection	   of	   mutations24.	  Moreover,	   the	  assay	   is	  able	   to	  discriminate	  SNPs	   in	  oligonucleotides	  of	  up	  to	  80bp	  and	  even	  with	  high	  GC	  content.	  By	  further	  improvement,	  the	  FO-­‐SPR	  melting	  assay	  was	  made	  compatible	  with	  complex	  samples	  such	  as	  PCR	  mixtures,	  which	  contain	  both	  enzymes	  and	  DNA,	  steering	  thus	  its	  application	   towards	   differentiation	   of	   highly	   homologous	   bacterial	  serogroups34.	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5.2 Aim	  of	  this	  chapter	  In	  this	  chapter	  the	  FO-­‐SPR	  melting	  assay	  is	  applied	  to	  unravel	  mutations	  in	   the	  dotA	  gene	  of	  L.	  pneumophila	  PCR	  samples.	   Identifying	  mutations	  in	  PCR	  samples	   is	  particularly	   challenging	  as	  mutations	   in	   the	  priming	  region	   become	   low	   abundant	   after	   a	   few	   PCR	   cycles	   due	   to	   the	  incorporation	  of	  the	  primers	  in	  the	  amplification	  products.	  Furthermore	  additional	   mutations	   can	   be	   introduced	   by	   the	   polymerase	   enzyme.	  However,	  these	  mutations	  are	  the	  ones	  of	  most	  importance	  as	  they	  can	  influence	   the	   efficiency	   of	   qPCR	   reaction	   and	   result	   in	   false	   negative	  results.	   Therefore	   it	   is	   of	   great	   importance	   to	   asses	   the	   genetic	  variability	  in	  genetic	  regions	  before	  implementing	  them	  as	  qPCR	  target	  regions.	   This	   article	   focuses	   on	   comparing	   this	   new	   approach	   with	  current	  standard	  technologies	  routinely	  applied	  in	  genetic	  testing,	  such	  as	  HRM	  and	  Sanger	  sequencing	  (Figure	  5.1).	  Results	  show	  that	  FO-­‐SPR	  solid	   phase	  melting	   in	   combination	  with	   SNA	   signal	   enhancement	   can	  readily	   be	   applied	   on	   PCR	   amplified	   bacterial	   targets	   to	   assess	  mutations.	  Furthermore,	  the	  FO-­‐SPR	  approach	  surpassed	  both	  standard	  techniques	  in	  detecting	  rare	  mutations.	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Figure	  5.1:	   Schematic	  overview	  of	  different	  methods	   for	  bacterial	   serotyping.	  A)	  
Different	  serogroups	  contain	  distinct	  versions	  of	  the	  target	  gene,	  due	  to	  mutations	  
that	  accumulated	  in	  the	  bacterial	  genome	  over	  time.	  When	  the	  target	  region	  of	  the	  
gene	  is	  amplified	  through	  PCR,	  the	  abundance	  of	  mutations	  in	  the	  priming	  regions	  
can	   decrease.	   B)	   The	   obtained	   PCR	   product	   is	   subsequently	   used	   for	   the	   actual	  
differentiation.	   This	   differentiation	   can	   be	   based	   on	   traditional	   HRM,	   which	   is	  
known	  to	  offer	   limited	  resolution	   in	  particular	  cases,	  especially	  when	  mutations	  
occur	   in	   close	  proximity.	  Full	   sequencing	  of	   the	  genetic	  material	  does	  not	   suffer	  
this	   limitation	   but	   is	   expensive,	   time-­‐consuming	   and	   amplification	   bias	   can	   still	  
occur.	   FO-­‐SPR	   offers	   high-­‐resolution	   differentiation	   of	   sequences	   because	   the	  
surface	  hybridization	  is	  inherently	  location	  specific,	  it	  will	  either	  hybridize	  to	  the	  
Au	  NPs	  or	  the	  sensor	  surface,	  which	  affects	  the	  melting	  temperature	  differently.	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5.3 	  Materials	  and	  methods	  
5.3.1. Reagents	  Oligonucleotides	   were	   purchased	   from	   Integrated	   DNA	   Technologies	  (Haasrode,	  Belgium).	  All	  chemicals	  were	  purchased	  from	  Sigma-­‐Aldrich	  (Belgium)	   unless	   stated	   otherwise.	   Au	   NPs	   with	   a	   diameter	   of	  approximately	   20	  nm	  were	   purchased	   from	  BBI	   international	   (Cardiff,	  United	  Kingdom).	  
5.3.2 Primers	  and	  probe	  design	  For	   the	   presented	   assays,	   different	   primer	   and	   detection	   probe	  sequences	   were	   adopted	   from	   literature	   to	   amplify	   a	   region	   of	   the	  Macrophage	   Infection	  Progenitor	   (MIP)	  and	   the	  defect	   in	   the	  organelle	  trafficking	  A	  (dotA)	  genes	  and	  modified	  in	  correspondence	  with	  specific	  assay	   requirements	   (Table	  5.1).	   qPCR	  was	  based	  on	   a	  Taqman	  design,	  which	   requires	   two	  primers	   and	   a	   Taqman	  probe	  with	   a	   5’	   FAM	   label	  and	   a	   3’	   prime	   minor	   groove	   binder.	   For	   the	   HRM	   assay	   only	   the	  primers	   were	   used	   of	   the	   Taqman	   qPCR	   assay	   without	   modifications.	  For	  the	  FO-­‐SPR	  assay	  probes	  complementary	  to	  the	  full	  qPCR	  amplicon	  were	  designed	  and	  the	  specificity	  towards	  the	  target	  sequence	  and	  self-­‐complementarity	  was	  checked	  using	  mFold7.	  The	  probes	  were	  modified	  with	  a	  5’	  thiol	  for	  the	  Au	  NP	  probe	  and	  3’	  thiol	  modification	  for	  the	  FO-­‐SPR	  sensor	  tip.	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Table	  5.1:	  Overview	  of	  the	  different	  assays	  and	  their	  corresponding	  primer-­‐probe	  
combinations.	   ThioMC6:	   5’	   thiol	   group	   coupled	   at	   carbon	   6	   at	   the	   5’	   end	   of	   the	  
phosphate	   backbone	   of	   the	   oligonucleotide.	   ThioMC3:	   thiol	   at	   the	   3’	   end	   of	   the	  
DNA	  oligo.	  FAM:	  Carboxyfluorescein	  MGB:	  minor	  groove	  binder.	  
Assay	   Type	   Sequence	   Ref.	  
dotA	  qPCR	   Fw	  Primer*	   5’-­‐ATTGTCTCGCGCGATTGC-­‐3’	   35	  
	   Rev	  Primer*	   5’-­‐CCGGATCATTATTAACCATCACC-­‐3’	   	  	   Taqman	  probe	   FAM	  5’-­‐ATACAGCAAATGTATGTGACTT-­‐3’	  MGB	   	  	   	   	   	  
MIP	  qPCR	   Fw	  Primer*	   5’-­‐	  TTCATTTGYTGYTCGGTTAAAGC-­‐3’	   9	  
	   Rev	  Primer*	   5’-­‐	  AWTGGCTAAAGGCATGCAAGAC-­‐3’	   	  
	   Taqman	  probe	   FAM	  5’-­‐	  AGCGCCACTCATAG-­‐3’	  MGB	   	  	   	   	   	  
FO-­‐SPR	  
(dotA)	  
Fiber	  probe	   5’-­‐AGTCACATACATTTGCTGTATAGCAATCGCGCGAGACAAT	  -­‐	  T18	  –	  Thio	  -­‐	  3’	   Chapter	  4	  
	   Au	   NP	  probe	   5’-­‐Thio-­‐T18	  CCGGATCATTATTAACCATCACCTGTGCCACCGTAGATAA	  -­‐3’	   	  *These	  primers	  were	  also	  used	  for	  the	  HRM	  assay	  	  
5.3.3 Culture	  analysis	  and	  DNA	  extraction	  
L.	   pneumophila	   serogroups,	   which	   are	   closely	   related	   strains	   of	   L.	  
pneumophila	   expressing	   different	   antigens,	   were	   obtained	   from	   the	  American	   Type	   Culture	   Collection	   (ATCC).	   Seven	   clinical	   isolates	   of	   L.	  
pneumophila	   serogroup	   1,	   among	   which	   the	   L.	   pneumophila	   Corby	  isolate,	   originated	   from	   different	   outbreaks	   of	   L.	   pneumophila.	   A	   list	  with	  the	  ATCC	  numbers	  of	  all	  serogroups	  and	  the	  origin	  of	   the	  Clinical	  Isolates	   can	   be	   found	   in	   the	   supporting	   information	   (table	   S1).	   The	  L.	  
pneumophila	   strains	  were	   cultured	   at	   37°C	   on	   buffered	   charcoal	   yeast	  extract	   supplemented	   with	   L-­‐cysteine	   and	   ferric	   pyrophosphate.	   The	  grown	   bacteria	   were	   used	   to	   spike	   samples	   of	   autoclaved	   Ringer	  solution.	  Cell	  numbers	  were	  first	  estimated	  using	  UV-­‐VIS	  measurements	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of	   bacterial	   suspensions	   at	   650	   nm,	   for	   all	   experiments	   106	   bacteria	  were	   used.	   The	   cell	   suspensions	   were	   plated	   and	   resulting	   colonies	  were	  counted	  after	  5	  days	  according	  to	  the	  NEN	  6265	  standard	  (1991).	  The	  culture	  detection	  limit	  was	  found	  to	  be	  50	  cfu/L.	  	  The	   DNA	   of	   the	   bacterial	   suspensions	   was	   extracted	   using	   a	  NucleoSpin®	   Tissue	   kit	   (Machery-­‐Nagel,	   Germany),	   according	   to	   the	  manufacturer’s	   instructions.	   Extracted	   DNA	   was	   stored	   at	   -­‐20°C	   in	  aliquots	  prior	  to	  usage.	  
5.3.4 FO-­‐SPR	  setup	  and	  sensor	  manufacturing	  The	  FO-­‐SPR	  biosensor	  used	  was	   identical	   to	   the	  setup	  described	   in	  Chapter	   3	   Section	   3.3.3.	   FO-­‐SPR	   sensor	   tips	   were	   also	   manufactured	  according	   to	   the	   protocol	   described	   in	   Chapter	   3	   Section	   3.3.4.	  Afterwards	   these	   FO-­‐SPR	   sensor	   tips	   were	   functionalized	   using	   the	  protocol	   described	   in	   Chapter	   4	   Section	   4.3.3.	   Subsequently,	   the	   DNA	  coated	   FO-­‐SPR	   tips	   were	   backfilled	   in	   order	   to	   block	   non-­‐specific	  binding	   of	   proteins	   to	   the	   sensor	   tip	   as	   described	   earlier34	   (a	   detailed	  description	  of	  the	  backfilling	  concept	  can	  be	  found	  in	  Chapter	  1	  section	  1.6,	   using	   10	   µM	   of	   an	   hydroxyl	   terminated	   alkanethiol	   with	   8	  polyethylene	   oxide	   repeats	   (Polypure,	   Norway).	   This	   molecule	   was	  dissolved	  in	  ethanol	  and	  allowed	  to	  react	  for	  3	  h	  before	  rinsing	  the	  fiber	  with	   ethanol	   and	   placing	   it	   in	   phosphate	   buffer	   at	   4°C	   for	   storage.	   In	  order	  to	  augment	  the	  FO-­‐SPR	  device	  signal,	  Au	  NPs	  with	  complementary	  DNA	  probes	  were	  produced.	  Thiol-­‐functionalized	  DNA	  was	  immobilized	  on	  the	  Au	  NPs	  by	  adding	  activated	  and	  purified	  DNA	  to	  a	  concentrated	  nanoparticle	   solution.	   A	   fast	   salt	   maturation	   protocol	   was	   used	   to	  maximize	   the	   DNA	   loading	   on	   the	   Au	   NPs36.	   Afterwards	   Au	   NPs	  were	  washed	  three	  times	   in	  phosphate	  buffer	  with	  0.02%	  SDS	  and	  stored	  at	  4°C	  prior	  to	  use.	  
5.3.5 Quantitative	  PCR	  Taqman	  Q-­‐PCR	  was	  performed	  on	  an	  ABI	  Prism	  7000	  system,	  in	  96-­‐well	  optical	   reaction	   plates	   (Applied	   biosystems,	   USA).	   The	   final	   reaction	  volume	  was	  25	  µl.	   For	   the	  MIP	  qPCR,	  0.56	  µl	   (10	  µM)	  of	  both	  primers	  was	  used,	  1	  µl	  (0.2	  µM)	  of	  probe,	  2.5	  µl	  2%	  bovine	  serum	  albumin	  (BSA,	  Sigma	   Aldrich,	   USA),	   12.5	   µl	   1X	   Taqman®	   universal	   master	   mix	  (Applied	   biosystems,	   USA),	   and	   5	   µl	   of	   template	   DNA	   which	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corresponded	   to	   a	   starting	   volume	   of	   106	   genome	   units	   (GU)	   of	   L.	  
pneumophila	  genome	  DNA.	  The	  dotA	  qPCR	  was	  obtained	  from	  Labaqua	  (Spain),	   and	   used	   according	   to	   the	   manufacturer’s	   instructions.	   The	  following	  thermal	  cycling	  conditions	  were	  used	  for	  both	  qPCR	  reactions:	  10	  min	  95	  °C	  followed	  by	  50	  cycles	  of	  15	  s	  at	  95°C	  and	  1	  min	  at	  60	  °C.	  Fam	  and	  respectively	  Rox	  dye,	  were	  used	   to	  monitor	   the	  amplification	  and	   the	   background	   during	   PCR	   amplification,	   these	   signals	   were	  obtained	   after	   each	   thermal	   cycle.	   The	   efficiency	   of	   the	   reaction	   was	  very	  close	  and	  in	  some	  cases	  even	  above	  1.	  
5.3.6 High	  resolution	  melting	  analysis	  Post-­‐PCR	   HRM	   melting	   analysis	   was	   performed	   using	   a	   commercial	  HRM	  kit	  (Quanta,	  USA)	  in	  a	  Rotor	  gene	  6000	  5-­‐plex	  HRM	  device	  (Qiagen,	  USA).	   Before	   HRM,	   the	   samples	   were	   amplified	   using	   primers	   for	   the	  
MIP	  gene	  as	  described	  earlier9	  or	  the	  dotA	  gene	  as	  reported	  in	  Yanez	  et	  
al.35.	  Both	  MIP	  and	  dotA	  HRM	  qPCR	  used	  a	  15	  µl	   final	  reaction	  volume,	  which	  contained	  7.5	  µl	  of	  2X	  AccuMelt™	  HRM	  SuperMix	  (Quanta,	  USA),	  0.3	   µl	   (1	   µM)	   of	   each	   primer,	   6.5	   µl	   PCR	   H20	   (5PRIME,	   Gaithersburg,	  USA)	  and	  1	  µl	  of	  sample.	  
5.3.7 FO-­‐SPR	  Melting	  analysis	  An	  overview	  of	  the	  FO-­‐SPR	  assay	  concept	  can	  be	  seen	  in	  Figure	  5.1B.	  The	  FO-­‐SPR	  melting	  analysis	  was	  performed	  in	  a	  final	  volume	  of	  100	  µL,	  which	  was	  covered,	  with	  60	  µL	  of	  Silicon	  oil	  (Bio-­‐Rad,	  Hercules,	  USA)	  to	  prevent	  evaporation.	  The	  samples	  consisted	  of	  5	  µl	  of	   the	  non-­‐purified	  qPCR	  product,	  containing	  the	  amplified	  DNA	  (final	  concentration	  of	  DNA	  ≈	  1	  µM,	  which	  was	  well	  above	  the	  1	  nM	  detection	  limit	  of	  the	  system,	  as	  determined	  in	  Chapter	  4),	  80	  µL	  PBS	  with	  300	  mM	  NaCl	  and	  15	  µL	  of	  10	  nM	   Au	   NPs.	   Before	   each	   measurement,	   the	   samples	   were	   briefly	  centrifuged	   to	   remove	   air	   bubbles	   and	  were	   heated	   to	   94°C	   for	   5	   s	   to	  denature	  the	  dsDNA	  in	  ssDNA	  that	  could	  interact	  with	  the	  probes	  on	  the	  FO-­‐SPR	  sensor	  and	  on	   the	  Au	  NPs.	  Subsequently,	   the	   temperature	  was	  lowered	   to	  50°C	   to	  allow	  hybridization.	  After	  15	  min,	   the	   temperature	  was	   slowly	   raised	   (0.1°C	   s-­‐1)	   to	   determine	   the	   exact	   melting	  temperature	   (Tm).	   The	   total	   assay	   time	   was	   18	   min.	   Negative	   control	  measurements	  were	   performed	   using	   the	   non-­‐template	   control	   (NTC)	  reaction	  mixture	  of	  the	  qPCR	  reaction.	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5.3.8 Sequencing	  and	  sequence	  alignment	  Before	   sequencing,	   all	   samples	   were	   amplified	   using	   Taq	   polymerase	  (Invitrogen)	  with	  the	  dotA	  primers	  as	  described	  earlier.	  Next,	  they	  were	  cloned	   into	   the	   pGEM-­‐T	   vector	   (Promega,	  Madison,	   USA)	   according	   to	  manufacturer	  guidelines.	  Samples	  were	  sequenced	  with	  the	  SP6	  primer	  at	  the	  genetic	  sequencing	  facility	  of	  the	  VIB	  (Antwerp,	  Belgium).	  The	   obtained	   sequences	   were	   compared	   with	   sequences	   of	   L.	  
pneumophila	   serogroups	   available	   in	   the	   National	   Center	   for	  Biotechnology	  (NCBI)	  database,	  which	  can	  be	  accessed	  using	  the	  online	  tool	   nucleotide	   BLAST	   (http://www.ncbi.nlm.nih.gov/BLAST)37.	   The	  query	  on	  Entrez	  was	   limited	  by	  the	  keyword:	  “Bacteria”.	  The	  sequence	  of	  L.	  pneumophila	  serogroup	  1	  (ATCC	  33152),	  available	  under	  accession	  number	   AF9009	   in	   the	  NCBI	   database	  was	   found	   and	   used	   as	   base	   of	  comparison	  for	  all	  serogroups	  because	  the	  original	  primers	  and	  probes	  for	   the	   Taqman	   qPCR	   of	   Yanez	   et	   al.35	   were	   designed	   using	   this	  sequence.	   The	  ATCC	   serogroups	   analyzed	   in	   this	   research	   could	   all	   be	  found	   in	   the	  NCBI	   database	   except	   for	   one	   serogroup	   (serogroup	   15	   -­‐	  ATCC	  35251).	  
5.3.9 Data	  analysis	  Data	  were	   collected	   and	   analyzed	   using	   the	   appropriate	   software.	   For	  ABI	   Prism	   data	   the	   SDS	   1.1	   software	   (Applied	   Biosystems)	   was	   used.	  HRM	  data	  was	  analyzed	  using	   the	  Rotor	  Gene	  Q	  1.7	  build	  94	  software.	  The	  FO-­‐SPR	  setup	  was	  operated	  using	  a	  National	   instruments	  Labview	  program	  that	  was	  developed	  in-­‐house.	  Further	  analyses	  of	  the	  SPR	  data	  were	  performed	  using	  Excel	   (Microsoft,	  USA),	  Origin	   (Originlabs,	  USA)	  and	  Matlab	  (The	  Mathworks,	  USA).	  
5.4 Results	  
5.4.1 Mutation	  detection	  through	  sequencing	  Recently,	   it	   was	   discovered	   that	   the	   L.	   pneumophila	   dotA	   gene	   has	  relatively	   high	   variability	   among	   different	   serogroups16.	   Because	   this	  gene	   is	   often	   used	   for	   detection	   of	   L.	   pneumophila	   by	   qPCR,	   it	   is	  important	   to	   asses	   the	   impact	   this	   genetic	   variability	   has	   on	   the	  outcome	  of	   this	  quantification	  assay.	  Therefore,	   in	   this	  paper,	   an	  80bp	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region	   of	   the	   dotA	   gene,	   which	   is	   expected	   to	   contain	   different	  mutations18,	   was	   first	   screened	   among	   9	   American	   Type	   Culture	  Collection	  (ATCC)	  L.	  pneumophila	  serogroups	  using	  the	  standard	  Sanger	  sequencing	  method.	  
	  
Figure	   5.2:	   Results	   of	   sequencing	   the	  dotA	   gene	   of	   9	   interesting	   L.	  pneumophila	  
serogroups.	  The	  bases	  marked	  are	  mutations	  detected	  using	  sequencing.	  Primer	  
and	  Taqman	  probe	  regions	  are	  marked	  with	  a	  dashed	  line.	  The	  acquired	  sequences	  were	  compared	  to	   those	  available	   in	   the	  NCBI	  database	  (Figure	  5.3).	  Surprisingly,	  among	  the	  9	  sequenced	  serogroups,	  only	   two	  were	   found	   to	   be	   completely	   free	   of	  mutations	   (serogroup	  3	  and	   4).	   Other	   serogroups	   encompassed	   several	   mutations	   each,	   with	  some	  of	   them	  being	   recurrent	  between	  different	   serogroups.	  However	  most	  of	  these	  mutations	  were	  not	  present	  in	  the	  NCBI	  database	  and	  only	  4	   among	   9	   sequenced	   serogroups	   were	   found	   to	   have	   mutations	  reported	  in	  the	  NCBI	  database.	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Figure	   5.3:	   Results	   of	   analyzing	   the	   dotA	   gene	   of	   9	   interesting	   L.	   pneumophila	  
serogroups	  using	  the	  NCBI	  database.	  The	  bases	  marked	  are	   identified	  mutations	  
using	   the	  NCBI	   database.	   Primer	   and	  Taqman	  probe	   regions	   are	  marked	  with	   a	  
dashed	  line.	  These	   results	   show	   that	   the	  dotA	   sequence	   is	   highly	   variable	   and	   that	  most	   of	   the	   serogroups	   tested	   have	   acquired	   several	   mutations.	   It	  cannot	   be	   excluded	   that	   these	   mutations	   are	   introduced	   by	   Taqman	  polymerase	   DNA	   amplification,	   although	   this	   would	   be	   highly	  coincidently	  as	  these	  mutations	  are	  in	   	  exact	   the	  same	  positions	  as	  can	  be	  found	  in	  other	  L.	  pneumophilia	  serogroups.	  Unexpectedly,	  sequencing	  did	   not	   reveal	   any	   mutations	   in	   the	   priming	   regions	   of	   serogroups	  (Figure	  5.2),	  while	  several	  mutations	  were	  found	  in	  the	  priming	  regions	  of	   different	   serogroups	   in	   the	  NCBI	   database.	   This	   discrepancy	   can	   be	  explained	   by	   the	   intrinsic	   limitations	   of	   the	   Sanger	   sequencing	  technique.	   When	   sequencing	   is	   applied	   directly	   to	   a	   PCR	   product,	  chances	  of	  detecting	  mutations	  in	  the	  priming	  regions	  are	  low,	  because	  primers	   are	   incorporated	   in	   the	   PCR	   product	   during	   amplification,	  resulting	   in	  a	   irrelevant	   low	  number	  of	   copied	   strands	  with	  mutations	  from	  the	  original	  priming	  region	  sequence.	  	  To	   further	   test	   this	   hypothesis,	   the	   same	   80bp	   region	   of	   the	   dotA	  gene	   was	   used	   as	   a	   target	   in	   qPCR	   to	   quantify	   all	   15	   L.	   pneumophila	  serogroups	   available.	   If	   mutations	   are	   present	   within	   the	   priming	   or	  Taqman	  probe	  regions,	  the	  qPCR	  based	  quantification	  of	  bacteria	  will	  be	  affected38,	   causing	   thus	   a	   clear	  discrepancy	   compared	   to	   the	   reference	  method	   of	   bacterial	   colony	   counting	   (Figure	   5.4).	   The	   results	   showed	  that	   indeed	   dotA	   qPCR	   quantification	   for	   several	   serogroups	   is	  substantially	  different	  from	  results	  obtained	  through	  counting	  bacterial	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colonies,	   whereas	   there	   is	   a	   good	   correlation	   between	   this	   reference	  technique	   and	   the	   qPCR	   quantifications	   of	   the	   more	   conserved	  ‘Macrophage	  Infection	  Potentiator’	  (MIP)	  gene9.	  	  The	  differences	  were	  especially	  pronounced	   for	   serogroups	  1,	  2,	  6,	  12	   and	   15.	   For	   some	   of	   them	   (2,	   6	   and	   12)	  mutations	   in	   the	   priming	  region	  are	   reported	   in	   the	  NCBI	  database	   (Figure	  5.3).	  Moreover,	   they	  all	  have	  the	  same	  mutation	  at	  base	  4	  of	  the	  3’	  end	  of	  the	  reverse	  primer.	  It	  has	  already	  been	  studied	  extensively	   that	  a	  single	  mutation	  at	   the	  3’	  end	  of	  a	  primer	  has	  the	  largest	  impact	  on	  PCR39,40	  41.	  	  
	  
Figure	  5.4:	  Results	  of	  quantification	  of	  15	  L.	  pneumophila	  serogroups	  using	  qPCR	  
assays	  based	  on	  MIP	  and	  dotA	  genes.	  The	  logarithm	  of	  the	  qPCR	  genomic	  counts	  is	  
subtracted	   by	   the	   logarithm	   of	   the	   standard	   plating	   counts	   and	   the	   actual	  
differences	   in	   quantification	   are	   represented	   as	   bar	   graphs.	   Variability	   is	  
expressed	  as	  standard	  deviation	  (n=4).	  GU=	  genomic	  units,	  CFU=	  Colony	  forming	  
units.	  On	  the	  other	  hand	  serogroup	  4	  had	  according	  to	  the	  NCBI	  database	  a	  mutation	  at	  base	  2	  of	   the	  5’	  end	  of	   the	  reverse	  primer,	  explaining	  thus	  why	   this	   mutation	   does	   not	   affect	   the	   qPCR	   reaction	   (Figure	   5.4).	  Surprisingly	  serogroup	  1	  and	  15	  had	  no	  mutations	  in	  the	  priming	  region	  according	   to	   the	   NCBI	   database	   although	   they	   showed	   large	  discrepancies	   in	  quantification	  when	  using	  the	  two	  methods.	  However,	  Sanger	   sequencing	   revealed	   in	   their	   non-­‐priming	   region	   the	   same	  cluster	   of	   mutations	   as	   in	   the	   inhibited	   serogroups	   2	   and	   12.	   This	  suggests	   that	   serogroups	   1	   and	   15	   might	   have	   acquired	   the	   same	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mutations	   as	   serogroup	   2	   and	   12,	   including	   the	   ones	   in	   the	   priming	  region,	   which	  might	   explain	   the	   observed	   PCR	   inhibition.	   To	   test	   this	  hypothesis	   and	   to	   reveal	  whether	   serogroups	   1,	   2,	   12	   and	   15	   all	   have	  similar	  mutations	   a	   new	   fast	   genetic	   screening	   technique	  was	   applied	  based	  on	  DNA	  melting.	  
5.4.2 Mutation	  detection	  through	  high	  resolution	  melting	  To	   evaluate	   the	   potential	   merits	   of	   DNA	   melting	   assays	   for	   the	  identification	   of	   mutations	   in	   L.	   pneumophila,	   two	   high-­‐resolution	  melting	   assays	   were	   performed	   (Figure	   5.1).	   The	   first	   assay	   is	   the	  routinely	   applied	   qPCR	   -­‐	   high	   resolution	   melting	   (qPCR-­‐HRM),	   which	  uses	   a	   saturating	   intercalating	   dye	   to	  monitor	   the	  melting	   of	   the	  DNA	  double	   strand	   in	   solution	   directly	   after	   qPCR.	   The	   other	   assay	   is	   the	  new,	  by	  our	  group,	  developed	  FO-­‐SPR	  melting	  assay,	  which	  can	  monitor	  DNA	  melting	   in	   real	   time.	   It	   is	   also	   applied	   directly	   after	   PCR,	   but	   the	  melting	   process	   is	   monitored	   on	   a	   solid	   surface,	   which	   provides	   a	  significant	  resolution	  gain	  as	  has	  been	  shown	  in	  our	  previous	  work24.	  Among	   several	   serogroups	   that	   showed	   consistency	   in	  quantification	  (Figure	  5.4),	  only	  few	  were	  included	  in	  these	  experiments	  (such	  as	  serogroup	  3,	  4,	  5	  and	  11),	  as	  no	  mutations	  are	  expected	  in	  their	  priming	   region.	   The	   DNA	   melting	   principle	   was	   first	   tested	   by	  comparing	   the	   general	   variation	   in	   melting	   temperatures	   of	   the	   dotA	  gene	   amplicon	   with	   those	   of	   the	  MIP	   gene	   amplicon	   for	   the	   different	  serogroups.	  This	   is	   a	   good	  benchmark,	   because	   the	   sequencing	   results	  already	   have	   proven	   that	   dotA	   is	   highly	   variable	  while	  MIP	   should	   be	  more	   conserved.	   Results	   are	   visualized	   as	   a	   heat	  map,	  which	   displays	  the	  difference	  in	  Tm	  between	  L.	  pneumophila	  serogroups	  but	  at	  the	  same	  time	  shows	   the	  overall	   variability	  within	   the	   sequence	  of	   interest.	  The	  Tm	   is	   approximately	   79.7°C	   for	   all	   serogroups	   in	   the	   case	   of	  MIP	   PCR	  amplicon	  with	   a	  maximal	   variation	   of	   0.2°C	   pointing	   to	   low	   or	   almost	  absent	  genetic	  variability.	  Contrary	  to	  this,	  Tm	  values	  for	  the	  dotA	  qPCR	  amplicon	  have	  a	  broad	  span	  with	  Tm	  values	  measured	  between	  78°C	  and	  81°C	   for	   different	   serogroups.	   This	   is	   represented	   by	   the	   colored	  pattern	   of	   the	   heat	   map	   for	   the	   dotA	   amplicon,	   which	   indicates	  pronounced	  differences	  in	  Tm	  values	  ranging	  from	  -­‐2	  to	  +2	  °C	  and	  thus	  sequence	   variability	   for	   the	   tested	   serogroups	   (Figure	   5.5	   A,	   top	  triangle).	   The	   same	   samples	   were	   further	   analyzed	   with	   the	   FO-­‐SPR	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HRM	   assay.	   The	   heat	   map	   in	   5.5	   B	   represents	   a	   comparison	   between	  qPCR	  HRM	  (bottom	  triangle)	  and	  FO-­‐SPR	  HRM	  assay	  (top	   triangle)	   for	  the	   dotA	   amplicon.	   Noticeably,	   the	   variability	   in	   Tm	   values	   between	  different	   serogroups	   is	   even	   more	   pronounced	   with	   FO-­‐SPR	   HRM	  compared	   to	   qPCR	   HRM,	   further	   supporting	   observations	   from	   our	  previous	  work	  on	  higher	  resolution	  of	  the	  former	  melting	  assay.	  
	  
Figure	   5.5:	   A)	   ΔTm	   Heat	  map	   of	   HRM	   results,	   showing	   the	   difference	   in	   genetic	  
variability	  of	  the	  PCR	  amplified	  MIP	  locus	  and	  the	  dotA	  locus.	  The	  dotA	  locus	  has	  a	  
much	  larger	  span	  of	  Tm	  values,	   indicating	  higher	  genetic	  variability.	  B)	  Heat	  map	  
of	  HRM	  melting	  analysis	   for	   the	  dotA	   locus	   in	  comparison	  to	  FO-­‐SPR	  determined	  
Tm	   values.	   The	   range	   of	   Tm	   values	   measured	   by	   FO-­‐SPR	   is	   larger	   compared	   to	  
qPCR-­‐HRM	   indicating	   the	   higher	   sensitivity	   towards	   mutation	   detection	   by	   FO-­‐
SPR.	  To	   further	   link	   the	   sequencing	   results	   and	   the	   results	   from	   DNA	  melting	   assays,	   the	   Tm	   of	   the	   sequences	   obtained	   with	   Sanger	  sequencing	  were	  predicted	  in	  silico	  using	  µMelt,	  an	  algorithm	  developed	  for	   the	   prediction	   of	   HRM	   melting	   data42.	   The	   in	   silico	   obtained	   Tm	  values	  were	  compared	  to	  the	  Tm	  of	  every	  serogroup	  as	  measured	  with	  qPCR-­‐HRM	   and	   FO-­‐SPR	  HRM.	   All	   Tm	   values	  were	   subtracted	  with	   the	  Tm	   of	   the	   original	   sequence	   on	   which	   the	   dotA	   primers	   were	   based	  (genebank	   accession	   number:	   AF9009)	   and	   the	   (∆Tm)	   differences	   are	  shown	  as	  bar	  graphs	  on	  Figure	  5.6.	  For	  the	  MIP	  gene	  no	  mutations	  were	  found	  in	  the	  amplification	  region.	  A	  first	  thing	  to	  notice	  is	  that	  there	  is	  a	  strong	  correlation	  in	  trend	  between	  the	  µMelt	  predictions	  and	  the	  actual	  measured	   ∆Tm	   with	   qPCR	   HRM	   (blue	   and	   grey	   bars).	   For	   all	   the	  serogroups	  tested	  ∆Tm	  is	  larger	  than	  zero,	  except	  for	  serogroup	  3	  as	  this	  serogroup	  has	  no	  mutations.	  When	  the	  mutations	  in	  the	  priming	  region	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from	   the	   NCBI	   database	   (Figure	   5.2,	   red	   dots)	   are	   included	   into	   the	  Sanger	   sequencing	   results,	   used	   in	   the	   µMelt	   model,	   this	   correlation	  between	  qPCR	  HRM	  measured	  ∆Tm	  and	  predicted	  ∆Tm	  further	  improved	  (Figure	  5.6,	  black	  bars	  indicated	  with	  arrows).	  For	  instance	  serogroup	  4	  had	  no	  mutations	  according	  to	  Sanger	  sequencing	  (note	  the	  absence	  of	  grey	  bars),	   though	  both	  DNA	  melting	  methods	  detect	  a	  ∆Tm.	  When	   the	  sequence	  was	   supplemented	  with	   the	  mutations	  of	   the	  NCBI	  database,	  the	  predicted	  ∆Tm	  (black	  bar)	  was	  similar	   to	   the	  qPCR-­‐HRM	  measured	  one	  (blue	  bar).	  Similar	  results	  were	  obtained	   for	  serogroup	  6,	  where	  a	  negative	   value	   of	   ∆Tm,	   predicted	   with	   µMelt	   for	   Sanger	   sequencing,	  changed	   into	  positive	  ∆Tm	  after	  NCBI	  primer	  corrections	  were	  applied.	  This	   change	   again	   corresponded	   with	   the	   ∆Tm	   measured	   with	   qPCR-­‐HRM.	   For	   FO-­‐SPR	   (green	   bars)	   ∆Tm	   is	   larger	   compared	   to	   qPCR	   HRM	  and	   µMelt	   prediction	   for	   the	   L.	   pneumophila	   serogroups.	   Nonetheless	  the	   trend	   in	   the	   shifts	   corresponds	   perfectly	   with	   the	   presence	   or	  absence	   of	   mutations.	   These	   results	   altogether	   prove	   that	   detecting	  mutations	  in	  the	  priming	  region	  is	  possible	  when	  using	  melting	  assays,	  as	  opposed	  to	  Sanger	  sequencing.	  
	  
Figure	  5.6:	  ∆Tm	   for	   the	  dotA	   gene	  among	  different	  L.	  pneumophila	   serogroups	  as	  
measured	  with	  the	  melting	  assays	  in	  comparison	  with	  the	  in	  silico	  determined	  Tm	  
of	   the	   sequencing	   results	   (visualized	   in	   absolute	   ∆Tm	   from	   the	   Tm	   of	   the	   non	  
mutated	  sequence).	  For	   serogroup	  3,	  no	  ∆Tm	  bars	  are	  present	  as	   this	   serogroup	  
has	  no	  mutations.	  The	  error	  bars	  correspond	  to	  the	  variability	  of	   the	  qPCR-­‐HRM	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melting	  assay	  and	  FO-­‐SPR	  HRM	  assay,	   respectively.	  The	  serogroups	  which	  had	  a	  
different	  Tm	  after	  correction	   for	   the	  priming	  region	  mutations	  are	  marked	  with	  
an	  arrow.	  Variability	  is	  expressed	  as	  standard	  deviation	  (n=4).	  From	  Figure	  5.5	   it	   can	  be	   seen	   that	   serogroups	  1,	   2,	   12	   and	  15	   all	  have	   a	   large	   ∆Tm,	   pointing	   to	   our	   initial	   hypothesis	   that	   these	   four	  serogroups	  all	  have	  the	  same	  cluster	  of	  mutations.	  The	  same	  trend	  was	  found	   for	  all	  methods	  except	   that	   for	   serogroup	  15	  only	  FO-­‐SPR	  could	  detect	   a	   ∆Tm	   indicative	   of	   the	   highest	   number	   of	   mutations.	   This	  discrepancy	  is	  due	  to	  the	  probe-­‐based	  design	  of	  the	  FO-­‐SPR	  HRM	  assay,	  which	   is	   sensitive	   to	   individual	   mutations	   while	   qPCR-­‐HRM,	   on	   the	  other	  hand,	   is	   sensitive	   to	   the	  overall	  ∆	  Tm	  of	   the	  qPCR	  amplicon	  DNA	  duplex.	  	  
5.4.3 Mutation	  detection	  in	  clinical	  samples	  of	  L.	  pneumophilia	  Next,	  the	  same	  approach	  to	  identify	  mutations	  in	  the	  dotA	  sequence	  was	  applied	   on	   a	   panel	   of	   clinically	   isolated	   L.	   pneumophila	   serogroup1	  bacteria.	   Different	   isolates	  were	   first	   quantified	   using	   both	  dotA	  qPCR	  and	  MIP	  qPCR	  and	  the	  results	  were	  compared	  with	  plate	  culture	  counts.	  Two	  of	   the	  seven	   tested	   isolates	   (isolate	  3	  and	  Legionella	  pneumophila	  strain	   Corby)	   differed	   in	   their	   quantification	   between	   the	   two	   used	  methods	  (Figure	  5.7,	  part	  A).	  Especially	  for	  the	  very	  virulent	  strain	  of	  L.	  
pneumophila,	   known	   as	   Corby43,	   there	   was	   no	   detectable	   PCR	  amplification	  of	  the	  dotA	  gene.	  After	   qPCR,	   the	   amplicons	  were	   ligated	   in	   a	   vector	   and	   sequenced	  (Figure	  5.7,	  part	  B).	  Several	  mutations	  were	  discovered	  in	  the	  clinically	  isolated	  L.	  pneumophila	   that	  resembled	  to	  a	  great	  extent	  the	  mutations	  found	   in	   the	  L.	  pneumophila	   serogroups.	  A	  new	  mutation	  was	   found	   in	  the	  Corby	  isolate,	  which	  was	  located	  in	  the	  middle	  of	  the	  Taqman	  probe	  hybridization	  site	  on	  the	  dotA	  gene.	  Previously,	  a	  similar	  mutation	  was	  also	   found	   in	   serogroup	  6	  but	   this	  mutation	  did	  not	   interfere	  with	   the	  PCR	   reaction.	   However,	   for	   the	   Corby	   strain	   the	   PCR	   reaction	   was	  completely	   inhibited.	   In	   order	   to	   evaluate	  whether	   this	   inhibition	  was	  the	  result	  of	  a	  mutation	  within	  primer	  or	  probe	  a	  PCR	  reaction	  without	  Taqman	   probe	   was	   performed.	   This	   resulted	   in	   normal	   amplification,	  indicating	   that	   the	   mutation	   in	   the	   probe	   sequence	   is	   responsible	   for	  inhibition	   of	   the	   qPCR,	   which	   was	   confirmed	   with	   an	   agarose	   gel	  identification	  of	  the	  amplified	  product	  (confirmed	  by	  a	  fluorescent	  band	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in	  the	  gel	  at	  the	  80bp	  DNA	  ladder	  marker,	  data	  not	  shown).	  For	  another	  isolate	  with	   differences	   in	   quantification,	   isolate	   3,	   no	  mutations	  were	  present	  in	  either	  the	  probe	  or	  priming	  zones.	  To	  further	  analyze	  this,	  all	  bacterial	   isolates	  were	   subjected	   to	  both	  DNA	  melting	   assays.	   A	  direct	  comparison	  of	   these	   results	   is	   summarized	   in	  Figure	  5.7,	  part	  C.	  Using	  qPCR	  HRM,	  small	  variations	  in	  Tm	  are	  visible,	  including	  the	  Corby	  strain.	  In	   line	   with	   our	   results	   on	   serogroups,	   FO-­‐SPR	   HRM	   assay	   again	  revealed	   more	   pronounced	   differences	   in	   ∆Tm.	   Although	   both	  techniques	  were	  able	  to	  sense	  increased	  genetic	  variability	  to	  a	  different	  extent,	  there	  seemed	  to	  be	  no	  connection	  with	  qPCR	  results.	  	  
 
Figure	   5.7:	   A)	   qPCR	   quantification	   of	   different	   L.	   pneumophila	   clinical	   isolates	  
using	  the	  dotA	  and	  the	  MIP	  gene	  expressed	  as	  the	  logarithmic	  difference	  with	  the	  
plating	  counts.	  The	  symbol	  *	  marks	  isolates	  that	  showed	  no	  amplification	  for	  dotA.	  
Variability	  is	  expressed	  as	  standard	  deviation	  (n=4).	  	  B)	  Sequencing	  results	  of	  6	  L.	  
pneumophila	   clinical	   isolates.	   The	   bases	   marked	   in	   blue	   are	   the	   mutations	  
detected	   using	   sequencing.	   Primer	   and	   probe	   regions	   are	   marked	   with	   dashed	  
lines.	  C)	  Heat	  map	  comparison	  of	   the	  Tm	   for	  different	  L.	  pneumophila	   isolates	  as	  
measured	  with	  qPCR	  HRM	  (bottom)	  and	  FO-­‐SPR	  HRM	  (top)	  assay.	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Therefore,	   the	   sequencing	   data	  were	   linked	  with	   the	   DNA	  melting	  data	  using	  the	  same	  µMelt	  in	  silico	  Tm	  predictions.	  The	  ∆Tm	  of	  µMelt	  has	  a	   good	   correlation	   with	   the	   qPCR	   HRM	   concerning	   the	   height	   of	   the	  signal	   (compare	   black	   and	  blue	   bars	   on	   the	   graph,	   Figure	   5.8).	  On	   the	  other	  hand	  the	  discrepancy	  between	  FO-­‐SPR	  HRM	  is	  attributable	  to	  the	  sensitivity	   of	   the	   FO-­‐SPR	   HRM	   assay	   towards	   mutations.	   As	   a	   result,	  ∆Tm	  is	  much	  higher	  than	  the	  µMelt	  predicted	  value,	  which	  allows	  easy	  discrimination	  of	  mutated	  bacterial	  isolates	  with	  the	  FO-­‐SPR	  HRM	  assay.	  	  Most	  of	   the	  mutations	   in	   the	   isolates	  were	  at	   the	  detection	   limit	  of	  the	  qPCR-­‐HRM	  assay	  and	  were	   therefore	  not	   always	  detectable	   as	   can	  be	  seen	   in	  Figure	  5.8.	  Some	   isolates	   (isolates	  3,	  4,	  6	  and	  corby)	  on	   the	  other	   hand	   had	   large	   ∆Tm	   values,	   caused	   by	   the	   same	   cl,n	   uster	   of	  mutations,	  but	   those	  could	  only	  be	  measured	  with	  FO-­‐SPR	  HRM	  assay.	  For	   isolate	   3,	   a	   particular	   discrepancy	   in	   ∆Tm	   values	   was	   observed	  between	  µMelt	  prediction	  and	  both	  the	  qPCR	  HRM	  and	  the	  FO-­‐SPR	  HRM	  assay.	  Unsurprisingly,	  this	  is	  the	  only	  isolate	  where	  qPCR	  inhibition	  was	  observed	   and	   no	   PCR	   primer	   or	   probe	  mutation	   could	   be	   found	   with	  Sanger	   sequencing.	   Mutations	   in	   the	   primer	   were	   not	   detected	   with	  sequencing,	  as	  was	  the	  case	  for	  the	  Legionella	  serogroups.	  
	  
Figure	   5.8:	   Relative	   ∆Tm	   for	   the	   different	   L.	   pneumophila	   clinical	   isolates	   as	  
measured	  with	  the	  melting	  assays	  in	  comparison	  to	  the	  in	  silico	  determined	  Tm	  of	  
the	  sequencing	  results	  (visualized	  in	  absolute	  ∆Tm	  from	  the	  Tm	  of	  the	  non	  mutated	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sequence)	  The	  symbol	  *	  marks	  that	  isolate	  Corby	  has	  a	  higher	  ∆Tm	  than	  5	  (∆Tm	  =	  
7.12	  ±	  0.28).	  Variability	  is	  expressed	  as	  standard	  deviation	  (n=4).	  Further	   proof	   for	   increased	   resolution	   of	   FO-­‐SPR	   HRM	   assay	   was	  obtained	   from	   the	   actual	   melting	   curves	   (Figure	   5.9).	   The	   qPCR	   HRM	  melting	   peaks	   of	  mutated	   Legionella	  pneumophila	   isolates	   had	   neither	  special	   features,	   nor	   a	   large	   shift	   in	   ∆Tm.	   The	   FO-­‐SPR	   melting	   curves	  showed	  multiple	  melting	  points,	  which	  indicated	  variation	  in	  the	  target	  sequence.	   As	   these	   variations	   had	   very	   similar	   melting	   temperatures,	  this	   led	   only	   to	   a	   widening	   of	   the	   melting	   curve	   for	   qPCR	   HRM	  additionally	  explaining	  why	  this	  assay	  did	  not	  comply	  with	  the	   in	  silico	  predictions.	   In	   the	   FO-­‐SPR	   HRM	   assay	   Au	   NP	   probe	   hybridization	  induced	   a	   larger	   ∆Tm	   with	   sufficient	   resolution	   for	   identifying	   SNP	  mismatches.
	  
Figure	  5.9:	  A)	  First	  derivative	  of	  the	  melting	  curve	  measured	  with	  qPCR	  HRM	  for	  a	  
selection	  of	  5	  clinical	   isolates.	  B)	  First	  derivative	  of	   the	  measured	  melting	  signal	  
with	  FO-­‐SPR	  HRM	  assay	  for	  a	  selection	  of	  5	  clinical	  isolates.	  
5.5 Conclusion	  In	   this	   paper	   we	   made	   a	   direct	   comparison	   between	   DNA	   high	  resolution	   melting	   assays	   and	   Sanger	   sequencing	   exposing	   thus	   the	  advantages	  and	  disadvantages	  of	  both	  technologies.	  Sanger	  sequencing	  proved	  not	  to	  be	  suited	  for	  fast	  screening	  of	  genomic	  regions,	  which	  are	  highly	   variable	   among	   different	   closely	   related	   bacteria.	   This	   can	   be	  explained	  with	   the	   use	   of	   this	   sequencing	  method	   post	   cloning,	  which	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can	   only	   reveal	   the	   sequence	   of	   one	   selected	   clone,	   while	   different	  subtypes	  of	  a	  particular	  sequence	  present	   in	  other	  non-­‐selected	  clones	  cannot	   be	   revealed.	   DNA	   melting	   on	   the	   other	   hand,	   can	   be	   applied	  directly	  after	  PCR	  without	  any	  purification	  or	  processing	  of	  the	  DNA	  and	  when	   different	   variations	   of	   the	   target	   sequence	   are	   present	   in	   the	  sample,	  not	  only	   the	  most	  abundant	   type	  will	  be	  detectable44.	  The	  PCR	  reaction	   that	  precedes	   the	  DNA	  melting	  holds	  valuable	   information	  on	  the	  priming	  region.	  However,	  some	  mutations	  in	  the	  priming	  region	  can	  have	  serious	  impact	  on	  the	  PCR	  reaction,	  as	  was	  the	  case	  for	  several	  L.	  
pneumophila	  serogroups,	  and	  can	  cause	  a	  complete	  PCR	  inhibition.	  	  Previously	   the	   merits	   of	   solution	   based	   DNA	   melting	   over	   solid	  phase	   DNA	   melting	   were	   summarized29,	   although	   never	   compared	  experimentally.	   In	   this	   paper,	   both	   techniques	  were	   applied	   to	   screen	  for	   mutations	   in	   L.	   pneumophila	   and	   proved	   to	   be	   very	   sensitive	   in	  detecting	   the	   mutations	   present	   in	   the	   dotA	   gene.	   However,	   the	  differences	  in	  Tm	  for	  FO-­‐SPR	  were	  more	  pronounced	  than	  was	  the	  case	  for	   qPCR	   HRM	   and	   thus	   resulted	   in	   more	   information	   on	   the	   target	  sequence.	   Although	   the	   actual	   resolution	   of	   sequencing	   is	   unmet,	   as	  sequencing	  delivers	  the	  exact	  base	  pairs,	  the	  FO-­‐SPR	  melting	  assay	  was	  able	   to	   detect	   low	   abundant	   variations	   in	   the	   priming	   sequence	   at	   a	  fraction	  of	   time	  and	  cost.	  Thus	   for	   the	  moment	  both	  platforms	  need	  to	  be	   applied	   as	   complementary	   technologies	   whereby	   DNA	   melting	  identifies	   the	   samples	   with	   mutations	   that	   need	   to	   be	   sequenced.	  However,	   with	   FO-­‐SPR	   already	   a	   considerable	   gain	   in	   resolution	   is	  achieved	   especially	   considering	   that	  mutations	   located	   in	   the	   priming	  region	   could	   not	   be	   detected	   with	   qPCR	   HRM	   or	   sequencing.	   On	   the	  other	   hand,	   FO-­‐SPR	  HRM	  detected	   consistently	   differences	   in	   Tm	   even	  with	   the	  mutations	   in	   the	   priming	   region.	   The	   gain	   in	   resolution	   was	  particularly	   pronounced	   for	   the	   analyzed	   clinical	   samples	   where	  multiple	   melting	   peaks	   were	   evident	   with	   FO-­‐SPR	   HRM	   while	   only	   a	  single	  melting	  signal	  was	  visible	  for	  qPCR	  HRM.	  These	  results	  are	  a	  clear	  testament	   for	   the	   advantages	   of	   the	   solid	   phase	   melting	   approach.	  However,	   the	   technique	   remains	   prone	   to	   a	   loss	   in	   resolution	   at	   the	  priming	   regions	   introduced	   by	   the	   PCR	   reaction.	   Therefore	   future	  research	  should	  be	  directed	  at	   increasing	   the	  sensitivity	  of	   the	  FO-­‐SPR	  assay,	  while	  maintaining	  the	  sensitivity	  towards	  mutations.	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In	   the	   following	   chapter,	   the	   sensitivity	   issue	   of	   FO-­‐SPR	   will	   be	  addressed	   by	   integrating	   different	   target	   amplification	   strategies.	   The	  amplification	   strategies	   will	   be	   chosen	   with	   a	   particular	   emphasis	   on	  mutation	  detection	  and	  their	  impact	  on	  the	  FO-­‐SPR	  melting	  assay	  will	  be	  evaluated	  in	  detail.	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Chapter	  6 	  	  
Real-­‐time	   FO-­‐SPR	   ligation	   assay	   for	   DNA	  
quantification	  and	  identification	  
6.1 Introduction	  Nowadays	  new	  point-­‐of-­‐care	  (POC)	  diagnostic	  tests	  in	  microbiology	  are	  expected	   to	   deliver	   fast	   and	   sensitive	   detection	   of	   micro-­‐organisms1.	  However,	   detection	   on	   its	   own	   is	   often	   not	   sufficient,	   as	   both	  quantification	   of	   the	   micro-­‐organisms	   and	   specific	   identification	   of	  particular	   mutations2,3	   has	   become	   essential	   for	   various	   applications.	  Therefore,	   many	   different	   assays,	   including	   quantitative	   PCR	   (qPCR)4	  and	   ligation	  assays5	  have	  been	  developed	   to	  meet	   these	   requirements.	  Already,	   qPCR	   has	   shown	   extensive	   utility,	   as	   it	   combines	   extreme	  sensitivity	  with	  real-­‐time	  detection	  and	  multiplexing	  capacity6.	  Despite	  this,	   several	   characteristics	   of	   this	   assay,	   among	   which	   a	   high	   cost,	  complexity	   of	   the	   assay	   and	   fluorescence	   used	   to	   monitor	   the	  amplification	  process	  in	  real-­‐time7,	  have	  limited	  its	  application	  towards	  POC	   diagnostics.	   Therefore,	   in	   the	   last	   decade,	   numerous	   efforts	   have	  been	   made	   to	   use	   nanoparticles	   (NPs),	   and	   in	   particular	   Au	   NPs,	   as	  transducers	   for	   detection	   of	   bacteria8,9.	   Au	   NPs	   combine	   colorimetric	  read-­‐out	  with	  high	  molecular	   stability	   and	   are	   therefore	   ideally	   suited	  for	   integration	   in	   POC	   sensors10.	   However,	   the	   sensitivity	   of	   Au	   NP	  assays	   remained	   for	   years	   inferior	   to	   qPCR,	   as	   the	   enzymatic	  amplification	  of	  DNA	  during	  PCR	  strongly	  boosts	  the	  detection	  limit.	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Recently,	   it	  was	  proven	   that	  Au	  NPs	   could	  be	   combined	  with	  DNA	  amplification	   through	   the	   ligation	  chain	  reaction	  (LCR)11,12.	   In	   the	  LCR,	  DNA	   is	   amplified	   exponentially,	   much	   in	   the	   same	   way	   as	   in	   the	   PCR	  reaction.	  However,	  a	  thermophilic	  ligation	  enzyme	  is	  used	  to	  covalently	  bind	   the	   phosphorylated	   5‘	   end	   of	   one	  DNA	   strand	  with	   the	   3’	   end	   of	  another	  strand,	   these	  hybridization	  probes,	  are	  only	   ligated	  when	  they	  are	  hybridized	  to	  a	  perfectly	  matching	  target	  sequence	  (Figure	  6.1,	  part	  B).	  In	  this	  way,	  multiple	  DNA	  probes	  can	  be	  linked	  together	  even	  when	  only	   one	   target	   strand	   is	   present,	   as	   the	   complex	   formed	   between	  ligated	   probes	   and	   target	   is	   denatured	   at	   a	   temperature	   above	   its	  melting	   temperature	   (Tm),	   liberating	   target	   strands	   for	   the	   multiple	  subsequent	   ligation	   cycles.	   The	   reaction	   results	   in	   an	   exponential	  amplification,	   as	   each	   ligated	   target	   will	   function	   as	   a	   template	   for	  ligation	   of	   reverse	   probes	   complementary	   to	   the	   original	   ligation	  probes.	   In	   this	   way,	   Shen	   et	   al.11	   linked	   together	   DNA	   probes	  immobilized	  on	  Au	  NPs	  only	  in	  the	  presence	  of	  the	  target	  sequence.	  As	  a	  result,	   an	   increasing	   amount	   of	   Au	   NPs	   irreversibly	   aggregated	   with	  increasing	   number	   of	   ligation	   cycles,	   causing	   a	   gradual	   shift	   in	   the	  absorbance	   of	   the	   Au	   NP	   solution	   due	   to	   LSPR	   adsorption	   band	  coupling.	   The	   assay	   could	   quantify	   the	   initial	   target	   concentration	   by	  determining	   the	   number	   of	   ligation	   cycles	   necessary	   to	   generate	   a	  colorimetric	  change	  in	  the	  Au	  NP	  solution.	  This	  colorimetric	  assay	  had	  a	  linear	  range	  spanning	  6	  orders	  of	  magnitude	  and	  a	  detection	  limit	  of	  50	  aM.	  	  In	   this	   chapter,	   the	   Au	   NP	   LCR	   reaction	   is	   further	   improved	   by	  replacing	   the	   colorimetric	   read-­‐out	   of	   the	   assay,	   which	   is	   limited	   in	  measurement	  speed	  and	  sensitivity,	  with	  SPR	  that	  directly	  measures	  Au	  NP	  binding	  and	  considerably	  increases	  assay	  sensitivity13.	  In	  this	  regard,	  we	  redesign	  the	  original	  assay	  by	  ligating	  probes	  in	  free	  solution	  instead	  of	   on	   Au	   NPs,	   which	   were	   then	   binding	   to	   complementary	   probes	  immobilized	  on	  both	  the	  Au	  NP	  surface	  and	  the	  FO-­‐SPR	  sensor	  surface	  (Figure	   6.1).	   Each	   cycle	   of	   the	   LCR	   reaction	   resulted	   in	   more	   ligated	  probes,	   allowing	  more	  Au	  NPs	   to	   bind	   to	   the	   FO-­‐SPR,	  which	   gradually	  increased	   the	   FO-­‐SPR	   signal	   from	   cycle	   to	   cycle.	   LCR	   products	   were	  quantified	   by	   counting	   the	   number	   of	   cycles	   necessary	   to	   reach	   the	  amplification	   threshold.	   Moreover,	   the	   Au	   NP-­‐ligated	   probe	   complex	  formed	   on	   the	   FO-­‐SPR	   surface	   was	   melted	   during	   each	   LCR	   cycle,	  allowing	  identification	  of	  the	  amplified	  strands	  during	  the	  LCR	  reaction.	  Hence,	   in	   this	   approach,	   Au	   NPs	   were	   used	   to	   their	   full	   potential	   as	  labels	   in	  melting	   analysis	   and	   identification	   of	   the	   amplified	   targets14,	  contrary	  to	  their	  utilization	  in	  the	  LCR	  Au	  NP	  assay	  as	  this	  assay	  is	  based	  on	  irreversible	  aggregation	  of	  NPs.	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6.2 Aim	  of	  this	  chapter	  In	   this	   chapter,	   the	   FO-­‐SPR	   melting	   assay,	   which	   was	   developed	   and	  benchmarked	  in	  the	  previous	  chapters,	  will	  be	  integrated	  with	  the	  LCR	  reaction.	   This	   will	   enable	   both	   quantification	   and	   cycle-­‐to-­‐cycle	  identification	   of	   the	   reaction	   products.	   It	   is	   important	   to	   notice	   that	  mutations	   in	   close	   vicinity	   of	   the	   ligation	   site	   will	   inhibit	   the	   ligation	  reaction,	  therefore	  every	  target	  containing	  mutations	  in	  the	  ligation	  site	  needs	   a	   new	   set	   of	   hybridization	   probes	   for	   successful	   amplification.	  The	  ligation	  reaction	  improves	  the	  detection	  limit	  of	  the	  FO-­‐SPR	  melting	  assay	   drastically	   improved	   while	   the	   main	   advantage	   of	   the	   FO-­‐SPR	  sensor,	   namely	   SNP	   detection,	   will	   be	   conserved.	   To	   this	   end,	   the	  performance	   of	   the	   FO-­‐SPR	   melt	   assay	   must	   be	   carefully	   evaluated,	  because	   higher	   DNA	  melting	   speeds	   are	   necessary	   to	   allow	   successful	  implementation	  of	  the	  LCR	  assay.	  Integration	  of	  DNA	  quantification	  is	  a	  significant	   step	   towards	   development	   of	   a	   FO-­‐SPR	   POC	   biosensor	   for	  detection	  of	  bacteria	  and	  viruses.	  	  
	  
Figure	   6.1:	   Schematic	   overview	  of	   the	   FO-­‐SPR	   LCR.	   	   A.)	  Different	   components	   of	  
the	   reaction.	   B.)	   LCR	   reaction	  where	   the	   forward	   (fw)	   and	   reverse	   (rev)	   probes	  
are	  ligated	  only	  in	  the	  presence	  of	  the	  target	  sequence,	  resulting	  in	  an	  exponential	  
amplification	   during	  multiple	   thermal	   cycles.	   C.)	   The	   forward	   LCR	   product	   can,	  
during	   the	   LCR	   reaction,	   form	   a	   complex	   with	   two	   complementary	   probes	  
immobilized	  on	  the	  FO-­‐SPR	  sensor	  and	  on	  Au	  NPs,	  allowing	  real-­‐time	  monitoring	  
of	  the	  reaction	  by	  means	  of	  its	  reaction	  products.	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6.3 Materials	  and	  methods	  
6.3.1 Reagents	  The	   chemically	   synthesized	   oligonucleotides	   were	   purchased	   from	  integrated	   DNA	   technologies	   (Haasrode,	   Belgium)	   an	   overview	   can	   be	  found	   in	   Table	   6.1.	   Both	   capture	   probes,	   used	   to	   capture	   the	   target	  sequence,	   are	   modified	   with	   a	   3’	   C3	   or	   5’	   C6	   thiol	   modifier	   (-­‐SH)	   for	  immobilization	  of	  the	  oligonucleotides	  on	  the	  on	  the	  FO-­‐SPR	  sensor	  and	  the	   Au	   NPs	   gold	   surfaces,	   respectively.	   All	   chemicals	   were	   purchased	  from	  Sigma-­‐Aldrich	  (Bornem,	  Belgium)	  unless	  stated	  otherwise.	  	  
Table	  6.1:	  Overview	  of	  used	  oligonucleotides	  	  
Targets	  (5’à3’)	  	  
Wildtype (WT) ATC	  CTT	  ATC	  AAT	  ATT	  TAA	  CAA	  TAA	  TCC	  CTC	  
Mismatch (MM) ATC	  CTT	  ATC	  AAT	  GTT	  TAA	  CAA	  TAA	  TCC	  CTC	  
Probes	  (5’à3’)	  
Ligation probe FW 1 
/5Phos/AAT	  ATT	  GAT	  AAG	  GAT	  
Ligation probe FW 2 GAG	  GGA	  TTA	  TTG	  TTA	  
Ligation probe Rev 1	  /5Phos/TAA	  CAA	  TAA	  TCC	  CTC	  
Ligation probe Rev 2 ATC	  CTT	  ATC	  AAT	  ATT	  
Ligation probe FW 2 Mismatch  /5Phos/AAC	  ATT	  GAT	  AAG	  GAT	  
Ligation probe Rev 1 Mismatch ATC	  CTT	  ATC	  AAT	  GTT	  
Probe FO-SPR TAA	  CAA	  TAA	  TCC	  CTC	  A20/3ThioMC3-­‐D/	   
Probe Au NP	  /5ThioMC6-­‐D/	  A20	  ATC	  CTT	  ATC	  AAT	  ATT	  	  	  Thiol-­‐functionalized	  DNA	  was	  immobilized	  on	  the	  Au	  NPs	  by	  adding	  1	   µM	   of	   5’	   thiol	   functionalized	  DNA	   oligo	   activated	  with	   dithiothreitol	  (DTT,	  0.1	  M	  in	  PB	  0.18	  mM,	  pH	  8.3)	  to	  break	  up	  thiol	  dimers	  that	  could	  inhibit	   the	   DNA	   functionalization.	   DNA	   was	   first	   purified	   using	   a	  sephadex	  column	  (GE,	  Oslo,	  Norway)	  to	  remove	  any	  traces	  of	  active	  DTT	  before	  it	  was	  added	  to	  the	  concentrated	  nanoparticle	  solution.	  A	  fast	  salt	  maturation	  protocol15	  was	  used	  to	  maximize	  the	  DNA	  loading	  on	  the	  Au	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NPs.	  Afterwards,	  Au	  NPs	  were	  washed	  three	  times	  in	  phosphate	  buffer	  with	  0.01	  %	  SDS	  and	  stored	  at	  4°C	  prior	  to	  use.	  
6.3.2 FO-­‐SPR	  sensor	  fabrication	  and	  Au	  NP	  functionalization	  The	   FO-­‐SPR	   device	   and	   sensors	   were	   manufactured	   as	   described	   in	  Chapter	   4	   Sections	   3.3.3	   and	   3.3.4.	   Citrate	   stabilized	   Au	   NPs,	   with	   a	  mean	   diameter	   of	   20	   nm,	   were	   purchased	   from	   BBI	   international	  (Cardiff,	   United	   Kingdom)	   and	   functionalized	   using	   the	   protocol	  described	  in	  Chapter	  4	  Section	  4.3.3.	  
6.3.3 Gold	  surface	  backfilling	  Both	  the	  FO-­‐SPR	  sensor	  and	  Au	  NPs	  were	  backfilled,	  prior	  to	  use	  in	  the	  LCR	   assay.	   Backfilling	   is	   a	   process	   used	   to	   fill	   in	   ‘empty	   spots’	   in	  between	  DNA	  molecules	  immobilized	  on	  a	  surface,	  which	  is	  often	  done	  using	   alkane	   thiols	  with	   a	   PEG	  moiety16	   (a	   detailed	   description	   of	   the	  backfilling	   concept	   can	   be	   found	   in	   chapter	   1	   section	   1.6).	   Here,	  backfilling	   is	  performed	   in	  order	   to	  make	   the	  DNA	   functionalized	  gold	  surfaces	   more	   stable	   at	   elevated	   temperatures17	   as	   well	   as	   protein	  repellant18,	  preventing	  enzyme	  inhibition	  during	  the	  LCR	  reaction.	  Both	  FO-­‐SPR	  sensors	  and	  Au	  NPs	  were	  incubated	  for	  3	  h	  with	  a	  50	  µM	  alkane	  thiol	   PEG	   (Polypure,	   Oslo,	   Norway)	   dissolved	   in	   pure	   ethanol.	  Afterwards,	  the	  FO-­‐SPR	  sensor	  surface	  and	  Au	  NPs	  were	  washed	  3	  times	  with	  a	  0.01	  %	  SDS	  phosphate	  buffer.	  
6.3.4 Ligation	  chain	  reaction	  The	  LCR	  was	  performed	  to	  link	  the	  5’	  phosphate-­‐functionalized	  probe	  2	  to	   the	   3’	   end	   of	   probe	   1.	   A	   thermophilic	   ligation	   enzyme	   (9°N™	   DNA	  Ligase,	   New	   England	   Bioscience,	   Ipswich,	   USA)	   was	   used	   as	   it	   can	  withstand	   thermocycling	   of	   the	   reaction	   solution	   between	   different	  temperatures:	  the	  probe	  hybridization	  temperature	  (2	  min	  at	  35	  °C),	  the	  optimal	   ligation	   temperature	   (2	   min	   at	   42.5	   °C)	   and	   the	   denaturing	  temperature	  of	  the	  ligation	  product	  (5	  s	  at	  70	  °C).	  The	  thermal	  ramping	  speed	   had	   to	   be	   lowered	   compared	   to	   5	   °C/s	   standardly	   used	   in	   LCR	  assays	  to	  allow	  a	  good	  FO-­‐SPR	  signal	  acquisition	  during	  DNA	  melting.	  It	  was	   optimized	   for	   achieving	   reasonable	   speed	   and	   thus	   safeguarding	  the	  total	  assay	  timev(1	  °C/s,	  0.5	  °C/s	  and	  0.1	  °C/s).	  Another	  parameter	  that	  was	   optimized	  was	   the	   ligation	   buffer,	  which	   standardly	   contains	  DTT,	  known	  to	  reduce	   thiol	  bonds19.	  Therefore,	   three	  DTT	   free	  buffers	  with	   different	   ionic	   contents	   were	   evaluated	   for	   their	   performance	  during	  the	  LCR	  reaction	  (Table	  6.2).	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Table	   6.2:	   Composition	   of	   ligation	   buffers	   (10x	   concentrated)	   used	   to	   evaluate	  
optimal	  LCR	  conditions;	  all	  buffers	  were	  adjusted	  to	  pH	  7.5	  using	  HCl.	  
	   Standard	  buffer	   Buffer	  1	   Buffer	  2	   Buffer	  3	  Tris-­‐Hcl	   100	  mM	   100	  mM	   100	  mM	   100	  mM	  ATP	   6	  mM	   6	  mM	   6	  mM	   6	  mM	  MgCl2	   25	  mM	   25	  mM	   50	  mM	   25	  mM	  NaCl	   0	   0	   0	   600	  mM	  Triton	  X-­‐100	   1	  %	   1	  %	   1	  %	   1	  %	  DTT	   25	  mM	   0	   0	   0	  	  The	   final	   ligation	   reaction	   mixture	   used	   for	   the	   FO-­‐SPR	   LCR	  calibration	  curves	  and	  sample	  analysis	  consisted	  of	  10	  µL	   ligase	  buffer	  (10x	  concentrated),	  10	  µL	  of	  9°N	  enzyme	  (10	  u/µL),	  2.5	  µL	  Fw	  ligation	  probes	  (10	  µM,	  for	  each	  target	  sequence),	  2.5	  µL	  Rev	  ligation	  probes	  (1	  µM,	   for	   each	   target	   sequence),	   50	   µL	   Au	   NPs	   (0.5	   nmol/L	   in	   distilled	  nuclease	  free	  H2O),	  10	  µL	  target	  DNA,	  15	  µL	  distilled	  nuclease	  free	  H2O	  making	   a	   total	   reaction	   volume	   of	   100µL.	   After	   adding	   all	   these	  components	   the	   LCR	   reaction	   mixture	   was	   mixed	   very	   carefully	   and	  covered	   with	   60	   µL	  mineral	   oil	   (Immobiline	   DryStrip	   Cover	   Fluid,	   GE	  healthcare,	   Diegem,	   Belgium)	   to	   prevent	   evaporation	   during	  thermocycling.	  	  
6.3.5 Data	  processing	  Data	   acquisition	   on	   the	   two	   spectrometers	   and	   NiDaq	   coupled	  thermocouples	   was	   done	   with	   the	   in-­‐house	   developed	   LabView	  program	  (National	   Instruments,	  Austin,	  Texas)	  as	  described	  in	  Chapter	  5	   Section	   5.3.9.	   Once	   the	   SPR	   data	   and	   thermocouple	   data	   were	  combined,	  a	  first	  order	  derivative	  was	  made	  for	  each	  LCR	  melting	  cycle.	  The	  resulting	  melting	  peak	  was	  fitted	  using	  a	  Gaussian	  fit	  in	  Matlab	  (the	  mathworks,	   Natick,	   USA)	   to	   determine	   the	   melting	   temperature	   (Tm)	  and	  evaluate	  the	  melting	  peak	  quality	  for	  each	  LCR	  cycle.	  
6.4 Results	  
6.4.1 LCR	  buffer	  optimization	  The	  first	  step	  in	  the	  implementation	  of	  the	  LCR	  reaction	  on	  the	  FO-­‐SPR	  platform	  was	   selection	   of	   the	   buffer	   compatible	  with	   both	   the	   FO-­‐SPR	  melting	   assay	   and	   the	   LCR	   reaction.	   The	   standard	   ligation	   buffer	  supplied	   by	   the	   manufacturer	   of	   the	   ligation	   enzyme	   9°N	   was	   not	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compatible	   with	   FO-­‐SPR	   assay	   due	   to	   the	   presence	   of	   DTT,	   which	  reduces	   thiol	   bonds	   essential	   for	   immobilization	   of	  DNA	  molecules	   on	  gold	   surfaces.	   Furthermore,	   a	   buffer	   with	   certain	   ionic	   strength	   was	  needed	   to	   stabilize	   the	  Au	  NPs	  and	   to	   speed	  up	   their	  hybridization	  on	  the	  FO-­‐SPR	  surface	  during	   the	  LCR	  reaction.	  Therefore,	   three	  different	  compositions	  of	  the	  standard	  ligation	  buffer	  (Table	  6.2)	  were	  evaluated	  for	  their	  performance	  both	  in	  the	  LCR	  reaction	  (Figure	  6.2,	  part	  A)	  and	  the	  FO-­‐SPR	  melting	  assay	  (Figure	  6.3).	  The	  ligation	  yield	  was	  measured	  using	   qPCR	   High	   Resolution	   Melting	   (HRM)	   analysis	   on	   a	   ligated	  product.	   Here,	   the	   size	   of	   the	   melting	   signal	   was	   indicative	   for	   the	  ligation	   reaction	  yield.	  The	   results	   suggested	   that	  next	   to	   the	   standard	  buffer,	  using	  buffer	  1	  resulted	  also	   in	   the	  highest	   ligation	  yield	  (visible	  from	   the	   height	   of	   the	   melting	   peak),	   confirming	   that	   DTT	   is	   not	   a	  necessary	  component	  for	  the	  LCR	  enzyme.	  On	  the	  other	  hand,	  doubling	  the	   amount	   of	  MgCl2	   in	   buffer	   2	   drastically	   lowered	   the	   ligation	   yield,	  while	  the	  yield	  of	  LCR	  in	  buffer	  3	  was	  only	  a	  fraction	  lower	  than	  in	  the	  standard	   buffer.	   Because	   buffer	   3	   contains	   the	   same	   components	   as	  standard	  buffer,	  except	  for	  60	  mM	  NaCl,	  these	  results	  clearly	  suggested	  that	  monovalent	   salts	  have	  a	   less	  drastic	   effect	  on	   the	   ligation	  yield	   in	  comparison	  with	  the	  divalent	  MgCl2.	  Based	  on	  these	  results,	  buffer	  2	  was	  already	   excluded	   from	   further	   tests	   for	   selecting	   a	   buffer	   compatible	  with	  both	  assays.	  It	  should	  also	  be	  mentioned	  that	  buffer	  1	  and	  buffer	  2	  have	  a	  small	  shift	  in	  Tm	  in	  comparison	  with	  the	  standard	  buffer	  provided	  by	  the	  manufacturer	  of	  the	  ligation	  enzyme	  (NEB).	  This	  is	  probably	  the	  result	   in	   a	   slight	   deviation	  of	   one	  of	   the	   components	   in	   the	   respective	  buffers	  (ionic	  strength,	  surfactant).	  
	  
Figure	  6.2:	  A)	  qPCR	  HRM	  following	  the	  ligation	  reaction	  under	  different	  buffering	  
conditions.	   B)	   UV-­‐Vis	   derived	  maximal	   absorbance	   of	   Au	   NPs	   with	   and	  without	  
backfilling	  (BF)	  after	  35	  ligation	  cycles	  under	  different	  buffering	  conditions.	  The	  
reference	  Au	  NPs	  did	  not	  undergo	  the	  ligation	  reaction.	  	  Next,	   the	   stability	   of	   Au	   NPs	   coated	   with	   DNA	   was	   tested	   in	   the	  three	  remaining	  buffers,	   i.e.	   standard	  buffer,	  buffer	  1	  and	  buffer	  3.	  For	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this	  purpose,	  Au	  NPs,	  prepared	  both	  with	  and	  without	  backfilling,	  were	  compared	  in	  LCR,	  as	  it	   is	  known	  that	  backfilled	  Au	  NPs	  should	  have	  an	  increased	   stability	   and	   performance	   in	   hybridization	   assays17.	   When	  unstable,	   Au	   NPs	   aggregate,	   which	   leads	   to	   coupling	   of	   the	   LSPR	  adsorption	  band	  of	  the	  individual	  NPs,	  resulting	  in	  a	  color	  change	  of	  the	  Au	  NP	  solution.	  Au	  NP	  aggregation	  could	  by	  no	  means	  be	   the	  result	  of	  ligation	  as	  they	  only	  contain	  a	  single	  probe	  complementary	  to	  the	  target	  sequence.	   Therefore,	   the	   stability	   of	   Au	   NPs	   can	   be	   evaluated	   by	  measuring	  the	  optical	  density	  of	  the	  solution	  at	  the	  λ	  max of	  the	  Au	  NP	  LSPR.	   As	   seen	   part	   B	   of	   Figure	   6.2,	   the	   increase	   in	   absorbance	   clearly	  shows	  that	  backfilled	  particles	  perform	  better	  in	  all	  buffers,	  even	  when	  DTT	  is	  present,	  such	  as	  in	  the	  standard	  buffer.	  The	  best	  Au	  NP	  stability	  was	   observed	   in	   buffer	   3,	   therefore	   in	   a	   final	   test,	   buffer	   1	   was	  compared	   with	   buffer	   3	   to	   evaluate	   the	   performance	   of	   the	   FO-­‐SPR	  melting	  assay	  in	  these	  buffers.	  Figure	  6.3	  summarizes	  results	  of	  the	  FO-­‐SPR	   melting	   assay	   as	   described	   in	   Chapter	   4	   for	   the	   30bp	   target	  sequence	   in	   the	   two	   selected	   buffers.	   Here	   buffer	   3,	   which	   already	  proved	  to	  result	  in	  the	  highest	  Au	  NP	  stability,	  was	  also	  the	  most	  suited	  buffer	  for	  the	  FO-­‐SPR	  melting	  assay,	  as	  it	  resulted	  in	  the	  highest	  melting	  signal.	  
	  
Figure	  6.3:	  FO-­‐SPR	  melting	  analysis	  of	  BF	  Au	  NPs	  in	  two	  different	  buffers.	  
6.4.2 DNA	  Melting	  optimization	  In	   Chapters	   4	   and	   5,	   DNA	   melting	   analysis	   was	   performed	   at	   a	  temperature	   ramping	   speed	   of	   0.1	   °C/s.	   However,	   this	   ramping	   speed	  considerably	  slows	  down	  the	  LCR	  reaction	  and	  increases	  the	  total	  assay	  time.	  Therefore,	  we	  evaluated	  if	  higher	  ramping	  speeds	  of	  0.5	  °C/s	  and	  1	  °C/s	  could	  result	  in	  the	  same	  melting	  resolution.	  To	  test	  this,	  a	  melting	  analysis	  was	  performed	  using	  the	  same	  targets	  as	  described	  in	  Chapter	  4.	  Results	  are	  shown	  in	  part	  A	  of	  Figure	  6.4.	  As	  can	  be	  expected,	  the	  best	  melting	  signal	  was	  obtained	  at	  the	  slowest	  ramping	  speed	  with	  almost	  2	  fold	  and	  3	  fold	  decrease	  in	  signal	  at	  0.5	  °C/s	  and	  1	  °C/s	  ramping	  speeds,	  respectively.	   Moreover,	   at	   the	   slowest	   cycling	   speed,	   the	   inter	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measurement	   variability	   was	   the	   lowest	   (standard	   deviation	   obtained	  on	  the	  mean	  Tm	  is	  0.01	  °C	  for	  n=4),	  while	  with	  increasing	  ramping	  speed	  this	  variability	  increased	  to	  0.1	  °C	  and	  0.16	  °C	  for	  0.5	  °C/s	  and	  1.0	  °C/s	  ramping	  speeds,	   respectively.	  Furthermore,	  at	  1.0	   °C/s	  ramping	  speed,	  the	  melting	  temperature	  also	  shifted	  to	  a	  higher	  value	  (from	  56.8	  °C	  at	  0.5	  and	  0.1	  °C/s	  to	  59.5	  °C	  at	  1.0°C/s)	  and	  the	  width	  of	  the	  fitted	  peak	  of	  the	   melting	   signal	   considerably	   increased	   (from	   2.5	   °C	   at	   0.5	   and	   0.1	  °C/s	  to	  4.2°C	  at	  1.0	  °C/s),	  which	  could	  potentially	   lower	  the	  sensitivity	  of	  the	  FO-­‐SPR	  melting	  assay	  and	  compromise	  SNP	  detection.	  To	  evaluate	  this,	   30bp	   target	   sequences	   carrying	   two	   SNPs	   at	   different	   positions	  were	   compared	   to	   the	   wild	   type	   (WT)	   target	   of	   the	   same	   size	   as	  previously	   described	   (Chapter	   4,	   Table	   4.1).	   The	   acquired	   melting	  signal,	  visualized	  in	  part	  B	  of	  Figure	  6.4,	  confirmed	  that	  even	  at	  a	  10	  fold	  increased	   ramping	   speed,	   all	   mutations	   could	   clearly	   be	   resolved,	  justifying	  the	  choice	  for	  1.0	  °C/s	  ramping	  speed	  in	  further	  experiments.	  For	   each	   FO-­‐SPR	  melting	   experiment,	   35	   consecutive	   repetitions	  were	  performed	   on	   the	   same	   FO-­‐SPR	   sensor,	   to	   evaluate	   assay	   variability.	  Each	   cycle	   consisted	   of	   two	   steps,	   a	   first	   step	   where	   the	   target	   was	  allowed	  to	  bind	  for	  10	  min.	   followed	  by	  a	  melting	  step,	  this	  resulted	  in	  35	  individual	  melt	  peaks	  that	  had	  very	  low	  variability	  confirming	  a	  good	  assay	  performance	  (Figure	  6.4,	  part	  B).	  	  
	  
Figure	  6.4:	  A)	  Performance	  of	  the	  FO-­‐SPR	  melting	  assay	  at	  different	  temperature	  
ramping	  speeds.	  B)	  FO-­‐SPR	  melting	  analysis	  in	  the	  LCR	  optimal	  buffer	  3	  of	  the	  wild	  
type	  (WT)	  target	  in	  comparison	  with	  two	  targets	  containing	  a	  mutation	  at	  the	  5’	  or	  
3’	   end	  of	   the	   target.	   The	   graph	   represents	   an	   overlay	   of	   35	   consecutive	  melting	  
cycles,	   proving	   the	   low	   variation	   between	   assays	   even	   after	   extensive	  
thermocycling.	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Figure	   6.5:	   Overview	   of	   typical	   FO-­‐SPR	   LCR	  measurements	   and	   data	   processing	  
performed	  on	   the	  WT	   target	  DNA.	  A)	  The	   flow	  diagram	  shows	   the	   raw	   signal	   as	  
measured	   with	   the	   FO-­‐SPR	   device.	   B)	   This	   diagram	   is	   further	   cut	   in	   individual	  
reaction	  cycles.	  Therefore,	   the	   acquired	   melting	   signal	   in	   the	   melting	   phase	   is	  uniquely	  attributable	  to	  the	  acquired	  LCR	  products	  and	  can	  thus	  be	  used	  to	  both	  identify	  and	  quantify	  the	  LCR	  product	  (Figure	  6.6).	  Importantly,	  Au	  NP	  and	  FO-­‐SPR	  probes	  cannot	  be	  ligated	  because	  they	  do	  not	  have	  a	  phosphate	  group	  necessary	  for	  the	  formation	  of	  a	  phosphodiester	  bond	  between	  the	  3’	  hydroxyl	  group	  of	  probe	  1	  and	  the	  5’	  phosphate	  group	  of	  probe	  2.	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Figure	  6.6:	  The	  melting	  signal	  of	  each	  cycle	  is	  obtained	  by	  plotting	  the	  derivative	  
of	   the	   FO-­‐SPR	   signal	   and	   thermocouple	   signal	   during	   the	   melting	   phase	   as	   a	  
function	  of	  temperature.	  
6.4.4 Quantification	  of	  DNA	  targets	  using	  FO-­‐SPR	  LCR	  assay	  Next,	   the	   FO-­‐SPR	   LCR	   assay	   was	   used	   to	   determine	   the	   target	  concentration	   by	   examining	   the	   number	   of	   LCR	   cycles	   necessary	   to	  obtain	   a	   FO-­‐SPR	   melting	   point	   of	   the	   corresponding	   DNA	   target.	   In	  	  Figure	   6.7	   (part	   A),	   the	   concept	   is	   shown	   for	   a	   WT	   DNA	   target	  concentration	   of	   100	   fM.	   Out	   of	   40	   LCR	   cycles	   performed,	   no	   clear	  melting	  point	  was	  observed	   for	   this	   target	   in	   the	   first	  27	  cycles.	   In	   the	  subsequent	   cycles,	   a	  melting	  point	   appeared	   first	   at	  51	   °C	   followed	  by	  gradual	  increase	  towards	  52.3	  °C.	  This	  shift	  in	  Tm	  is	  expected	  and	  can	  be	  attributed	   to	   the	   dependence	   of	   Tm	   on	   the	   increasing	   target	  concentration	  through	  LCR	  cycles20.	  In	  comparison	  with	  the	  Tm	  obtained	  during	   the	   DNA	   melting	   optimization	   experiments	   described	   in	  paragraph	  6.4.2,	  the	  Tm	  has	  shifted	  almost	  7	  °C,	  this	  is	  both	  a	  result	  from	  shorter	   hybridization	   times	   in	   the	   actual	   LCR	   assay	   and	   slight	  differences	  in	  ionic	  makeup	  of	  the	  reaction	  mixture	  in	  comparison	  with	  the	  pure	  buffer	  used	  during	  the	  optimization	  experiments.	  	  Similar	  FO-­‐SPR	  LCR	  reactions	  were	   then	  performed	   for	  7	  different	  target	  concentrations	  (100	  nM,	  10	  nM,	  1	  nM,	  100	  pM,	  10	  pM,	  1	  pM	  and	  100	   fM)	   including	  a	  negative	   control	  without	  DNA	   target	   (no	   template	  control,	  NTC).	  For	  each	  concentration,	  the	  height	  of	  melting	  peaks	  were	  derived	   from	   all	   40	   LCR	   cycles	   and	   normalized	   to	   1.	   These	   values,	  represented	   in	   Figure	   6.7,	   part	   B	   as	   a	   function	   of	   the	   total	   number	   of	  reaction	  cycles,	  pointed	  out	   that	  an	   increasing	  number	  of	  LCR	  reaction	  cycles	   is	   necessary	   for	   lower	   target	   concentrations.	   At	   approximately	  the	  35th	  cycle,	  a	  positive	  melting	  signal	  became	  evident	  also	  for	  the	  NTC,	  suggesting	   either	   contamination	   of	   the	   reaction	   mixture	   with	   target	  DNA	  or	  the	  occurrence	  of	  non-­‐specific	  amplification	  in	  the	  LCR	  assay	  at	  these	   later	   cycles.	   Next	   the	   cycle	   threshold	   was	   chosen	   -­‐this	   is	   the	  
Results	  
163	  
minimal	   SPR	   shift	   above	   baseline-­‐	   that	   is	   indicative	   of	   successful	   LCR	  amplification.	  By	  using	  a	  cycle	   threshold	  of	  0.25	  (horizontal	  red	   line	   in	  part	   B	   of	   Figure	   6.7),	   Ct	   values	   for	   each	   target	   concentration	   were	  derived	   and	   plotted	   as	   a	   function	   of	   the	   concentration,	   resulting	   in	   a	  calibration	   curve	   for	   the	   FO-­‐SPR	   LCR	   assay	   (Figure	   6.7,	   part	   C).	   The	  assay	  had	  a	  linear	  range	  spanning	  7	  orders	  of	  magnitude,	  which	  is	  only	  1	   order	   less	   than	   a	   conventional	   qPCR	   assay.	   The	   lowest	   detectable	  concentration	   was	   100	   fM,	   at	   lower	   concentrations,	   the	   Ct	   was	  indistinguishable	   from	   the	  Non	   template	   control	   signal.	   Thus,	   the	   LCR	  reaction	   improved	   the	   detection	   limit	   with	   4	   orders	   of	   magnitude	   in	  comparison	  with	  results	  from	  previous	  chapters	  on	  the	  FO-­‐SPR	  melting	  assay	   (e.g.	   Chapter	   4).	   Although	   still	   far	   from	   the	   detection	   limit	   of	  qPCR21,	   a	   considerable	   improvement	   in	  detection	   limit	   is	   possible.	   For	  instance,	   the	   ligation	   was	   not	   performed	   at	   the	   optimal	   ligation	  temperature	  of	  the	  enzyme	  (45-­‐90°C)	  because	  of	  the	  low	  hybridization	  temperature	  (35	  °C),	  resulting	  in	  less	  than	  optimal	  assay22.	  Better	  probe	  design	   and	   selection	   of	   targets	   would	   allow	   the	   LCR	   assay	   to	   be	  performed	   at	   higher	   hybridization	   temperatures,	   which	   can	   improve	  ligase	   performance	   and	   eliminate	   non-­‐specific	   binding,	   thus	   further	  decreasing	  the	  detection	  limit.	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Figure	   6.7:	   A)	   FO-­‐SPR	   LCR	   reaction	   results	   for	   one	   concentration	   of	   target	   DNA	  
(100	  fM).	  The	  results	  are	  an	  overlay	  of	  the	  derived	  melting	  signal	  obtained	  from	  
40	   thermal	   cycles.	   Starting	   from	   cycle	   27	   the	   melting	   peak	   height	   gradually	  
increases.	   B)	   The	   increase	   in	   melting	   peak	   signal	   for	   different	   target	  
concentrations	  (100	  nm,	  10	  nm,	  1	  nm,	  100	  pM,	  10	  pM,	  1	  pM,	  100	  fM	  and	  NTC,	  each	  
with	   a	   repetition)	   is	   represented	   as	   sigmoidal	   second	   order	   fit	   of	   the	  
corresponding	   points.	   The	   red	   horizontal	   line	   indicates	   the	   cycle	   threshold	   (Ct)	  
used	   to	  derive	  a	  calibration	  curve.	  C)	  The	  derived	  calibration	  curve	  of	  Ct	  values,	  
with	  a	  linear	  range	  spanning	  7	  orders	  of	  magnitude	  for	  DNA	  concentrations.	  Red	  
line	   is	   a	   logarithmic	   fit	   of	   the	   Ct	   values	   for	   each	   measured	   concentration	  
(R2=0.99).	  Variability	  is	  expressed	  as	  standard	  deviation	  (n=2).	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6.4.5 Target	  identification	  using	  FO-­‐SPR	  LCR	  assay	  A	  final	  experiment	  was	  done	  to	  evaluate	  the	  performance	  of	  the	  FO-­‐SPR	  LCR	   reaction	   for	   SNP	   detection.	   In	   order	   to	   detect	   a	   SNP	   within	   the	  target	  DNA	  strand	  using	  LCR	  assay,	   two	  new	  ligation	  probes,	  matching	  the	   SNP	   in	   the	   target,	   needed	   to	   be	   introduced	   in	   the	   assay.	   This	  adjustment	   was	   necessary	   to	   fulfill	   the	   requirement	   of	   the	   ligation	  enzyme	   for	   perfect	   sequence	   complementarity	   between	   target	   strand	  and	   two	   ligation	   probes.	   The	   FO-­‐SPR	   assay	   allows	   to	   discriminate	   the	  different	   LCR	   products	   because	   even	   a	   single	   base	   pair	   mismatch	  between	   the	   sensor	   immobilized	   hybridization	   probes	   and	   the	   ligated	  probes,	  will	  shift	  the	  Tm	  to	  lower	  temperatures.	  Furthermore,	  mutations	  in	  the	  target	  sequence	  that	  will	  not	  affect	  the	  ligation	  reaction	  can	  also	  be	   discriminated	   with	   the	   FO-­‐SPR	   assay.	   This	   means	   that	   not	   all	  mutations	   in	   the	   target	   sequence	   have	   to	   be	   known.	   The	   two	   LCR	  reactions	   performed	   both	   for	  WT	   and	   the	   MM	   target	   were	   compared	  with	  a	  melting	  analysis	  of	   the	  same	  targets	  (as	  described	  previously	   in	  Chapter	   4).	   Although	   the	   MM	   target	   clearly	   had	   a	   lower	   Tm	   value	  compared	  to	  the	  WT,	  as	  expected,	  it	  surprisingly	  showed	  better	  yield	  of	  the	  LCR	  reaction	   (Figure	  6.8).	  This	   can	  be	  explained	  by	  a	  difference	   in	  hybridization	   yield.	   The	   MM	   ligation	   probes	   are	   hybridized	   at	   a	  temperature	   further	   below	   the	   melting	   point	   of	   probes	   and	   targets,	  which	   is	   known	   to	   give	   a	   good	   hybridization	   yield23.	   As	   for	   the	   WT	  ligation	   probes,	   the	   hybridization	   temperature	   is	   less	   optimal,	  explaining	  why	  there	  is	  a	  difference	  in	  ligation	  yield.	  Importantly,	  the	  Tm	  measured	   during	   the	   LCR	   reaction	   allowed	   discrimination	   of	   the	   SNP	  bearing	   target	   from	   the	   WT	   target.	   In	   comparison	   with	   the	   melting	  analysis	   performed	   at	   a	   lower	   ramping	   speed,	   the	   melting	   signal	  obtained	   from	   the	   LCR	   assay	   was	   considerably	   lower	   with	   wider	  melting	   peaks.	   However,	   the	   resolution	   of	   the	   fast	  melting	   cycles	  was	  better	   with	   a	   ∆Tm	  between	   WT	   and	   MM	   target	   of	   4.3°C	   compared	   to	  3.8°C	  in	  the	  slow	  melting	  analysis.	  Similar	  trends	  in	  Tm	  were	  also	  visible	  during	  the	  optimization	  experiments	  for	  thermal	  ramping	  speed.	  It	  can	  be	  speculated	  that	  the	  increased	  ramping	  speed	  results	  in	  the	  formation	  of	   less	  bonds	  between	  the	  Au	  NPs	  and	  the	  FO-­‐SPR	  surface	  through	  the	  target	  DNA,	  which	  broadens	  the	  melting	  transition14.	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Figure	   6.8:	   Obtained	   signals	   for	   the	   FO-­‐SPR	   LCR	   assay	   using	  WT	   and	  MM	   target	  
DNA	  	  (target	  [C]=	  10nM).	  The	  mutant	  clearly	  has	  a	  higher	  yield	  but	  a	  lower	  melting	  
point.
6.5 Conclusion	  Integration	   of	   LCR	   with	   the	   FO-­‐SPR	   melting	   assay	   considerably	  increased	   the	   value	   of	   both	   assays.	   The	   combined	   assay	   allowed	  quantifying	   and	   identifying	   DNA	   targets	   over	   a	   wide	   concentration	  range.	   Moreover,	   the	   assay	   could	   discriminate	   SNPs	   without	   any	   post	  reaction	   analysis.	   The	   integration	   of	   the	   two	   assays	   required	   initial	  optimization,	   especially	   buffer	   ionic	   strength	   and	   thermal	   ramping	  speed	   as	   these	   parameters	   both	   influence	   the	   ligation	   enzyme	  performance	   and	   the	  hybridization	   yield	  of	   the	  Au	  NPs	  on	   the	  FO-­‐SPR	  sensor.	  Here,	  the	  higher	  temperature	  ramping	  speeds	  were	  selected	  for	  at	   the	   cost	   of	   melting	   resolution	   as	   the	   assay	   speed	   is	   an	   important	  factor	  for	   its	   future	  applications.	  Nonetheless,	  even	  at	  a	  ramping	  speed	  10	   times	   higher	   than	   classic	   FO-­‐SPR	   DNA	   melting	   assays,	   the	  discrimination	   of	   SNP	   bearing	   targets	   was	   still	   feasible	   with	   high	  precision.	  The	  FO-­‐SPR	  LCR	  assay	  had	  a	  LOD	  of	  100	  fM,	  which	  is	  only	  1	  order	   of	  magnitude	   higher	   than	  PCR.	   Better	   ligation	   probe	   design	   and	  selection	   of	   optimal	   ligation	   conditions	   could	   decrease	   the	   LOD	   even	  further	   to	   a	   similar	   level	   as	   PCR.	   Finally,	   in	   comparison	   with	   earlier	  described	   LCR	   assays,	   the	   FO-­‐SPR	   implementation	   offered	   the	  advantage	  of	  cycle-­‐to-­‐cycle	  information	  on	  the	  amplified	  target	  strands,	  eliminating	  any	  time-­‐consuming	  post	  reaction	  analysis	  steps.	  Therefore,	  the	  FO-­‐SPR	  LCR	  assay	  represents	  a	  great	  improvement	  in	  development	  of	  fast	  POC	  assays.	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Chapter	  7 	  	  
Real-­‐time	   FO-­‐SPR	   PCR	   monitoring	   for	   multiplex	  
DNA	  identification	  
7.1 Introduction	  In	  the	  previous	  chapters,	   the	  FO-­‐SPR	  assay	  was	  applied	  to	   identify	  and	  quantify	   single	   DNA	   target	   with	   high	   precision.	   However,	   current	  microbiological	   diagnostics	   have	   a	   need	   for	   microbiological	   tests	  capable	   of	   identifying	   the	   presence	   of	   multiple	   pathogens	   with	   even	  discriminating	  their	  particular	  phenotypes1.	  Although	  PCR	  is	  capable	  of	  multiplexing,	  the	  current	  generation	  of	  quantitative	  PCR	  (qPCR)	  devices	  is	  somewhat	  limited	  for	  diagnostic	  applications	  as	  the	  transducer,	  being	  fluorescence,	  makes	   them	  bulky,	  complex	  and	  expensive.	  Furthermore,	  the	  maximal	   number	   of	   dyes	   that	   can	   be	   used	   in	   one	   PCR	   reaction	   is	  limited	  because	  of	  spectral	  overlap	  between	  their	  emission	  spectra2.	  As	  a	   result,	   most	   qPCR	   assays	   detect	   simultaneously	   only	   2-­‐3	   targets,	  although	  conventional	  PCR	  could	  support	  many	  more	  targets3.	  Recently	  this	  was	  proven	  by	  using	  the	  characteristic	  melting	  temperature	  (Tm)	  of	  PCR	   amplicons	   as	   a	   secondary	   label	   in	   qPCR	   allowing	   identification	   of	  50	  different	  DNA	  sequences	  in	  one	  sample4.	  	  
Chapter	  7:	  Multiplex	  DNA	  quantification	  and	  identification	  
170	  
Multiplex	  DNA	  detection	   by	   analyzing	   the	  Tm	   of	   the	   amplicons	   has	  already	  been	  applied	  multiple	  times	  in	  PCR	  assays5.	  Because	  the	  melting	  analysis	   is	   always	   applied	   post	   PCR,	   it	   does	   not	   allow	   monitoring	  specific	  targets	  during	  the	  PCR	  reaction	  and	  as	  a	  result	  cannot	  be	  used	  to	  quantitate	  DNA,	  but	   solely	   for	   identifying	   the	  presence	  of	  particular	  DNA	  targets.	  These	   limitations	  of	  DNA	  melting	  make	   the	   technology	   in	  practice	   only	   useful	   as	   a	   screening	   tool	   for	   the	   presence	   of	  mutations.	  However,	  the	  newly	  acquired	  resolution	  would	  also	  make	  Tm	  a	  good	  tool	  for	   multiplex	   quantification,	   surpassing	   thus	   the	   limitations	   of	  fluorescent	  dyes.	  	  
7.2 Aim	  of	  this	  chapter	  The	   aim	   of	   this	   chapter	   is	   to	   study	   the	   potential	   of	   the	   FO-­‐SPR	  technology	  for	  multiplex	  DNA	  identification.	  The	  FO-­‐SPR	  melting	  assay,	  as	   described	   in	   the	   previous	   chapters,	   is	   used	   to	   monitor	   PCR	   based	  DNA	   amplification.	   Previously	   the	   FO-­‐SPR	   was	   already	   applied	   for	  monitoring	   solid-­‐phase	   PCR	   reactions6,	   however	   in	   this	   chapter,	   a	  solution	  phase	  multiplex	  PCR	  will	  be	  evaluated.	  In	  comparison	  the	  new	  FO-­‐SPR	   assay	   enables	   both	   quantification	   and	   cycle-­‐to-­‐cycle	  identification	  of	  the	  reaction	  products,	  which	  was	  not	  possible	  with	  the	  solid-­‐phase	   variant.	   Hereto,	   two	   sets	   of	   hybridization	   probes	   are	  immobilized	   on	   the	   FO-­‐SPR	   sensor	   and	   Au	   NPs	   are	   used	   to	   allow	   the	  detection	  of	  the	  two	  different	  target	  sequences	  (Figure	  7.1).	  As	  a	  proof-­‐of-­‐concept,	  a	  multiplex	  PCR	  reaction	  will	  be	  used	  to	  amplify	  conserved	  regions	   of	   the	   genome	   of	   Mycobacterium	   bovis	   (M.	   Bovis)	   and	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7.3 Materials	  and	  methods	  
7.3.1 Reagents	  The	   chemically	   synthesized	   oligonucleotides	   were	   purchased	   from	  integrated	  DNA	   technologies	   (Haasrode,	   Belgium).	   An	   overview	   of	   the	  targets,	  capture	  probes	  and	  primer	  sequences	  can	  be	  found	  in	  Table	  7.1.	  Both	  capture	  probes,	  used	  to	  capture	  the	  target	  sequence,	  are	  modified	  with	   a	   3’	   C3	   or	   5’	   C6	   thiol	   modifier	   (-­‐SH)	   for	   immobilization	   of	   the	  oligonucleotides	   on	   the	   FO-­‐SPR	   sensor	   and	   the	   Au	   NPs	   gold	   surfaces,	  respectively.	   The	   free	   3’	   end	   of	   the	   hybridization	   probes	  was	   blocked	  from	   extension	   by	   the	   polymerase	   enzyme	   using	   a	   3’	   phosphate	  modification.	   All	   chemicals	   were	   purchased	   from	   Sigma-­‐Aldrich	  (Bornem,	  Belgium)	  unless	  stated	  otherwise.	  	  
Table	  7.1:	  Overview	  of	  used	  oligonucleotides	  	  
Targets	  (5’à3’)	  	  M.	  Bovis	  Wild	  Type	  (WT),	  76bp	  
GCA GAA GCG CAA CAC TCT TGG AGT GGC CTA CAA CGG CGCTCT CCG CGG 
CGC GGG CGT ACC GGA TAT CTT AGC TGGT  M.	  Bovis	  5’	  Mismatch1	  SNPs	  (MM1BOV),	  76bp	  
GCA GAA GCG CAA CAC TCT TTG AGT GGC CTA CAA CGG CGCTCT CCG CGG 
CGC GGG CGT ACC GGA TAT CTT AGC TGG T M.	  Bovis	  5’	  Mismatch	  3	  SNPs	  (MM3BOV),	  76	  bp	  
GCA GAA GCG CAA CAC TCT TTG AGC GTC CTA CAA CGG CGCTCT CCG CGG 
CGC GGG CGT ACC GGATAT CTT AGC TGG T MAP	  Wild	  Type	  (WT),	  56	  bp	  
TGG TCG TCT GCT GGGTTG ATC TGG ACA ATG ACG GTT ACG GAG GTG GTT 
GTG GC -3	  MAP	  5’	  Mismatch	  1	  SNPs	  (MM1MAP),	  56bp	  
TGG TCG TCT GCT GGG TTG ATA TGG ACA ATG ACG GTT ACG GAG GTG GTT 
GTG GC -3	  MAP	  5’	  Mismatch	  3	  SNPs	  (MM3MAP),	  56bp	  
TGG TCG TCT GCT GGG TTG ATA TTA ACA ATG ACG GTT ACG GAG GTG GTT 
GTG GC 	  
Primers	  (5’à3’)	  M.	  Bovis	  primer	  forward,	  19bp	  
GCA GAA GCG CAA CAC TCT T	  M.	  Bovis	  primer	  reverse,	  22bp	  
ACC AGC TAA GAT ATC CGG TAC G	  MAP	  primer	  forward,	  19bp	  
TGG TCG TCT GCT GGG TTG A 
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MAP	  primer	  reverse,	  20bp	  
GCC ACA ACC ACC TCC GTA AC	  
Hybridization	  probes	  (5’à3’)	  M.	  Bovis	  probe	  1,	  48bp	  
CGC CGT TGT AGG CCA CTC CAA GAG TGT TGC GCT TCT GCT TTT TTT TTT - 
SH 	  M.	  Bovis	  probe	  2,	  48bp	  
SH- TTT TTT TTT TAC CAG CTA AGA TAT CCG GTA CGC CCG CGC CGC GGA 
GAG – Phos	  MAP	  probe	  1,	  45bp	  
TGT CCA GAT CAA CCC AGC AGA CGA CCATTT TTT TTT TTT TTT TTT - SH 	  MAP	  probe	  2,	  44bp	  
SH - TTT TTT TTT TTT TTT TTT GCC ACA ACC ACCTCC GTA ACC GTC AT -Phos 	  Thiol-­‐functionalized	  DNA	  was	  immobilized	  on	  the	  Au	  NPs	  by	  adding	  1	   µM	   of	   5’	   thiol	   functionalized	  DNA	   oligo	   activated	  with	   dithiothreitol	  (DTT,	  0.1	  M	  in	  PB	  0.18	  mM,	  pH	  8.3)	  to	  break	  up	  thiol	  dimers	  that	  could	  inhibit	   the	   DNA	   functionalization.	   DNA	   was	   first	   purified	   using	   a	  sephadex	  column	  (GE,	  Oslo,	  Norway)	  to	  remove	  any	  traces	  of	  active	  DTT	  before	  it	  was	  added	  to	  the	  concentrated	  nanoparticle	  solution.	  A	  fast	  salt	  maturation	  protocol7	  was	  used	  to	  maximize	  the	  DNA	  loading	  on	  the	  Au	  NPs.	  Afterwards,	  Au	  NPs	  were	  washed	  three	  times	  in	  phosphate	  buffer	  with	  0.01	  %	  SDS	  and	  stored	  at	  4°C	  prior	  to	  use.	  
7.3.2 FO-­‐SPR	  sensor	  fabrication	  and	  Au	  NP	  functionalization	  The	  FO-­‐SPR	  device	  and	  sensors	  were	  manufactured	  as	  described	  in	  the	  previous	  chapters.	  Citrate	  stabilized	  Au	  NPs	  with	  a	  mean	  diameter	  of	  20	  nm	  were	   purchased	   from	   BBI	   international	   (Cardiff,	   United	   Kingdom)	  and	   functionalized	   using	   the	   protocol	   described	   in	   Chapter	   4.	   This	  standard	  protocol	  was	  adjusted	  for	  the	  simultaneous	  immobilization	  of	  two	   hybridization	   probes	   during	   the	   functionalization	   process.	   Both	  probes	  were	  added	  to	  the	  Au	  NPs	  in	  equal	  amounts	  	  (Figure	  7.1).	  
7.3.3 Gold	  surface	  backfilling	  Both	  the	  FO-­‐SPR	  sensor	  and	  Au	  NPs	  were	  backfilled,	  as	  described	  in	  the	  material	  and	  methods	  section	  of	  Chapter	  6	  (a	  detailed	  description	  of	  the	  backfilling	  concept	  can	  be	  found	  in	  Chapter	  1	  section	  1.6).	  
7.3.4 DNA	  melting	  analysis	  The	   multiplex	   DNA	   melting	   analysis	   on	   the	   FO-­‐SPR	   device	   was	  performed	  using	  a	  hybridization	  step	  at	  55°C	   for	  10	  minutes,	   followed	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by	   an	   increase	   in	   temperature	   to	   90°C	   at	   0.1°C/s.	   Experiments	   were	  performed	   in	  a	  10	  mM	  Tris	  HCl	  buffer	  with	  2.5	  mM	  MgCl2	  and	  60	  mM	  NaCl	  and	  0.1%	  triton	  X-­‐100.	  The	  target	  DNA	  concentration	  was	  500	  nM	  when	   individual	   DNA	   targets	   were	   analyzed	   and	   250	   nM	   when	   a	  multiplex	  target	  analysis	  was	  carried	  out.	  
7.3.5 Polymerase	  chain	  reaction	  (PCR)	  PCR	  was	  performed	   to	  extend	  primers	   for	  a	   specific	   region	  of	  M.	  Bovis	  and	   MAP.	   Primers	   for	   MAP	   were	   adopted	   from	   Ravva	   et	   al.8,	   who	  selected	  these	  primers	  using	  the	   insertion	  sequence	  IS900,	  a	  repetitive	  element	   present	   only	   in	   the	   MAP	   genome.	   Primers	   for	  M.	   Bovis	   were	  designed	   for	   the	   so-­‐called	   regions	   of	   difference	   (RD),	   which	   contain	  sequence	   deletions	   in	   the	   genome	   of	  M.	   Bovis	   that	   are	   not	   present	   in	  other	  Mycobacteriacae9.	  A	  PCR	  mastermix	  (DimerEraser,	  Takara,	  Shiga,	  Japan)	  containing	  all	  necessary	  components	   for	   the	  PCR	  reaction,	  except	  primers,	  was	  used.	  The	   total	   reaction	   volume	   was	   100	   µL,	   this	   volume	   is	   considerably	  larger	  than	  for	  a	  standard	  PCR	  reaction,	  but	  was	  necessary	  to	  submerge	  the	  FO-­‐SPR	  sensor	  completely	  in	  the	  PCR	  mixture.	  Future	  FO-­‐SPR	  design	  improvements	   should	   allow	   reducing	   this	   volume	   considerably.	   The	  reaction	   mixture	   consisted	   of	   50	   µL	   Takara	   mastermix,	   3	   µL	   of	   each	  primer	   (300	   nM	   final	   concentration),	   20	   µL	   Au	   NPs	   (1.0	   nmol/L	   in	  distilled	  nuclease	  free	  H2O),	  4	  µL	  MgCl2	  (50	  mM),	  4	  µL	  NaCl,	  10	  µL	  target	  DNA.	   The	   reaction	   mixture	   was	   protected	   from	   evaporation	   during	  thermocycling	   by	   covering	   it	   with	   a	   layer	   of	   mineral	   oil	   (Immobiline	  DryStrip	  Cover	  Fluid,	  GE	  healthcare,	  Diegem,	  Belgium).	  The	   sample	   temperature	   was	   cycled	   according	   to	   the	   following	  program:	  1)	  Enzyme	  activation	  
§ 30	  s	  at	  95°C	  2)	  Three	  step	  PCR	  protocol	  (45	  consecutive	  cycles):	  
§ 30	  s	  at	  55°C	  (ramp	  speed	  =	  5.0°C/s)	  
§ 30	  s	  at	  72°C	  (ramp	  speed	  =	  5.0°C/s)	  




7.4.1 Evaluation	  of	  multiplex	  FO-­‐SPR	  performance	  Simultaneous	  immobilization	  of	  different	  	  oligonucleotide	  probes	  on	  the	  FO-­‐SPR	   sensor	   decreases	   the	   absolute	   number	   of	   each	   particular	  hybridization	   probe	   on	   the	   surface.	   Furthermore	   because	   the	   DNA	  sequence	   and	   length	   will	   influence	   immobilization	   efficiency,	   a	  particular	  hybridization	  probe	  can	  be	   favored	  during	   immobilization10.	  To	  study	  this	  possible	  effect,	  a	  FO-­‐SPR	  melting	  analysis	  was	  performed	  with	   FO-­‐SPR	   sensors	   functionalized	   with	   individual	   and	   multiplex	  hybridization	  probes.	  The	  melting	   analysis	   of	   the	   individual	   probe-­‐target	   complexes	  was	  performed	   identically	   to	   the	  protocol	   optimized	   in	   Chapter	   4.	  A	   target	  concentration	   of	   200nM	  was	   used	   as	   this	   is	   well	   above	   the	   detection	  limit	   of	   the	   FO-­‐SPR	   biosensor	   and	   should	   result	   in	   a	   clear	   signal.	   In	  Figure	  7.2A	   the	   results	   of	   the	  melting	   analysis	   are	  depicted.	   From	   this	  graph	   it	   can	   be	   observed	   that	   both	   bacterial	   targets	   can	   be	   easily	  identified,	   with	   the	  M.	  Bovis	   and	  MAP	   target	   having	   a	   Tm	   of	   87°C	   and	  80°C,	  respectively.	  A	  similar	  experiment	  was	  successfully	  performed	  in	  the	  multiplex	  FO-­‐SPR	  setting,	  with	  a	  mixture	  of	  both	   target	   sequences.	  	  (Figure	  7.2B).	  	  
	  
Figure	   7.2:	   A)	   Individual	   and	   B)	  Multiplex	   FO-­‐SPR	  melting	   analysis	   for	   the	  MAP	  
and	  M.	  Bovis	  target	  sequences.	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Figure	   7.3:	   Multiplex	   FO-­‐SPR	   melting	   analysis	   for	   the	   MAP	   and	  M.	   Bovis	   target	  
sequence	  performed	  in	  PCR	  buffer.	  
7.4.2 FO-­‐SPR	  PCR	  assay	  The	   FO-­‐SPR	   implementation	   of	   PCR	   resembles	   the	   LCR	   reaction	  described	   in	   the	   previous	   chapter.	   The	  main	   difference	   between	   both	  reactions	  is	  that	  in	  PCR	  primers	  are	  extended	  while	  in	  LCR,	  DNA	  probes	  are	   ligated.	   This	   makes	   that	   both	   reactions	   require	   different	  thermocycling	   conditions	   and	   different	   reaction	   mixtures.	   The	   buffer	  used	   for	  LCR	   is,	  as	  described	  above,	  not	  applicable	   for	  PCR	  as	   the	  PCR	  enzyme	  is	  very	  sensitive	  to	  changes	  in	  ionic	  strength.	  In	  Figure	  7.4	  nine	  cycles	  of	  a	  PCR	  reaction	  are	  shown.	   Initially,	   the	  FO-­‐SPR	   signal	   is	   the	   invers	   of	   the	   temperature	   change,	   which	   is	  continually	  monitored	  with	  a	  thermocouple.	  However,	  from	  the	  moment	  DNA	  target	  is	  amplified	  through	  PCR	  above	  the	  detection	  limit	  of	  the	  FO-­‐SPR	   signal,	   the	   melting	   signal	   of	   the	   amplified	   DNA	   target	   will	  superimpose	  on	  the	  refraction	  index	  shift	  of	  the	  temperature	  measured	  with	  the	  FO-­‐SPR	  sensor.	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Figure	  7.4:	  Raw	  data	  of	  an	  FO-­‐SPR	  PCR	  measurement.	  Two	  measurement	  channels	  
(channel	  1	  and	  channel	  2)	  measure	  continuously	  changes	  in	  refractive	  index	  due	  
to	   the	   thermocycling.	   As	   a	   result,	   the	   FO-­‐SPR	   signal	   is	   the	   inverse	   of	   the	  
temperature	   measured	   with	   a	   thermocouple.	   From	   the	   moment	   a	   target	   DNA	  
species	  is	  present,	   the	  FO-­‐SPR	  signal	  will	  obtain	  a	  characteristic	  melting	  point	  of	  
the	   particular	   DNA	   target,	   which	   is	   superimposed	   on	   the	   FO-­‐SPR	   signal	   of	   the	  




Figure	  7.5:	  FO-­‐SPR	  signal	  for	  each	  PCR	  cycle	  (represented	  with	  differently	  colored	  
lines)	   in	   a	  multiplex	  PCR	   reaction	   containing	  bacterial	  DNA	  of	   both	  MAP	  and	  M.	  
Bovis	  at	  a	  concentration	  of	  1nM.	  Initially,	  the	  FO-­‐SPR	  signal	  is	  the	  exact	  inverse	  of	  
the	   temperature	   signal.	   When	   DNA	   reaches	   the	   detection	   limit	   of	   the	   FO-­‐SPR	  
sensor,	  a	  melting	  signal	  for	  each	  DNA	  target	  becomes	  visible.	  By	   taking	   the	   first	   order	   derivative	   of	   the	   SPR	   signal	   and	  temperature	   signal,	   the	   Tm	   of	   each	   DNA	   target	   can	   be	   resolved	   very	  precisely,	  allowing	  an	  easy	  identification	  of	  both	  targets.	  In	  comparison	  with	  the	  earlier	  optimization	  reactions,	  the	  Tm	  of	  both	  targets	  is	  shifted	  approximately	  3	  °C.	  The	  shift	  in	  Tm	  is	  the	  result	  of	  a	  slightly	  higher	  ionic	  strength	  of	  buffer,	  necessary	  to	  stabilize	  the	  Au	  NPs	  in	  the	  PCR	  mixture.	  Use	  of	  increased	  ionic	  concentrations	  allowed	  keeping	  the	  Au	  NPs	  stable	  during	   the	  PCR	  reaction,	   as	   they	  appeared	   to	  be	   instable	  and	  prone	   to	  aggregation	   after	   extensive	   thermocycling	   (data	   not	   shown).	   The	  increased	  ionic	  strength	  was	  carefully	  optimized	  to	  prevent	  inhibition	  of	  the	  PCR	  reaction	  while	  having	  at	  the	  same	  time	  a	  stable	  Au	  NP	  solution	  capable	  of	  withstanding	  multiple	  thermal	  cycles.	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Figure	   7.6:	   First	   order	   derivative	   of	   the	   FO-­‐SPR	   signal	   and	   temperature,	   which	  
allows	  resolving	  the	  melting	  point	  of	  the	  two	  target	  DNA	  types	  amplified	  with	  the	  
multiplex	   PCR.	   The	   MAP	   sequence	   has	   a	   lower	   melting	   point,	   because	   it	   is	  
considerably	   shorter.	   Both	   targets	   can	   easily	   be	   resolved	   as	   the	   signals	   are	  
separated	  by	  5.7°C.	  The	  different	  lines	  indicate	  the	  individual	  PCR	  cycles	  used	  to	  
amplify	  the	  target	  DNA.	  From	  these	  curves	  the	  DNA	  quantity	  could	  potentially	  be	  
derived.	  




Figure	   7.7:	   FO-­‐SPR	   PCR	   analysis	   of	   the	   wild	   type	   MAP	   and	   M.	   Bovis	   target	  
sequences	  at	  a	   concentration	  of	  10	  pM.	  Again	   the	  different	   curves	   represent	   the	  
signal	   for	   each	   PCR	   cycle.	  With	   increasing	   numbers	   of	   PCR	   cycles	   a	   better	  melt	  
signal	  is	  obtained.	  Next,	   target	   sequences	   of	   MAP	   and	   M.	   Bovis	   bearing	   a	   single	  mutation	   (MM1MAP	   and	   MM1BOV)	   were	   analyzed	   at	   the	   same	  concentrations	   of	   10	   pM.	   The	   mutation	   in	   the	   target	   sequence	   was	  located	   just	   outside	   the	   priming	   regions,	   in	   order	   to	   prevent	   PCR	  inhibition	  or	  loss	  of	  the	  mutation	  due	  to	  PCR	  amplification	  (see	  Chapter	  5).	  The	  FO-­‐SPR	  analysis	  of	  MM1	  resulted	   in	  a	  clear	  melting	  signal	  with	  two	  melting	  points	  (Figure	  7.8).	  	  
	  
Figure	  7.8:	  FO-­‐SPR	  PCR	  melting	  analysis	  of	  MAP	  and	  M.	  Bovis	  sequences	  bearing	  a	  
single	  SNP	  (MM1MAP	  and	  MM1BOV).	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  The	  presence	  of	  a	  SNP	  in	  the	  M.	  Bovis	   target	  changes	  Tm	  value	  only	  for	  0.5°C,	  while	  the	  change	  for	  MAP	  target	  Tm	  is	  1.3°C.	  This	  difference	  is	  the	  result	  of	  the	  target	  length.	  Thus,	  SNP	  will	  have	  a	  bigger	  influence	  on	  hybridization	   and	   consequently	   melting	   of	   a	   shorter	   target,	   i.e.	   MAP	  sequence	  that	  is	  55	  bp	  long	  compared	  to	  M.	  Bovis,	  which	  is	  76bp	  long.	  To	   evaluate	   whether	   it	   is	   possible	   to	   differentiate	   targets	   with	   a	  single	   mutation	   from	   targets	   bearing	   multiple	   mutations,	   the	   FO-­‐SPR	  PCR	  assay	  was	  applied	  to	  analyze	  both	  targets	  with	  three	  SNPs	  (MM3MAP	  and	  MM3BOV).	  As	  can	  been	  seen	  from	  the	  results	  in	  Figure	  7.9,	  the	  extra	  mutations	  resulted	   in	  a	   larger	  change	  of	   the	  Tm	  values	   for	  both	   targets	  compared	   to	   wild	   type	   sequences.	   The	   Δ	   Tm	   for	   the	   MAP	   target	  increased	  to	  1.5°C	  and	  for	  M.	  Bovis	  to	  1.0°C.	  Although	  these	  results	  need	  a	  further	  evaluation	  they	  give	  a	  first	  indication	  of	  the	  possibilities	  of	  the	  FO-­‐SPR	   biosensor	   to	   discriminate	   between	   targets	   bearing	   single	   and	  multiple	  mutations.	  
	  
Figure	  7.9:	  FO-­‐SPR	  PCR	  melting	  analysis	  of	  MAP	  and	  M.	  Bovis	   sequences	  bearing	  
triple	  mutations	  (MM3MAP	  and	  MM3BOV).	  	  Furthermore,	   it	   can	   be	   seen	   that	   also	   melting	   peak	   and	   cycle	  numbers	  are	  affected	  by	  the	  mutations	  present	  in	  the	  target	  sequences	  when	   the	   FO-­‐SPR	  melting	   peak	   height	   is	   plotted	   versus	   the	   PCR	   cycle	  number	  for	  both	  WT	  and	  MM	  targets	  (Figure	  7.10).	  When	  this	  signal	  for	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the	   WT	   is	   compared	   with	   targets	   bearing	   either	   single	   or	   triple	  mutations,	   it	   is	   evident	   that	   more	   PCR	   cycles	   are	   needed	   for	   both	  mutated	  targets	  to	  reach	  the	  FO-­‐SPR	  detection	  limit.	  Moreover,	  melting	  peaks	  are	  substantially	  smaller	  for	  both	  mutated	  targets	  in	  comparison	  with	   the	  melting	   signal	   of	   the	  WT	   target.	   Because	  mutations	  were	   not	  located	   in	   the	   priming	   regions	   and	   therefore	   could	   not	   influence	   PCR	  efficiency,	  these	  findings	  can	  only	  be	  explained	  by	  a	  lower	  hybridization	  efficiency	  of	  the	  two	  hybridization	  probes	  on	  FO-­‐SPR	  sensor	  surface	  and	  Au	   NPs.	   The	   lower	   hybridization	   efficiency	   results	   from	   base	   pair	  mismatches	   between	   the	   target	   DNA	   with	   mutations	   and	   the	  immobilized	  hybridization	  probes	  on	  the	  FO-­‐SPR	  biosensor	  and	  the	  gold	  nanoparticles.	   As	   a	   result	   the	   detection	   limit	   of	   the	   FO-­‐SPR	   PCR	  biosensor	   for	   target	   sequences	   with	  mutations	   will	   always	   be	   slightly	  higher	  than	  for	  the	  wild	  type	  targets.	  
	  
Figure	  7.10:	  Plot	  of	  the	  height	  of	  the	  FO-­‐SPR	  obtained	  melting	  peak	  versus	  the	  PCR	  
cycle	   numbers.	   From	   this	   graph	   it	   can	   be	   seen	   that	   mismatches	   in	   the	   target	  
sequence	  shift	  the	  cycle	  threshold	  to	  a	  higher	  value	  and	  that	  the	  final	  yield	  of	  the	  
PCR	   reaction	   is	   lower.	   Full	   lines	   represent	   a	   sigmoidal	   fit	   of	   the	   corresponding	  
colored	  data	  points.	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7.5 Conclusion	  In	   this	   chapter,	   it	   has	   been	   demonstrated	   that	   the	   FO-­‐SPR	   assay	   is	  amenable	   to	   multiplex	   target	   analysis.	   The	   FO-­‐SPR	   bioassay,	   used	   for	  real	  time	  monitoring	  of	  a	  multiplex	  PCR	  directed	  at	  detecting	  MAP	  and	  
M.	   Bovis	   bacterial	   targets,	   was	   able	   to	   differentiate	   these	   two	   targets	  with	   the	   same	   resolution	   as	   the	   singleplex	  FO-­‐SPR	  melting	   assay.	  This	  opens	   the	   possibility	   of	   developing	   a	   novel	   non-­‐fluorescence	   based	  platform	   for	   quantitative	   multiplex	   PCR.	   Detecting	   the	   presence	   of	  mutations	  in	  the	  target	  sequences	  was	  possible	  as	  both	  a	  single	  SNP	  and	  multiple	   SNPs	   could	   be	   resolved.	   Shorter	   sequences	   were	   more	  sensitive	  to	  mutations,	  which	  is	  in	  agreement	  with	  the	  results	  of	  Chapter	  4.	   The	   targets	   could	   be	   identified	   during	   thermocycling,	   which	   is	   in	  qPCR	   only	   possible	   when	   multiple	   fluorescence	   dyes	   are	   used.	   It	   can	  thus	  be	  concluded	  that	  the	  FO-­‐SPR	  has	  some	  particular	  features,	  which	  could	  prove	  useful	  in	  POC	  biosensors	  such	  as	  the	  detection	  of	  	  multiple	  bacteria	  in	  real-­‐time.	  	  
	   	   References	  
185	  
References	  1.	   A.	  P.	  Malanoski,	  B.	  Lin,	  Z.	  Wang,	   J.	  M.	  Schnur	  and	  D.	  A.	  Stenger,	  
Nucleic	  Acids	  Res.,	  2006,	  34,	  5300-­‐5311.	  2.	   C.	  T.	  Wittwer,	  M.	  G.	  Herrmann,	  C.	  N.	  Gundry	  and	  K.	  S.	  Elenitoba-­‐Johnson,	  Methods,	  2001,	  25,	  430-­‐442.	  3.	   I.	  M.	  Mackay,	  K.	  E.	  Arden	  and	  A.	  Nitsche,	  Nucleic	  Acids	  Res.,	  2002,	  
30,	  1292-­‐1305.	  4.	   Y.	  Liao,	  X.	  Wang,	  C.	  Sha,	  Z.	  Xia,	  Q.	  Huang	  and	  Q.	  Li,	  Nucleic	  Acids	  
Res.,	  2013,	  41,	  e76.	  5.	   J.	   Li,	   R.	   Berbeco,	   R.	   J.	   Distel,	   P.	   A.	   Janne,	   L.	   Wang	   and	   G.	   M.	  Makrigiorgos,	  Nucleic	  Acids	  Res.,	  2007,	  35,	  e84.	  6.	   J.	  Pollet,	  K.	  P.	  Janssen,	  K.	  Knez	  and	  J.	  Lammertyn,	  Small,	  2011,	  7,	  1003-­‐1006.	  7.	   S.	   J.	  Hurst,	  A.	  K.	  Lytton-­‐Jean	  and	  C.	  A.	  Mirkin,	  Anal.	  Chem.,	  2006,	  




Chapter	  8 	  
General	  conclusion	  and	  perspectives	  
8.1 	  General	  conclusions	  In	   the	   last	  decade,	  a	   considerable	  amount	  of	  money	  and	  resources	  has	  been	   allocated	   to	   the	   development	   of	   the	   next	   generation	   detection	  methods	   for	   micro-­‐organisms1.	   Despite	   these	   efforts,	   only	   a	   small	  number	   of	   new	   diagnostic	   assays	   have	   reached	   the	   market2,	   often	  without	   being	   able	   to	  meet	   all	   the	   expectations	   and	   needs	   in	  medical	  diagnostics,	   industrial	   and	   environmental	   monitoring.	   As	   a	   result,	  technologies	  based	  on	  actual	  culturing	  of	  microorganisms	  or	  other	  time	  consuming	   and	   expensive	   laboratory	   tests	   have	   remained	   the	   gold	  standard3.	   Because	   of	   this,	   a	   pragmatic	   approach	   continues	   to	   be	   the	  preferred	  method	   of	   choice,	   where	   drastic,	   non-­‐specific	   measures	   are	  practiced	   -­‐such	   as	   use	   of	   broad-­‐spectrum	   anti-­‐bacterial	   agents-­‐	  whenever	   the	   presence	   of	   micro-­‐organisms	   is	   suspected4,5.	   This	   has	  resulted	  in	  antibiotic	  misuse	  over	  years	  and	  created	  a	  global	  problem	  of	  increased	  resistance	   in	  bacteria	   that	   can	  hardly	  be	   treated	  with	  any	  of	  the	   existing	   antibiotics.	   Therefore,	   the	   development	   of	   new	   diagnostic	  tests,	  which	   can	   rapidly	   and	   accurately	   identify	   patients	   truly	   needing	  antibiotics,	   is	   essential	   for	   changing	   the	   daily	   clinicians’	   practice	   from	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groundless	   decision	  making	   to	   those	   being	   rational	   towards	   adequate	  use	  of	  antibiotics.	  	  One	   of	   the	   problems	   in	   the	   development	   of	   applicable	   diagnostic	  tools	   in	   the	   field	  of	  micro-­‐organism	  detection	   is	   that	  many	  new	  assays	  are	   built	   on	   very	   complex	   laboratory	   techniques	   such	   as	   mass	  spectroscopy6	   and	   sequencing	   technology7.	   Although	   these	   high-­‐end	  technologies	  give	  us	  valuable	  new	  insights	  in	  the	  virulence,	  spread	  and	  biomarkers	  of	  micro-­‐organisms,	  they	  are	  not	  the	  answer	  to	  the	  current	  diagnostic	   needs.	   The	   exact	   requirements	   for	   microbiological	  diagnostics	  are	  simple,	  fast,	  sensitive,	  selective	  and	  versatile	  assays	  that	  are	  portable	  and	  robust8.	  	  New	  developments	   in	  nanotechnology	  and	  molecular	  biology	  point	  towards	   new	  opportunities	   for	   development	   of	   desired	   diagnostics,	   as	  was	  extensively	  reviewed	  in	  Chapter	  2.	  In	  general,	  the	  improvements	  in	  SNP	  detection	  have	  been	  achieved	  with	  technological	  advances	  in	  three	  domains,	   being	   an	   improved	  mutation	  discrimination,	   a	   better	   limit	   of	  detection	   and	   greater	   multiplexing	   capabilities.	   To	   achieve	   these	  improvements	   various	   strategies	   have	   been	   applied	   of	   which	  introduction	  of	  secondary	  structures	  in	  hybridization	  probes,	  enzymatic	  cascades	  and	   thermal	  denaturing	  have	  great	  potential	   in	   fast	  mutation	  detection.	   From	   this	   overview	   it	   can	   be	   concluded	   that	   the	   current	  limitations	  of	   diagnostics	  will	   not	   be	   resolved	  by	   implementing	  one	  of	  these	   new	   technologies,	   but	   by	   selecting	   the	   ideal	   combination	   of	  available	  technologies.	  	  Therefore,	   this	   dissertation	   was	   devoted	   to	   the	   development	   of	  assays	   for	   detection	   of	   micro-­‐organisms	   that	   could	   answer	   some	   of	  these	  unmet	  needs	  and	  thus	  become	  suited	  for	  integration	  in	  POC	  tests.	  More	   specifically,	   the	   assays	  were	   developed	   on	   an	   FO-­‐SPR	   biosensor	  platform	  that	  was	  established	  in	  the	  biosensor	  group.	  This	  platform	  has	  several	  unique	  advantages	  that	  make	  it	  a	  very	  attractive	  technology	  for	  the	  next	  generation	  of	  microbiological	  diagnostics	  tests.	  First,	  SPR	  based	  transducers	   allow	   real-­‐time	   monitoring	   of	   the	   assay	   flow	   with	   a	   high	  measurement	   sensitivity.	   Second,	   introducing	   the	   FO	   sensor	   tip	   into	  samples	   is	   simple	   and	   resembles	   a	   concept	   of	   one	   of	   the	   most	  straightforward	  diagnostic	  tools	  available	  to	  date:	  a	  ‘dipstick’	  test.	  Third,	  due	  to	  the	  optical	  fibers,	  this	  platform	  offers	  a	  great	  cost	  advantage	  over	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commercial	   SPR	  devices.	  Therefore,	   implementing	   improved	  bioassays	  for	   detecting	   micro-­‐organisms	   on	   such	   platform	   could	   result	   in	   a	  diagnostic	  tool	  applicable	  even	  in	  resource	  limited	  environments.	  In	  times	  when	  demands	  for	  sensitivity	  and	  specificity	  of	  biosensors	  are	  greater	  than	  ever,	  turning	  to	  multivalent	  bioreceptors	  is	  frequently	  becoming	  a	  strategy	  for	  improving	  the	  bioassay	  performance.	  This	  trend	  has	   also	   been	   witnessed	   by	   replacing	   bacteriophage	   affinity	   peptides	  with	   the	   entire	   phage	   as	   a	   receptor,	   despite	   scarce	   knowledge	   on	   the	  binding	  kinetics	  of	  complete	  phage	  particles.	   In	  Chapter	  3,	   the	  FO-­‐SPR	  sensor	   was	   used	   to	   study	   the	   affinity	   and	   binding	   kinetics	   of	   phages,	  displaying	   peptide	   libraries	   with	   affinity	   for	   eGFP.	   The	   eGFP	   was	  immobilized	  on	  the	  FO-­‐SPR	  biosensor	  surface	  as	  a	  target	  protein	  of	  the	  viral	  particles,	  which	  allowed	  real-­‐time	  monitoring	  of	  their	   interaction.	  Although	   the	   bioassay	   based	   on	   the	   detection	   of	   the	   entire	   viruses	  showed	  limited	  sensitivity,	  it	  proved	  to	  be	  a	  valuable	  tool	  for	  comparing	  binding	   kinetics	   of	   different	   viral	   particles,	   which	   expressed	   affinity	  peptides	  in	  different	  densities	  on	  the	  surface.	  	  With	  a	  need	  for	  both	  detecting	  and	  identifying	  pathogens	  within	  the	  same	  POC	  test,	  a	  universal	  bioassay	  can	  be	  created	  by	  using	  the	  genetic	  material	  of	  micro-­‐organisms9.	  However,	   the	   sensitivity	  of	   SPR	   towards	  DNA	   is	  poor,	  as	   this	  molecule	  has	  a	   limited	   impact	  on	  refractive	   index.	  Therefore,	   in	  Chapter	  4,	  a	  new	  approach	  was	  described	  for	   improving	  the	  SPR	  sensitivity	  in	  DNA	  based	  bioassays.	  Here,	  thermal	  denaturation	  of	  DNA	  complexes	  was	  measured	  on	  the	  FO-­‐SPR	  biosensor.	  These	  DNA	  complexes	  were	  formed	  between	  the	  target	  DNA	  and	  two	  probes,	  each	  complementary	   to	   one	   half	   of	   the	   target	   molecule	   and	   immobilized	  either	  on	  the	  Au	  NPs	  or	  the	  sensor	  surface.	  Application	  of	  Au	  NP	  labels	  resulted	  in	  a	  clear	  signal,	  which	  superimposed	  the	  SPR	  signal	  caused	  by	  temperature	   changes	   during	  DNA	  melting	   analysis.	   From	   the	   obtained	  melting	   curves,	   presence	   of	   SNPs	   was	   resolved	   in	   DNA	   targets	   with	  variable	  size	  (30,	  56	  and	  80	  bp	  long	  sequences)	  and	  for	  some	  of	  the	  used	  targets	   even	   further	   insight	   into	   the	   position	   of	   these	   SNPs	   was	  obtained.	  	  This	   assay	   was	   further	   challenged	   in	   Chapter	   5	   by	   directly	  screening	  PCR	  amplified	  DNA	  for	  mutations.	  The	  test	  case	  was	  built	  on	  the	  measurement	  of	  genetic	  variability	   in	   two	  genes	  of	  L.	  pneumophila,	  
Chapter	  8:	  General	  conclusion	  and	  perspectives	  
190	  
which	   is	   a	   common	   human	   pathogen	   responsible	   for	   atypical	  pneumonia.	  Although	  the	  two	  selected	  genes	  are	  frequently	  used	  for	  the	  quantification	  of	  this	  bacteria,	  one	  of	  them	  is	  well	  documented	  as	  highly	  variable	   and	   therefore	   prone	   to	   introducing	   amplification	   bias	   in	   PCR	  based	   molecular	   diagnostic	   tests.	   Two	   different	   assays,	   being	  sequencing	  and	  qPCR	  DNA	  melting	  assay,	  were	  used	  in	  parallel	  with	  the	  FO-­‐SPR	   DNA	  melting	   assay	   to	   determine	   the	   genetic	   variability	   in	   the	  bacterial	   qPCR	   priming	   regions.	   This	   cross	   platform	   comparison	  allowed	  assessing	  true	  POC	  potential	  of	  the	  FO-­‐SPR	  bioassay.	  The	  sensor	  proved	   to	   be	   reliable	   for	   detecting	   mutations	   in	   those	   samples	   that	  previously	  displayed	  ambiguous	  qPCR	  quantification	  results.	  Moreover,	  it	   showed	   advantages	   as	   a	   high	   resolution	   and	   fast	   genetic	   screening	  tool	   that	   can	   compete	   with	   the	   current	   standard	   techniques	   for	   SNP	  detection.	   Additionally,	   this	   research	   identified	   a	   genetic	   region	   of	   L.	  
pneumophila	   that	   should	   be	   avoided	   when	   selecting	   PCR	   primers	   for	  bacteria	  quantification.	  In	  Chapter	   6,	   the	   possibilities	   of	   the	   FO-­‐SPR	  DNA	  biosensor	  were	  further	   explored.	   Here	   a	   quantification	   method	   was	   introduced	   for	  allowing	   not	   only	   identification	   of	   micro-­‐organisms,	   but	   also	   their	  quantification.	   At	   the	   same	   time	   efforts	   were	   made	   to	   safeguard	   the	  assay	   sensitivity,	   as	   the	   quantification	  method	   required	   a	   shorter	   FO-­‐SPR	  DNA	  melting	  assay	  time.	  Careful	  optimization	  of	  buffer	  and	  thermal	  ramping	   speed	   resulted	   in	   a	   level	   of	   SNP	   sensitivity	   similar	   to	   the	  FO-­‐SPR	  melt	   assay	  described	   in	  Chapters	  4	   and	  5.	   The	  new	  FO-­‐SPR	  assay	  was	   able	   to	   monitor	   in	   real-­‐time	   the	   quantitative	   ligation	   assay.	   The	  gradual	  increase	  in	  signal	  over	  multiple	  DNA	  ligation	  cycles	  was	  used	  to	  determine	   DNA	   concentrations	   over	   7	   orders	   of	   magnitude	   with	   a	  detection	  limit	  of	  100	  fM.	  Even	  more	  importantly,	  the	  obtained	  melting	  signal	   during	   each	   cycle	   of	   the	   ligation	   was	   accurate	   enough	   to	  discriminate	  a	  SNP	  in	  the	  amplified	  target	  molecule.	  Such	  resolution	  in	  melting	  assays	  has	  been	  demonstrated	  until	  now	  only	  when	  using	  a	  post	  amplification	  reaction	  HRM	  analysis.	  In	  Chapter	   7,	   two	  related	  bacteria,	  Mycobacterium	  bovis	   (M.	  Bovis)	  and	   Mycobacterium	   avium	   subspecies	   paratuberculosis	   (MAP)	   were	  detected	  simultanously	  using	  the	  FO-­‐SPR	  biosensor.	  The	  FO-­‐SPR	  sensor	  tip	   and	   the	   Au	   NP	   labels	   were	   therefore	   functionalized	   with	   two	  different	  sets	  of	  hybridization	  probes,	  each	  targeting	  a	  region	  of	  interest	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in	  a	  different	  bacterial	  species.	  First	  experiments	  were	  done	  to	  evaluate	  if	   these	   alterations	   on	   the	   FO-­‐SPR	   sensor	   DNA	   density	   had	   any	  significant	   effects	  on	   the	  performance	  of	   the	  FO-­‐SPR	  biosensor.	  Next	   a	  multiplex	   assay	   was	   used,	   to	   improve	   the	   sensitivity	   of	   this	   assay	   by	  amplifying	  the	  target	  DNA.	  This	  also	  allowed	  FO-­‐SPR	  to	  monitor	  in	  real-­‐time	   the	   PCR	   reaction,	   which	   makes	   this	   multiplex	   FO-­‐SPR	   also	   a	  quantitative	   assay.	   The	   assay	   was	   able	   to	   resolve	   presence	   of	   one	   or	  both	  bacteria	  and	  could	  even	  detect	  mutations	  in	  the	  target	  sequences.	  
8.2 Future	  research	  and	  perspectives	  In	  this	  dissertation,	  the	  potential	  of	  FO-­‐SPR	  as	  a	  biosensor	  for	  detection	  of	  micro-­‐organisms	  was	  demonstrated.	  Nonetheless,	  several	  challenges	  remain	  before	  this	  technology	  finds	  its	  way	  to	  end–users.	  These	  will	  be	  addressed	  in	  the	  following	  sections.	  	  
8.2.1	  Multiplexing	  A	   useful	   biosensor	   for	  micro-­‐organism	   detection	   should	   be	   capable	   of	  detecting	   simultaneously	   multiple	   pathogens	   or	   even	   multiple	  phenotypes	  within	  each	  pathogen.	  Therefore,	  the	  capacity	  of	  the	  FO-­‐SPR	  biosensor	   as	   described	   in	   this	   thesis	   is	   insufficient	   and	   should	   be	  improved.	  However,	  SPR	  cannot	  be	  simply	  multiplexed	  by,	  for	  instance,	  using	   a	   different	   secondary	   label.	   In	   general,	   SPR	   is	  multiplexed	   using	  two	  different	  approaches.	  Most	   commercial	  SPR	  devices	  divide	  an	  SPR	  sensing	   surface	   in	   different	   regions,	   which	   are	   individually	  functionalized	  and	  addressed	  by	  using	  a	  complex	  microfluidic	  system.	  In	  this	  way,	  the	  SPR	  system	  can	  be	  multiplexed	  from	  4	  up	  to	  20	  channels	  in	  the	   high	   end	   products.	   A	   second	   approach,	   known	   as	   SPR	   imaging	  (SPRi),	   uses	   an	   entirely	   different	   SPR	   readout	   in	   order	   to	   enable	  multiplexing.	   As	   can	   be	   recalled	   from	   Section	   1.4	   of	   Chapter	   1,	   a	  standard	  Kretchmann	  SPR	  configuration	  uses	  a	  goniometer	  with	  a	  diode	  array	  detector	  to	  determine	  the	  angle	  of	  the	  incident	  light	  at	  which	  the	  SPR	  signal	   is	  excited.	   In	  SPRi,	  a	  charge	  coupled	  device	  (CCD)	  is	  used	  to	  monitor	   the	  same	  effect	  on	  an	  array	  of	  96	  SPR	  sensitive	  spots	  at	  once.	  The	   only	   downside	   of	   this	   technology	   is	   that	   biomolecules	   need	   to	   be	  immobilized	   on	   the	   surface	   using	   a	   microspotter,	   which	   is	   time	  consuming	  and	  costly10.	  
Chapter	  8:	  General	  conclusion	  and	  perspectives	  
192	  
However,	   none	   of	   these	   approaches	   is	   applicable	   for	   the	   FO-­‐SPR	  system.	   Introduction	  of	  microfluidics	  would	  compromise	  the	  simplicity	  of	   the	   dipstick	   sensor	   concept,	   while	   spotting	   would	   be	   technically	  challenging	   as	   a	   result	   of	   the	   fiber	   geometry.	   Thus,	   the	   creation	   of	   a	  multichannel	   FO-­‐SPR	   sensor	   has	   to	   be	   approached	   differently.	   In	   one	  approach,	   two	   SPR	   sensitive	   zones	   are	   created	   on	   one	   sensor	   by	  depositing	  different	  metal	  layers	  or	  those	  of	  different	  thicknesses	  on	  the	  respective	   SPR	   sensitive	   regions,	   which	   will	   have	   an	   SPR	   adsorption	  band	   at	   different	  wavelengths.	  Depositing	   an	   SPR	   sensitive	   zone	  using	  another	  metal	  such	  as	  for	  example	  silver	  can	  shift	  the	  SPR	  dip	  to	  lower	  wavelengths11	  while	  a	  thicker	  gold	   layer	  will	  shift	   the	  SPR	  dip	  towards	  higher	   wavelengths12	   (Figure	   8.1A).	   In	   practice	   this	   configuration	  results	  in	  two	  serially	  connected	  SPR	  sensors,	  which	  can	  be	  excited	  with	  a	   single	   light	   beam.	   The	   SPR	   signal	   has	   to	   have	   a	   clear	   wavelength	  division	   resulting	   in	   a	  multichannel	   FO-­‐SPR	   biosensor	   that	   can	   detect	  simultaneously	  multiple	  analytes.	  From	  Section	  1.4	  of	  Chapter	  1,	   it	  can	  be	  recalled	  that	  when	  a	  different	  SPR	  metal	  is	  used,	  light	  with	  the	  same	  angle	  of	  incidence	  can	  excite	  a	  surface	  plasmon	  wave	  (SPW)	  while	  with	  a	   different	  metal	   thickness,	   a	   different	   angle	   of	   incidence	   is	   needed	   to	  excite	  an	  SPW.	  
	  
Figure	   8.1:	   A)	   Schematic	   overview	   of	   the	  multichannel	   FO-­‐SPR	   sensing	   concept,	  
where	  coupling	  of	  the	  light	  with	  two	  different	  metals	  (metal	  1	  and	  metal	  2)	  results	  
in	   excitation	   of	   two	   SPR	   signals	   at	   different	   wavelengths.	   The	   expected	   sensor	  
signal,	   is	  shown	  below.	  B)	  Biofunctionalization	  approach	  of	  the	  dual	  channel	  FO-­‐
SPR	  sensor	  to	  immobilize	  unique	  biomolecules	  on	  each	  channel.	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The	   choice	   of	   the	   most	   appropriate	   metal	   and	   deposition	   layer	  thickness	  can	  be	   facilitated	  using	  mathematical	  models	   to	   theoretically	  determine	   the	  exact	  position	  of	   the	  SPR	  dip	   for	   each	  metal11.	  To	  allow	  comparison	   of	   measurements	   performed	   on	   different	   channels	   of	   the	  FO-­‐SPR	  biosensors,	  sensitivity	  of	  the	  channels	  towards	  refractive	  index	  (RI)	   shifts	   should	   be	   similar.	   This	   can	   be	   achieved	   by	   including	   RI	  sensitivity	   in	   the	   mathematical	   modeling.	   When	   appropriate	   SPR	  applicable	  metals	  are	  applied,	  signals	  of	  multiple	  measurement	  channels	  can	   easily	   be	   differentiated	   using	   a	   normal	   visible	   light	   spectrometer	  (Figure	  8.1,	  part	  A).	  The	  different	  metal	  layers	  can	  be	  deposited	  by	  using	  a	  mask	  to	  first	  cover	  sensing	  zone	  2,	  while	  metal	  1	  is	  deposited	  and	  visa	  versa	   for	   the	   second	   metal.	   Functionalization	   of	   each	   channel	   with	  different	   biomolecules	   can	   be	   done	   without	   complex	   technologies	   by	  simply	   using	   an	   intermediary	   oil	   layer	   to	   separate	   the	   two	   solutions	  with	  different	  biomolecules	  (Figure	  8.1,	  part	  B).	  	  However,	  resolving	  each	  measurement	  accurately	  when	  using	  more	  than	  two	  channels	  would	  be	  challenging	  with	  this	  approach.	  Therefore,	  to	  further	  extend	  the	  number	  of	  measurement	  channels,	  multiple	  optical	  fiber	   sensors	   can	   be	   assembled	   in	   one	   connector,	   creating	   what	   is	  known	   in	   optics	   as	   a	   fiber	   bundle.	   Fiber	   bundles	   are	   widely	   used	   for	  bioanalytical	   purposes.13.	   The	   FO-­‐SPR	   bundles	   would	   be	   simply	   a	  combination	  of	  different	  FO-­‐SPR	  sensors	  in	  one	  optical	  connector,	  which	  is	   illuminated	   by	   a	   single	   light	   source	   and	   imaged	   by	   a	   single	   CCD	  (Figure	   8.2).	   To	   resolve	   the	   SPR	   signal	   from	   the	   reflected	   light,	   the	  polychromatic	  light	  beam	  has	  to	  be	  split	  into	  the	  constituent	  wavelength	  components.	  This	  can	  be	  achieved	  with	  a	  grating.	  This	  step	  happens	   in	  the	   current	   FO-­‐SPR	   device	   in	   the	   spectrophotometer,	   which	   also	  contains	   a	   CCD.	   Therefore	   in	   this	   new	   configuration	   each	   FO-­‐SPR	  measurement	  channel	  would	  have,	   in	  comparison	  with	  the	  current	  FO-­‐SPR	   configuration,	   a	   much	   smaller	   detector	   for	   the	   same	   reflected	  signal,	   which	   would	   result	   in	   a	   lower	   sensitivity.	   Another	   possible	  problem	   in	   this	   configuration	   could	   be	   that	  molecular	   diffusion	  would	  be	   limited	   by	   the	   close	   packing	   of	   FO-­‐SPR	   sensors	   in	   one	   well.	   To	  exclude	   these	   effects	   of	   diffusion	   limitation	   and	   capillarity,	   the	   fiber	  bundles	  should	  contain	  a	   limited	  number	  of	   fibers,	  with	  2-­‐5	   fibers	   in	  a	  standard	  PCR	  tube	  having	  a	  diameter	  of	  6.4	  mm.	  
Chapter	  8:	  General	  conclusion	  and	  perspectives	  
194	  
Fibers	   could	   be	   manufactured	   and	   functionalized	   as	   described	   in	  this	  dissertation	  before	  being	  assembled	   in	   the	   fiber	  bundle.	  However,	  the	  bifurcated	  fiber,	  which	  is	  used	  in	  the	  current	  FO-­‐SPR	  design	  to	  guide	  light	   from	   the	   light	   source	   to	   the	   FO-­‐SPR	   sensor	   and	   back	   to	   the	  spectrophotometer,	   would	   become	   redundant	   when	   using	   the	   fiber	  bundle.	   This	  would	   allow	   further	  miniaturization	  of	   the	   entire	   FO-­‐SPR	  biosensor	   and	   even	  more	   importantly	  would	   considerably	   shorten	   the	  light	  path,	  potentially	  eliminating	  loss	  in	  signal,	  which	  requires	  use	  of	  a	  powerful	  light	  source	  in	  the	  current	  FO-­‐SPR	  setup.	  Combination	  of	  both	  multiplexing	   options	   would	   increase	   the	   number	   of	   measurement	  channels	  from	  two	  in	  the	  current	  FO-­‐SPR	  biosensor	  to	  twenty	  individual	  measurement	  channels.	  	  
	  
Figure	  8.2:	   Fiber	  bundle	   concept	   to	   increase	   the	  number	  of	  measuring	   channels	  
available	  on	  the	  FO-­‐SPR	  biosensor.	  
8.2.2	  Improving	  FO-­‐SPR	  bioassay	  throughput	  and	  sensitivity	  The	   longest	   DNA	   strands	   analyzed	   on	   the	   FO-­‐SPR	   biosensor	   in	   this	  thesis	  had	  a	  length	  of	  80bp.	  Increasing	  the	  length	  of	  targets	  would	  be	  of	  great	   interest	   for	   improving	   the	   throughput	   of	   the	   FO-­‐SPR	   assay.	  However,	   the	   SPR	   sensitivity	   decays	   exponentially	   with	   increasing	  distance	   from	   the	   surface14	   (one	   third	   the	  wavelength	   of	   excitation	   as	  described	  in	  Section	  1.4,	  Chapter	  1).	  Therefore,	  targets	  exceeding	  80bp	  cannot	   be	   analyzed	   with	   the	   same	   sensitivity	   as	   shorter	   targets.	  Excitation	   of	   long-­‐range	   surface	   plasmon	  waves,	   allows	   extending	   the	  penetration	  depth	  of	  the	  SPR	  signal	  up	  to	  a	  few	  micrometers15.	  As	  can	  be	  seen	   in	   Figure	   8.3,	   Long-­‐range	   Surface	   Plasmon	   (LRSP)	   waves	   are	  typically	   first	  excited	  along	  a	   thin	  gold	   layer,	  by	  embedding	   it	  between	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media	  with	  a	  similar	  refractive	  index	  (RI)16.	  This	  results	  in	  excitation	  of	  plasma	  waves	  on	  opposite	  sides	  of	  the	  thin	  metal,	  that	  are	  coupled	  and	  lead	  to	  an	  enhancement	  of	  the	  penetration	  depth	  of	  the	  surface	  plasmon	  wave	   (SPW).	   For	   biosensing	   implementations,	   this	   would	   require	   a	  material	  with	  a	  refractive	   index	  close	  to	  the	  sensing	  medium	  (typically	  1.33),	   which	   has	   to	   be	   deposited	   underneath	   the	   gold	   layer.	   The	  polymer	   Teflon	   AF	   (Dupont,	   Wilmington,	   Delaware,	   U.S.)	   is	   a	   good	  candidate	   because	   of	   its	   refractive	   index	   of	   approximately	   1.31	  resembling	   many	   biologic	   buffering	   solutions.	   Using	   this	   approach,	  several	  groups	  were	  able	  to	  reach	  a	  sensitivity	  and	  resolution	  similar	  or	  even	  better	  than	  the	  best	  known	  commercial	  SPR	  devices17.	  
	  
Figure	   8.3:	   Comparison	   between	   conventional	   SPR	   and	   long	   range	   (LR)	   SPR,	  
where	   the	   LR	   SPR	   penetrates	   the	   sample	   at	   a	   greater	   depth	   by	   introducing	   an	  
intermediary	  Teflon	  layer	  (SPW:	  surface	  plasmon	  wave,	  EW:	  evanescent	  wave,	  RI:	  
Refractive	  index)	  Better	  sensitivity	  towards	  longer	  DNA	  target	  strands	  is	  also	  possible	  by	   increasing	   the	   density	   of	   Au	   NP	   labels	   per	   strand.	   This	   can	   be	  achieved	  by	  using	  shorter	  hybridization	  probes	   immobilized	  on	  the	  Au	  NP	   surface.	  Not	   only	  will	   this	   result	   in	   an	   improved	   sensitivity	   for	   the	  target	   strand,	  but	   it	  will	   also	  allow	   increasing	  mutation	  discrimination	  capabilities.	   As	   was	   discussed	   in	   Section	   2.1	   of	   Chapter	   2,	   shorter	  hybridization	   probes	   are	   more	   sensitive	   towards	  mutations.	   However	  the	  organization	  of	  the	  Au	  NP	  labels	  when	  hybridized	  on	  the	  target	  DNA	  has	  to	  be	  carefully	  studied,	  such	  that	  Au	  NP	  labels	  will	  not	  influence	  the	  hybridization	   yield	   due	   to	   steric	   hindrance.	   Furthermore,	   location	  awareness	   can	   be	   obtained	   by	   choosing	   oligonucleotides	   of	   different	  length	  with	  distinctive	  melting	  temperatures,	  enabling	  to	  trace	  back	  the	  mutation	  by	  looking	  at	  Tm	  shifts	  of	  particular	  hybridization	  probes.	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Another	   option	   to	   increase	   the	   sensitivity	   of	   the	   FO-­‐SPR	   is	   an	  extensive	   optimization	   of	   the	   ionic	   components	   in	   the	   reaction	   buffer.	  The	   ionic	   concentration	   is	   crucial	   in	   any	  FO-­‐SPR	   assay,	   because	   of	   the	  dependence	  of	  Au	  NP	  stability,	  enzyme	  performance	  and	  hybridization	  rate.	   Previous	   research	   reports	   already	   have	   shown	   that	   a	   thorough	  optimization	  of	  these	  components	  can	  result	  in	  a	  considerable	  increase	  in	   assay	   sensitivity18.	   Here	   a	   comparison	   was	   made	   between	  monovalent	   (NaCl)	   and	   divalent	   (MgCl2)	   salts	   as	   components	   in	  hybridization	   buffers.	   The	   divalent	   salts	   consistently	   give	   a	   higher	  hybridization	   yields	   as	   a	   result	   of	   a	   better	   shielding	   of	   the	   negative	  charges	   of	   the	   DNA	   target	   molecule	   during	   hybridization	   on	   the	  negatively	  charged	  DNA	  coated	  surface,	  which	  also	  can	  be	  found	  on	  the	  FO-­‐SPR	  sensor.	  This	  results	  in	  a	  better	  mutation	  discrimination	  and	  in	  a	  better	  stabilization	  of	  long	  DNA	  duplexes	  (>80bp)	  on	  the	  surface.	  	  Finally,	   some	   types	   of	   mutations	   such	   as	   base	   pair	   neutral	  mutations,	  where	  a	  nucleotide	  is	  replaced	  with	  its	  complementary	  base	  and	   thus	   the	  G/C	   content	   remains	   the	   same,	  will	   result	   in	   only	   a	   very	  small	   shift	   in	   thermodynamic	   stability	   of	   the	  duplex19.	   To	   improve	   the	  mutation	  detection	  capabilities	  of	  the	  FO-­‐SPR	  assay	  in	  these	  situations,	  short	   oligonucleotides	   that	   have	   a	   considerable	   influence	   on	   the	  Tm	   of	  the	   reaction	   products	   can	   be	   used.	   These	   oligonucleotide	   labels	   are	  known	  as	  temperature	  tags.	  In	  Chapter	  2,	  an	  assay	  developed	  by	  Liao	  et	  al.	   used	   such	   to	   improve	   the	   multiplexing	   capacity	   of	   a	   DNA	   melting	  assay	   considerably20.	   In	   a	   similar	   fashion	   these	   tags	   could	   also	   be	  implemented	  on	  the	  FO-­‐SPR	  melting	  assay.	  The	  temperature	  tags	  can	  be	  ligated	   on	   the	   target	   sequence	  when	   containing	   a	   particular	  mutation.	  Because	   the	  Tm	   tag	  will	   shift	   the	  melting	   temperature	   of	   the	   target-­‐Tm	  tag	   complex	   to	   slightly	   higher	   or	   lower	   temperatures,	   closely	   related	  mutations	  can	  be	  more	  easily	  resolved	  (Figure	  8.4).	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Figure	   8.4:	   Improved	   FO-­‐SPR	   DNA	   sensing	   of	   closely	   related	   targets	   with	  
mutations	  that	  are	  normally	  very	  difficult	  to	  discriminate	  using	  DNA	  melting,	  but	  
resolved	  much	  easier	  when	  using	  Tm	  tags.	  The	  sensitivity	  of	   the	  FO-­‐SPR	  assay	   can	  also	  be	   influenced	  by	  non-­‐specific	   interactions	   of	   DNA	   probes,	   as	   is	   proven	   in	   Section	   6.4.4	   of	  Chapter	  6.	  Here	  the	  detection	  limit	  of	  the	   ligation	  assay	  was	  limited	  by	  the	   generation	   of	   a	   non-­‐specific	   signal	   due	   to	   probe	   interactions	   in	  absence	  of	  the	  target	  strands.	  Therefore,	  careful	  design	  of	  hybridization	  probes	   used	   in	   FO-­‐SPR	   DNA	   assays	   and	   selection	   of	   target	   sequences	  could	   substantially	   improve	   the	   assay	   performance.	   In	   recent	   years,	  considerable	   efforts	   have	  been	  made	   to	  develop	   algorithms	   capable	   of	  screening	  primer	  sequences	  to	  be	  combined	  in	  PCR21,22.	  Although	  these	  large-­‐scale	   primer	   design	   tools	   have	   been	   developed	   for	   sequencing,	  they	   could	   be	   adopted	   for	   FO-­‐SPR	   probe	   design.	   Better	   probe	   design	  would	  also	  exclude	  sequences	  prone	  to	  secondary	  structures	  formation,	  as	   they	   are	   known	   to	   slow	   down	   surface	   hybridization23.	   However,	   as	  mentioned	  in	  Chapter	  2,	  some	  secondary	  structures,	  such	  as	  a	  hairpins	  found	   in	  molecular	   beacons,	   are	   favorable	   for	   hybridization	   specificity	  and	   can	   even	   improve	   hybridization	   efficiency	   on	   secondary	   structure	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containing	  targets24.	  Therefore	  the	  design	  of	  an	  algorithm	  both	  capable	  of	   eliminating	   non-­‐specific	   interactions	   and	   unwanted	   secondary	  structures	   but	   at	   the	   same	   time	   allowing	   integration	   of	   desirable	  secondary	   structures,	   could	   further	   improve	   the	   robustness	   and	  performance	  of	  the	  FO-­‐SPR.	  
8.2.3	  Integration	  of	  FO-­‐SPR	  in	  POC	  test	  	  Current	  POC	  platforms	  for	  micro-­‐organisms	  struggle	  mostly	  with	  a	  cost-­‐benefit	   imbalance,	   especially	   for	   resource	   limited	   countries25,26.	  One	  of	  the	   main	   drivers	   in	   cost	   reduction	   is	   production	   scale.	   Consequently,	  dedicated	   instruments	   are	   very	   expensive	   as	   they	   are	   produced	   in	  relatively	   small	   numbers27.	   On	   the	   other	   hand,	   when	   using	   standard	  consumer	   electronic	   devices	   (CED)	   as	   a	   base	   for	   new	  POC	   biosensors,	  this	  problem	  could	  be	  overcome,	  which	  has	  been	  already	  proven	  by	  the	  development	   of	   several	   such	   functional	   platforms28,29.	   Additionally,	  these	   compact	   POC	   biosensors	   can	   thrive	   from	   the	   extensive	   features	  and	  continuously	  increasing	  capabilities	  of	  CEDs.	  One	   of	   the	   most	   promising	   CED	   biosensor	   platforms	   is	   a	  smartphone,	   as	   this	   device	  has	   the	  most	   extensive	  number	  of	   features	  among	  all	   available	  CEDs30.	  Owing	   to	   these	   features,	   it	  was	  possible	   to	  implement	  complex	  analytical	  devices	  such	  as	  fluorescence	  microscopy	  on	  a	  smartphone31.	  In	  a	  similar	  engineering	  effort,	  Preechaburana	  et	  al.	  tried	  to	  integrate	  angle	  resolved	  SPR	  on	  a	  smartphone32.	  They	  designed	  a	   disposable	   optical	   coupling	   device,	   which	   could	   be	   attached	   to	   the	  smartphone	  screen	  and	  camera	  (Figure	  8.5,	  part	  A).	  This	  optic	  coupler	  guided	  light	  from	  the	  smartphone	  screen	  to	  a	  gold	  sensor	  surface	  where	  an	   SPR	   signal	   was	   generated.	   Reflected	   light	   passed	   then	   through	   the	  optical	   coupler	   and	  was	   transported	   to	   the	   camera	   of	   the	   smartphone	  where	  the	  SPR	  adsorption	  angle	  was	  monitored	  (Figure	  8.5,	  part	  B).	  The	  researchers	  noticed	  that	  existing	  smartphone	  components	  (such	  as	  light	  source	  and	  camera)	  are	  well	  suited	  for	  SPR	  and	  as	  a	  result	  require	  fewer	  adaptations	   than	   for	   fluorescence	   measurements.	   The	   created	   SPR	  biosensor	   reached	   a	   sensitivity	   of	   11x10-­‐3	   refractive	   index	   units	   per	  degree	   change	   in	   angle	   (RIU/°),	  which	  was	   approximately	   4	   orders	   of	  magnitude	   lower	   than	   the	   best	   performing	   commercial	   devices.	  However,	   this	   sensitivity	   sufficed	   to	   perform	   an	   antibody	   based	  bioassay	   for	   the	   protein	   β2-­‐microglobulin,	   which	   is	   an	   unspecific	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predictive	  biomarker	  used	  for	  evaluating	  disease	  state	  and	  progression	  in	   several	   pathologies	   such	   as	   cancer	   (lymphoma),	   inflammation	   and	  kidney	  disease,	  with	  a	  detection	  limit	  that	  is	  sufficient	  to	  discriminate	  a	  state	  of	  disease	  (0.1	  µg/mL).	  Further	  improvements	  of	  the	  smartphone	  SPR	   implementation,	   by	   using	   the	   complete	   resolution	   capabilities	   of	  the	  standard	  smartphone	  Video	  Graphics	  Array	  camera,	  better	  known	  as	  VGA	  with	   a	   resolution	   of	   640	   pixels,	  would	   allow	   in	   theory	   to	   reach	   a	  sensitivity	   of	   2.96x10-­‐7	   RIU/°,	   which	   approximates	   a	   table	   top	   SPR	  device17.	   A	   similar	   adaptation	   could	   be	   manufactured	   for	   the	   FO-­‐SPR	  device	  with	  the	  most	  challenging	  part	  being	  the	  integration	  of	  a	  heating	  element	  for	  performing	  the	  melting	  analysis.	  	  
	  
Figure	   8.5:	   A)	   Smartphone	   implementation	   of	   angle-­‐resolved	   SPR	   where	   the	  
smartphone	   screen	   is	   used	   for	   illumination	   and	   the	   front	   camera	   as	   a	   detector	  
optically	   coupled	   by	   disposable	   device	   with	   integrated	   lab	   on	   a	   chip	   (LOC)	   for	  
sample	   handling.	   b)	   2D	   drawing	   of	   the	   experimental	   arrangement	   showing	   the	  
light	  path	  from	  screen	  to	  camera	  (from	  Preechaburana	  et	  al.32)	  In	  conclusion,	  numerous	  options	  are	  available	   to	  both	   improve	   the	  FO-­‐SPR	  hardware	  and	  the	  implemented	  DNA	  melting	  assay.	  As	  a	  result,	  the	  FO-­‐SPR	  DNA	  melting	  assay	  has	  great	  potential	  to	  become	  a	  valuable	  POC	   biosensor	   that	   combines	   a	   simple	   assay	   format	   with	   good	  specificity	  and	  sensitivity	  at	  an	  affordable	  price.	  	  
Chapter	  8:	  General	  conclusion	  and	  perspectives	  
200	  
References	  1.	   D.	  Mabey,	  R.	  W.	  Peeling,	  A.	  Ustianowski	  and	  M.	  D.	  Perkins,	  Nat.	  
Rev.	  Micro.,	  2004,	  2,	  231-­‐240.	  2.	   R.	   S.	   Wallis,	   M.	   Pai,	   D.	   Menzies,	   T.	   M.	   Doherty,	   G.	   Walzl,	   M.	   D.	  Perkins	  and	  A.	  Zumla,	  Lancet,	  2010,	  375,	  1920-­‐1937.	  3.	   A.	   Niemz,	   T.	   M.	   Ferguson	   and	   D.	   S.	   Boyle,	   Trends	   Biotechnol.,	  2011,	  29,	  240-­‐250.	  4.	   F.	  Aarestrup,	  Nature,	  2012,	  486,	  465-­‐466.	  5.	   M.	  Blaser,	  Nature,	  2011,	  476,	  393-­‐394.	  6.	   S.	  Sauer	  and	  M.	  Kliem,	  Nat.	  Rev.	  Microbiol.,	  2010,	  8,	  74-­‐82.	  7.	   N.	  J.	  Loman,	  et	  al.,	  Nat.	  Rev.	  Microbiol.,	  2012,	  10,	  599-­‐606.	  8.	   D.	  A.	  Giljohann	  and	  C.	  A.	  Mirkin,	  Nature,	  2009,	  462,	  461-­‐464.	  9.	   H.	   J.	   Chung,	   C.	  M.	   Castro,	   H.	   Im,	   H.	   Lee	   and	   R.	  Weissleder,	  Nat.	  
Nanotechnol.,	  2013,	  8,	  369-­‐375.	  10.	   G.	  J.	  Wegner,	  A.	  W.	  Wark,	  H.	  J.	  Lee,	  E.	  Codner,	  T.	  Saeki,	  S.	  Fang	  and	  R.	  M.	  Corn,	  Anal.	  Chem.,	  2004,	  76,	  5677-­‐5684.	  11.	   Y.	   Yuan,	   L.	   Wang	   and	   J.	   Huang,	   Sens.	   Actuators,	   B,	   2012,	   161,	  269-­‐273.	  12.	   A.	   D.	   Taylor,	   J.	   Ladd,	   Q.	   Yu,	   S.	   Chen,	   J.	   Homola	   and	   S.	   Jiang,	  
Biosens.	  Bioelectron.,	  2006,	  22,	  752-­‐758.	  13.	   D.	  R.	  Walt,	  Chem.	  Soc.	  Rev.,	  2010,	  39,	  38-­‐50.	  14.	   M.	  Vala,	  S.	  Etheridge,	  J.	  A.	  Roach	  and	  J.	  Homola,	  Sens.	  Actuators,	  B,	  2009,	  139,	  59-­‐63.	  15.	   M.	   Vala,	   R.	   Robelek,	   M.	   Bockova,	   J.	   Wegener	   and	   J.	   Homola,	  
Biosens.	  Bioelectron.,	  2013,	  40,	  417-­‐421.	  16.	   K.	  Matsubara,	  S.	  Kawata	  and	  S.	  Minami,	  Opt.	  Lett.,	  1990,	  15,	  75-­‐77.	  17.	   J.	  Homola,	  Chem	  Rev,	  2008,	  108,	  462-­‐493.	  18.	   T.	   Springer,	   H.	   Sipova,	   H.	   Vaisocherova,	   J.	   Stepanek	   and	   J.	  Homola,	  Nucleic	  Acids	  Res.,	  2010,	  38,	  7343-­‐7351.	  19.	   C.	  N.	  Gundry,	  et	  al.,	  Nucleic	  Acids	  Res.,	  2008,	  36,	  3401-­‐3408.	  20.	   Y.	  Liao,	  X.	  Wang,	  C.	  Sha,	  Z.	  Xia,	  Q.	  Huang	  and	  Q.	  Li,	  Nucleic	  Acids	  
Res.,	  2013.	  21.	   S.	   Weckx,	   P.	   De	   Rijk,	   C.	   Van	   Broeckhoven	   and	   J.	   Del-­‐Favero,	  
Bioinformatics,	  2005,	  21,	  385-­‐387.	  22.	   K.	  Li,	  et	  al.,	  BMC	  Bioinformatics,	  2008,	  9,	  191.	  23.	   Y.	  Gao,	  L.	  K.	  Wolf	  and	  R.	  M.	  Georgiadis,	  Nucleic	  Acids	  Res.,	  2006,	  
34,	  3370-­‐3377.	  24.	   D.	  Y.	  Zhang,	  S.	  X.	  Chen	  and	  P.	  Yin,	  Nat.	  Chem.,	  2012,	  4,	  208-­‐214.	  
References	  
201	  
25.	   C.	  C.	  Boehme,	  et	  al.,	  N.	  Engl.	  J.	  Med.,	  2010,	  363,	  1005-­‐1015.	  26.	   C.	  A.	  Evans,	  PLoS	  Med,	  2011,	  8,	  e1001064.	  27.	   D.	  Figeys	  and	  D.	  Pinto,	  Anal.	  Chem.,	  2000,	  72,	  330A-­‐335A.	  28.	   S.	  A.	  Lange,	  et	  al.,	  Angew.	  Chem.	  Int.	  Ed.	  Engl.,	  2005,	  45,	  270-­‐273.	  29.	   Y.	  Li,	  L.	  M.	  Ou	  and	  H.	  Z.	  Yu,	  Anal.	  Chem.,	  2008,	  80,	  8216-­‐8223.	  30.	   D.	  Gallegos,	  et	  al.,	  Lab	  Chip,	  2013,	  13,	  2124-­‐2132.	  31.	   I.	  Navruz,	  et	  al.,	  Lab	  Chip,	  2013.	  32.	   P.	   Preechaburana,	   M.	   C.	   Gonzalez,	   A.	   Suska	   and	   D.	   Filippini,	  




203	  	  	  
Publications	  
1.1 Articles	  in	  internationally	  reviewed	  academic	  journals	  
Knez,	   K.,	   Spasic,	   D.,	   Janssen,	   K.,	   Lammertyn,	   J.	   (2013),	   Emerging	  technologies	   for	   hybridization	   based	   single	   nucleotide	   polymorphism	  detection.	  Analyst.	  (in	  press)	  
Knez,	   K.,	  Noppe,	   W.,	  Geukens,	   N.,	  Janssen,	   K.,	  Spasic,	   D.,	  Heyligen,	  J.,	  Vriens,	  K.,	  Thevissen,	  K.,	  Cammue,	  B.,	  Petrenko,	  V.,	  Ulens,	  C.,	  Deckmyn,	  H.,	  Lammertyn,	   J.	  (2013).	  Affinity	   comparison	   of	   p3	   and	   p8	   peptide	  displaying	   bacteriophages	   using	   surface	   plasmon	   resonance.	  Analytical	  
Chemistry.	  (in	  press)	  
Knez,	   K.,	  Janssen,	   K.,	  Spasic,	   D.,	  Declerck,	   P.,	  Vanysacker,	   L.,	  Denis,	  C.,	  Tran,	   T.,	  Lammertyn,	   J.	  (2013).	  Spherical	   Nucleic	   Acid	   enhanced	   FO-­‐SPR	  DNA	  melting	  for	  detection	  of	  mutations	  in	  Legionella	  pneumophila.	  
Analytical	  Chemistry,	  85	  (3),	  	  1734-­‐1742.	  
Knez,	   K.,	  Janssen,	   K.,	  Pollet,	   J.,	  Spasic,	   D.,	  Lammertyn,	   J.	  (2012).	  Fiber	  optic	   high-­‐resolution	   genetic	   screening	   using	   gold-­‐labeled	   gene	  probes.	  Small,	  8	  (6),	  868-­‐872.	  Tran,	  T.*,	  Knez,	  K.*,	  Janssen,	  K.,	  Pollet,	  J.,	  Spasic,	  D.,	  Lammertyn,	  J.	  (2013)	  Selection	  of	  aptamers	  against	  Ara	  h	  1	  protein	  for	  FO-­‐SPR	  biosensing	  of	  peanut	  allergens	  in	  food	  matrices	  (*	  Tran	  T.	  and	  Knez	  K.	  are	  joint	  first	  author).	  Biosensors	  &	  Bioelectronics,	  43,	  245-­‐251.	  Janssen,	  K.,	  Knez,	   K.,	  Spasic,	  D.,	  Lammertyn,	   J.	  (2013).	  Nucleic	   acids	   for	  ultra-­‐sensitive	  protein	  detection.	  Sensors,	  13,	  	  898-­‐930.	  
Publications	  
204	  	  	  
Ceyssens,	   F.,	  Witters,	   D.,	  Van	   Grimbergen,	   T.,	  Knez,	   K.,	  Lammertyn,	  J.,	  Puers,	  B.	  (2013).	  Integrating	  optical	  waveguides	  in	  electrowetting-­‐on-­‐dielectric	   digital	   microfluidic	   chips.	  Sensors	   and	   Actuators	   B,	  
Chemical,	  181,	  166-­‐171.	  Witters,	   D.,	  Knez,	   K.,	  Ceyssens,	   F.,	  Puers,	   B.,	  Lammertyn,	   J.	  (2013).	   	  Digital	   microfluidics-­‐enabled	   single-­‐molecule	   detection	   by	  printing	  and	  sealing	  single	  magnetic	  beads	  in	  femtoliter	  droplets.	  Lab	  on	  
a	  Chip,	  13	  (11),	  2047-­‐2054.	  Janssen,	   K.,	  Knez,	   K.,	  Spasic,	   D.,	  Schrooten,	   J.,	  Lammertyn,	  J.	  (2012).	   	  Multiplexed	   protein	   detection	   using	   an	   affinity	   aptamer	  amplification	   assay.	  Analytical	   and	   Bioanalytical	   Chemistry,	  404	  (6-­‐7),	  2073-­‐2081.	  Delport,	   F.,	  Pollet,	   J.,	  Janssen,	   K.,	  Verbruggen,	   B.,	  Knez,	   K.,	  Spasic,	  D.,	  Lammertyn,	   J.	  (2012).	  Real-­‐time	   monitoring	   of	   DNA	   hybridization	  and	   melting	   processes	   using	   a	   fiber	   optic	  sensor.	  Nanotechnology,	  23	  (6),	  065503.	  Janssen,	   K.,	  Knez,	   K.,	  Vanysacker,	   L.,	  Schrooten,	   J.,	  Spasic,	  D.,	  Lammertyn,	   J.	  (2012).	  Enabling	   fiber	   optic	   serotyping	   of	   pathogenic	  bacteria	   through	   improved	   anti-­‐fouling	   functional	  surfaces.	  Nanotechnology,	  23	  (23),	  art.nr.NANO/425045/PAP.	  Janssen,	   K.,	  Knez,	   K.,	  Pollet,	   J.,	  Roberts,	   S.,	  Schrooten,	   J.,	  Lammertyn,	  J.	  (2011).	  Assay	   design	   considerations	   for	   use	   of	   affinity	   aptamer	  amplification	   in	   ultra-­‐sensitive	   protein	   assays	   using	   capillary	  electrophoresis.	  Analytical	  methods,	  3,	  2156-­‐2159.	  Pollet,	   J.,	  Janssen,	   K.,	  Knez,	   K.,	  Lammertyn,	   J.	  (2011).	  Real-­‐Time	  Monitoring	  of	  Solid-­‐Phase	  PCR	  Using	  Fiber-­‐Optic	  SPR.	  Small,	  7	  (8),	  1003-­‐1006.	  
1.2 Papers	   at	   international	   scientific	   conferences	   and	  
symposia,	  published	  in	  full	  in	  proceedings	  Witters,	   D.,	  Knez,	   K.,	  Janssen,	   K.,	  Verbruggen,	   B.,	  Puers,	   B.,	  Lammertyn,	  J.	  (2012).	  High-­‐Throughput	   Patterning	   of	   Single	   Magnetic	   Beads	   Using	  
Publications	  
205	  	  	  
Digital	   Microfluidic	   Technology.	  .	  MicroTAS	   2012.	  Okinawa,	   Japan,	  28	  October-­‐1	  November	  2012.	  Vermeir,	   S.,	  Witters,	   D.,	  Vergauwe,	   N.,	  Knez,	   K.,	  Gijs,	   M.,	  Puers,	  B.,	  Lammertyn,	   J.	  (2012).	  Ferromagnetic	   particles	   for	   an	   improved	  heterogeneous	   bioassay	   performance	   on	   a	   digital	   lab-­‐on-­‐a-­‐chip.	  .	  Microtas2012.	  Okinawa,	  Japan,	  28	  October-­‐1	  November,	  2012.	  
1.3 Meeting	   abstracts,	   presented	   at	   international	   scientific	  
conferences	   and	   symposia,	   published	  or	  not	  published	   in	  
proceedings	  or	  journals	  
Knez,	   K.,	  Janssen,	   K.,	  Spasic,	   D.,	  Lammertyn,	   J.	  (2012).	  Real-­‐time	  monitoring	  of	  solid-­‐phase	  PCR	  and	  point	  mutation	  screening	  using	  fiber	  optic	   biosensor.	  Biosensors.	  Cancún,	  15-­‐18	   may	   2012,	   Abstract	  No.	  BIOS2012_054.	  Arghir,	   I.,	  Knez,	   K.,	  Janssen,	   K.,	  Pollet,	   J.,	  Lammertyn,	   J.,	  Spasic,	  D.	  (2012).	  Nanostructuring	   Optical	   Surfaces	   towards	   FO–SPR	  Biosensors	   with	   Improved	   Performances.	  International	   Conference	   on	  Scientific	   and	   Clinical	   Applications	   of	   Magnetic	   Carriers.	  Minneapolis,	  MN,	  USA,	  22-­‐26	  May	  2012.	  Pollet,	   J.,	  Knez,	   K.,	  Janssen,	   K.,	  Spasic,	   D.,	  Lammertyn,	   J.	  (2012).	  Fiber	  optic	  SPR	  assay	  for	  enhanced	  real-­‐time	  PCR	  analysis	  of	  non-­‐transparent	  samples.	  ACS	  National	  Meeting.	  San	  Diego,	  March	  25-­‐29,	  2012.	  Janssen,	   K.,	  Pollet,	   J.,	  Knez,	   K.,	  Lammertyn,	   J.	  (2011).	  Real-­‐Time	  Monitoring	   of	   Solid	   Phase	   PCR	   using	   Fiber-­‐Optic	   SPR.	  International	  Conference	   on	   Bio-­‐Sensing	   Technology	   2011.	  Amsterdam,	  10-­‐12	  October	  2011,	  Abstract	  No.	  0056.	  
Knez,	   K.,	  Janssen,	   K.,	  Pollet,	   J.,	  Tran,	   T.,	  Delport,	   F.,	  Lammertyn,	  J.	  (2011).	  Improving	   solid	   phase	   PCR	   on	   gold	   surfaces	   by	   means	   of	  alkanethiol	   backfilling.	  Hybrid	   Materials	   2011.	  Straßburg,	  6-­‐10	   March	  2011.	  Delport,	   F.,	  Knez,	   K.,	  Tran,	   T.,	  Janssen,	   K.,	  Pollet,	   J.,	  Sels,	   B.,	  Hofkens,	  J.,	  Lammertyn,	  J.	  (2011).	  Binding	  Strategies	  to	  carboxyl	  nanoparticles	  for	  
Publications	  
206	  	  	  
high	   performance	   DNA	   hybridization	   bio-­‐assays.	  Multifunctional,	  Hybrid	  and	  Nanomaterials.	  Strasbourg,	  6-­‐10	  March	  2011.	  	  	  	  
